SKPD :
KABUPATEN :
PROVINSI : SULAWESI TENGARA
626 78 48,828 0
Antasida, kombinasi : aluminium hidroksida 200
18 mg + magnesium hidroksida 200 mg Suspensi Botol 0 2,213 -
0 2,213 - 0
0 0
Antibakteri, kombinasi : basitrasin 500 UI/g+
19 Polimiskin B 10.000 UI/g Tube 7 2,767 19,369
10 2,200 22,000 0
Anti Parkinson kombinasi : benzerasid 25 mg +
22 Kaps -
levodopa 100 mg
Anti Migren, kombinasi : ergotamin 1 mg+ kafein
23 Tab 7 149 1,043
50 mg
100 149 14,900 0
24 Antalgin (metampirom) tablet 100 mg Tab 0 155 -
25 Antalgin (metampirom) injeksi 250 mg/ml-2 ml Ampul 0 1,346 -
26 Asam asetilsalisilat (asetosal) tab 100 mg Tab 60 110 6,600
1000 127 127,000 0
27 Asam asetilsalisilat (asetosal) tab 500 mg Tab 0 178 -
28 Asam asetilsalisilat (asetosal) tab 80 mg (Miniaspi Tab -
29 80)
Asam askorbat (vitamin C) tab 50 mg Tab 0 105 -
0 105 - 0
30 Asam folat tab 1 mg Tab 0 52 -
1000 52 52,000 0
5 15,386 76,930
Mengetahui
Kepala Puskesmas Rumbia
Rahmat, AMK
Nip. 19721021 199403 1 004
Mutasi Masuk Mutasi Pengeluaran Saldo Akhir
Obat Puskesmas bulan januari Per 31 Desember 2015
Harga Satuan Nilai ( Rp) Jumlah Harga Satuan Nilai (Rp) Jumlah Harga Satuan
10 11 7 8 12
1,499 - - 0
78 - 0 78 - 0 78
1,650 - - 0
- - 0
127 - 0 127 - 0 127
127 - 0 127 - 0 127
127 - 840 127 106,680 1280 127
3,650 - 0 3,650 - 25 3,650
55 - 0 73 - 0 73
55 - 520 55 28,600 55
22,727 - 0 22,727 - 0 22,727
22,727 - 0 22,727 - 4 22,727
1,596 - 0 1,596 - 0 1,596
1,596 - 30 1,596 47,880 56 1,596
600 - - 0
6,045 - - 0
4,990 - - 0
- - 0
110,500 - - 0
423 - 42 - 0 42
68 - 0 68 - 0 68
68 - 350 68 23,800 2720 68
3,000 - - 0
31 - 0 31 - 0 31
31 - 0 31 - 0 31
31 - 386 31 11,966 11780 31
5,867 - - 0
660 - - 0
5,720 - 0 5,720 - 38 5,720
6,270 - 0 6,270 - 15 6,270
6,270 - - 0
230 - 0 230 - 0 230
230 - 5 230 1,150 120 230
62 - 0 62 - 0 62
76 - 0 76 - 0 76
76 - 0 76 - 200 76
105 - 105 - 0 105
105 - 0 105 - 0 105
105 - 0 105 - 0 105
38,500 - 38,500 - 0 38,500
40 - 0 40 - 0 40
40 - 90 40 3,600 4500 40
2,938 - - 0
330 - 0 330 - 0 330
3,849 - 0 4,949 - 0 4,949
121 - 62 127 7,877 210 127
121 - 0 121 - 500 121
157 - 0 157 - 0 157
157 - 240 157 37,680 310 157
90,000 - - 0
174 - - 0
36,960 - - 0
98 - 98 - 0 98
98 - 0 98 - 160 98
10,000 - 10,000 - 17 10,000
7,800 - 9,519 - 20 9,519
76 - 0 51 - 0 51
76 - 0 76 - 0 76
76 - 310 76 23,560 320 76
69 - 69 - 0 69
69 - 300 69 20,700 1670 69
0 97 - 0 97
97 - 0 97 - 0 97
269 - - 0 269
- - 0
63,400 - 110,000 - 0 110,000
320 - 0 320
320 - 0 320 - 220 320
5,150 - 0 5,150 - 0 5,150
5,150 - 1 5,150 5,150 0 5,150
2,665 - 2,665 - 0 2,665
2,665 - 0 2,665 - 90 2,665
3,600 - - 0
0 405 - 0 405
-
1,680 - - 0 1,680
20 275 5,500 90 275
275 - 275
1,680 - 0 1,680 - 0 1,680
1,680 - 0 1,680 - 19 1,680
4,016 - 0 4,016 - 14 4,016
26 - 0 26 - 0 26
26 - 0 26 - 0 26
26 - 426 26 11,246 6639 26
1,210 - 0 1,210 - 0 1,210
162 - 152 - 0 152
75 - 0 50 - 94 50
5,990 - - 0
79 - 0 79 - 0 79
79 - 0 79 - 480 79
- - 0 6,820
6,820 - 0 6,820
116 - 112 - 0 112
521 - - 0
581 - 581 - 0 581
40,000 - - 0
929 - 0 1,499 - 0 1,499
929 - 0 1,499 - 0 1,499
929 - 0 1,499 - 0 1,499
54,995 - 0 54,995 - 0 54,995
54,995 - 0 54,995 - 0 54,995
97 - 97 - 0 97
97 - 0 97 - 205 97
170 - 170 - 0 170
7,260 - 7,260 - 0 7,260
7,260 - 1 7,260 7,260 7,260
7,260 - 7,260 - 0 7,260
7,260 - 0 7,260 - 20 7,260
1,130 - 1,130 - 0 1,130
3,887 - 3,887 - 0 3,887
248 - 0 248 - 90 248
125 - - 0
280 - - 0
2,750 - 0 1,639 - 0 1,639
169 - 0 133 - 80 133
230 - - 0
1,100 - 0 1,100 - 0 1,100
1,100 - 0 1,100 - 0 1,100
1,100 - 5 1,100 5,500 1 1,100
2,900 - - 0
- 0 40,202
40,202 - 40,202
530 98 51,675 314 98
98 - 0 98
125 - 0 125 - 985 125
12,021 - 12,021 - 0 12,021
12,021 - 17 12,021 204,357 2 12,021
351 - 297 - 200 297
114 - 0 80 - 90 80
1,340 - - 0
128 - 0 128 - 0 128
128 - 570 128 72,960 480 128
968 - - 0
440 - 440 - 0 440
624 - 624 - 0 624
863 - 863 - 0 863
5,720 - 0 5,720 - 0 5,720
5,720 - 38 5,720 217,360 26 5,720
65 - 0 92 - 0 92
65 - 0 65 - 0 65
65 - 30 65 1,950 320 65
93 - 0 93 - 0 93
93 - 80 93 7,440 710 93
76 - 57 - 0 57
116 - 0 116
572 - 0 572
193 - 191 - 100 191
- 0 275
275 - 0 0 275
162 - - 0 162
1,109 - 0 1,108 - 0 1,108
1,109 - 0 1,109 - 0 1,109
162 - - 0 162
112 - 116 - 0 116
167 - - 0 167
125 - - 0 125
318 - - 0 318
109 - - 0 109
45 - - 0 45
854 - 854 - 0 854
22,727 - - 0 22,727
480 - - 0 480
31 - 31 - 0 31
56 - - 0 56
- - 0
- 0 765,000
765,000 - 0 765,000
242,000 - - 0 242,000
- 0 338,800
338,800 - 0 338,800
390,000 - 0 390,000 - 0 390,000
390,000 - 0 390,000 - 0 390,000
18,333 - 0 18,333 34,610 0 18,333
18,333 - 0 18,333 - 0 18,333
105,000 - 1 105,000 0 105,000
105,000 - 0 105,000
170,000 - - 0 170,000
197,895 - 395,000 - 0 395,000
197,895 - 1 197,895 0 197,895
55,000 - - 1 55,000
93,500 - 93,500 - 0 93,500
93,500 - 0 93,500 - 2 93,500
34,000 - 0 34,000
34,000 - 0 34,000
176,000 - 176,000 - 0 176,000
- - 0
363 - 425 - 0 425
24,384 - - 0 24,384
27,569 - 27,569 - 0 27,569
27,569 - 27,569 - 8 27,569
104 - 104 - 0 104
104 - 0 104 - 2000 104
825,000 - - 0 825,000
4,545 - - 0 4,545
236,490 - 236,490 - 0 236,490
396,000 - 396,000 - 0 396,000
1,319,990 - 1,319,990 - 0 1,319,990
175,990 - 175,899 - 0 175,899
145,000 - - 0 145,000
150,000 - - 0 150,000
168,300 - - 0 168,300
46,200 - - 0 46,200
45,560 - - 0 45,560
42,350 - - 0 42,350
20,454 - - 0 20,454
- 4,438 - 0 4,438
- - 0
- - 0
- - 0
- - 0
- - 0
285,000 - - 0 285,000
Penanggung Jawab
Laporan
30,800
-
-
-
25,725
-
-
81,834
-
122,490
-
8,600
-
12,300
-
-
-
-
-
194,560
-
-
77,000
-
-
298,530
13,260
-
-
19,369
27,248
1,043
14,900
-
-
6,600
127,000
-
-
-
-
-
36,400
-
-
-
162,560
91,250
101,200
349,800
-
-
47,600
-
-
-
17,550
-
-
90,908
-
89,376
-
-
-
-
-
-
184,960
128,612
-
29,949
-
136,634
-
-
-
2,380
-
54,520
10,300
-
-
36,660
-
-
52,350
-
90,480
-
6,720
126,000
267,300
438,480
371,469
506,385
-
-
-
231,000
-
4,695
-
-
21,080
-
-
14,600
-
178,200
-
-
69,800
-
-
-
78,468
-
44,520
-
-
-
-
-
-
-
69,043
-
-
19,520
-
-
-
365,180
-
-
217,360
94,050
-
-
27,600
-
-
15,200
-
-
-
-
-
180,000
-
-
-
26,681
60,500
-
48,670
-
-
-
-
15,680
170,000
190,380
-
-
24,320
-
115,230
-
-
-
-
-
-
70,400
-
-
-
239,850
-
-
-
-
24,750
-
-
31,920
56,224
-
-
175,270
-
-
4,700
-
392,616
37,920
16,086
-
-
-
-
-
-
-
-
-
-
-
-
19,885
-
-
-
-
145,200
-
-
22,320
-
-
-
10,648
-
-
-
1,100
8,400
-
-
116,820
-
41,760
-
99,372
-
107,100
-
-
41,610
-
-
-
79,130
-
-
180,950
-
119,888
85,120
-
90,090
-
-
28,000
-
-
-
123,450
-
404,712
-
36,100
-
-
-
-
319,370
-
-
30,700
-
10,500
-
-
83,160
-
-
-
-
29,700
-
50,700
85,600
-
-
241,000
-
111,020
-
-
-
-
-
-
-
22,040
-
-
-
100,792
61,544
-
30,615
-
123,125
-
24,042
59,400
7,200
-
-
61,440
-
-
-
-
-
148,720
-
-
20,800
-
66,030
-
39,600
-
-
-
-
-
317,160
-
-
-
-
-
-
-
-
-
-
-
-
-
70,000
-
-
-
-
-
115,500
-
-
-
-
-
-
11,616
-
7,200
-
-
-
-
156,800
-
-
-
-
97,680
-
13,950
62,370
-
141,000
-
-
-
-
19,100
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
55,000
-
187,000
-
-
-
-
-
-
-
220,552
-
208,000
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
109,424
-
84,825
-
-
60,226
-
303,413
-
216,300
-
159,600
160,000
622,080
-
648,000
-
-
-
-
-
92,208
-
79,344
24,000
-
-
-
70,083
-
-
261,921
194,675
-
-
-
-
-
-
-
-
27,821
-
-
-
-
299,929
-
-
-
-
-
-
92,547
-
-
-
-
65,000
-
212,625
-
788,802
-
-
-
-
-
1,154,000
398,130
1,148,230
-
1,154,000
-
-
-
-
3,375
-
601,350
-
-
-
9,031,908
22,026,203
REKAPAN PENGGUNAAN OBAT DAN PERBE
PUSKESMAS SELAMA 1 TAHUN
TAHUN 2016
1 Air untuk injeksi amp 25 ml (aqua pro injeksi) Ampul 0 6,050 - 6,050
0 2,200 - 10 2,200
83 Fitomenadion (vitamin K 1) tab sal 10 mg Tab sal 100 698 69,800 698
317 317
104 Glukosa Larutan Infus 10% steril Botol 15 6,270 94,050 6,270
122 Kalsium glukonat inj 100 mg/ml Ampul 20 9,519 190,380 9,519
0 152 - 152
2583 152 392,616 152
480 79 37,920 79
179 Nistatin tab vaginal 100.000 UI Tab 190 448 85,120 448
Botol 300
205 Povidon iodin lar 100 mg/ml 0 15,386 - 15,386
ml
4 15,386 61,544 15,386
Botol 1000
206 Povidon iodin lar 100 mg/ml 0 40,202 - 40,202
ml
40,202 - 40,202
230 Sianokobalamin (vitamin B12) inj 500 mcg/ml Vial 0 1,451 - 1,451
231 Sianokobalamin (vitamin B12) tab 50 mcg Tab 0 150 - 150
245 Tiamin (vitamin B1) injeksi 100 mg/ml Tab 0 770 - 770
B.OBAT GIGI 0 -
1 Bonding Botol 0 765,000 - 765,000
0 765,000 - 765,000
C.OBAT PROGRAM 0 -
1 Albedazole 400mg Tab 0 425 - 425
2 Artemether inj 80 mg/ml Ampul 0 24,384 - 24,384
3 Artesunat serb inj 60 mg/ml (i.v./i.m.) Vial 0 27,569 - 27,569
8 27,569 220,552 27,569
38 Sofratulle Set 0 -
Mengetahui
Kepala Puskesmas Rumbia
Rahmat, AMK
Nip. 19721021 199403 1 004
AN OBAT DAN PERBEKES
SELAMA 1 TAHUN
UN 2016
BULAN : JANUARI
TAHUN : 2016
- 6,050 - 0 6,050 -
- 123 - 0 123 -
- 123 - 100 123 12,300
- - 0 -
- 1,863 - 0 1,863 -
- - 0 -
- - 0 -
- - 0 -
- 2,560 - 0 2,560 -
- 2,560 - 0 2,560 -
- 2,560 - 0 2,560 -
153,600 33 2,560 84,480 103 2,560 263,680
- - 0 -
- 220 - 0 220 -
- 220 - 0 220 -
- 210 220 46,200 140 220 30,800
- - 0 -
- 279 - 0 279 -
- 279 - 0 279 -
- 970 279 270,630 100 279 27,900
- - 0 -
- - 0 -
- - 0 -
- 78 - 0 78 -
- 2,213 - 0 2,213 -
- 2,213 - 0 2,213 -
- - 0 -
- - 0 -
- - 0 -
- 33,000 - 0 33,000 -
- - 0 -
- - 0 -
- 1,265 - 0 1,265 -
- - 0 -
- 251 - 0 251 -
25,100 100 251 25,100 0 251 -
- - 0 -
- 1,400 - 34 1,400 47,600
- - 0 -
- 81 - 0 81 -
- - 0 -
- - 0 -
- - 0 -
- 1,180 - 0 1,180 -
13,500 10 1,350 13,500 13 1,350 17,550
- - 0 -
- 73 - 0 73 -
- 55 - 0 55 -
- - 0 -
- 22,727 - 0 22,727 -
- 22,727 - 4 22,727 90,908
- - 0 -
- 1,596 - 0 1,596 -
39,900 39 1,596 62,244 42 1,596 67,032
- - 0 -
- - 0 -
- - 0 -
- - 0 -
- - 0 -
- - 0 -
- - 0 -
- - 0 -
- - 0 -
- - 0 -
- - 0 -
- 42 - 0 42 -
- - 0 -
- 68 - 0 68 -
- 170 68 11,560 2550 68 173,400
- - 0 -
- 1,738 - 74 1,738 128,612
- - 0 -
- - 0 -
- 9,983 - 3 9,983 29,949
- - 0 -
- 2,578 - 0 2,578 -
- 2,578 - 53 2,578 136,634
- - 0 -
- - 0 -
- - 0 -
- - 0 -
- - 0 -
- 28 - 0 28 -
- - 0 -
- 28 - 85 28 2,380
- - 0 -
- - 0 -
- - 0 -
- 1,160 - 47 1,160 54,520
- - 0 -
- 103 - 100 103 10,300
- - 0 -
- - 0 -
- - 0 -
- 141 - 0 141 -
- 141 - 260 141 36,660
- - 0 -
27,830 0 278 - 100 278 27,830
- - 0 -
- 3,490 - 0 3,490 -
209,400 10 3,490 34,900 65 3,490 226,850
- - 0 -
- 174 - 0 174 -
- 174 - 520 174 90,480
- - 0 -
- 56 - 0 56 -
- - 0 -
- 42 - 160 42 6,720
- 42 - 3000 42 126,000
- - 0 -
- - 0 -
- 522 - 840 522 438,480
- 522 - 0 522 -
- - 0 -
- 7,581 - 49 7,581 371,469
- - 0 -
- 1,013 - 500 1,013 506,385
- 1,023 - 0 1,023 -
- - 0 -
- 2,625 - 0 2,625 -
- 2,625 - 0 2,625 -
- 15 2,625 39,375 73 2,625 191,625
- - 0 -
- 4,695 - 0 4,695 -
- 1 4,695 4,695 0 4,695 -
- - 0 -
- 124 - 0 124 -
- - 0 -
- - 0 -
- 170 124 21,080 0 124 -
- - 0 -
- - 0 -
- - 0 -
- - - 0 - -
- 146 - 100 146 14,600
- - 0 -
- 37 - 0 37 -
- 1,980 - 90 1,980 178,200
- - 0 -
- - 0 -
- - 0 -
- 37 - 0 37 -
- - 0 -
- 698 - 0 698 -
- - 0 -
- 698 - 100 698 69,800
- - 0 -
- - 0 -
- - 0 -
- - 0 -
- - 0 -
- 2,012 - 0 2,012 -
- - 0 -
- 2,012 - 39 2,012 78,468
- - 0 -
- 84 - 0 84 -
- 170 84 14,280 360 84 30,240
- - 0 -
- 317 - 0 317 -
- 317 - 0 317 -
- - 0 -
- 2,420 - 0 2,420 -
- - 0 -
- 323 - 0 323 -
- - 0 -
- - 0 -
- - 0 -
- 3,739 - 0 3,739 -
- - 0 -
- - 0 -
- - 0 -
- 2,340 - 0 2,340 -
- 35 1,469 51,415 12 1,469 17,628
- - 0 -
- 3,194 - 0 3,194 -
- - 0 -
- 61 - 0 61 -
- 61 - 320 61 19,520
- - 0 -
- - 0 -
- - 0 -
- - 0 -
- - 0 -
- 31 - 0 31 -
- 31 - 0 31 -
- 490 31 15,190 11290 31 349,990
- - 0 -
- - 0 -
- - 0 -
- - 0 -
- - 0 -
- 5,720 - 38 5,720 217,360
- - 0 -
- 6,270 - 15 6,270 94,050
- - 0 -
- - 0 -
- - 0 -
- 230 - 0 230 -
- 100 230 23,000 20 230 4,600
- - 0 -
- 62 - 0 62 -
- - 0 -
- 76 - 0 76 -
- 10 76 760 190 76 14,440
- - 0 -
- 105 - 0 105 -
- 105 - 0 105 -
- 105 - 0 105 -
- - 0 -
- 38,500 - 0 38,500 -
- - 0 -
- 40 - 0 40 -
- 40 - 4500 40 180,000
- - 0 -
- - 0 -
- - 0 -
- 330 - 0 330 -
- - 0 -
- 4,949 - 0 4,949 -
- - 0 -
- 40 127 5,082 170 127 21,599
- 121 - 500 121 60,500
- - 0 -
- 157 - 0 157 -
- 50 157 7,850 260 157 40,820
- - 0 -
- - 0 -
- - 0 -
- - 0 -
- - 0 -
- - 0 -
- - 0 -
- 98 - 0 98 -
- 70 98 6,860 90 98 8,820
- - 0 -
- 10,000 - 17 10,000 170,000
- - 0 -
- 9,519 - 20 9,519 190,380
- - 0 -
- 51 - 0 51 -
- 76 - 0 76 -
- 210 76 15,960 110 76 8,360
- - 0 -
- 69 - 0 69 -
- 720 69 49,680 950 69 65,550
- - 0 -
- 97 - 0 97 -
- 97 - 0 97 -
- - 0 -
- 269 - 0 269 -
- - 0 -
- - 0 -
- - 0 -
- 110,000 - 0 110,000 -
- - 0 -
- 320 - 0 320 -
- 320 - 220 320 70,400
- - 0 -
- 5,150 - 0 5,150 -
- 5,150 - 0 5,150 -
- - 0 -
- 2,665 - 0 2,665 -
- 2,665 - 90 2,665 239,850
- - 0 -
- - 0 -
- - 0 -
- 405 - 0 405 -
- - 0 -
- 1,680 - 0 1,680 -
- - 0 -
- 275 - 90 275 24,750
- 275 - 0 275 -
- - 0 -
- 1,680 - 0 1,680 -
- 6 1,680 10,080 13 1,680 21,840
- - 0 -
- 1 4,016 4,016 13 4,016 52,208
- - 0 -
- 26 - 0 26 -
- 26 - 0 26 -
- 1780 26 46,992 4859 26 128,278
- - 0 -
- 1,210 - 0 1,210 -
- - 0 -
- 152 - 0 152 -
- - 0 -
- 50 - 94 50 4,700
- - 0 -
- 531 - 0 531 -
- - 0 -
- - 0 -
- - 0 -
- 152 - 0 152 -
- 152 - 0 152 -
- 152 - 2583 152 392,616
- - 0 -
- 79 - 0 79 -
- 79 - 480 79 37,920
- - 0 -
- - 0 -
- 6,820 - 0 6,820 -
- 6,820 - 0 6,820 -
- - 0 -
- 112 - 0 112 -
- - 0 -
- - 0 -
- - 0 -
- 581 - 0 581 -
- - 0 -
- - 0 -
- - 0 -
- 1,499 - 0 1,499 -
- 1,499 - 0 1,499 -
- 1,499 - 0 1,499 -
- - 0 -
- 54,995 - 0 54,995 -
- 54,995 - 0 54,995 -
- - 0 -
- 97 - 0 97 -
- 97 - 205 97 19,885
- - 0 -
- 170 - 0 170 -
- - 0 -
- 7,260 - 0 7,260 -
- 7,260 - 0 7,260 -
- - 0 -
- 7,260 - 0 7,260 -
- 7,260 - 20 7,260 145,200
- - 0 -
- 1,130 - 0 1,130 -
- - 0 -
- 3,887 - 0 3,887 -
- - 0 -
- 248 - 90 248 22,320
- - 0 -
- - 0 -
- - 0 -
- - 0 -
- - 0 -
- 1,639 - 0 1,639 -
- - 0 -
- 40 133 5,324 40 133 5,324
- - 0 -
- - 0 -
- - 0 -
- 1,100 - 0 1,100 -
- 1,100 - 0 1,100 -
33,000 1 1,100 1,100 30 1,100 33,000
- - 0 -
- - 0 -
- - 0 -
- 7 100 700 77 100 7,700
- - 0 -
- - 0 -
- - 0 -
- 12,980 - 0 12,980 -
- 12,980 - 9 12,980 116,820
- - 0 -
- 116 - 0 116 -
- 10 116 1,160 350 116 40,600
- - 0 -
- - 0 -
- 218 169 36,842 370 169 62,530
- - 0 -
- 3,150 - 0 3,150 -
- 14 3,150 44,100 20 3,150 63,000
- - 0 -
- 146 - 0 146 -
- 146 - 0 146 -
- 205 146 29,930 80 146 11,680
- - 0 -
- 193 - 0 193 -
- 193 - 0 193 -
- 193 - 0 193 -
77,200 470 193 90,710 340 193 65,620
- - 0 -
- 5,170 - 0 5,170 -
- 5,170 - 0 5,170 -
- 25 5,170 129,250 10 5,170 51,700
- - 0 -
- 127 - 0 127 -
- 40 127 5,080 904 127 114,808
- - 0 -
- 704 - 0 704 -
- - 0 -
- 25,350 - 0 25,350 -
- 1 25,350 25,350 1 25,350 25,350
- - 0 -
- 107 - 800 107 85,600
- 107 - 0 107 -
- - 0 -
- 964 - 0 964 -
- 964 - 250 964 241,000
- - 0 -
- 854 - 0 854 -
- 854 - 130 854 111,020
- - 0 -
- 60,500 - 0 60,500 -
- - 0 -
- 9,100 - 0 9,100 -
- - 0 -
- 318 - 0 318 -
9,540 0 318 - 30 318 9,540
- - 0 -
- 19 - 0 19 -
- 19 - 0 19 -
- - 0 -
- 116 - 0 116 -
46,400 170 116 19,720 420 116 48,720
- - 0 -
- 18,635 - 0 18,635 -
- 18,635 - 0 18,635 -
- - 0 -
- 2,344 - 0 2,344 -
- 15,386 - 0 15,386 -
- 4 15,386 61,544 0 15,386 -
- - 0 -
- 40,202 - 0 40,202 -
- 40,202 - 0 40,202 -
- - 0 -
- 314 98 30,615 0 98 -
98,000 116 98 11,368 884 98 86,632
- - 0 -
- 125 - 985 125 123,125
- - 0 -
- 12,021 - 0 12,021 -
360,630 8 12,021 96,168 24 12,021 288,504
- - 0 -
- 100 297 29,700 100 297 29,700
- - 0 -
- 80 - 90 80 7,200
- - 0 -
- - 0 -
- - 0 -
- 128 - 0 128 -
115,200 540 128 69,120 840 128 107,520
- - 0 -
- - 0 -
- - 0 -
- 440 - 0 440 -
- - 0 -
- 624 - 0 624 -
- - 0 -
- 863 - 0 863 -
- - 0 -
- 5,720 - 0 5,720 -
228,800 25 5,720 143,000 41 5,720 234,520
- - 0 -
- 92 - 0 92 -
- 65 - 0 65 -
- 40 65 2,600 280 65 18,200
- - 0 -
- 93 - 0 93 -
- 60 93 5,580 650 93 60,450
- - 0 -
- 1,980 - 0 1,980 -
- 1,451 - 0 1,451 -
- - 0 -
- 150 - 0 150 -
- - 0 -
- 138 - 0 138 -
27,600 200 138 27,600 0 138 -
- - 0 -
- 177 - 0 177 -
- - 0 -
- 480 - 0 480 -
- - 0 -
- - 0 -
- - 0 -
- 312 - 0 312 -
- - 0 -
- - 0 -
- 350 - 200 350 70,000
- - 0 -
- - 0 -
- - 0 -
- - 0 -
- - 0 -
- - 0 -
95,400 200 477 95,400 0 477 -
- - 0 -
- - 0 -
- 1,155 - 100 1,155 115,500
- - 0 -
- 183 - 0 183 -
- - 0 -
- 283 - 0 283 -
- - 0 -
- 42 - 0 42 -
- 42 - 0 42 -
- - 0 -
- 770 - 0 770 -
- - 0 -
- 2,680 - 0 2,680 -
- - 0 -
- 10 363 3,630 22 363 7,986
- - 0 -
- 45 - 0 45 -
- 45 - 160 45 7,200
- - 0 -
- 63 - 0 63 -
- - 0 -
- 7,392 - 0 7,392 -
- - 0 -
- 112 - 0 112 -
- 112 - 0 112 -
112,000 2200 112 246,400 200 112 22,400
- - 0 -
- 521 - 0 521 -
- 521 - 0 521 -
- 521 - 0 521 -
- - 0 -
- 8,140 - 0 8,140 -
- 5 8,140 40,700 7 8,140 56,980
- - 0 -
- 573 - 0 573 -
- 6,975 - 2 6,975 13,950
- - 0 -
- 2 10,395 20,790 4 10,395 41,580
- - 0 -
- 155 - 0 155 -
- 141 - 1000 141 141,000
- - 0 -
- - 0 -
- 1,210 - 0 1,210 -
- - 0 -
- 57 - 0 57 -
- - 0 -
- 116 - 0 116 -
- 572 - 0 572 -
- - 0 -
- 191 - 100 191 19,100
- - 0 -
- 275 - 0 275 -
- 275 - 0 275 -
- - 0 -
- 162 - 0 162 -
- - 0 -
- 1,108 - 0 1,108 -
- 1,109 - 0 1,109 -
- - 0 -
- 162 - 0 162 -
- - 0 -
- 116 - 0 116 -
- - 0 -
- 167 - 0 167 -
- - 0 -
- 125 - 0 125 -
- - 0 -
- 318 - 0 318 -
- - 0 -
- 109 - 0 109 -
- - 0 -
- 45 - 0 45 -
- - 0 -
- 854 - 0 854 -
- - 0 -
- 42,727 - 0 42,727 -
- 42,727 - 0 42,727 -
- 1,480 - 0 1,480 -
592,000 150 1,480 222,000 250 1,480 370,000
- 31 - 0 31 -
- - 0 -
- 56 - 0 56 -
- - 0 -
- - 0 -
- 765,000 - 0 765,000 -
- 765,000 - 0 765,000 -
- - 0 -
- 242,000 - 0 242,000 -
- - 0 -
- 338,800 - 0 338,800 -
- 338,800 - 0 338,800 -
- - 0 -
- 390,000 - 0 390,000 -
- 390,000 - 0 390,000 -
- - 0 -
- 18,333 - 0 18,333 -
- 18,333 - 0 18,333 -
- - 0 -
- 105,000 - 0 105,000 -
- 105,000 - 0 105,000 -
- - 0 -
- 170,000 - 0 170,000 -
- - 0 -
- 395,000 - 0 395,000 -
- 197,895 - 0 197,895 -
- - 0 -
- 55,000 - 1 55,000 55,000
- - 0 -
- 93,500 - 0 93,500 -
- 93,500 - 2 93,500 187,000
- - 0 -
- 34,000 - 0 34,000 -
- 34,000 - 0 34,000 -
- - 0 -
- 176,000 - 0 176,000 -
- - 0 -
- - 0 -
- 425 - 0 425 -
- 24,384 - 0 24,384 -
- 27,569 - 0 27,569 -
- 27,569 - 8 27,569 220,552
- - 0 -
- 104 - 0 104 -
- 104 - 2000 104 208,000
- - 0 -
- 825,000 - 0 825,000 -
- 4,545 - 0 4,545 -
- 236,490 - 0 236,490 -
- 396,000 - 0 396,000 -
- 1,319,990 - 0 1,319,990 -
- 175,899 - 0 175,899 -
- 145,000 - 0 145,000 -
- 150,000 - 0 150,000 -
- 168,300 - 0 168,300 -
- 46,200 - 0 46,200 -
- 45,560 - 0 45,560 -
- 42,350 - 0 42,350 -
- 20,454 - 0 20,454 -
- 4,438 - 0 4,438 -
- - 0 -
- - 0 -
- - 0 -
- - 0 -
- - 0 -
- 285,000 - 0 285,000 -
- 695,752 - 0 695,752 -
- 412 - 0 412 -
- 286 - 0 286 -
- 497 - 0 497 -
- - 0 -
- - 0 -
- 1,093 - 0 1,093 -
- 848 - 0 848 -
- 18 848 15,269 111 848 94,156
- - 0 -
- 1,038 - 0 1,038 -
- 33 848 27,992 67 848 56,833
- - 0 -
- 1,038 - 0 1,038 -
- 848 - 0 848 -
- 35 848 29,689 36 848 30,537
- - 0 -
- 1,038 - 0 1,038 -
- 14 979 13,703 296 979 289,710
- - 0 -
- 2,099 - 0 2,099 -
- 2,100 - 103 2,100 216,300
- - 0 -
- 2,099 - 0 2,099 -
- 26 2,100 54,600 50 2,100 105,000
- - 0 -
- 6,400 - 25 6,400 160,000
- 25,920 - 24 25,920 622,080
- - 0 -
- 5,900 - 0 5,900 -
- 27,000 - 24 27,000 648,000
- - 0 -
- 6,595 - 0 6,595 -
- - 0 -
- 6,595 - 0 6,595 -
- - 0 -
- 4,250 - 0 4,250 -
- 7,684 - 0 7,684 -
- - 0 -
- 4,250 - 0 4,250 -
384,200 50 7,684 384,200 12 7,684 92,208
- - 0 -
- 3,500 - 0 3,500 -
41,760 16 4,176 66,816 13 4,176 54,288
- - 0 -
- 2 4,000 8,000 4 4,000 16,000
- 4,568 - 0 4,568 -
- - 0 -
- 7,937 - 0 7,937 -
- - 0 -
- 6,600 - 0 6,600 -
- - 0 -
- 3 7,787 23,361 6 7,787 46,722
- - - 0 - -
- 7,787 - 0 7,787 -
- 3 7,937 23,811 30 7,937 238,110
- - 0 -
- 11 7,787 85,657 14 7,787 109,018
- - 0 -
- 10,440 - 0 10,440 -
- - 0 -
- 8,495 - 0 8,495 -
- 10,440 - 0 10,440 -
- - 0 -
- 8,495 - 0 8,495 -
- 10,440 - 0 10,440 -
- - 0 -
- 495 - 0 495 -
- 10,440 - 0 10,440 -
- - 0 -
- 7,500 - 0 7,500 -
- 1 27,821 27,821 0 27,821 -
- - 0 -
- 17,250 - 0 17,250 -
- - 0 -
- 800 - 0 800 -
- - 0 -
- 887 - 0 887 -
- - 0 -
- 607 - 0 607 -
- 28 6,121 171,388 21 6,121 128,541
- - 0 -
- 887 - 0 887 -
- - 0 -
- 1,871 - 0 1,871 -
- 5,621 - 0 5,621 -
- - 0 -
- 8,600 - 0 8,600 -
- 11,724 - 0 11,724 -
- - 0 -
- 10,467 - 0 10,467 -
- 7 13,221 92,547 0 13,221 -
- - 0 -
- - 0 -
- 137,025 - 0 137,025 -
- - 0 -
- 55,200 - 0 55,200 -
267,642 2 133,821 267,642 0 133,821 -
- - 0 -
- 32,500 - 2 32,500 65,000
- - 0 -
- 23,625 - 0 23,625 -
- 2 23,625 47,250 7 23,625 165,375
- - 0 -
- 5,082 - 0 5,082 -
- 18 18,781 338,058 24 18,781 450,744
- - 0 -
- - 0 -
- - 0 -
- - 0 -
- - 0 -
- - 0 -
- - 0 -
- 4,000 - 0 4,000 -
- - 0 -
- 5,770 - 0 5,770 -
- 5,770 - 200 5,770 1,154,000
- - 0 -
- 5,770 - 69 5,770 398,130
- 5,770 - 199 5,770 1,148,230
- - 0 -
- 5,770 - 0 5,770 -
- 5,770 - 200 5,770 1,154,000
- - 0 -
- 5,770 - 0 5,770 -
- - 0 -
- 22,000 - 0 22,000 -
- - 0 -
- 22,000 - 0 22,000 -
- - 0 -
- 1,125 - 0 1,125 -
- 1,125 - 3 1,125 3,375
- - 0 -
- 200,455 - 0 200,455 -
- 8,018 - 75 8,018 601,350
- - 0 -
- 68,181 - 0 68,181 -
- - 0 -
- 68,181 - 0 68,181 -
- - 0 -
- 6,825 - 0 6,825 -
693,602 1,677,803 8,047,707
5,671,714 5,451,711 22,246,206
Penanggung Jawab
Laporan
1 Air untuk injeksi amp 25 ml (aqua pro injeksi) Ampul 0 6,050 - 6,050
0 - - -
Antasida, kombinasi : aluminium hidroksida
17 Tab kunyah 0 78 - 78
200 mg + magnesium hidroksida 200 mg
0 - - -
mg + heksaklorofen 2,5 mg + lidokain
lidokain 10 mg+ seng oksida 120 mg + sup
21 ad 2 g Suppo 0 33,000 - 50 33,000
0 - - -
0 - - -
41 Bedak salisil serb 2% Botol 0 1,180 - 1,180
13 1,350 17,550 35 1,350
0 - - -
Besi (II) sulfat 200 mg + asam folat 0.25 mg
42 Sachet 0 73 - 73
(tablet tambah darah)
0 55 - 55
0 - - -
43 Becefort syrup Botol 0 22,727 - 22,727
4 22,727 90,908 22,727
0 - - -
44 Betametason krim 0,1% Tube 0 1,596 - 1,596
42 1,596 67,032 75 1,596
0 - - -
45 Betahistin mesilate tablet tablet 0 - - -
0 - - -
46 Bisakodil sup 10 mg (Stolax) Botol 0 - - -
0 - - -
47 Bisakodil tab sal 5 mg Tab sal 0 - - -
0 - - -
48 Bismecon salep tube 0 - - -
0 - - -
Budesonid-formoterol (fixed combination)* ih
49 Botol 0 - - -
80/4,5 mcg
0 - - -
50 Bromheksin tablet tablet 0 42 - 42
0 - - -
51 Deksametason tab 0,5 mg Tab 0 68 - 68
2550 68 173,400 68
0 - - -
52 Deksametason inj 5 mg/ml (i.v./i.m.) Vial 74 1,738 128,612 1,738
0 - - -
53 Desoksimetason salep 0,25% Tube 0 - - -
3 9,983 29,949 9,983
0 - - -
54 Diazepam inj 5 mg/ml (i.v./i.m.) Vial 0 2,578 - 2,578
53 2,578 136,634 2,578
0 - - -
0 - - -
56 Diazepam supposutoria suppo 0 - - -
0 - - -
57 Diazepam tab 2 mg Tab 0 28 - 28
0 - - -
58 Diazepam tab 5 mg Tab 85 28 2,380 28
0 - - -
59 Dietilkarbamazin tab 100 mg Tab 0 - - -
0 - - -
60 Difenhidramin inj 10 mg/ml (i.v./i.m.) Ampul 47 1,160 54,520 1,160
0 - - -
61 Digoksin tab 0,25 mg Tab 100 103 10,300 103
0 - - -
62 Diltiazem kaps SR 100 mg Kaps 0 - - -
0 - - -
63 Diltiazem tab 30 mg Tab 0 141 - 141
260 141 36,660 300 141
0 - - -
64 Doksisiklin tablet 100 mg Tab 100 278 27,830 100 278
0 - - -
65 Domperidon susp 5 mg/5 ml Botol 0 3,490 - 3,490
65 3,490 226,850 40 3,490
0 - - -
66 Domperidon tab 10 mg Tab 0 174 - 174
520 174 90,480 100 174
0 - - -
67 Efedrin HCl tablet Tab 0 56 - 200 56
0 - - -
68 Ekstrak belladon tablet 10 mg tab 160 42 6,720 42
3000 42 126,000 1,000 42
0 - - -
0 - - -
70 Eritromisin kaps 250 mg Kaps 840 522 438,480 522
0 522 - 522
0 - - -
71 Eritromisin sir 200 mg/5 ml Botol 49 7,581 371,469 7,581
0 - - -
72 Eritromisin tab 500 mg Tab 500 1,013 506,385 1,013
0 1,023 - 1,023
0 - - -
73 Etanol 70% cairan 70% Botol 0 2,625 - 2,625
0 2,625 - 2,625
73 2,625 191,625 40 2,625
0 - - -
74 Etakridin (rivanol) larutan 0.1% Botol 0 4,695 - 4,695
0 4,695 - 1 4,695
0 - - -
75 Etil klorida semprot 100 ml Botol 0 124 - 124
0 - - -
76 Famotidin tablet 20 mg Tab 0 - - -
0 124 - 124
0 - - -
77 Fenitoin Na inj 50 mg/ml Ampul 0 - - -
0 - - -
78 Fenitoin Na kaps 100 mg Kaps 0 - - -
100 146 14,600 146
0 - - -
79 Fenobarbital inj 50 mg/ml Ampul 0 37 - 37
90 1,980 178,200 1,980
0 - - -
80 Fenobarbital tab 100 mg Tab 0 - - -
0 - - -
81 Fenobarbital tab 30 mg Tab 0 37 - 37
0 - - -
0 - - -
83 Fitomenadion (vitamin K 1) tab sal 10 mg Tab sal 100 698 69,800 698
0 - - -
84 Flukonazol kaps 150 mg Kaps 0 - - -
0 - - -
85 Flusinolon asetonid krim 0,025% Tube 0 - - -
0 - - -
86 Flunarizin tablet tablet 0 2,012 - 2,012
0 - - -
87 Furosemid inj 10 mg/ml (i.v./i.m.) Ampul 39 2,012 78,468 2,012
0 - - -
88 Furosemid tab 40 mg Tab 0 84 - 84
360 84 30,240 84
0 - - -
Garam oralit kombinasi : natrium klorida 0,52
g + kalium klorida 0,30 g + trinatrium sitrat
89 Sachet 0 317 - 317
0,58 g + glukosa anhidrat 2,7 g
0 317 - 317
0 - - -
90 Gameksan lotion 1 % Botol 0 2,420 - 2,420
0 - - -
91 Gemfibrozil kaps 300 mg Kaps 0 323 - 323
0 - - -
92 Gemfibrozil kaps 600 mg Kaps 0 - - -
0 - - -
93 Gentamisin inj 10 mg/ml Ampul 0 3,739 - 3,739
0 - - -
94 Gentamisin salep mata 0,3% Tube 0 - - -
0 - - -
95 Gentamisin salep Kulit Tube 0 2,340 - 2,340
12 1,469 17,628 1,469
0 - - -
96 Gentamisin tts mata 0,3% Botol 0 3,194 - 3,194
0 - - -
97 Glibenklamid tab 5 mg Tab 0 61 - 61
320 61 19,520 61
0 - - -
98 Glimepirid tab 4 mg Tab 0 - - -
0 - - -
99 Glipizid tablet 5 mg (Glucotrol 5 mg) Tab 0 - - -
0 - - -
100 Gliseril Guaiakolat tab 100 mg Tab 0 31 - 31
0 31 - 31
11290 31 349,990 31
0 - - -
101 Gliserin lar 50% Botol 0 - - -
0 - - -
102 Glukosamin tablet 500 mg Tab 0 - - -
0 - - -
103 Glukosa Larutan Infus 5% steril Botol 38 5,720 217,360 5,720
0 - - -
104 Glukosa Larutan Infus 10% steril Botol 15 6,270 94,050 6,270
0 - - -
105 Glukosa Larutan Infus 40% steril Botol 0 - - -
0 - - -
106 Griseofulvin (micronized) tab 125 mg Tab 0 230 - 230
20 230 4,600 230
0 - - -
107 Haloperidol tab 0,5 mg Tab 0 62 - 62
0 - - -
108 Haloperidol tab 1,5 mg Tab 0 76 - 76
190 76 14,440 76
0 - - -
109 Haloperidol tab 5 mg Tab 0 105 - 105
0 105 - 105
0 105 - 105
0 - - -
110 Hidrogen peroksida (H2O2) cairan 3% Botol 0 38,500 - 38,500
0 - - -
111 Hidroklorotiazid (HCT) tab 25 mg Tab 0 40 - 40
4500 40 180,000 5,000 40
0 - - -
112 Hidrokortison krim 2,5% Tube 0 - - -
0 - - -
113 Hiosina butilbromida tab 10 mg Tab 0 330 - 330
0 - - -
114 Ibuprofen susp 100 mg/5 ml Botol 0 4,949 - 4,949
0 - - -
115 Ibuprofen tab 200 mg Tab 170 127 21,599 127
500 121 60,500 121
0 - - -
116 Ibuprofen tab 400 mg Tab 0 157 - 157
260 157 40,820 700 157
0 - - -
Ipratropium bromida nebulizer 0,025%
117 Botol 0 - - -
(Atroven sol. for inhalation 0.025%)
0 - - -
118 Isoniazid tab 300 mg Tab 0 - - -
0 - - -
119 Isosorbid dinitrat inj 10 mg/10 ml (Fasorbid) Vial 0 - - -
0 - - -
120 Isosorbid dinitrat tab 5 mg Tab 0 98 - 98
90 98 8,820 98
0 - - -
121 KA-EN 3B Cairan Infus Botol 17 10,000 170,000 10,000
0 - - -
122 Kalsium glukonat inj 100 mg/ml Ampul 20 9,519 190,380 9,519
0 - - -
123 Kalsium laktat (kalk) tab 500 mg Tab 0 51 - 51
0 76 - 76
110 76 8,360 1,000 76
0 - - -
124 Kaptopril tab 12,5 mg Tab 0 69 - 69
950 69 65,550 500 69
0 - - -
125 Kaptopril tab 25 mg Tab 0 97 - 97
0 97 - 600 97
0 - - -
126 Karbamazepin tab 200 mg Tab 0 269 - 269
0 - - -
127 Karbo adsorben (Norit) tab 500 mg Tab 0 - - -
0 - - -
128 Ketamin inj 50 mg/ml (i.v.) Ampul 0 110,000 - 110,000
0 - - -
129 Ketokonazol tab 200 mg Tab 0 320 - 320
220 320 70,400 320
0 - - -
130 Ketokonazol krim 2% Tube 0 5,150 - 5,150
0 5,150 - 5,150
0 - - -
131 Ketorolak inj 10 mg/ml Ampul 0 2,665 - 2,665
90 2,665 239,850 2,665
0 - - -
132 Klaritromisin tab 500 mg Tab 0 - - -
0 - - -
133 Klindamisin kaps 150 mg Kaps 0 405 - 405
0 - - -
134 Kloramfenikol tts mata 0,5% Botol 0 1,680 - 1,680
0 - - -
135 Kloramfenikol kaps 250 mg Kaps 90 275 24,750 275
0 275 - 275
0 - - -
136 Kloramfenikol salep mata 1% Tube 0 1,680 - 1,680
13 1,680 21,840 1,680
0 - - -
137 Kloramfenikol susp 125 mg/5 ml Botol 13 4,016 52,208 4,016
0 - - -
138 Klorfeniramin (CTM) tab 4 mg Tab 0 26 - 26
0 26 - 26
4859 26 128,278 26
0 - - -
139 Klorpromazin inj 25 mg/ml (i.m.) Ampul 0 1,210 - 1,210
0 - - -
140 Klorpromazin tab sal 100 mg Tab sal 0 152 - 152
0 - - -
141 Klorpromazin tab sal 25 mg Tab sal 94 50 4,700 50
0 - - -
0 - - -
Kotrimoksazol (dewasa) kombinasi :
sulfametoksazol 400 mg+ trimetoprim 80
144 Tab 0 152 - 1,100 152
mg
0 152 - 152
2583 152 392,616 152
0 - - -
Kotrimoksazol (anak) kombinasi :
sulfametoksazol 100 mg+ trimetoprim 20
145 Tab 0 79 - 79
mg
480 79 37,920 79
0 - - -
Kotrimoksazol (dewasa) kombinasi tiap 5 ml
146 suspensi : sulfametoksazol 200 mg + Botol 10 2,298 22,980 2,298
trimetoprim 40 mg
0 - - -
147 Kuinin inj 25% (i.v.) Vial 0 6,820 - 6,820
0 6,820 - 6,820
0 - - -
148 Kloroquin tab 150 mg Tab 0 112 - 112
0 - - -
149 Lansoprazol kaps 30 mg Kaps 0 - - -
0 - - -
150 Levofloksasin tab 500 mg Tab 0 581 - 581
0 - - -
151 Lidokain gel 2% Tube 0 - - -
0 - - -
152 Lidokain inj 2% (hcl) Vial 0 1,499 - 1,499
0 1,499 - 150 1,499
0 1,499 - 1,499
0 - - -
153 Lisol Botol 0 54,995 - 54,995
0 54,995 - 54,995
0 - - -
154 Loperamid tab 2 mg Tab 0 97 - 97
205 97 19,885 97
0 - - -
155 Loratadin tab 10 mg Tab 0 170 - 170
0 - - -
156 Magnesium sulfat inj 20% Vial 0 7,260 - 7,260
0 7,260 - 7,260
0 - - -
157 Magnesium sulfat inj 40% Vial 0 7,260 - 7,260
20 7,260 145,200 7,260
0 - - -
158 Magnesium sulfat serb, ktg 30 g Sachet 0 1,130 - 1,130
0 - - -
159 Mebendazol sir 50 mg/ml Botol 0 3,887 - 3,887
0 - - -
160 Mebendazol tab 100 mg Tan 90 248 22,320 248
0 - - -
161 Metformin tab 500 mg Tab 0 - - -
0 - - -
162 Metformin tab 850 mg Tab 0 - - -
0 - - -
163 Metilergometrin inj 0,2 mg/ml Ampul 0 1,639 - 1,639
0 - - -
164 Metilergometrin tab salut 0,125 mg Tab sal 40 133 5,324 133
0 - - -
165 Metilprednisolon tab 4 mg Tab 0 - - -
0 - - -
166 Metoklopramid inj 5 mg/ml Vial 0 1,100 - 1,100
0 1,100 - 1,100
30 1,100 33,000 30 1,100
0 - - -
0 - - -
168 Metoklopramid tab 10 mg Tab 77 100 7,700 200 100
0 - - -
169 Metronidazol supposutoria 500 mg suppo 0 - - -
0 - - -
170 Metronidazol larutan infus Botol 0 12,980 - 12,980
9 12,980 116,820 12,980
0 - - -
171 Metronidazol tab 250 mg Tab 0 116 - 116
350 116 40,600 100 116
0 - - -
172 Metronidazol tab 500 mg Tab 0 - - -
370 169 62,530 600 169
0 - - -
173 Mikonazol krim 2% Tube 0 3,150 - 3,150
20 3,150 63,000 3,150
0 - - -
174 Natrium diklofenak tab 25 mg Tab 0 146 - 146
0 146 - 146
80 146 11,680 1,000 146
0 - - -
175 Natrium diklofenak tab 50 mg Tab 0 193 - 193
0 193 - 193
0 193 - 193
340 193 65,620 1,400 193
0 - - -
176 NaCl 0,9% Larutan infus Botol 0 5,170 - 5,170
0 5,170 - 5,170
10 5,170 51,700 20 5,170
0 - - -
177 Nifedipin kaps 10 mg Kaps 0 127 - 127
904 127 114,808 127
0 - - -
0 - - -
179 Nistatin tab vaginal 100.000 UI Tab 190 448 85,120 448
0 - - -
180 Obat Batuk Hitam (OBH) Botol 0 2,310 - 2,310
15 2,310 34,650 60 2,310
0 - - -
181 Ofloksasin tab 200 mg Tab 0 440 - 440
0 - - -
182 Ofloksasin tab 400 mg Tab 0 700 - 700
40 700 28,000 700
0 - - -
183 Oksitetrasiklin hcl inj 500 mg/ml Vial 0 3,410 - 3,410
0 - - -
184 Oksitetrasiklin hcl salep kulit 3% Tube 0 2,010 - 2,010
0 1,646 - 1,646
66 1,646 108,636 1,646
0 - - -
185 Oksitetrasiklin hcl salep mata 1 % Tube 0 2,772 - 2,772
144 2,772 399,168 2,772
0 - - -
186 Oksitosin inj 10 UI/ml Ampul 0 6,875 - 6,875
18 1,900 34,200 1,900
0 - - -
187 Omeprazol kaps 20 mg Kaps 0 221 - 221
0 221 - 221
0 221 - 221
0 - - -
188 Papaverin tablet 40 mg Tab 0 109 - 109
2910 109 317,190 109
0 - - -
189 Parasetamol sir 120 mg/5 ml Botol 0 1,535 - 1,535
0 1,535 - 1,535
36 1,535 55,260 168 1,535
0 - - -
190 Parasetamol tab 100 mg Tab 0 105 - 105
100 105 10,500 700 105
0 - - -
191 Parasetamol tab 500 mg Tab 0 88 - 88
0 88 - 88
0 88 - 2,200 88
0 - - -
192 Parasetamol rectal suppo 0 - - -
0 - - -
193 Pehavral tablet multivitamin Tab 0 849 - 849
0 297 - 297
0 297 - 297
100 297 29,700 297
0 - - -
230 Sianokobalamin (vitamin B12) inj 500 mcg/ml Vial 0 1,451 - 100 1,451
0 - - -
231 Sianokobalamin (vitamin B12) tab 50 mcg Tab 0 150 - 150
0 - - -
232 Simetidin tablet 200 mg Tab 0 138 - 138
0 138 - 138
0 - - -
233 Simvastatin tab sal 10 mg Tab sal 0 177 - 177
0 - - -
234 Simvastatin tab sal 20 mg Tab sal 0 480 - 480
0 - - -
235 Siprofloksasin inf 2 mg/ml Botol 0 - - -
0 - - -
236 Siprofloksasin tab scored 500 mg Tab 0 312 - 700 312
0 - - -
237 Spironolakton tab 100 mg Tab 0 - - -
200 350 70,000 350
0 - - -
238 Sulfasetamid Natrium Tetes mata 1.5% Botol 0 - - -
0 - - -
239 Sukralfat susp 500 mg/5 ml (Ulsafate) Botol 0 - - -
0 - - -
240 Sukralfat tab 500 mg (Ulsidex) Tab 0 - - -
0 477 - 200 477
0 - - -
241 Teofilin tab SR 300 mg (Rethapyl) Tab 0 - - -
100 1,155 115,500 1,155
0 - - -
242 Tetrasiklin kaps 250 mg Kaps 0 183 - 183
0 - - -
243 Tetrasiklin kaps 500 mg Kaps 0 283 - 283
0 - - -
0 - - -
Mengetahui
Kepala Puskesmas Rumbia
Rahmat, AMK
Nip. 19721021 199403 1 004
AN OBAT DAN PERBEKES
SELAMA 1 TAHUN
UN 2016
BULAN : FEBRUARI
TAHUN : 2016
- 6,050 - 0 6,050 -
- 123 - 0 123 -
- 123 - 100 123 12,300
- - - 0 - -
- 1,863 - 0 1,863 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 2,560 - 0 2,560 -
- 2,560 - 0 2,560 -
- 2,560 - 0 2,560 -
512,000 72 2,560 184,320 231 2,560 591,360
- - - 0 - -
- 220 - 0 220 -
- 220 - 0 220 -
- 140 220 30,800 0 220 -
- - - 0 - -
- 279 - 0 279 -
- 279 - 0 279 -
864,900 320 279 89,280 2880 279 803,520
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 78 - 0 78 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 149 - 0 149 -
- 1,265 - 0 1,265 -
- - - 0 - -
- 251 - 0 251 -
50,200 0 251 - 200 251 50,200
- - - 0 - -
- 1,400 - 34 1,400 47,600
- - - 0 - -
- 81 - 0 81 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 1,180 - 0 1,180 -
47,250 9 1,350 12,150 39 1,350 52,650
- - - 0 - -
- 73 - 0 73 -
- 55 - 0 55 -
- - - 0 - -
- 22,727 - 0 22,727 -
- 22,727 - 4 22,727 90,908
- - - 0 - -
- 1,596 - 0 1,596 -
119,700 30 1,596 47,880 87 1,596 138,852
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 42 - 0 42 -
- - - 0 - -
- 68 - 0 68 -
- 680 68 46,240 1870 68 127,160
- - - 0 - -
- 1,738 - 74 1,738 128,612
- - - 0 - -
- - - 0 - -
- 9,983 - 3 9,983 29,949
- - - 0 - -
- 2,578 - 0 2,578 -
- 2,578 - 53 2,578 136,634
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 28 - 0 28 -
- - - 0 - -
- 28 - 85 28 2,380
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 1,160 - 47 1,160 54,520
- - - 0 - -
- 103 - 100 103 10,300
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 141 - 0 141 -
42,300 141 - 560 141 78,960
- - - 0 - -
27,830 10 278 2,783 190 278 52,877
- - - 0 - -
- 3,490 - 0 3,490 -
139,600 21 3,490 73,290 84 3,490 293,160
- - - 0 - -
- 174 - 0 174 -
17,400 71 174 12,354 549 174 95,526
- - - 0 - -
11,278 56 - 200 56 11,278
- - - 0 - -
- 42 - 160 42 6,720
42,000 42 - 4000 42 168,000
- - - 0 - -
- - - 0 - -
- 522 - 840 522 438,480
- 522 - 0 522 -
- - - 0 - -
- 7,581 - 49 7,581 371,469
- - - 0 - -
- 1,013 - 500 1,013 506,385
- 1,023 - 0 1,023 -
- - - 0 - -
- 2,625 - 0 2,625 -
- 2,625 - 0 2,625 -
105,000 22 2,625 57,750 91 2,625 238,875
- - - 0 - -
- 4,695 - 0 4,695 -
4,695 1 4,695 4,695 0 4,695 -
- - - 0 - -
- 124 - 0 124 -
- - - 0 - -
- - - 0 - -
- 124 - 0 124 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 146 - 100 146 14,600
- - - 0 - -
- 37 - 0 37 -
- 1,980 - 90 1,980 178,200
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 37 - 0 37 -
- - - 0 - -
- 698 - 0 698 -
- - - 0 - -
- 698 - 100 698 69,800
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 2,012 - 0 2,012 -
- - - 0 - -
- 2,012 - 39 2,012 78,468
- - - 0 - -
- 84 - 0 84 -
- 84 - 360 84 30,240
- - - 0 - -
- 317 - 0 317 -
- 317 - 0 317 -
- - - 0 - -
- 2,420 - 0 2,420 -
- - - 0 - -
- 323 - 0 323 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 3,739 - 0 3,739 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 2,340 - 0 2,340 -
- 2 1,469 2,938 10 1,469 14,690
- - - 0 - -
- 3,194 - 0 3,194 -
- - - 0 - -
- 61 - 0 61 -
- 61 - 320 61 19,520
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 31 - 0 31 -
- 31 - 0 31 -
- 300 31 9,300 10990 31 340,690
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 1 5,720 5,720 37 5,720 211,640
- - - 0 - -
- 6,270 - 15 6,270 94,050
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 230 - 0 230 -
- 20 230 4,600 0 230 -
- - - 0 - -
- 62 - 0 62 -
- - - 0 - -
- 76 - 0 76 -
- 76 - 190 76 14,440
- - - 0 - -
- 105 - 0 105 -
- 105 - 0 105 -
- 105 - 0 105 -
- - - 0 - -
- 38,500 - 0 38,500 -
- - - 0 - -
- 40 - 0 40 -
200,000 40 - 9500 40 380,000
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 330 - 0 330 -
- - - 0 - -
- 4,949 - 0 4,949 -
- - - 0 - -
- 80 127 10,164 90 127 11,435
- 121 - 500 121 60,500
- - - 0 - -
- 157 - 0 157 -
109,900 160 157 25,120 800 157 125,600
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 98 - 0 98 -
- 98 - 90 98 8,820
- - - 0 - -
- 10,000 - 17 10,000 170,000
- - - 0 - -
- 9,519 - 20 9,519 190,380
- - - 0 - -
- 51 - 0 51 -
- 76 - 0 76 -
76,000 300 76 22,800 810 76 61,560
- - - 0 - -
- 69 - 0 69 -
34,500 570 69 39,330 880 69 60,720
- - - 0 - -
- 97 - 0 97 -
58,200 10 97 970 590 97 57,230
- - - 0 - -
- 269 - 0 269 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 110,000 - 0 110,000 -
- - - 0 - -
- 320 - 0 320 -
- 30 320 9,600 190 320 60,800
- - - 0 - -
- 5,150 - 0 5,150 -
- 5,150 - 0 5,150 -
- - - 0 - -
- 2,665 - 0 2,665 -
- 2,665 - 90 2,665 239,850
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 405 - 0 405 -
- - - 0 - -
- 1,680 - 0 1,680 -
- - - 0 - -
- 275 - 90 275 24,750
- 275 - 0 275 -
- - - 0 - -
- 1,680 - 0 1,680 -
- 1,680 - 13 1,680 21,840
- - - 0 - -
- 4,016 - 13 4,016 52,208
- - - 0 - -
- 26 - 0 26 -
- 26 - 0 26 -
- 860 26 22,704 3999 26 105,574
- - - 0 - -
- 1,210 - 0 1,210 -
- - - 0 - -
- 152 - 0 152 -
- - - 0 - -
- 50 50 2,500 44 50 2,200
- - - 0 - -
- 531 - 0 531 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 152 - 0 152 -
- 152 - 2583 152 392,616
- - - 0 - -
- 79 - 0 79 -
- 79 - 480 79 37,920
- - - 0 - -
- - - 0 - -
- 6,820 - 0 6,820 -
- 6,820 - 0 6,820 -
- - - 0 - -
- 112 - 0 112 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 581 - 0 581 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 1,499 - 0 1,499 -
224,850 35 1,499 52,465 115 1,499 172,385
- 1,499 - 0 1,499 -
- - - 0 - -
- 54,995 - 0 54,995 -
- 54,995 - 0 54,995 -
- - - 0 - -
- 97 - 0 97 -
- 100 97 9,700 105 97 10,185
- - - 0 - -
- 170 - 0 170 -
- - - 0 - -
- 7,260 - 0 7,260 -
- 7,260 - 0 7,260 -
- - - 0 - -
- 7,260 - 0 7,260 -
- 7,260 - 20 7,260 145,200
- - - 0 - -
- 1,130 - 0 1,130 -
- - - 0 - -
- 3,887 - 0 3,887 -
- - - 0 - -
- 248 - 90 248 22,320
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 1,639 - 0 1,639 -
- - - 0 - -
- 30 133 3,993 10 133 1,331
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 1,100 - 0 1,100 -
- 1,100 - 0 1,100 -
33,000 5 1,100 5,500 55 1,100 60,500
- - - 0 - -
- - - 0 - -
- - - 0 - -
20,000 35 100 3,500 242 100 24,200
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 12,980 - 0 12,980 -
- 12,980 - 9 12,980 116,820
- - - 0 - -
- 116 - 0 116 -
11,600 250 116 29,000 200 116 23,200
- - - 0 - -
- - - 0 - -
101,400 170 169 28,730 800 169 135,200
- - - 0 - -
- 3,150 - 0 3,150 -
- 9 3,150 28,350 11 3,150 34,650
- - - 0 - -
- 146 - 0 146 -
- 146 - 0 146 -
146,000 610 146 89,060 470 146 68,620
- - - 0 - -
- 193 - 0 193 -
- 193 - 0 193 -
- 193 - 0 193 -
270,200 450 193 86,850 1290 193 248,970
- - - 0 - -
- 5,170 - 0 5,170 -
- 5,170 - 0 5,170 -
103,400 12 5,170 62,040 18 5,170 93,060
- - - 0 - -
- 127 - 0 127 -
- 10 127 1,270 894 127 113,538
- - - 0 - -
- 704 - 0 704 -
- - - 0 - -
- 25,350 - 0 25,350 -
76,050 1 25,350 25,350 3 25,350 76,050
- - - 0 - -
- 107 - 800 107 85,600
- 107 - 0 107 -
- - - 0 - -
- 964 - 0 964 -
- 30 964 28,920 220 964 212,080
- - - 0 - -
- 854 - 0 854 -
- 854 - 130 854 111,020
- - - 0 - -
3,025,000 60,500 - 50 60,500 3,025,000
- - - 0 - -
455,000 9,100 - 50 9,100 455,000
- - - 0 - -
- 318 - 0 318 -
19,080 7 318 2,226 83 318 26,394
- - - 0 - -
- 19 - 0 19 -
19,000 20 19 380 980 19 18,620
- - - 0 - -
- 116 - 0 116 -
139,200 400 116 46,400 1220 116 141,520
- - - 0 - -
- 18,635 - 0 18,635 -
223,620 2 18,635 37,270 10 18,635 186,350
- - - 0 - -
- 2,344 - 0 2,344 -
- 40,202 - 0 40,202 -
- 40,202 - 0 40,202 -
- - - 0 - -
- 98 - 0 98 -
196,000 50 98 4,900 2834 98 277,732
- - - 0 - -
- 125 - 985 125 123,125
- - - 0 - -
- 12,021 - 0 12,021 -
601,050 16 12,021 192,336 58 12,021 697,218
- - - 0 - -
- 297 - 100 297 29,700
- - - 0 - -
- 80 - 90 80 7,200
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 128 - 0 128 -
- 720 128 92,160 120 128 15,360
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 440 - 0 440 -
- - - 0 - -
- 624 - 0 624 -
- - - 0 - -
- 863 - 0 863 -
- - - 0 - -
- 5,720 - 0 5,720 -
343,200 74 5,720 423,280 27 5,720 154,440
- - - 0 - -
- 92 - 0 92 -
- 65 - 0 65 -
19,500 110 65 7,150 470 65 30,550
- - - 0 - -
- 93 - 0 93 -
- 90 93 8,370 560 93 52,080
- - - 0 - -
- 1,980 - 0 1,980 -
- - - 0 - -
- 150 - 0 150 -
- - - 0 - -
- 138 - 0 138 -
- 138 - 0 138 -
- - - 0 - -
- 177 - 0 177 -
- - - 0 - -
- 480 - 0 480 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
218,680 312 - 700 312 218,680
- - - 0 - -
- - - 0 - -
- 350 - 200 350 70,000
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
95,400 477 - 200 477 95,400
- - - 0 - -
- - - 0 - -
- 1,155 - 100 1,155 115,500
- - - 0 - -
- 183 - 0 183 -
- - - 0 - -
- 283 - 0 283 -
- - - 0 - -
- 42 - 0 42 -
- 42 - 0 42 -
- - - 0 - -
- 770 - 0 770 -
- - - 0 - -
- 2,680 - 0 2,680 -
- - - 0 - -
- 363 - 22 363 7,986
- - - 0 - -
- 45 - 0 45 -
- 45 - 160 45 7,200
- - - 0 - -
- 63 - 0 63 -
- - - 0 - -
- 7,392 - 0 7,392 -
- - - 0 - -
- 112 - 0 112 -
- 112 - 0 112 -
336,000 1310 112 146,720 1890 112 211,680
- - - 0 - -
- 521 - 0 521 -
208,400 521 - 400 521 208,400
- 521 - 0 521 -
- - - 0 - -
- 8,140 - 0 8,140 -
- 2 8,140 16,280 5 8,140 40,700
- - - 0 - -
- 573 - 0 573 -
- 6,975 - 2 6,975 13,950
- - - 0 - -
- 10,395 - 4 10,395 41,580
- - - 0 - -
- 155 - 0 155 -
- 141 - 1000 141 141,000
- - - 0 - -
- - - 0 - -
- 1,210 - 0 1,210 -
- - - 0 - -
- 57 - 0 57 -
- - - 0 - -
- 116 - 0 116 -
- 572 - 0 572 -
- - - 0 - -
- 191 - 100 191 19,100
- - - 0 - -
- 275 - 0 275 -
- 275 - 0 275 -
- - - 0 - -
- 162 - 0 162 -
- - - 0 - -
- 1,108 - 0 1,108 -
26,616 1 1,109 1,109 23 1,109 25,507
- - - 0 - -
- 162 - 0 162 -
- - - 0 - -
- 116 - 0 116 -
- - - 0 - -
- 167 - 0 167 -
- - - 0 - -
- 125 - 0 125 -
- - - 0 - -
- 318 - 0 318 -
- - - 0 - -
- 109 - 0 109 -
- - - 0 - -
- 45 - 0 45 -
- - - 0 - -
- 854 - 0 854 -
- - - 0 - -
- 42,727 - 0 42,727 -
854,540 5 42,727 213,635 15 42,727 640,905
- -
- 1,480 - 0 1,480 -
1,480,000 250 1,480 370,000 1000 1,480 1,480,000
- -
- 31 - 0 31 -
- - - 0 - -
- 56 - 0 56 -
- - - 0 - -
- - - 0 - -
- 765,000 - 0 765,000 -
1,530,000 765,000 - 2 765,000 1,530,000
- - - 0 - -
- 242,000 - 0 242,000 -
- - - 0 - -
- 338,800 - 0 338,800 -
677,600 338,800 - 2 338,800 677,600
- - - 0 - -
- 390,000 - 0 390,000 -
- 390,000 - 0 390,000 -
- - - 0 - -
- 18,333 - 0 18,333 -
- 18,333 - 0 18,333 -
- - - 0 - -
- 105,000 - 0 105,000 -
420,000 105,000 - 4 105,000 420,000
- - - 0 - -
- 170,000 - 0 170,000 -
- - - 0 - -
- 395,000 - 0 395,000 -
395,790 2 197,895 395,790 0 197,895 -
- - - 0 - -
- 55,000 - 1 55,000 55,000
- - - 0 - -
- 93,500 - 0 93,500 -
- 93,500 - 2 93,500 187,000
- - - 0 - -
- 34,000 - 0 34,000 -
- 34,000 - 0 34,000 -
- - - 0 - -
- 176,000 - 0 176,000 -
- - - 0 - -
- - - 0 - -
- 425 - 0 425 -
- 24,384 - 0 24,384 -
- 27,569 - 0 27,569 -
- 27,569 - 8 27,569 220,552
- - - 0 - -
- 104 - 0 104 -
- 104 - 2000 104 208,000
- - - 0 - -
- 825,000 - 0 825,000 -
- 4,545 - 0 4,545 -
- 236,490 - 0 236,490 -
- 396,000 - 0 396,000 -
- 1,319,990 - 0 1,319,990 -
- 175,899 - 0 175,899 -
- 145,000 - 0 145,000 -
- 150,000 - 0 150,000 -
- 168,300 - 0 168,300 -
- 46,200 - 0 46,200 -
- 45,560 - 0 45,560 -
- 42,350 - 0 42,350 -
- 20,454 - 0 20,454 -
- 4,438 - 0 4,438 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 285,000 - 0 285,000 -
- 695,752 - 0 695,752 -
- 412 - 0 412 -
- 286 - 0 286 -
- 497 - 0 497 -
- - - 0 - -
- - - 0 - -
- 1,093 - 0 1,093 -
- 848 - 0 848 -
84,825 17 848 14,420 194 848 164,561
- - - 0 - -
- 1,038 - 0 1,038 -
- 17 848 14,420 50 848 42,413
- - - 0 - -
- 1,038 - 0 1,038 -
- 848 - 0 848 -
84,825 25 848 21,206 111 848 94,156
- - - 0 - -
- 1,038 - 0 1,038 -
- 48 979 46,980 248 979 242,730
- - - 0 - -
- 2,099 - 0 2,099 -
- 2,100 - 103 2,100 216,300
- - - 0 - -
- 2,099 - 0 2,099 -
- 13 2,100 27,300 37 2,100 77,700
- - - 0 - -
- 6,400 - 25 6,400 160,000
- 25,920 - 24 25,920 622,080
- - - 0 - -
- 5,900 - 0 5,900 -
- 27,000 - 24 27,000 648,000
- - - 0 - -
- 6,595 - 0 6,595 -
- - - 0 - -
- 6,595 - 0 6,595 -
- - - 0 - -
- 4,250 - 0 4,250 -
- 7,684 - 0 7,684 -
- - - 0 - -
- 4,250 - 0 4,250 -
1,536,800 27 7,684 207,468 185 7,684 1,421,540
- - - 0 - -
- 3,500 - 0 3,500 -
83,520 18 4,176 75,168 15 4,176 62,640
- - - 0 - -
- 4,000 - 4 4,000 16,000
31,976 4,568 - 7 4,568 31,976
- - - 0 - -
- 7,937 - 0 7,937 -
- - - 0 - -
- 6,600 - 0 6,600 -
- - - 0 - -
- 7,787 - 6 7,787 46,722
- - - 0 - -
- 7,787 - 0 7,787 -
- 1 7,937 7,937 29 7,937 230,173
- - - 0 - -
389,350 7,787 - 64 7,787 498,368
- - - 0 - -
- 10,440 - 0 10,440 -
- - - 0 - -
- 8,495 - 0 8,495 -
- 10,440 - 0 10,440 -
- - - 0 - -
- 8,495 - 0 8,495 -
- 10,440 - 0 10,440 -
- - - 0 - -
- 495 - 0 495 -
- 10,440 - 0 10,440 -
- - - 0 - -
- 7,500 - 0 7,500 -
111,284 27,821 - 4 27,821 111,284
- - - 0 - -
- 17,250 - 0 17,250 -
- - - 0 - -
- 800 - 0 800 -
- - - 0 - -
- 887 - 0 887 -
- - - 0 - -
- 607 - 0 607 -
- 21 6,121 128,541 0 6,121 -
- - - 0 - -
- 887 - 0 887 -
- - - 0 - -
- 1,871 - 0 1,871 -
- 5,621 - 0 5,621 -
- - - 0 - -
- 8,600 - 0 8,600 -
- 11,724 - 0 11,724 -
- - - 0 - -
- 10,467 - 0 10,467 -
- 13,221 - 0 13,221 -
- - - 0 - -
- - - 0 - -
- 137,025 - 0 137,025 -
- - - 0 - -
- 55,200 - 0 55,200 -
535,284 1 133,821 133,821 3 133,821 401,463
- - - 0 - -
- 32,500 - 2 32,500 65,000
- - - 0 - -
- 23,625 - 0 23,625 -
- 3 23,625 70,875 4 23,625 94,500
- - - 0 - -
- 5,082 - 0 5,082 -
- 1 18,781 18,781 23 18,781 431,963
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 4,000 - 0 4,000 -
- - - 0 - -
- 5,770 - 0 5,770 -
- 5,770 - 200 5,770 1,154,000
- - - 0 - -
- 5,770 - 69 5,770 398,130
- 5,770 - 199 5,770 1,148,230
- - - 0 - -
- 5,770 - 0 5,770 -
- 5,770 - 200 5,770 1,154,000
- - - 0 - -
- 5,770 - 0 5,770 -
- - - 0 - -
- 22,000 - 0 22,000 -
- - - 0 - -
- 22,000 - 0 22,000 -
- - - 0 - -
- 1,125 - 0 1,125 -
168,750 1,125 - 153 1,125 172,125
- - - 0 - -
- 200,455 - 0 200,455 -
1,002,250 125 8,018 1,002,250 75 8,018 601,350
- - - 0 - -
- 68,181 - 0 68,181 -
- - - 0 - -
- 68,181 - 0 68,181 -
- - - 0 - -
- 6,825 - 0 6,825 -
4,028,864 1,769,168 10,307,403
25,869,207 6,678,828 41,436,584
Penanggung Jawab
Laporan
1 Air untuk injeksi amp 25 ml (aqua pro injeksi) Ampul 0 6,050 - 6,050
0 - - -
Antasida, kombinasi : aluminium hidroksida
17 Tab kunyah 0 78 - 78
200 mg + magnesium hidroksida 200 mg
2250 78 175,500 78
0 - - -
Antasida, kombinasi : aluminium hidroksida
18 200 mg + magnesium hidroksida 200 mg Botol 62 2,213 137,206 2,213
Suspensi
61 2,213 134,993 2,213
0 2,213 - 2,213
0 - - -
Antibakteri, kombinasi : basitrasin 500 UI/g+
19 Tube 7 2,767 19,369 2,767
Polimiskin B 10.000 UI/g
Antifungi salep, kombinasi : asam benzoat 6% 0 - - -
+ asam salisilat 3%
20 Tube 11 2,096 23,056 2,096
0 - - -
mg + heksaklorofen 2,5 mg + lidokain
lidokain 10 mg+ seng oksida 120 mg + sup
21 ad 2 g Suppo 38 33,000 1,254,000 33,000
0 - - -
0 - - -
41 Bedak salisil serb 2% Botol 0 1,180 - 1,180
39 1,350 52,650 1,350
0 - - -
Besi (II) sulfat 200 mg + asam folat 0.25 mg
42 Sachet 0 73 - 73
(tablet tambah darah)
0 55 - 55
0 - - -
43 Becefort syrup Botol 0 22,727 - 22,727
4 22,727 90,908 22,727
0 - - -
44 Betametason krim 0,1% Tube 0 1,596 - 1,596
87 1,596 138,852 1,596
0 - - -
45 Betahistin mesilate tablet tablet 0 - - -
0 - - -
46 Bisakodil sup 10 mg (Stolax) Botol 0 - - -
0 - - -
47 Bisakodil tab sal 5 mg Tab sal 0 - - -
0 - - -
48 Bismecon salep tube 0 - - -
0 - - -
Budesonid-formoterol (fixed combination)* ih
49 Botol 0 - - -
80/4,5 mcg
0 - - -
50 Bromheksin tablet tablet 0 42 - 42
0 - - -
51 Deksametason tab 0,5 mg Tab 0 68 - 68
1870 68 127,160 68
0 - - -
52 Deksametason inj 5 mg/ml (i.v./i.m.) Vial 74 1,738 128,612 1,738
0 - - -
53 Desoksimetason salep 0,25% Tube 0 - - -
3 9,983 29,949 9,983
0 - - -
54 Diazepam inj 5 mg/ml (i.v./i.m.) Vial 0 2,578 - 2,578
53 2,578 136,634 2,578
0 - - -
0 - - -
56 Diazepam supposutoria suppo 0 - - -
0 - - -
57 Diazepam tab 2 mg Tab 0 28 - 28
0 - - -
58 Diazepam tab 5 mg Tab 85 28 2,380 28
0 - - -
59 Dietilkarbamazin tab 100 mg Tab 0 - - -
0 - - -
60 Difenhidramin inj 10 mg/ml (i.v./i.m.) Ampul 47 1,160 54,520 1,160
0 - - -
61 Digoksin tab 0,25 mg Tab 100 103 10,300 103
0 - - -
62 Diltiazem kaps SR 100 mg Kaps 0 - - -
0 - - -
63 Diltiazem tab 30 mg Tab 0 141 - 141
560 141 78,960 141
0 - - -
64 Doksisiklin tablet 100 mg Tab 190 278 52,877 278
0 - - -
65 Domperidon susp 5 mg/5 ml Botol 0 3,490 - 3,490
84 3,490 293,160 3,490
0 - - -
66 Domperidon tab 10 mg Tab 0 174 - 174
549 174 95,526 174
0 - - -
67 Efedrin HCl tablet Tab 200 56 11,278 56
0 - - -
68 Ekstrak belladon tablet 10 mg tab 160 42 6,720 42
4000 42 168,000 42
0 - - -
0 - - -
70 Eritromisin kaps 250 mg Kaps 840 522 438,480 522
0 522 - 522
0 - - -
71 Eritromisin sir 200 mg/5 ml Botol 49 7,581 371,469 7,581
0 - - -
72 Eritromisin tab 500 mg Tab 500 1,013 506,385 1,013
0 1,023 - 1,023
0 - - -
73 Etanol 70% cairan 70% Botol 0 2,625 - 2,625
0 2,625 - 2,625
91 2,625 238,875 2,625
0 - - -
74 Etakridin (rivanol) larutan 0.1% Botol 0 4,695 - 4,695
0 4,695 - 4,695
0 - - -
75 Etil klorida semprot 100 ml Botol 0 124 - 124
0 - - -
76 Famotidin tablet 20 mg Tab 0 - - -
0 124 - 124
0 - - -
77 Fenitoin Na inj 50 mg/ml Ampul 0 - - -
0 - - -
78 Fenitoin Na kaps 100 mg Kaps 0 - - -
100 146 14,600 146
0 - - -
79 Fenobarbital inj 50 mg/ml Ampul 0 37 - 37
90 1,980 178,200 1,980
0 - - -
80 Fenobarbital tab 100 mg Tab 0 - - -
0 - - -
81 Fenobarbital tab 30 mg Tab 0 37 - 37
0 - - -
0 - - -
83 Fitomenadion (vitamin K 1) tab sal 10 mg Tab sal 100 698 69,800 698
0 - - -
84 Flukonazol kaps 150 mg Kaps 0 - - -
0 - - -
85 Flusinolon asetonid krim 0,025% Tube 0 - - -
0 - - -
86 Flunarizin tablet tablet 0 2,012 - 2,012
0 - - -
87 Furosemid inj 10 mg/ml (i.v./i.m.) Ampul 39 2,012 78,468 2,012
0 - - -
88 Furosemid tab 40 mg Tab 0 84 - 84
360 84 30,240 84
0 - - -
Garam oralit kombinasi : natrium klorida 0,52
g + kalium klorida 0,30 g + trinatrium sitrat
89 Sachet 0 317 - 317
0,58 g + glukosa anhidrat 2,7 g
0 317 - 317
0 - - -
90 Gameksan lotion 1 % Botol 0 2,420 - 2,420
0 - - -
91 Gemfibrozil kaps 300 mg Kaps 0 323 - 323
0 - - -
92 Gemfibrozil kaps 600 mg Kaps 0 - - -
0 - - -
93 Gentamisin inj 10 mg/ml Ampul 0 3,739 - 3,739
0 - - -
94 Gentamisin salep mata 0,3% Tube 0 - - -
0 - - -
95 Gentamisin salep Kulit Tube 0 2,340 - 2,340
10 1,469 14,690 20 1,469
0 - - -
96 Gentamisin tts mata 0,3% Botol 0 3,194 - 3,194
0 - - -
97 Glibenklamid tab 5 mg Tab 0 61 - 61
320 61 19,520 61
0 - - -
98 Glimepirid tab 4 mg Tab 0 - - -
0 - - -
99 Glipizid tablet 5 mg (Glucotrol 5 mg) Tab 0 - - -
0 - - -
100 Gliseril Guaiakolat tab 100 mg Tab 0 31 - 31
0 31 - 31
10990 31 340,690 31
0 - - -
101 Gliserin lar 50% Botol 0 - - -
0 - - -
102 Glukosamin tablet 500 mg Tab 0 - - -
0 - - -
103 Glukosa Larutan Infus 5% steril Botol 37 5,720 211,640 5,720
0 - - -
104 Glukosa Larutan Infus 10% steril Botol 15 6,270 94,050 6,270
0 - - -
105 Glukosa Larutan Infus 40% steril Botol 0 - - -
0 - - -
106 Griseofulvin (micronized) tab 125 mg Tab 0 230 - 230
0 230 - 230
0 - - -
107 Haloperidol tab 0,5 mg Tab 0 62 - 62
0 - - -
108 Haloperidol tab 1,5 mg Tab 0 76 - 76
190 76 14,440 76
0 - - -
109 Haloperidol tab 5 mg Tab 0 105 - 105
0 105 - 105
0 105 - 105
0 - - -
110 Hidrogen peroksida (H2O2) cairan 3% Botol 0 38,500 - 38,500
0 - - -
111 Hidroklorotiazid (HCT) tab 25 mg Tab 0 40 - 40
9500 40 380,000 40
0 - - -
112 Hidrokortison krim 2,5% Tube 0 - - -
0 - - -
113 Hiosina butilbromida tab 10 mg Tab 0 330 - 330
0 - - -
114 Ibuprofen susp 100 mg/5 ml Botol 0 4,949 - 4,949
0 - - -
115 Ibuprofen tab 200 mg Tab 90 127 11,435 127
500 121 60,500 121
0 - - -
116 Ibuprofen tab 400 mg Tab 0 157 - 157
800 157 125,600 200 157
0 - - -
Ipratropium bromida nebulizer 0,025%
117 Botol 0 - - -
(Atroven sol. for inhalation 0.025%)
0 - - -
118 Isoniazid tab 300 mg Tab 0 - - -
0 - - -
119 Isosorbid dinitrat inj 10 mg/10 ml (Fasorbid) Vial 0 - - -
0 - - -
120 Isosorbid dinitrat tab 5 mg Tab 0 98 - 98
90 98 8,820 98
0 - - -
121 KA-EN 3B Cairan Infus Botol 17 10,000 170,000 10,000
0 - - -
122 Kalsium glukonat inj 100 mg/ml Ampul 20 9,519 190,380 9,519
0 - - -
123 Kalsium laktat (kalk) tab 500 mg Tab 0 51 - 51
0 76 - 76
810 76 61,560 76
0 - - -
124 Kaptopril tab 12,5 mg Tab 0 69 - 69
880 69 60,720 69
0 - - -
125 Kaptopril tab 25 mg Tab 0 97 - 97
590 97 57,230 97
0 - - -
126 Karbamazepin tab 200 mg Tab 0 269 - 269
0 - - -
127 Karbo adsorben (Norit) tab 500 mg Tab 0 - - -
0 - - -
128 Ketamin inj 50 mg/ml (i.v.) Ampul 0 110,000 - 110,000
0 - - -
129 Ketokonazol tab 200 mg Tab 0 320 - 320
190 320 60,800 320
0 - - -
130 Ketokonazol krim 2% Tube 0 5,150 - 5,150
0 5,150 - 5,150
0 - - -
131 Ketorolak inj 10 mg/ml Ampul 0 2,665 - 2,665
90 2,665 239,850 2,665
0 - - -
132 Klaritromisin tab 500 mg Tab 0 - - -
0 - - -
133 Klindamisin kaps 150 mg Kaps 0 405 - 405
0 - - -
134 Kloramfenikol tts mata 0,5% Botol 0 1,680 - 1,680
0 - - -
135 Kloramfenikol kaps 250 mg Kaps 90 275 24,750 275
0 275 - 275
0 - - -
136 Kloramfenikol salep mata 1% Tube 0 1,680 - 1,680
13 1,680 21,840 1,680
0 - - -
137 Kloramfenikol susp 125 mg/5 ml Botol 13 4,016 52,208 4,016
0 - - -
138 Klorfeniramin (CTM) tab 4 mg Tab 0 26 - 26
0 26 - 26
3999 26 105,574 26
0 - - -
139 Klorpromazin inj 25 mg/ml (i.m.) Ampul 0 1,210 - 1,210
0 - - -
140 Klorpromazin tab sal 100 mg Tab sal 0 152 - 152
0 - - -
141 Klorpromazin tab sal 25 mg Tab sal 44 50 2,200 50
0 - - -
0 - - -
Kotrimoksazol (dewasa) kombinasi :
sulfametoksazol 400 mg+ trimetoprim 80
144 Tab 1100 152 167,200 152
mg
0 152 - 152
2583 152 392,616 152
0 - - -
Kotrimoksazol (anak) kombinasi :
sulfametoksazol 100 mg+ trimetoprim 20
145 Tab 0 79 - 79
mg
480 79 37,920 79
0 - - -
Kotrimoksazol (dewasa) kombinasi tiap 5 ml
146 suspensi : sulfametoksazol 200 mg + Botol 3 2,298 6,894 2,298
trimetoprim 40 mg
0 - - -
147 Kuinin inj 25% (i.v.) Vial 0 6,820 - 6,820
0 6,820 - 6,820
0 - - -
148 Kloroquin tab 150 mg Tab 0 112 - 112
0 - - -
149 Lansoprazol kaps 30 mg Kaps 0 - - -
0 - - -
150 Levofloksasin tab 500 mg Tab 0 581 - 581
0 - - -
151 Lidokain gel 2% Tube 0 - - -
0 - - -
152 Lidokain inj 2% (hcl) Vial 0 1,499 - 1,499
115 1,499 172,385 1,499
0 1,499 - 1,499
0 - - -
153 Lisol Botol 0 54,995 - 54,995
0 54,995 - 54,995
0 - - -
154 Loperamid tab 2 mg Tab 0 97 - 97
105 97 10,185 97
0 - - -
155 Loratadin tab 10 mg Tab 0 170 - 170
0 - - -
156 Magnesium sulfat inj 20% Vial 0 7,260 - 7,260
0 7,260 - 7,260
0 - - -
157 Magnesium sulfat inj 40% Vial 0 7,260 - 7,260
20 7,260 145,200 7,260
0 - - -
158 Magnesium sulfat serb, ktg 30 g Sachet 0 1,130 - 1,130
0 - - -
159 Mebendazol sir 50 mg/ml Botol 0 3,887 - 3,887
0 - - -
160 Mebendazol tab 100 mg Tan 90 248 22,320 248
0 - - -
161 Metformin tab 500 mg Tab 0 - - -
0 - - -
162 Metformin tab 850 mg Tab 0 - - -
0 - - -
163 Metilergometrin inj 0,2 mg/ml Ampul 0 1,639 - 1,639
0 - - -
164 Metilergometrin tab salut 0,125 mg Tab sal 10 133 1,331 133
0 - - -
165 Metilprednisolon tab 4 mg Tab 0 - - -
0 - - -
166 Metoklopramid inj 5 mg/ml Vial 0 1,100 - 1,100
0 1,100 - 1,100
55 1,100 60,500 1,100
0 - - -
0 - - -
168 Metoklopramid tab 10 mg Tab 242 100 24,200 100
0 - - -
169 Metronidazol supposutoria 500 mg suppo 0 - - -
0 - - -
170 Metronidazol larutan infus Botol 0 12,980 - 12,980
9 12,980 116,820 12,980
0 - - -
171 Metronidazol tab 250 mg Tab 0 116 - 116
200 116 23,200 116
0 - - -
172 Metronidazol tab 500 mg Tab 0 - - -
800 169 135,200 169
0 - - -
173 Mikonazol krim 2% Tube 0 3,150 - 3,150
11 3,150 34,650 3,150
0 - - -
174 Natrium diklofenak tab 25 mg Tab 0 146 - 146
0 146 - 146
470 146 68,620 146
0 - - -
175 Natrium diklofenak tab 50 mg Tab 0 193 - 193
0 193 - 193
0 193 - 193
1290 193 248,970 193
0 - - -
176 NaCl 0,9% Larutan infus Botol 0 5,170 - 5,170
0 5,170 - 5,170
18 5,170 93,060 20 5,170
0 - - -
177 Nifedipin kaps 10 mg Kaps 0 127 - 127
894 127 113,538 127
0 - - -
0 - - -
179 Nistatin tab vaginal 100.000 UI Tab 190 448 85,120 448
0 - - -
180 Obat Batuk Hitam (OBH) Botol 0 2,310 - 2,310
63 2,310 145,530 2,310
0 - - -
181 Ofloksasin tab 200 mg Tab 0 440 - 440
0 - - -
182 Ofloksasin tab 400 mg Tab 0 700 - 700
40 700 28,000 700
0 - - -
183 Oksitetrasiklin hcl inj 500 mg/ml Vial 0 3,410 - 3,410
0 - - -
184 Oksitetrasiklin hcl salep kulit 3% Tube 0 2,010 - 2,010
0 1,646 - 1,646
60 1,646 98,760 1,646
0 - - -
185 Oksitetrasiklin hcl salep mata 1 % Tube 0 2,772 - 2,772
139 2,772 385,308 2,772
0 - - -
186 Oksitosin inj 10 UI/ml Ampul 0 6,875 - 6,875
14 1,900 26,600 1,900
0 - - -
187 Omeprazol kaps 20 mg Kaps 0 221 - 221
0 221 - 221
0 221 - 221
0 - - -
188 Papaverin tablet 40 mg Tab 0 109 - 109
2850 109 310,650 109
0 - - -
189 Parasetamol sir 120 mg/5 ml Botol 0 1,535 - 1,535
0 1,535 - 1,535
124 1,535 190,340 150 1,535
0 - - -
190 Parasetamol tab 100 mg Tab 0 105 - 105
600 105 63,000 105
0 - - -
191 Parasetamol tab 500 mg Tab 0 88 - 88
0 88 - 88
1085 88 95,480 1,400 88
0 - - -
192 Parasetamol rectal suppo 0 - - -
0 - - -
193 Pehavral tablet multivitamin Tab 0 849 - 849
0 297 - 297
0 297 - 297
0 297 - 297
0 - - -
230 Sianokobalamin (vitamin B12) inj 500 mcg/ml Vial 99 1,451 143,611 1,451
0 - - -
231 Sianokobalamin (vitamin B12) tab 50 mcg Tab 0 150 - 150
0 - - -
232 Simetidin tablet 200 mg Tab 0 138 - 138
0 138 - 138
0 - - -
233 Simvastatin tab sal 10 mg Tab sal 0 177 - 177
0 - - -
234 Simvastatin tab sal 20 mg Tab sal 0 480 - 480
0 - - -
235 Siprofloksasin inf 2 mg/ml Botol 0 - - -
0 - - -
236 Siprofloksasin tab scored 500 mg Tab 700 312 218,680 312
0 - - -
237 Spironolakton tab 100 mg Tab 0 - - -
200 350 70,000 350
0 - - -
238 Sulfasetamid Natrium Tetes mata 1.5% Botol 0 - - -
0 - - -
239 Sukralfat susp 500 mg/5 ml (Ulsafate) Botol 0 - - -
0 - - -
240 Sukralfat tab 500 mg (Ulsidex) Tab 0 - - -
200 477 95,400 477
0 - - -
241 Teofilin tab SR 300 mg (Rethapyl) Tab 0 - - -
100 1,155 115,500 1,155
0 - - -
242 Tetrasiklin kaps 250 mg Kaps 0 183 - 183
0 - - -
243 Tetrasiklin kaps 500 mg Kaps 0 283 - 283
0 - - -
0 - - -
Mengetahui
Kepala Puskesmas Rumbia
Rahmat, AMK
Nip. 19721021 199403 1 004
AN OBAT DAN PERBEKES
SELAMA 1 TAHUN
UN 2016
BULAN : MARET
TAHUN : 2016
- 6,050 - 0 6,050 -
- 123 - 0 123 -
- 123 - 100 123 12,300
- - - 0 - -
- 1,863 - 0 1,863 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 2,560 - 0 2,560 -
- 2,560 - 0 2,560 -
- 2,560 - 0 2,560 -
- 92 2,560 235,520 139 2,560 355,840
- - - 0 - -
- 220 - 0 220 -
- 220 - 0 220 -
- 220 - 0 220 -
- - - 0 - -
- 279 - 0 279 -
- 279 - 0 279 -
- 1980 279 552,420 900 279 251,100
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 78 - 0 78 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 149 - 0 149 -
- 1,265 - 0 1,265 -
- - - 0 - -
- 251 - 0 251 -
- 30 251 7,530 170 251 42,670
- - - 0 - -
- 1,400 - 34 1,400 47,600
- - - 0 - -
- 81 - 0 81 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 1,180 - 0 1,180 -
- 14 1,350 18,900 25 1,350 33,750
- - - 0 - -
- 73 - 0 73 -
- 55 - 0 55 -
- - - 0 - -
- 22,727 - 0 22,727 -
- 22,727 - 4 22,727 90,908
- - - 0 - -
- 1,596 - 0 1,596 -
- 25 1,596 39,900 62 1,596 98,952
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 42 - 0 42 -
- - - 0 - -
- 68 - 0 68 -
- 645 68 43,860 1225 68 83,300
- - - 0 - -
- 1,738 - 74 1,738 128,612
- - - 0 - -
- - - 0 - -
- 2 9,983 19,966 1 9,983 9,983
- - - 0 - -
- 2,578 - 0 2,578 -
- 2,578 - 53 2,578 136,634
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 28 - 0 28 -
- - - 0 - -
- 28 - 85 28 2,380
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 1,160 - 47 1,160 54,520
- - - 0 - -
- 103 - 100 103 10,300
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 141 - 0 141 -
- 141 - 560 141 78,960
- - - 0 - -
- 278 - 190 278 52,877
- - - 0 - -
- 3,490 - 0 3,490 -
- 24 3,490 83,760 60 3,490 209,400
- - - 0 - -
- 174 - 0 174 -
- 218 174 37,932 331 174 57,594
- - - 0 - -
- 100 56 5,639 100 56 5,639
- - - 0 - -
- 42 - 160 42 6,720
- 42 - 4000 42 168,000
- - - 0 - -
- - - 0 - -
- 522 - 840 522 438,480
- 522 - 0 522 -
- - - 0 - -
- 49 7,581 371,469 0 7,581 -
- - - 0 - -
- 1,013 - 500 1,013 506,385
- 1,023 - 0 1,023 -
- - - 0 - -
- 2,625 - 0 2,625 -
- 2,625 - 0 2,625 -
- 20 2,625 52,500 71 2,625 186,375
- - - 0 - -
- 4,695 - 0 4,695 -
- 4,695 - 0 4,695 -
- - - 0 - -
- 124 - 0 124 -
- - - 0 - -
- - - 0 - -
- 124 - 0 124 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 146 - 100 146 14,600
- - - 0 - -
- 37 - 0 37 -
- 1,980 - 90 1,980 178,200
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 37 - 0 37 -
- - - 0 - -
- 698 - 0 698 -
- - - 0 - -
- 698 - 100 698 69,800
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 2,012 - 0 2,012 -
- - - 0 - -
- 2,012 - 39 2,012 78,468
- - - 0 - -
- 84 - 0 84 -
- 84 - 360 84 30,240
- - - 0 - -
- 317 - 0 317 -
- 317 - 0 317 -
- - - 0 - -
- 2,420 - 0 2,420 -
- - - 0 - -
- 323 - 0 323 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 3,739 - 0 3,739 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 2,340 - 0 2,340 -
29,380 10 1,469 14,690 20 1,469 29,380
- - - 0 - -
- 3,194 - 0 3,194 -
- - - 0 - -
- 61 - 0 61 -
- 61 - 320 61 19,520
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 31 - 0 31 -
- 31 - 0 31 -
- 820 31 25,420 10170 31 315,270
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 5,720 - 37 5,720 211,640
- - - 0 - -
- 6,270 - 15 6,270 94,050
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 230 - 0 230 -
- 230 - 0 230 -
- - - 0 - -
- 62 - 0 62 -
- - - 0 - -
- 76 - 0 76 -
- 76 - 190 76 14,440
- - - 0 - -
- 105 - 0 105 -
- 105 - 0 105 -
- 105 - 0 105 -
- - - 0 - -
- 38,500 - 0 38,500 -
- - - 0 - -
- 40 - 0 40 -
- 40 - 9500 40 380,000
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 330 - 0 330 -
- - - 0 - -
- 4,949 - 0 4,949 -
- - - 0 - -
- 90 127 11,435 0 127 -
- 121 - 500 121 60,500
- - - 0 - -
- 157 - 0 157 -
31,400 592 157 92,944 408 157 64,056
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 98 - 0 98 -
- 98 - 90 98 8,820
- - - 0 - -
- 10,000 - 17 10,000 170,000
- - - 0 - -
- 9,519 - 20 9,519 190,380
- - - 0 - -
- 51 - 0 51 -
- 76 - 0 76 -
- 570 76 43,320 240 76 18,240
- - - 0 - -
- 69 - 0 69 -
- 650 69 44,850 230 69 15,870
- - - 0 - -
- 97 - 0 97 -
- 97 - 590 97 57,230
- - - 0 - -
- 269 - 0 269 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 110,000 - 0 110,000 -
- - - 0 - -
- 320 - 0 320 -
- 40 320 12,800 150 320 48,000
- - - 0 - -
- 5,150 - 0 5,150 -
- 5,150 - 0 5,150 -
- - - 0 - -
- 2,665 - 0 2,665 -
- 2,665 - 90 2,665 239,850
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 405 - 0 405 -
- - - 0 - -
- 1,680 - 0 1,680 -
- - - 0 - -
- 275 - 90 275 24,750
- 275 - 0 275 -
- - - 0 - -
- 1,680 - 0 1,680 -
- 1,680 - 13 1,680 21,840
- - - 0 - -
- 4,016 - 13 4,016 52,208
- - - 0 - -
- 26 - 0 26 -
- 26 - 0 26 -
- 1030 26 27,192 2969 26 78,382
- - - 0 - -
- 1,210 - 0 1,210 -
- - - 0 - -
- 152 - 0 152 -
- - - 0 - -
- 50 - 44 50 2,200
- - - 0 - -
- 531 - 0 531 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 152 - 0 152 -
- 152 - 2583 152 392,616
- - - 0 - -
- 79 - 0 79 -
- - - 0 - -
- 6,820 - 0 6,820 -
- 6,820 - 0 6,820 -
- - - 0 - -
- 112 - 0 112 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 581 - 0 581 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 1,499 - 0 1,499 -
- 64 1,499 95,936 51 1,499 76,449
- 1,499 - 0 1,499 -
- - - 0 - -
- 54,995 - 0 54,995 -
- 54,995 - 0 54,995 -
- - - 0 - -
- 97 - 0 97 -
- 90 97 8,730 15 97 1,455
- - - 0 - -
- 170 - 0 170 -
- - - 0 - -
- 7,260 - 0 7,260 -
- 7,260 - 0 7,260 -
- - - 0 - -
- 7,260 - 0 7,260 -
- 7,260 - 20 7,260 145,200
- - - 0 - -
- 1,130 - 0 1,130 -
- - - 0 - -
- 3,887 - 0 3,887 -
- - - 0 - -
- 248 - 90 248 22,320
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 1,639 - 0 1,639 -
- - - 0 - -
- 10 133 1,331 0 133 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 1,100 - 0 1,100 -
- 1,100 - 0 1,100 -
- 55 1,100 60,500 0 1,100 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 10 100 1,000 232 100 23,200
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 12,980 - 0 12,980 -
- 12,980 - 9 12,980 116,820
- - - 0 - -
- 116 - 0 116 -
- 20 116 2,320 180 116 20,880
- - - 0 - -
- - - 0 - -
- 220 169 37,180 580 169 98,020
- - - 0 - -
- 3,150 - 0 3,150 -
- 5 3,150 15,750 6 3,150 18,900
- - - 0 - -
- 146 - 0 146 -
- 146 - 0 146 -
- 410 146 59,860 60 146 8,760
- - - 0 - -
- 193 - 0 193 -
- 193 - 0 193 -
- 193 - 0 193 -
- 760 193 146,680 530 193 102,290
- - - 0 - -
- 5,170 - 0 5,170 -
- 5,170 - 0 5,170 -
103,400 18 5,170 93,060 20 5,170 103,400
- - - 0 - -
- 127 - 0 127 -
- 34 127 4,318 860 127 109,220
- - - 0 - -
- 704 - 0 704 -
- - - 0 - -
- 25,350 - 0 25,350 -
- 25,350 - 3 25,350 76,050
- - - 0 - -
- 107 - 800 107 85,600
- 107 - 0 107 -
- - - 0 - -
- 964 - 0 964 -
- 10 964 9,640 210 964 202,440
- - - 0 - -
- 854 - 0 854 -
- 854 - 130 854 111,020
- - - 0 - -
- 60,500 - 50 60,500 3,025,000
- - - 0 - -
- 1 9,100 9,100 49 9,100 445,900
- - - 0 - -
- 318 - 0 318 -
- 4 318 1,272 79 318 25,122
- - - 0 - -
- 19 - 0 19 -
- 430 19 8,170 550 19 10,450
- - - 0 - -
- 116 - 0 116 -
- 210 116 24,360 1010 116 117,160
- - - 0 - -
- 18,635 - 0 18,635 -
- 18,635 - 10 18,635 186,350
- - - 0 - -
- 2,344 - 0 2,344 -
- 40,202 - 0 40,202 -
- 40,202 - 0 40,202 -
- - - 0 - -
- 98 - 0 98 -
- 570 98 55,860 2264 98 221,872
- - - 0 - -
- 125 - 985 125 123,125
- - - 0 - -
- 12,021 - 0 12,021 -
- 18 12,021 216,378 40 12,021 480,840
- - - 0 - -
- 297 - 100 297 29,700
- - - 0 - -
- 80 - 90 80 7,200
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 128 - 0 128 -
12,800 220 128 28,160 0 128 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 440 - 0 440 -
- - - 0 - -
- 624 - 0 624 -
- - - 0 - -
- 863 - 0 863 -
- - - 0 - -
- 5,720 - 0 5,720 -
800,800 124 5,720 709,280 43 5,720 245,960
- - - 0 - -
- 92 - 0 92 -
- 65 - 0 65 -
- 190 65 12,350 280 65 18,200
- - - 0 - -
- 93 - 0 93 -
- 160 93 14,880 400 93 37,200
- - - 0 - -
- 1,980 - 0 1,980 -
- - - 0 - -
- 150 - 0 150 -
- - - 0 - -
- 138 - 0 138 -
- 138 - 0 138 -
- - - 0 - -
- 177 - 0 177 -
- - - 0 - -
- 480 - 0 480 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 312 - 700 312 218,680
- - - 0 - -
- - - 0 - -
- 350 - 200 350 70,000
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 100 477 47,700 100 477 47,700
- - - 0 - -
- - - 0 - -
- 1,155 - 100 1,155 115,500
- - - 0 - -
- 183 - 0 183 -
- - - 0 - -
- 283 - 0 283 -
- - - 0 - -
- 42 - 0 42 -
- 42 - 0 42 -
- - - 0 - -
- 770 - 0 770 -
- - - 0 - -
- 2,680 - 0 2,680 -
- - - 0 - -
- 363 - 22 363 7,986
- - - 0 - -
- 45 - 0 45 -
- 45 - 160 45 7,200
- - - 0 - -
- 63 - 0 63 -
- - - 0 - -
- 7,392 - 0 7,392 -
- - - 0 - -
- 112 - 0 112 -
- 112 - 0 112 -
112,000 1530 112 171,360 1360 112 152,320
- - - 0 - -
- 521 - 0 521 -
- 521 - 400 521 208,400
- 521 - 0 521 -
- - - 0 - -
- 8,140 - 0 8,140 -
- 8,140 - 5 8,140 40,700
- - - 0 - -
- 573 - 0 573 -
- 6,975 - 2 6,975 13,950
- - - 0 - -
- 4 10,395 41,580 0 10,395 -
- - - 0 - -
- 155 - 0 155 -
- 141 - 1000 141 141,000
- - - 0 - -
- - - 0 - -
- 1,210 - 0 1,210 -
- - - 0 - -
- 57 - 0 57 -
- - - 0 - -
- 116 - 0 116 -
- 572 - 0 572 -
- - - 0 - -
- 191 - 100 191 19,100
- - - 0 - -
- 275 - 0 275 -
- 275 - 0 275 -
- - - 0 - -
- 162 - 0 162 -
- - - 0 - -
- 1,108 - 0 1,108 -
- 7 1,109 7,763 16 1,109 17,744
- - - 0 - -
- 162 - 0 162 -
- - - 0 - -
- 116 - 0 116 -
- - - 0 - -
- 167 - 0 167 -
- - - 0 - -
- 125 - 0 125 -
- - - 0 - -
- 318 - 0 318 -
- - - 0 - -
- 109 - 0 109 -
- - - 0 - -
- 45 - 0 45 -
- - - 0 - -
- 854 - 0 854 -
- - - 0 - -
- 42,727 - 0 42,727 -
- 3 42,727 128,181 12 42,727 512,724
- -
- 1,480 - 0 1,480 -
- 265 1,480 392,200 735 1,480 1,087,800
- -
- 31 - 0 31 -
- - - 0 - -
- 56 - 0 56 -
- - - 0 - -
- - - 0 - -
- 765,000 - 0 765,000 -
- 765,000 - 2 765,000 1,530,000
- - - 0 - -
- 242,000 - 0 242,000 -
- - - 0 - -
- 338,800 - 0 338,800 -
- 338,800 - 2 338,800 677,600
- - - 0 - -
- 390,000 - 0 390,000 -
- 390,000 - 0 390,000 -
- - - 0 - -
- 18,333 - 0 18,333 -
- 18,333 - 0 18,333 -
- - - 0 - -
- 105,000 - 0 105,000 -
- 105,000 - 4 105,000 420,000
- - - 0 - -
- 170,000 - 0 170,000 -
- - - 0 - -
- 395,000 - 0 395,000 -
- 197,895 - 0 197,895 -
- - - 0 - -
- 55,000 - 1 55,000 55,000
- - - 0 - -
- 93,500 - 0 93,500 -
- 93,500 - 2 93,500 187,000
- - - 0 - -
- 34,000 - 0 34,000 -
- 34,000 - 0 34,000 -
- - - 0 - -
- 176,000 - 0 176,000 -
- - - 0 - -
- - - 0 - -
- 425 - 0 425 -
- 24,384 - 0 24,384 -
- 27,569 - 0 27,569 -
- 27,569 - 8 27,569 220,552
- - - 0 - -
- 104 - 0 104 -
- 104 - 2000 104 208,000
- - - 0 - -
- 825,000 - 0 825,000 -
- 4,545 - 0 4,545 -
- 236,490 - 0 236,490 -
- 396,000 - 0 396,000 -
- 1,319,990 - 0 1,319,990 -
- 175,899 - 0 175,899 -
- 145,000 - 0 145,000 -
- 150,000 - 0 150,000 -
- 168,300 - 0 168,300 -
- 46,200 - 0 46,200 -
- 45,560 - 0 45,560 -
- 42,350 - 0 42,350 -
- 20,454 - 0 20,454 -
- 4,438 - 0 4,438 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 285,000 - 0 285,000 -
- 695,752 - 0 695,752 -
- 412 - 0 412 -
- 286 - 0 286 -
- 497 - 0 497 -
- - - 0 - -
- - - 0 - -
- 1,093 - 0 1,093 -
- 848 - 0 848 -
- 15 848 12,724 179 848 151,837
- - - 0 - -
- 1,038 - 0 1,038 -
- 49 848 41,564 1 848 848
- - - 0 - -
- 1,038 - 0 1,038 -
- 848 - 0 848 -
- 848 - 111 848 94,156
- - - 0 - -
- 1,038 - 0 1,038 -
- 979 - 248 979 242,730
- - - 0 - -
- 2,099 - 0 2,099 -
- 2,100 - 103 2,100 216,300
- - - 0 - -
- 2,099 - 0 2,099 -
- 2,100 - 37 2,100 77,700
- - - 0 - -
- 6,400 - 25 6,400 160,000
- 25,920 - 24 25,920 622,080
- - - 0 - -
- 5,900 - 0 5,900 -
- 18 27,000 486,000 6 27,000 162,000
- - - 0 - -
- 6,595 - 0 6,595 -
- - - 0 - -
- 6,595 - 0 6,595 -
- - - 0 - -
- 4,250 - 0 4,250 -
- 7,684 - 0 7,684 -
- - - 0 - -
- 4,250 - 0 4,250 -
- 180 7,684 1,383,120 5 7,684 38,420
- - - 0 - -
- 3,500 - 0 3,500 -
162,864 27 4,176 112,752 27 4,176 112,752
- - - 0 - -
- 4 4,000 16,000 0 4,000 -
- 1 4,568 4,568 6 4,568 27,408
- - - 0 - -
- 7,937 - 0 7,937 -
- - - 0 - -
- 6,600 - 0 6,600 -
- - - 0 - -
- 6 7,787 46,722 0 7,787 -
70,083 2 7,787 15,574 7 7,787 54,509
- 7,787 - 0 7,787 -
- 18 7,937 142,866 11 7,937 87,307
- - - 0 - -
- 7,787 - 64 7,787 498,368
- - - 0 - -
- 10,440 - 0 10,440 -
- - - 0 - -
- 8,495 - 0 8,495 -
- 10,440 - 0 10,440 -
- - - 0 - -
- 8,495 - 0 8,495 -
- 10,440 - 0 10,440 -
- - - 0 - -
- 495 - 0 495 -
- 10,440 - 0 10,440 -
- - - 0 - -
- 7,500 - 0 7,500 -
- 27,821 - 4 27,821 111,284
- - - 0 - -
- 17,250 - 0 17,250 -
- - - 0 - -
- 800 - 0 800 -
- - - 0 - -
- 887 - 0 887 -
- - - 0 - -
- 607 - 0 607 -
- 6,121 - 0 6,121 -
- - - 0 - -
- 887 - 0 887 -
- - - 0 - -
- 1,871 - 0 1,871 -
- 5,621 - 0 5,621 -
- - - 0 - -
- 8,600 - 0 8,600 -
- 11,724 - 0 11,724 -
- - - 0 - -
- 10,467 - 0 10,467 -
- 13,221 - 0 13,221 -
- - - 0 - -
- - - 0 - -
- 137,025 - 0 137,025 -
- - - 0 - -
- 55,200 - 0 55,200 -
133,821 2 133,821 267,642 2 133,821 267,642
- - - 0 - -
- 32,500 - 2 32,500 65,000
- - - 0 - -
- 23,625 - 0 23,625 -
70,875 5 23,625 118,125 2 23,625 47,250
- - - 0 - -
- 5,082 - 0 5,082 -
- 12 18,781 225,372 11 18,781 206,591
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 4,000 - 0 4,000 -
- - - 0 - -
- 5,770 - 0 5,770 -
- 5,770 - 200 5,770 1,154,000
- - - 0 - -
- 2 5,770 11,540 67 5,770 386,590
- 5,770 - 199 5,770 1,148,230
- - - 0 - -
- 5,770 - 0 5,770 -
- 5,770 - 200 5,770 1,154,000
- - - 0 - -
- 5,770 - 0 5,770 -
- - - 0 - -
- 22,000 - 0 22,000 -
- - - 0 - -
- 22,000 - 0 22,000 -
- - - 0 - -
- 1,125 - 0 1,125 -
- 66 1,125 74,250 87 1,125 97,875
- - - 0 - -
- 200,455 - 0 200,455 -
- 8,018 - 75 8,018 601,350
- - - 0 - -
- 68,181 - 0 68,181 -
- - - 0 - -
- 68,181 - 0 68,181 -
- - - 0 - -
- 6,825 - 0 6,825 -
437,643 2,958,819 7,786,227
2,259,473 9,035,124 34,660,933
Penanggung Jawab
Laporan
1 Air untuk injeksi amp 25 ml (aqua pro injeksi) Ampul 0 6,050 - 6,050
0 - - -
Antasida, kombinasi : aluminium hidroksida
17 Tab kunyah 0 78 - 78
200 mg + magnesium hidroksida 200 mg
0 - - -
mg + heksaklorofen 2,5 mg + lidokain
lidokain 10 mg+ seng oksida 120 mg + sup
21 ad 2 g Suppo 37 33,000 1,221,000 33,000
0 - - -
0 - - -
41 Bedak salisil serb 2% Botol 0 1,180 - 1,180
25 1,350 33,750 30 1,350
0 - - -
Besi (II) sulfat 200 mg + asam folat 0.25 mg
42 Sachet 0 73 - 73
(tablet tambah darah)
0 55 - 3,000 55
0 - - -
43 Becefort syrup Botol 0 22,727 - 22,727
4 22,727 90,908 22,727
0 - - -
44 Betametason krim 0,1% Tube 0 1,596 - 1,596
62 1,596 98,952 50 1,596
0 - - -
45 Betahistin mesilate tablet tablet 0 - - -
0 - - -
46 Bisakodil sup 10 mg (Stolax) Botol 0 - - -
0 - - -
47 Bisakodil tab sal 5 mg Tab sal 0 - - -
0 - - -
48 Bismecon salep tube 0 - - -
0 - - -
Budesonid-formoterol (fixed combination)* ih
49 Botol 0 - - -
80/4,5 mcg
0 - - -
50 Bromheksin tablet tablet 0 42 - 42
0 - - -
51 Deksametason tab 0,5 mg Tab 0 68 - 68
1225 68 83,300 1,000 68
0 - - -
52 Deksametason inj 5 mg/ml (i.v./i.m.) Vial 74 1,738 128,612 1,738
0 - - -
53 Desoksimetason salep 0,25% Tube 0 - - -
1 9,983 9,983 2 9,983
0 - - -
54 Diazepam inj 5 mg/ml (i.v./i.m.) Vial 0 2,578 - 2,578
53 2,578 136,634 2,578
0 - - -
0 - - -
56 Diazepam supposutoria suppo 0 - - -
0 - - -
57 Diazepam tab 2 mg Tab 0 28 - 28
0 - - -
58 Diazepam tab 5 mg Tab 85 28 2,380 28
0 - - -
59 Dietilkarbamazin tab 100 mg Tab 0 - - -
0 - - -
60 Difenhidramin inj 10 mg/ml (i.v./i.m.) Ampul 47 1,160 54,520 1,160
0 - - -
61 Digoksin tab 0,25 mg Tab 100 103 10,300 103
0 - - -
62 Diltiazem kaps SR 100 mg Kaps 0 - - -
0 - - -
63 Diltiazem tab 30 mg Tab 0 141 - 141
560 141 78,960 141
0 - - -
64 Doksisiklin tablet 100 mg Tab 190 278 52,877 278
0 - - -
65 Domperidon susp 5 mg/5 ml Botol 0 3,490 - 3,490
60 3,490 209,400 3,490
0 - - -
66 Domperidon tab 10 mg Tab 0 174 - 174
331 174 57,594 400 174
0 - - -
67 Efedrin HCl tablet Tab 100 56 5,639 56
0 - - 300 56
0 - - -
70 Eritromisin kaps 250 mg Kaps 840 522 438,480 522
0 522 - 522
0 - - -
71 Eritromisin sir 200 mg/5 ml Botol 0 7,581 - 29 7,581
0 - - -
72 Eritromisin tab 500 mg Tab 500 1,013 506,385 1,013
0 1,023 - 1,023
0 - - -
73 Etanol 70% cairan 70% Botol 0 2,625 - 2,625
0 2,625 - 2,625
71 2,625 186,375 40 2,625
0 - - -
74 Etakridin (rivanol) larutan 0.1% Botol 0 4,695 - 4,695
0 4,695 - 4 4,695
0 - - -
75 Etil klorida semprot 100 ml Botol 0 124 - 124
0 - - -
76 Famotidin tablet 20 mg Tab 0 - - -
0 124 - 124
0 - - -
77 Fenitoin Na inj 50 mg/ml Ampul 0 - - -
0 - - -
78 Fenitoin Na kaps 100 mg Kaps 0 - - -
100 146 14,600 146
0 - - -
79 Fenobarbital inj 50 mg/ml Ampul 0 37 - 37
90 1,980 178,200 1,980
0 - - -
80 Fenobarbital tab 100 mg Tab 0 - - -
0 - - -
81 Fenobarbital tab 30 mg Tab 0 37 - 37
0 - - -
0 - - -
83 Fitomenadion (vitamin K 1) tab sal 10 mg Tab sal 100 698 69,800 698
0 - - -
84 Flukonazol kaps 150 mg Kaps 0 - - -
0 - - -
85 Flusinolon asetonid krim 0,025% Tube 0 - - -
0 - - -
86 Flunarizin tablet tablet 0 2,012 - 2,012
0 - - -
87 Furosemid inj 10 mg/ml (i.v./i.m.) Ampul 39 2,012 78,468 2,012
0 - - -
88 Furosemid tab 40 mg Tab 0 84 - 84
360 84 30,240 84
0 - - -
Garam oralit kombinasi : natrium klorida 0,52
g + kalium klorida 0,30 g + trinatrium sitrat
89 Sachet 0 317 - 317
0,58 g + glukosa anhidrat 2,7 g
0 317 - 317
0 - - -
90 Gameksan lotion 1 % Botol 0 2,420 - 2,420
0 - - -
91 Gemfibrozil kaps 300 mg Kaps 0 323 - 323
0 - - -
92 Gemfibrozil kaps 600 mg Kaps 0 - - -
0 - - -
93 Gentamisin inj 10 mg/ml Ampul 0 3,739 - 3,739
0 - - -
94 Gentamisin salep mata 0,3% Tube 0 - - -
0 - - -
95 Gentamisin salep Kulit Tube 0 2,340 - 2,340
20 1,469 29,380 20 1,469
0 - - -
96 Gentamisin tts mata 0,3% Botol 0 3,194 - 3,194
0 - - -
97 Glibenklamid tab 5 mg Tab 0 61 - 61
320 61 19,520 61
0 - - -
98 Glimepirid tab 4 mg Tab 0 - - -
0 - - -
99 Glipizid tablet 5 mg (Glucotrol 5 mg) Tab 0 - - -
0 - - -
100 Gliseril Guaiakolat tab 100 mg Tab 0 31 - 31
0 31 - 31
10170 31 315,270 1,000 31
0 - - -
101 Gliserin lar 50% Botol 0 - - -
0 - - -
102 Glukosamin tablet 500 mg Tab 0 - - -
0 - - -
103 Glukosa Larutan Infus 5% steril Botol 37 5,720 211,640 5,720
0 - - -
104 Glukosa Larutan Infus 10% steril Botol 15 6,270 94,050 6,270
0 - - -
105 Glukosa Larutan Infus 40% steril Botol 0 - - -
0 - - -
106 Griseofulvin (micronized) tab 125 mg Tab 0 230 - 230
0 230 - 300 230
0 - - -
107 Haloperidol tab 0,5 mg Tab 0 62 - 62
0 - - -
108 Haloperidol tab 1,5 mg Tab 0 76 - 76
190 76 14,440 76
0 - - -
109 Haloperidol tab 5 mg Tab 0 105 - 105
0 105 - 105
0 105 - 105
0 - - -
110 Hidrogen peroksida (H2O2) cairan 3% Botol 0 38,500 - 38,500
0 - - -
111 Hidroklorotiazid (HCT) tab 25 mg Tab 0 40 - 40
9500 40 380,000 40
0 - - -
112 Hidrokortison krim 2,5% Tube 0 - - -
0 - - -
113 Hiosina butilbromida tab 10 mg Tab 0 330 - 330
0 - - -
114 Ibuprofen susp 100 mg/5 ml Botol 0 4,949 - 4,949
0 - - -
115 Ibuprofen tab 200 mg Tab 0 127 - 127
500 121 60,500 500 121
0 - - -
116 Ibuprofen tab 400 mg Tab 0 157 - 157
408 157 64,056 800 157
0 - - -
Ipratropium bromida nebulizer 0,025%
117 Botol 0 - - -
(Atroven sol. for inhalation 0.025%)
0 - - -
118 Isoniazid tab 300 mg Tab 0 - - -
0 - - -
119 Isosorbid dinitrat inj 10 mg/10 ml (Fasorbid) Vial 0 - - -
0 - - -
120 Isosorbid dinitrat tab 5 mg Tab 0 98 - 98
90 98 8,820 98
0 - - -
121 KA-EN 3B Cairan Infus Botol 17 10,000 170,000 10,000
0 - - -
122 Kalsium glukonat inj 100 mg/ml Ampul 20 9,519 190,380 9,519
0 - - -
123 Kalsium laktat (kalk) tab 500 mg Tab 0 51 - 51
0 76 - 76
240 76 18,240 1,200 76
0 - - -
124 Kaptopril tab 12,5 mg Tab 0 69 - 69
230 69 15,870 69
0 - - -
125 Kaptopril tab 25 mg Tab 0 97 - 97
590 97 57,230 97
0 - - -
126 Karbamazepin tab 200 mg Tab 0 269 - 269
0 - - -
127 Karbo adsorben (Norit) tab 500 mg Tab 0 - - -
0 - - -
128 Ketamin inj 50 mg/ml (i.v.) Ampul 0 110,000 - 110,000
0 - - -
129 Ketokonazol tab 200 mg Tab 0 320 - 320
150 320 48,000 320
0 - - -
130 Ketokonazol krim 2% Tube 0 5,150 - 5,150
0 5,150 - 5,150
0 - - -
131 Ketorolak inj 10 mg/ml Ampul 0 2,665 - 2,665
90 2,665 239,850 2,665
0 - - -
132 Klaritromisin tab 500 mg Tab 0 - - -
0 - - -
133 Klindamisin kaps 150 mg Kaps 0 405 - 405
0 - - -
134 Kloramfenikol tts mata 0,5% Botol 0 1,680 - 1,680
0 - - -
135 Kloramfenikol kaps 250 mg Kaps 90 275 24,750 275
0 275 - 275
0 - - -
136 Kloramfenikol salep mata 1% Tube 0 1,680 - 1,680
13 1,680 21,840 1,680
0 - - -
137 Kloramfenikol susp 125 mg/5 ml Botol 13 4,016 52,208 4,016
0 - - -
138 Klorfeniramin (CTM) tab 4 mg Tab 0 26 - 26
0 26 - 26
2969 26 78,382 4,000 26
0 - - -
139 Klorpromazin inj 25 mg/ml (i.m.) Ampul 0 1,210 - 1,210
0 - - -
140 Klorpromazin tab sal 100 mg Tab sal 0 152 - 152
0 - - -
141 Klorpromazin tab sal 25 mg Tab sal 44 50 2,200 200 50
0 - - -
0 - - -
Kotrimoksazol (dewasa) kombinasi :
sulfametoksazol 400 mg+ trimetoprim 80
144 Tab 1100 152 167,200 152
mg
0 152 - 152
2583 152 392,616 4,000 152
0 - - -
Kotrimoksazol (anak) kombinasi :
sulfametoksazol 100 mg+ trimetoprim 20
145 Tab 0 79 - 79
mg
460 79 36,340 79
0 - - -
Kotrimoksazol (dewasa) kombinasi tiap 5 ml
146 suspensi : sulfametoksazol 200 mg + Botol 0 2,298 - 2,298
trimetoprim 40 mg
0 - - -
147 Kuinin inj 25% (i.v.) Vial 0 6,820 - 6,820
0 6,820 - 6,820
0 - - -
148 Kloroquin tab 150 mg Tab 0 112 - 112
0 - - -
149 Lansoprazol kaps 30 mg Kaps 0 - - -
0 - - -
150 Levofloksasin tab 500 mg Tab 0 581 - 581
0 - - -
151 Lidokain gel 2% Tube 0 - - -
0 - - -
152 Lidokain inj 2% (hcl) Vial 0 1,499 - 1,499
51 1,499 76,449 150 1,499
0 1,499 - 1,499
0 - - -
153 Lisol Botol 0 54,995 - 54,995
0 54,995 - 54,995
0 - - -
154 Loperamid tab 2 mg Tab 0 97 - 97
15 97 1,455 800 97
0 - - -
155 Loratadin tab 10 mg Tab 0 170 - 170
0 - - -
156 Magnesium sulfat inj 20% Vial 0 7,260 - 7,260
0 7,260 - 7,260
0 - - -
157 Magnesium sulfat inj 40% Vial 0 7,260 - 7,260
20 7,260 145,200 7,260
0 - - -
158 Magnesium sulfat serb, ktg 30 g Sachet 0 1,130 - 1,130
0 - - -
159 Mebendazol sir 50 mg/ml Botol 0 3,887 - 3,887
0 - - -
160 Mebendazol tab 100 mg Tan 90 248 22,320 248
0 - - -
161 Metformin tab 500 mg Tab 0 - - -
0 - - -
162 Metformin tab 850 mg Tab 0 - - -
0 - - -
163 Metilergometrin inj 0,2 mg/ml Ampul 0 1,639 - 1,639
0 - - -
164 Metilergometrin tab salut 0,125 mg Tab sal 0 133 - 200 133
0 - - -
165 Metilprednisolon tab 4 mg Tab 0 - - -
0 - - -
166 Metoklopramid inj 5 mg/ml Vial 0 1,100 - 1,100
0 1,100 - 1,100
0 1,100 - 1,100
0 - - -
0 - - -
168 Metoklopramid tab 10 mg Tab 232 100 23,200 100
0 - - -
169 Metronidazol supposutoria 500 mg suppo 0 - - -
0 - - -
170 Metronidazol larutan infus Botol 0 12,980 - 12,980
9 12,980 116,820 12,980
0 - - -
171 Metronidazol tab 250 mg Tab 0 116 - 116
180 116 20,880 500 116
0 - - -
172 Metronidazol tab 500 mg Tab 0 - - -
580 169 98,020 600 169
0 - - -
173 Mikonazol krim 2% Tube 0 3,150 - 3,150
6 3,150 18,900 3,150
0 - - -
174 Natrium diklofenak tab 25 mg Tab 0 146 - 146
0 146 - 146
60 146 8,760 900 146
0 - - -
175 Natrium diklofenak tab 50 mg Tab 0 193 - 193
0 193 - 193
0 193 - 193
530 193 102,290 800 193
0 - - -
176 NaCl 0,9% Larutan infus Botol 0 5,170 - 5,170
0 5,170 - 5,170
20 5,170 103,400 60 5,170
0 - - -
177 Nifedipin kaps 10 mg Kaps 0 127 - 127
860 127 109,220 127
0 - - -
0 - - 400 704
179 Nistatin tab vaginal 100.000 UI Tab 190 448 85,120 448
0 - - -
180 Obat Batuk Hitam (OBH) Botol 0 2,310 - 2,310
49 2,310 113,190 70 2,310
0 - - -
181 Ofloksasin tab 200 mg Tab 0 440 - 440
0 - - -
182 Ofloksasin tab 400 mg Tab 0 700 - 700
40 700 28,000 700
0 - - -
183 Oksitetrasiklin hcl inj 500 mg/ml Vial 0 3,410 - 3,410
0 - - -
184 Oksitetrasiklin hcl salep kulit 3% Tube 0 2,010 - 2,010
0 1,646 - 1,646
51 1,646 83,946 1,646
0 - - -
185 Oksitetrasiklin hcl salep mata 1 % Tube 0 2,772 - 2,772
131 2,772 363,132 2,772
0 - - -
186 Oksitosin inj 10 UI/ml Ampul 0 6,875 - 6,875
14 1,900 26,600 1,900
0 - - -
187 Omeprazol kaps 20 mg Kaps 0 221 - 221
0 221 - 221
0 221 - 180 221
0 - - -
188 Papaverin tablet 40 mg Tab 0 109 - 109
2830 109 308,470 109
0 - - -
189 Parasetamol sir 120 mg/5 ml Botol 0 1,535 - 1,535
0 1,535 - 1,535
122 1,535 187,270 300 1,535
0 - - -
190 Parasetamol tab 100 mg Tab 0 105 - 105
400 105 42,000 500 105
0 - - -
191 Parasetamol tab 500 mg Tab 0 88 - 88
0 88 - 88
720 88 63,360 4,800 88
0 - - -
192 Parasetamol rectal suppo 0 - - -
0 - - -
193 Pehavral tablet multivitamin Tab 0 849 - 849
0 297 - 297
0 297 - 297
0 297 - 297
0 - - -
0 - - -
0 - - -
232 Simetidin tablet 200 mg Tab 0 138 - 138
0 138 - 800 138
0 - - -
233 Simvastatin tab sal 10 mg Tab sal 0 177 - 177
0 - - -
234 Simvastatin tab sal 20 mg Tab sal 0 480 - 480
0 - - -
235 Siprofloksasin inf 2 mg/ml Botol 0 - - -
0 - - -
236 Siprofloksasin tab scored 500 mg Tab 700 312 218,680 312
0 - - -
237 Spironolakton tab 100 mg Tab 0 - - -
200 350 70,000 350
0 - - -
238 Sulfasetamid Natrium Tetes mata 1.5% Botol 0 - - -
0 - - -
239 Sukralfat susp 500 mg/5 ml (Ulsafate) Botol 0 - - -
0 - - -
240 Sukralfat tab 500 mg (Ulsidex) Tab 0 - - -
100 477 47,700 400 477
0 - - -
241 Teofilin tab SR 300 mg (Rethapyl) Tab 0 - - -
100 1,155 115,500 1,155
0 - - -
242 Tetrasiklin kaps 250 mg Kaps 0 183 - 700 183
0 - - -
243 Tetrasiklin kaps 500 mg Kaps 0 283 - 283
0 - - -
0 42 - 42
0 - - -
245 Tiamin (vitamin B1) injeksi 100 mg/ml Tab 0 770 - 770
0 - - -
246 Tramadol inj 50 mg/ml Ampul 0 2,680 - 2,680
0 - - -
247 Tramadol tablet 500 mg Tab 22 363 7,986 363
0 - - -
248 Triheksifenidil tab 2 mg Tab 0 45 - 45
160 45 7,200 45
0 - - -
249 Vitamin B12 tablet 50 mcg Tab 0 63 - 63
0 - - -
250 Vitamin B kompleks injeksi Vial 0 7,392 - 7,392
0 - - -
251 Vitamin B kompleks Tab 0 112 - 112
0 112 - 112
1360 112 152,320 6,000 112
0 - - -
252 Zinc tab disp 20 mg Tab 0 521 - 521
400 521 208,400 521
0 521 - 521
0 - - -
253 Zinc sirup 20 mg / 5 ml Botol 0 8,140 - 8,140
5 8,140 40,700 10 8,140
0 - - -
254 Larutan PK botol 0 573 - 573
2 6,975 13,950 6,975
0 - - -
255 Kanamisin inj Vial 0 10,395 - 50 10,395
0 - - -
256 Antalgin 500mg tab 0 155 - 155
1000 141 141,000 141
0 - - -
257 Klorpromazin inj 25 mg/ml (i.m.) Ampul 0 - - -
0 1,210 - 1,210
0 - - -
0 - - -
Mengetahui
Kepala Puskesmas Rumbia
Rahmat, AMK
Nip. 19721021 199403 1 004
AN OBAT DAN PERBEKES
SELAMA 1 TAHUN
UN 2016
BULAN : APRIL
TAHUN : 2016
- 6,050 - 0 6,050 -
- - - 0 - -
- - - 0 - -
- 78 - 0 78 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 149 - 0 149 -
- 1,265 - 0 1,265 -
- - - 0 - -
- 251 - 0 251 -
50,200 95 251 23,845 275 251 69,025
- - - 0 - -
- 1,400 - 34 1,400 47,600
- - - 0 - -
- 81 - 0 81 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 1,180 - 0 1,180 -
40,500 11 1,350 14,850 44 1,350 59,400
- - - 0 - -
- 73 - 0 73 -
- - - 0 - -
- 42 - 0 42 -
- - - 0 - -
- 68 - 0 68 -
68,000 880 68 59,840 1345 68 91,460
- - - 0 - -
- 4 1,738 6,952 70 1,738 121,660
- - - 0 - -
- - - 0 - -
19,966 9,983 - 3 9,983 29,949
- - - 0 - -
- 2,578 - 0 2,578 -
- 1 2,578 2,578 52 2,578 134,056
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 28 - 0 28 -
- - - 0 - -
- 28 - 85 28 2,380
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 1,160 - 47 1,160 54,520
- - - 0 - -
- 103 - 100 103 10,300
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 141 - 0 141 -
- 141 - 560 141 78,960
- - - 0 - -
- 278 - 190 278 52,877
- - - 0 - -
- 3,490 - 0 3,490 -
- 21 3,490 73,290 39 3,490 136,110
- - - 0 - -
- 174 - 0 174 -
69,600 288 174 50,112 443 174 77,082
- - - 0 - -
- 100 56 5,639 0 56 -
16,917 20 56 1,128 280 56 15,789
- - 0 -
- 42 - 160 42 6,720
42,000 42 - 5000 42 210,000
- - - 0 - -
- - - 0 - -
- 522 - 840 522 438,480
- 522 - 0 522 -
- - - 0 - -
219,849 5 7,581 37,905 24 7,581 181,944
- - - 0 - -
- 1,013 - 500 1,013 506,385
- 1,023 - 0 1,023 -
- - - 0 - -
- 2,625 - 0 2,625 -
- 2,625 - 0 2,625 -
105,000 9 2,625 23,625 102 2,625 267,750
- - - 0 - -
- 4,695 - 0 4,695 -
18,780 4,695 - 4 4,695 18,780
- - - 0 - -
- 124 - 0 124 -
- - - 0 - -
- - - 0 - -
- 124 - 0 124 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 146 - 100 146 14,600
- - - 0 - -
- 37 - 0 37 -
- 1,980 - 90 1,980 178,200
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 37 - 0 37 -
- - - 0 - -
- 698 - 0 698 -
- - - 0 - -
- 698 - 100 698 69,800
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 2,012 - 0 2,012 -
- - - 0 - -
- 2,012 - 39 2,012 78,468
- - - 0 - -
- 84 - 0 84 -
- 84 - 360 84 30,240
- - - 0 - -
- 317 - 0 317 -
- 317 - 0 317 -
- - - 0 - -
- 2,420 - 0 2,420 -
- - - 0 - -
- 323 - 0 323 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 3,739 - 0 3,739 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 2,340 - 0 2,340 -
29,380 5 1,469 7,345 35 1,469 51,415
- - - 0 - -
- 3,194 - 0 3,194 -
- - - 0 - -
- 61 - 0 61 -
- 120 61 7,320 200 61 12,200
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 31 - 0 31 -
- 31 - 0 31 -
31,000 1150 31 35,650 10020 31 310,620
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 10 5,720 57,200 27 5,720 154,440
- - - 0 - -
- 6,270 - 15 6,270 94,050
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 230 - 0 230 -
69,000 230 - 300 230 69,000
- - - 0 - -
- 62 - 0 62 -
- - - 0 - -
- 76 - 0 76 -
- 76 - 190 76 14,440
- - - 0 - -
- 105 - 0 105 -
- 105 - 0 105 -
- 105 - 0 105 -
- - - 0 - -
- 38,500 - 0 38,500 -
- - - 0 - -
- 40 - 0 40 -
- 40 - 9500 40 380,000
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 330 - 0 330 -
- - - 0 - -
- 4,949 - 0 4,949 -
- - - 0 - -
- 127 - 0 127 -
60,500 110 121 13,310 890 121 107,690
- - - 0 - -
- 157 - 0 157 -
125,600 428 157 67,196 780 157 122,460
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 98 - 0 98 -
- 98 - 90 98 8,820
- - - 0 - -
- 10,000 - 17 10,000 170,000
- - - 0 - -
- 9,519 - 20 9,519 190,380
- - - 0 - -
- 51 - 0 51 -
- 76 - 0 76 -
91,200 540 76 41,040 900 76 68,400
- - - 0 - -
- 69 - 0 69 -
- 150 69 10,350 80 69 5,520
- - - 0 - -
- 97 - 0 97 -
- 70 97 6,790 520 97 50,440
- - - 0 - -
- 269 - 0 269 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 110,000 - 0 110,000 -
- - - 0 - -
- 320 - 0 320 -
- 60 320 19,200 90 320 28,800
- - - 0 - -
- 5,150 - 0 5,150 -
- 5,150 - 0 5,150 -
- - - 0 - -
- 2,665 - 0 2,665 -
- 2,665 - 90 2,665 239,850
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 405 - 0 405 -
- - - 0 - -
- 1,680 - 0 1,680 -
- - - 0 - -
- 275 - 90 275 24,750
- 275 - 0 275 -
- - - 0 - -
- 1,680 - 0 1,680 -
- 1,680 - 13 1,680 21,840
- - - 0 - -
- 4,016 - 13 4,016 52,208
- - - 0 - -
- 26 - 0 26 -
- 26 - 0 26 -
105,600 1410 26 37,224 5559 26 146,758
- - - 0 - -
- 1,210 - 0 1,210 -
- - - 0 - -
- 152 - 0 152 -
- - - 0 - -
10,000 50 - 244 50 12,200
- - - 0 - -
- 531 - 0 531 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 152 - 0 152 -
608,000 152 - 6583 152 1,000,616
- - - 0 - -
- 79 - 0 79 -
- 2,298 - 0 2,298 -
- - - 0 - -
- 6,820 - 0 6,820 -
- 6,820 - 0 6,820 -
- - - 0 - -
- 112 - 0 112 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 581 - 0 581 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 1,499 - 0 1,499 -
224,850 34 1,499 50,966 167 1,499 250,333
- 1,499 - 0 1,499 -
- - - 0 - -
- 54,995 - 0 54,995 -
- 54,995 - 0 54,995 -
- - - 0 - -
- 97 - 0 97 -
77,600 110 97 10,670 705 97 68,385
- - - 0 - -
- 170 - 0 170 -
- - - 0 - -
- 7,260 - 0 7,260 -
- 7,260 - 0 7,260 -
- - - 0 - -
- 7,260 - 0 7,260 -
- 7,260 - 20 7,260 145,200
- - - 0 - -
- 1,130 - 0 1,130 -
- - - 0 - -
- 3,887 - 0 3,887 -
- - - 0 - -
- 248 - 90 248 22,320
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 1,639 - 0 1,639 -
- - - 0 - -
26,620 10 133 1,331 190 133 25,289
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 1,100 - 0 1,100 -
- 1,100 - 0 1,100 -
- 1,100 - 0 1,100 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 100 - 232 100 23,200
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 12,980 - 0 12,980 -
- 1 12,980 12,980 8 12,980 103,840
- - - 0 - -
- 116 - 0 116 -
58,000 80 116 9,280 600 116 69,600
- - - 0 - -
- - - 0 - -
101,400 560 169 94,640 620 169 104,780
- - - 0 - -
- 3,150 - 0 3,150 -
- 3,150 - 6 3,150 18,900
- - - 0 - -
- 146 - 0 146 -
- 146 - 0 146 -
131,400 146 - 960 146 140,160
- - - 0 - -
- 193 - 0 193 -
- 193 - 0 193 -
- 193 - 0 193 -
154,400 770 193 148,610 560 193 108,080
- - - 0 - -
- 5,170 - 0 5,170 -
- 5,170 - 0 5,170 -
310,200 25 5,170 129,250 55 5,170 284,350
- - - 0 - -
- 127 - 0 127 -
- 49 127 6,223 811 127 102,997
- - - 0 - -
- 704 - 0 704 -
- - 0 -
- 25,350 - 0 25,350 -
- 2,344 - 0 2,344 -
- 40,202 - 0 40,202 -
- 40,202 - 0 40,202 -
- - - 0 - -
- 98 - 0 98 -
98,000 830 98 81,340 2434 98 238,532
- - - 0 - -
- 125 - 985 125 123,125
- - - 0 - -
- 12,021 - 0 12,021 -
240,420 9 12,021 108,189 51 12,021 613,071
- - - 0 - -
59,400 100 297 29,700 200 297 59,400
- - - 0 - -
- 80 - 90 80 7,200
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 128 - 0 128 -
268,800 630 128 80,640 1470 128 188,160
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 440 - 0 440 -
- - - 0 - -
- 624 - 0 624 -
- - - 0 - -
- 863 - 0 863 -
- - - 0 - -
- 5,720 - 0 5,720 -
1,144,000 33 5,720 188,760 210 5,720 1,201,200
- - - 0 - -
- 92 - 0 92 -
- 65 - 0 65 -
26,000 100 65 6,500 580 65 37,700
- - - 0 - -
- 93 - 0 93 -
9,300 100 93 9,300 400 93 37,200
- - - 0 - -
- 1,980 - 0 1,980 -
- - - 0 - -
- 150 - 0 150 -
- - - 0 - -
- 138 - 0 138 -
110,400 12 138 1,656 788 138 108,744
- - - 0 - -
- 177 - 0 177 -
- - - 0 - -
- 480 - 0 480 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 312 - 700 312 218,680
- - - 0 - -
- - - 0 - -
- 350 - 200 350 70,000
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
190,800 100 477 47,700 400 477 190,800
- - - 0 - -
- - - 0 - -
- 1,155 - 100 1,155 115,500
- - - 0 - -
128,398 183 - 700 183 128,398
- - - 0 - -
- 283 - 0 283 -
- - - 0 - -
- 42 - 0 42 -
- 42 - 0 42 -
- - - 0 - -
- 770 - 0 770 -
- - - 0 - -
- 2,680 - 0 2,680 -
- - - 0 - -
- 10 363 3,630 12 363 4,356
- - - 0 - -
- 45 - 0 45 -
- 45 - 160 45 7,200
- - - 0 - -
- 63 - 0 63 -
- - - 0 - -
- 7,392 - 0 7,392 -
- - - 0 - -
- 112 - 0 112 -
- 112 - 0 112 -
672,000 1940 112 217,280 5420 112 607,040
- - - 0 - -
- 521 - 0 521 -
- 521 - 400 521 208,400
- 521 - 0 521 -
- - - 0 - -
- 8,140 - 0 8,140 -
81,400 2 8,140 16,280 13 8,140 105,820
- - - 0 - -
- 573 - 0 573 -
- 6,975 - 2 6,975 13,950
- - - 0 - -
519,750 10,395 - 50 10,395 519,750
- - - 0 - -
- 155 - 0 155 -
- 141 - 1000 141 141,000
- - - 0 - -
- - - 0 - -
- 1,210 - 0 1,210 -
- - - 0 - -
- 57 - 0 57 -
- - - 0 - -
- 116 - 0 116 -
- 572 - 0 572 -
- - - 0 - -
- 191 - 100 191 19,100
- - - 0 - -
- 275 - 0 275 -
- 275 - 0 275 -
- - - 0 - -
- 162 - 0 162 -
- - - 0 - -
- 1,108 - 0 1,108 -
- 1,109 - 16 1,109 17,744
- - - 0 - -
- 162 - 0 162 -
- - - 0 - -
- 116 - 0 116 -
- - - 0 - -
- 167 - 0 167 -
- - - 0 - -
- 125 - 0 125 -
- - - 0 - -
- 318 - 0 318 -
- - - 0 - -
- 109 - 0 109 -
- - - 0 - -
- 45 - 0 45 -
- - - 0 - -
- 854 - 0 854 -
- - - 0 - -
- 42,727 - 0 42,727 -
- 7 42,727 299,089 5 42,727 213,635
- - - 0 - -
- 1,480 - 0 1,480 -
592,000 465 1,480 688,200 670 1,480 991,600
- - - 0 - -
- 31 - 0 31 -
- - - 0 - -
- 56 - 0 56 -
- - - 0 - -
- - - 0 - -
- 765,000 - 0 765,000 -
- 1 765,000 765,000 1 765,000 765,000
- - - 0 - -
- 242,000 - 0 242,000 -
- - - 0 - -
- 338,800 - 0 338,800 -
- 1 338,800 338,800 1 338,800 338,800
- - - 0 - -
- 390,000 - 0 390,000 -
- 390,000 - 0 390,000 -
- - - 0 - -
- 18,333 - 0 18,333 -
18,333 18,333 - 1 18,333 18,333
- - - 0 - -
- 105,000 - 0 105,000 -
- 1 105,000 105,000 3 105,000 315,000
- - - 0 - -
- 170,000 - 0 170,000 -
- - - 0 - -
- 395,000 - 0 395,000 -
197,895 197,895 - 1 197,895 197,895
- - - 0 - -
- 55,000 - 1 55,000 55,000
- - - 0 - -
- 93,500 - 0 93,500 -
- 93,500 - 2 93,500 187,000
- - - 0 - -
- 34,000 - 0 34,000 -
- 34,000 - 0 34,000 -
- - - 0 - -
- 176,000 - 0 176,000 -
- - - 0 - -
- - - 0 - -
- 425 - 0 425 -
- 24,384 - 0 24,384 -
- 27,569 - 0 27,569 -
- 27,569 - 8 27,569 220,552
- - - 0 - -
- 104 - 0 104 -
- 104 - 2000 104 208,000
- - - 0 - -
- 825,000 - 0 825,000 -
- 4,545 - 0 4,545 -
- 236,490 - 0 236,490 -
- 396,000 - 0 396,000 -
- 1,319,990 - 0 1,319,990 -
- 175,899 - 0 175,899 -
- 145,000 - 0 145,000 -
- 150,000 - 0 150,000 -
- 168,300 - 0 168,300 -
- 46,200 - 0 46,200 -
- 45,560 - 0 45,560 -
- 42,350 - 0 42,350 -
- 20,454 - 0 20,454 -
- 4,438 - 0 4,438 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 285,000 - 0 285,000 -
- 695,752 - 0 695,752 -
- 412 - 0 412 -
- 286 - 0 286 -
- 497 - 0 497 -
- - - 0 - -
- - - 0 - -
- 1,093 - 0 1,093 -
- 848 - 0 848 -
- 26 848 22,055 153 848 129,782
- - - 0 - -
- 1,038 - 0 1,038 -
84,825 50 848 42,413 51 848 43,261
- - - 0 - -
- 1,038 - 0 1,038 -
- 848 - 0 848 -
84,825 30 848 25,448 181 848 153,533
- - - 0 - -
- 1,038 - 0 1,038 -
195,750 979 - 448 979 438,480
- - - 0 - -
- 2,099 - 0 2,099 -
- 2,100 - 103 2,100 216,300
- - - 0 - -
- 2,099 - 0 2,099 -
- 8 2,100 16,800 29 2,100 60,900
- - - 0 - -
- 6,400 - 25 6,400 160,000
622,080 25,920 - 48 25,920 1,244,160
- - - 0 - -
- 5,900 - 0 5,900 -
- 27,000 - 6 27,000 162,000
- - - 0 - -
- 6,595 - 0 6,595 -
- - - 0 - -
- 6,595 - 0 6,595 -
- - - 0 - -
- 4,250 - 0 4,250 -
- 7,684 - 0 7,684 -
- - - 0 - -
- 4,250 - 0 4,250 -
- 5 7,684 38,420 0 7,684 -
- - - 0 - -
- 3,500 - 0 3,500 -
208,800 12 4,176 50,112 65 4,176 271,440
- - - 0 - -
- 4,000 - 0 4,000 -
22,840 4 4,568 18,272 7 4,568 31,976
- - - 0 - -
- 7,937 - 0 7,937 -
- - - 0 - -
- 6,600 - 0 6,600 -
- - - 0 - -
- 7,787 - 0 7,787 -
389,350 2 7,787 15,574 55 7,787 428,285
- - - 0 - -
- 7,787 - 0 7,787 -
396,850 6 7,937 47,622 55 7,937 436,535
- - - 0 - -
- 7,787 - 64 7,787 498,368
- - - 0 - -
- 10,440 - 0 10,440 -
- - - 0 - -
- 8,495 - 0 8,495 -
- 10,440 - 0 10,440 -
- - - 0 - -
- 8,495 - 0 8,495 -
- 10,440 - 0 10,440 -
- - - 0 - -
- 495 - 0 495 -
104,400 1 10,440 10,440 9 10,440 93,960
- - - 0 - -
- 7,500 - 0 7,500 -
- 27,821 - 4 27,821 111,284
- - - 0 - -
- 17,250 - 0 17,250 -
- - - 0 - -
- 800 - 0 800 -
- - - 0 - -
- 887 - 0 887 -
- - - 0 - -
- 607 - 0 607 -
306,050 6,121 - 50 6,121 306,050
- - - 0 - -
- 887 - 0 887 -
- - - 0 - -
- 1,871 - 0 1,871 -
- 5,621 - 0 5,621 -
- - - 0 - -
- 8,600 - 0 8,600 -
- 11,724 - 0 11,724 -
- - - 0 - -
- 10,467 - 0 10,467 -
- 13,221 - 0 13,221 -
- - - 0 - -
- - - 0 - -
- 137,025 - 0 137,025 -
- - - 0 - -
- 55,200 - 0 55,200 -
669,105 3 133,821 401,463 4 133,821 535,284
- - - 0 - -
- 32,500 - 2 32,500 65,000
- - - 0 - -
- 23,625 - 0 23,625 -
141,750 2 23,625 47,250 6 23,625 141,750
- - - 0 - -
- 5,082 - 0 5,082 -
1,352,232 3 18,781 56,343 80 18,781 1,502,480
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 4,000 - 0 4,000 -
- - - 0 - -
- 5,770 - 0 5,770 -
- 5,770 - 200 5,770 1,154,000
- - - 0 - -
- 5,770 - 67 5,770 386,590
- 5,770 - 199 5,770 1,148,230
- - - 0 - -
- 5,770 - 0 5,770 -
- 5,770 - 200 5,770 1,154,000
- - - 0 - -
- 5,770 - 0 5,770 -
- - - 0 - -
- 22,000 - 0 22,000 -
- - - 0 - -
- 22,000 - 0 22,000 -
- - - 0 - -
- 1,125 - 0 1,125 -
- 55 1,125 61,875 32 1,125 36,000
- - - 0 - -
- 200,455 - 0 200,455 -
40,090 8,018 - 80 8,018 641,440
- - - 0 - -
- 68,181 - 0 68,181 -
- - - 0 - -
- 68,181 - 0 68,181 -
- - - 0 - -
- 6,825 - 0 6,825 -
4,618,947 854,086 11,551,088
18,033,489 8,259,920 44,434,502
Penanggung Jawab
Laporan
Wa Ode Wahyuni Hambe, S. Si, Apt
Nip. 19870305 201101 2 019
REKAPAN PENGGUNAAN OBAT DAN PERBE
PUSKESMAS SELAMA 1 TAHUN
TAHUN 2016
1 Air untuk injeksi amp 25 ml (aqua pro injeksi) Ampul 0 6,050 - 6,050
2050 78 159,900 78
83 Fitomenadion (vitamin K 1) tab sal 10 mg Tab sal 100 698 69,800 698
0 317 - 317
104 Glukosa Larutan Infus 10% steril Botol 15 6,270 94,050 6,270
122 Kalsium glukonat inj 100 mg/ml Ampul 20 9,519 190,380 9,519
0 152 - 152
6583 152 1,000,616 152
380 79 30,020 79
164 Metilergometrin tab salut 0,125 mg Tab sal 190 133 25,289 133
179 Nistatin tab vaginal 100.000 UI Tab 190 448 85,120 448
199 Pirantel pamoat susp 125 mg/5 ml Botol 48 9,100 436,800 9,100
Botol 300
205 Povidon iodin lar 100 mg/ml 1 15,386 15,386 15,386
ml
4 15,386 61,544 15,386
Botol 1000
206 Povidon iodin lar 100 mg/ml 0 40,202 - 40,202
ml
0 40,202 - 40,202
230 Sianokobalamin (vitamin B12) inj 500 mcg/ml Vial 58 1,451 84,136 1,451
236 Siprofloksasin tab scored 500 mg Tab 700 312 218,680 312
0 42 - 42
245 Tiamin (vitamin B1) injeksi 100 mg/ml Tab 0 770 - 770
B.OBAT GIGI 0 - - -
1 Bonding Botol 0 765,000 - 765,000
1 765,000 765,000 765,000
C.OBAT PROGRAM 0 - - -
1 Albedazole 400mg Tab 0 425 - 425
2 Artemether inj 80 mg/ml Ampul 0 24,384 - 24,384
3 Artesunat serb inj 60 mg/ml (i.v./i.m.) Vial 0 27,569 - 27,569
8 27,569 220,552 27,569
38 Sofratulle Set 0 - - -
Mengetahui
Kepala Puskesmas Rumbia
Rahmat, AMK
Nip. 19721021 199403 1 004
AN OBAT DAN PERBEKES
SELAMA 1 TAHUN
UN 2016
BULAN : MEI
TAHUN : 2016
- 6,050 - 0 6,050 -
- 12,750 - 0 12,750 -
- 363 - 0 363 -
- - - 0 - -
- - - 0 - -
- 245 - 0 245 -
- 18 245 4,410 186 245 45,570
- 18,635 - 0 18,635 -
- - - 0 - -
- 138 - 0 138 -
69,000 160 138 22,080 770 138 106,260
- - - 0 - -
- 2,722 - 0 2,722 -
- 2,722 - 13 2,722 35,386
- 4,204 - 0 4,204 -
- 86 - 100 86 8,600
- 86 - 400 86 34,400
- 123 - 0 123 -
- 123 - 100 123 12,300
- 1,863 - 0 1,863 -
- - - 0 - -
- 2,560 - 0 2,560 -
- 2,560 - 0 2,560 -
- 2,560 - 0 2,560 -
- 46 2,560 117,760 154 2,560 394,240
- 220 - 0 220 -
- 220 - 0 220 -
- 220 - 0 220 -
- 279 - 0 279 -
- 279 - 0 279 -
- 1135 279 316,665 1360 279 379,440
- - - 0 - -
- 78 - 0 78 -
- - - 0 - -
- 149 - 0 149 -
- 155 - 0 155 -
- 1,346 - 0 1,346 -
- 110 - 60 110 6,600
- 127 - 1100 127 139,700
- 178 - 0 178 -
- - - 0 - -
- 105 - 0 105 -
- 860 105 90,300 2900 105 304,500
- 52 - 0 52 -
- 54 52 2,808 430 52 22,360
- - - 0 - -
- 127 - 0 127 -
- 127 - 0 127 -
- 996 127 126,492 2994 127 380,238
- 1,265 - 0 1,265 -
- 81 - 0 81 -
- - - 0 - -
- 1,180 - 0 1,180 -
- 8 1,350 10,800 36 1,350 48,600
- 73 - 0 73 -
- 22,727 - 0 22,727 -
- 22,727 - 4 22,727 90,908
- 1,596 - 0 1,596 -
- 37 1,596 59,052 45 1,596 71,820
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 42 - 0 42 -
- 68 - 0 68 -
- 655 68 44,540 690 68 46,920
- - - 0 - -
- 9,983 - 3 9,983 29,949
- 2,578 - 0 2,578 -
- 2,578 - 52 2,578 134,056
- - - 0 - -
- - - 0 - -
- 28 - 0 28 -
- 8 28 224 77 28 2,156
- - - 0 - -
- - - 0 - -
- 141 - 0 141 -
- 141 - 560 141 78,960
- 3,490 - 0 3,490 -
- 3,490 - 39 3,490 136,110
- 174 - 0 174 -
- 174 - 443 174 77,082
- 56 - 0 56 -
- 111 56 6,259 169 56 9,530
- 42 - 160 42 6,720
- 42 - 5000 42 210,000
- 2,625 - 0 2,625 -
- 2,625 - 0 2,625 -
- 20 2,625 52,500 82 2,625 215,250
- 4,695 - 0 4,695 -
- 1 4,695 4,695 3 4,695 14,085
- 124 - 0 124 -
- - - 0 - -
- 124 - 0 124 -
- - - 0 - -
- - - 0 - -
- 146 - 100 146 14,600
- 37 - 0 37 -
- 1,980 - 90 1,980 178,200
- - - 0 - -
- 37 - 0 37 -
- - - 0 - -
- - - 0 - -
- 2,012 - 0 2,012 -
- 84 - 0 84 -
- 84 - 360 84 30,240
- 317 - 0 317 -
- 317 - 0 317 -
- 2,420 - 0 2,420 -
- 323 - 0 323 -
- - - 0 - -
- 3,739 - 0 3,739 -
- - - 0 - -
- 2,340 - 0 2,340 -
- 11 1,469 16,159 24 1,469 35,256
- 3,194 - 0 3,194 -
- 61 - 0 61 -
- 61 - 200 61 12,200
- - - 0 - -
- - - 0 - -
- 31 - 0 31 -
- 31 - 0 31 -
- 940 31 29,140 9080 31 281,480
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 230 - 0 230 -
- 80 230 18,400 220 230 50,600
- 62 - 0 62 -
- 76 - 0 76 -
- 76 - 190 76 14,440
- 105 - 0 105 -
- 105 - 0 105 -
- 105 - 0 105 -
- 38,500 - 0 38,500 -
- 40 - 0 40 -
- 40 - 9500 40 380,000
- - - 0 - -
- 330 - 0 330 -
- 4,949 - 0 4,949 -
- 127 - 0 127 -
- 80 121 9,680 810 121 98,010
- 157 - 0 157 -
- 410 157 64,370 370 157 58,090
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 98 - 0 98 -
- 98 - 90 98 8,820
- 51 - 0 51 -
- 76 - 0 76 -
- 450 76 34,200 450 76 34,200
- 69 - 0 69 -
- 10 69 690 70 69 4,830
- 97 - 0 97 -
58,200 530 97 51,410 590 97 57,230
- 269 - 0 269 -
- - - 0 - -
- 110,000 - 0 110,000 -
- 320 - 0 320 -
- 80 320 25,600 10 320 3,200
- 5,150 - 0 5,150 -
- 5,150 - 0 5,150 -
- 2,665 - 0 2,665 -
- 2,665 - 90 2,665 239,850
- - - 0 - -
- 405 - 0 405 -
- 1,680 - 0 1,680 -
- 1,680 - 0 1,680 -
- 1,680 - 13 1,680 21,840
- 26 - 0 26 -
- 26 - 0 26 -
- 1200 26 31,680 4359 26 115,078
- 1,210 - 0 1,210 -
- 152 - 0 152 -
- 50 - 244 50 12,200
- 531 - 0 531 -
- - - 0 - -
- 200 152 30,400 850 152 129,200
- 152 - 0 152 -
- 152 - 6583 152 1,000,616
- 79 - 0 79 -
- 79 - 380 79 30,020
- 2,298 - 0 2,298 -
- 6,820 - 0 6,820 -
- 6,820 - 0 6,820 -
- 112 - 0 112 -
- - - 0 - -
- 581 - 0 581 -
- - - 0 - -
- 1,499 - 0 1,499 -
- 85 1,499 127,415 82 1,499 122,918
- 1,499 - 0 1,499 -
- 54,995 - 0 54,995 -
- 54,995 - 0 54,995 -
- 97 - 0 97 -
- 180 97 17,460 525 97 50,925
- 170 - 0 170 -
- 7,260 - 0 7,260 -
- 7,260 - 0 7,260 -
- 7,260 - 0 7,260 -
- 7,260 - 20 7,260 145,200
- 1,130 - 0 1,130 -
- 3,887 - 0 3,887 -
- - - 0 - -
- - - 0 - -
- 1,639 - 0 1,639 -
- - - 0 - -
- 1,100 - 0 1,100 -
- 1,100 - 0 1,100 -
- 1,100 - 0 1,100 -
- - - 0 - -
- - - 0 - -
- 12,980 - 0 12,980 -
- 12,980 - 8 12,980 103,840
- 116 - 0 116 -
- 120 116 13,920 480 116 55,680
- - - 0 - -
84,500 300 169 50,700 820 169 138,580
- 3,150 - 0 3,150 -
53,550 2 3,150 6,300 21 3,150 66,150
- 146 - 0 146 -
- 146 - 0 146 -
- 480 146 70,080 480 146 70,080
- 193 - 0 193 -
- 193 - 0 193 -
- 193 - 0 193 -
- 420 193 81,060 140 193 27,020
- 5,170 - 0 5,170 -
- 5,170 - 0 5,170 -
- 5,170 - 55 5,170 284,350
- 127 - 0 127 -
- 101 127 12,827 710 127 90,170
- 704 - 0 704 -
- 2,310 - 0 2,310 -
- 5 2,310 11,550 93 2,310 214,830
- 440 - 0 440 -
- 700 - 0 700 -
- 700 - 40 700 28,000
- 3,410 - 0 3,410 -
- 2,010 - 0 2,010 -
- 1,646 - 0 1,646 -
- 9 1,646 14,814 28 1,646 46,088
- 2,772 - 0 2,772 -
- 1 2,772 2,772 127 2,772 352,044
- 6,875 - 0 6,875 -
- 1,900 - 13 1,900 24,700
- 221 - 0 221 -
- 221 - 0 221 -
- 90 221 19,890 90 221 19,890
- 109 - 0 109 -
- 109 - 2830 109 308,470
- 1,535 - 0 1,535 -
- 1,535 - 0 1,535 -
- 58 1,535 89,030 304 1,535 466,640
- 105 - 0 105 -
- 222 105 23,310 678 105 71,190
- 88 - 0 88 -
- 88 - 0 88 -
- 1255 88 110,440 3235 88 284,680
- - - 0 - -
- 849 - 0 849 -
- 297 - 0 297 -
- 297 - 0 297 -
- 297 - 0 297 -
- 25,350 - 0 25,350 -
- 964 - 0 964 -
- 964 - 200 964 192,800
- 854 - 0 854 -
- 10 854 8,540 110 854 93,940
- 318 - 0 318 -
- 318 - 469 318 149,142
- 19 - 0 19 -
- 19 - 1200 19 22,800
- 116 - 0 116 -
- 116 - 495 116 57,420
- 18,635 - 0 18,635 -
- 18,635 - 10 18,635 186,350
- 2,344 - 0 2,344 -
- 40,202 - 0 40,202 -
- 40,202 - 0 40,202 -
- 98 - 0 98 -
- 230 98 22,540 2204 98 215,992
- 12,021 - 0 12,021 -
- 4 12,021 48,084 47 12,021 564,987
- 80 - 90 80 7,200
- - - 0 - -
- 128 - 0 128 -
- 730 128 93,440 740 128 94,720
- - - 0 - -
- 440 - 0 440 -
- 624 - 0 624 -
- 863 - 0 863 -
- 5,720 - 0 5,720 -
- 37 5,720 211,640 173 5,720 989,560
- 92 - 0 92 -
- 65 - 0 65 -
- 65 - 580 65 37,700
- 93 - 0 93 -
- 120 93 11,160 280 93 26,040
- 1,980 - 0 1,980 -
- - - 0 - -
- - - 0 - -
- 548 - 0 548 -
- 610 548 334,280 2160 548 1,183,680
- 5,286 - 0 5,286 -
- 13 5,286 68,718 3 5,286 15,858
- - - 0 - -
- - - 0 - -
- 5,414 - 0 5,414 -
- - - 0 - -
- 150 - 0 150 -
- 138 - 0 138 -
- 48 138 6,624 740 138 102,120
- 177 - 0 177 -
- 480 - 0 480 -
- - - 0 - -
- - - 0 - -
- 350 - 200 350 70,000
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 477 - 400 477 190,800
- - - 0 - -
- 1,155 - 100 1,155 115,500
- 283 - 0 283 -
- 42 - 0 42 -
- 42 - 0 42 -
- 770 - 0 770 -
- 2,680 - 0 2,680 -
- 45 - 0 45 -
- 45 - 160 45 7,200
- 63 - 0 63 -
- 7,392 - 0 7,392 -
- 112 - 0 112 -
- 112 - 0 112 -
- 1310 112 146,720 4110 112 460,320
- 521 - 0 521 -
- 55 521 28,655 345 521 179,745
- 521 - 0 521 -
- 8,140 - 0 8,140 -
- 8,140 - 13 8,140 105,820
- 573 - 0 573 -
- 6,975 - 2 6,975 13,950
- 155 - 0 155 -
- 141 - 1000 141 141,000
- - - 0 - -
- 1,210 - 0 1,210 -
- 57 - 0 57 -
- 116 - 0 116 -
- 572 - 0 572 -
- 275 - 0 275 -
- 275 - 0 275 -
- 162 - 0 162 -
- 1,108 - 0 1,108 -
- 1,109 - 16 1,109 17,744
- 162 - 0 162 -
- 116 - 0 116 -
- 167 - 0 167 -
- 125 - 0 125 -
- 318 - 0 318 -
- 109 - 0 109 -
- 45 - 0 45 -
- 854 - 0 854 -
- 42,727 - 0 42,727 -
- 5 42,727 213,635 0 42,727 -
- 1,480 - 0 1,480 -
- 370 1,480 547,600 300 1,480 444,000
- 31 - 0 31 -
- 56 - 0 56 -
- - - 0 - -
- 765,000 - 0 765,000 -
- 765,000 - 1 765,000 765,000
- 242,000 - 0 242,000 -
- 338,800 - 0 338,800 -
- 338,800 - 1 338,800 338,800
- 390,000 - 0 390,000 -
- 390,000 - 0 390,000 -
- 18,333 - 0 18,333 -
- 18,333 - 1 18,333 18,333
- 105,000 - 0 105,000 -
- 1 105,000 105,000 2 105,000 210,000
- 170,000 - 0 170,000 -
- 395,000 - 0 395,000 -
- 197,895 - 1 197,895 197,895
- 93,500 - 0 93,500 -
- 93,500 - 2 93,500 187,000
- 34,000 - 0 34,000 -
- 34,000 - 0 34,000 -
- 176,000 - 0 176,000 -
- - - 0 - -
- 425 - 0 425 -
- 24,384 - 0 24,384 -
- 27,569 - 0 27,569 -
- 27,569 - 8 27,569 220,552
- 104 - 0 104 -
- 104 - 2000 104 208,000
- 825,000 - 0 825,000 -
- 4,545 - 0 4,545 -
- 236,490 - 0 236,490 -
- 396,000 - 0 396,000 -
- 1,319,990 - 0 1,319,990 -
- 175,899 - 0 175,899 -
- 145,000 - 0 145,000 -
- 150,000 - 0 150,000 -
- 168,300 - 0 168,300 -
- 46,200 - 0 46,200 -
- 45,560 - 0 45,560 -
- 42,350 - 0 42,350 -
- 20,454 - 0 20,454 -
- 4,438 - 0 4,438 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 285,000 - 0 285,000 -
- 695,752 - 0 695,752 -
- 412 - 0 412 -
- 286 - 0 286 -
- 497 - 0 497 -
- - - 0 - -
- - - 0 - -
- 1,093 - 0 1,093 -
- 848 - 0 848 -
- 15 848 12,724 138 848 117,059
- 1,038 - 0 1,038 -
- 20 848 16,965 31 848 26,296
- 1,038 - 0 1,038 -
- 848 - 0 848 -
- 1 848 848 180 848 152,685
- 1,038 - 0 1,038 -
- 8 979 7,830 440 979 430,650
- 2,099 - 0 2,099 -
- 2,100 - 103 2,100 216,300
- 2,099 - 0 2,099 -
- 13 2,100 27,300 16 2,100 33,600
- 5,900 - 0 5,900 -
- 27,000 - 6 27,000 162,000
- 6,595 - 0 6,595 -
- 6,595 - 0 6,595 -
- 4,250 - 0 4,250 -
- 7,684 - 0 7,684 -
- 4,250 - 0 4,250 -
768,400 2 7,684 15,368 98 7,684 753,032
- 3,500 - 0 3,500 -
- 11 4,176 45,936 54 4,176 225,504
- 4,000 - 0 4,000 -
- 2 4,568 9,136 5 4,568 22,840
- 7,937 - 0 7,937 -
- 6,600 - 0 6,600 -
- 7,787 - 0 7,787 -
- 9 7,787 70,083 46 7,787 358,202
- 7,787 - 0 7,787 -
- 3 7,937 23,811 52 7,937 412,724
- 10,440 - 0 10,440 -
- 8,495 - 0 8,495 -
- 10,440 - 0 10,440 -
- 8,495 - 0 8,495 -
- 10,440 - 0 10,440 -
- 495 - 0 495 -
- 10,440 - 9 10,440 93,960
- 7,500 - 0 7,500 -
- 2 27,821 55,642 2 27,821 55,642
- 17,250 - 0 17,250 -
- 800 - 0 800 -
- 887 - 0 887 -
- 607 - 0 607 -
- 18 6,121 110,178 32 6,121 195,872
- 887 - 0 887 -
- 1,871 - 0 1,871 -
- 5,621 - 0 5,621 -
- 8,600 - 0 8,600 -
- 11,724 - 0 11,724 -
- 10,467 - 0 10,467 -
- 13,221 - 0 13,221 -
- - - 0 - -
- 137,025 - 0 137,025 -
- 55,200 - 0 55,200 -
- 4 133,821 535,284 0 133,821 -
- 23,625 - 0 23,625 -
- 3 23,625 70,875 3 23,625 70,875
- 5,082 - 0 5,082 -
- 6 18,781 112,686 74 18,781 1,389,794
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 4,000 - 0 4,000 -
- 5,770 - 0 5,770 -
- 5,770 - 200 5,770 1,154,000
- 5,770 - 0 5,770 -
- 5,770 - 200 5,770 1,154,000
- 5,770 - 0 5,770 -
- 22,000 - 0 22,000 -
- 22,000 - 0 22,000 -
- 1,125 - 0 1,125 -
- 32 1,125 36,000 0 1,125 -
- 200,455 - 0 200,455 -
- 8,018 - 80 8,018 641,440
- 68,181 - 0 68,181 -
- 68,181 - 0 68,181 -
- 6,825 - 0 6,825 -
768,400 1,233,866 11,085,622
1,228,390 5,351,754 40,311,138
Penanggung Jawab
Laporan
1 Air untuk injeksi amp 25 ml (aqua pro injeksi) Ampul 0 6,050 - 6,050
0 - - -
Antasida, kombinasi : aluminium hidroksida
17 Tab kunyah 0 78 - 78
200 mg + magnesium hidroksida 200 mg
1630 78 127,140 78
0 - - -
Antasida, kombinasi : aluminium hidroksida
18 200 mg + magnesium hidroksida 200 mg Botol 0 2,213 - 2,213
Suspensi
36 2,213 79,668 2,213
0 2,213 - 2,213
0 - - -
Antibakteri, kombinasi : basitrasin 500 UI/g+
19 Tube 7 2,767 19,369 2,767
Polimiskin B 10.000 UI/g
Antifungi salep, kombinasi : asam benzoat 6% 0 - - -
+ asam salisilat 3%
20 Tube 9 2,096 18,864 2,096
0 - - -
mg + heksaklorofen 2,5 mg + lidokain
lidokain 10 mg+ seng oksida 120 mg + sup
21 ad 2 g Suppo 19 33,000 627,000 33,000
0 - - -
0 - - -
41 Bedak salisil serb 2% Botol 0 1,180 - 1,180
36 1,350 48,600 1,350
0 - - -
Besi (II) sulfat 200 mg + asam folat 0.25 mg
42 Sachet 0 73 - 73
(tablet tambah darah)
560 55 30,800 55
0 - - -
43 Becefort syrup Botol 0 22,727 - 22,727
4 22,727 90,908 22,727
0 - - -
44 Betametason krim 0,1% Tube 0 1,596 - 1,596
45 1,596 71,820 25 1,596
0 - - -
45 Betahistin mesilate tablet tablet 0 - - -
0 - - -
46 Bisakodil sup 10 mg (Stolax) Botol 0 - - -
0 - - -
47 Bisakodil tab sal 5 mg Tab sal 0 - - -
0 - - -
48 Bismecon salep tube 0 - - -
0 - - -
Budesonid-formoterol (fixed combination)* ih
49 Botol 0 - - -
80/4,5 mcg
0 - - -
50 Bromheksin tablet tablet 0 42 - 42
0 - - -
51 Deksametason tab 0,5 mg Tab 0 68 - 68
690 68 46,920 500 68
0 - - -
52 Deksametason inj 5 mg/ml (i.v./i.m.) Vial 168 1,738 291,984 1,738
0 - - -
53 Desoksimetason salep 0,25% Tube 0 - - -
3 9,983 29,949 9,983
0 - - -
54 Diazepam inj 5 mg/ml (i.v./i.m.) Vial 0 2,578 - 2,578
52 2,578 134,056 2,578
0 - - -
0 - - -
56 Diazepam supposutoria suppo 0 - - -
0 - - -
57 Diazepam tab 2 mg Tab 0 28 - 28
0 - - -
58 Diazepam tab 5 mg Tab 77 28 2,156 28
0 - - -
59 Dietilkarbamazin tab 100 mg Tab 0 - - -
0 - - -
60 Difenhidramin inj 10 mg/ml (i.v./i.m.) Ampul 47 1,160 54,520 1,160
0 - - -
61 Digoksin tab 0,25 mg Tab 100 103 10,300 103
0 - - -
62 Diltiazem kaps SR 100 mg Kaps 0 - - -
0 - - -
63 Diltiazem tab 30 mg Tab 0 141 - 141
560 141 78,960 141
0 - - -
64 Doksisiklin tablet 100 mg Tab 190 278 52,877 278
0 - - -
65 Domperidon susp 5 mg/5 ml Botol 0 3,490 - 3,490
39 3,490 136,110 3,490
0 - - -
66 Domperidon tab 10 mg Tab 0 174 - 174
443 174 77,082 174
0 - - -
67 Efedrin HCl tablet Tab 0 56 - 56
169 56 9,530 100 56
0 - - -
68 Ekstrak belladon tablet 10 mg tab 160 42 6,720 42
5000 42 210,000 42
0 - - -
0 - - -
70 Eritromisin kaps 250 mg Kaps 840 522 438,480 522
0 522 - 522
0 - - -
71 Eritromisin sir 200 mg/5 ml Botol 24 7,581 181,944 7,581
0 - - -
72 Eritromisin tab 500 mg Tab 500 1,013 506,385 1,013
0 1,023 - 1,023
0 - - -
73 Etanol 70% cairan 70% Botol 0 2,625 - 2,625
0 2,625 - 2,625
82 2,625 215,250 2,625
0 - - -
74 Etakridin (rivanol) larutan 0.1% Botol 0 4,695 - 4,695
3 4,695 14,085 4,695
0 - - -
75 Etil klorida semprot 100 ml Botol 0 124 - 124
0 - - -
76 Famotidin tablet 20 mg Tab 0 - - -
0 124 - 124
0 - - -
77 Fenitoin Na inj 50 mg/ml Ampul 0 - - -
0 - - -
78 Fenitoin Na kaps 100 mg Kaps 0 - - -
100 146 14,600 146
0 - - -
79 Fenobarbital inj 50 mg/ml Ampul 0 37 - 37
90 1,980 178,200 1,980
0 - - -
80 Fenobarbital tab 100 mg Tab 0 - - -
0 - - -
81 Fenobarbital tab 30 mg Tab 0 37 - 37
0 - - -
0 - - -
83 Fitomenadion (vitamin K 1) tab sal 10 mg Tab sal 100 698 69,800 698
0 - - -
84 Flukonazol kaps 150 mg Kaps 0 - - -
0 - - -
85 Flusinolon asetonid krim 0,025% Tube 0 - - -
0 - - -
86 Flunarizin tablet tablet 0 2,012 - 2,012
0 - - -
87 Furosemid inj 10 mg/ml (i.v./i.m.) Ampul 39 2,012 78,468 2,012
0 - - -
88 Furosemid tab 40 mg Tab 0 84 - 84
360 84 30,240 84
0 - - -
Garam oralit kombinasi : natrium klorida 0,52
g + kalium klorida 0,30 g + trinatrium sitrat
89 Sachet 0 317 - 317
0,58 g + glukosa anhidrat 2,7 g
0 317 - 317
0 - - -
90 Gameksan lotion 1 % Botol 0 2,420 - 2,420
0 - - -
91 Gemfibrozil kaps 300 mg Kaps 0 323 - 323
0 - - -
92 Gemfibrozil kaps 600 mg Kaps 0 - - -
0 - - -
93 Gentamisin inj 10 mg/ml Ampul 0 3,739 - 3,739
0 - - -
94 Gentamisin salep mata 0,3% Tube 0 - - -
0 - - -
95 Gentamisin salep Kulit Tube 0 2,340 - 2,340
24 1,469 35,256 30 1,469
0 - - -
96 Gentamisin tts mata 0,3% Botol 0 3,194 - 3,194
0 - - -
97 Glibenklamid tab 5 mg Tab 0 61 - 61
200 61 12,200 61
0 - - -
98 Glimepirid tab 4 mg Tab 0 - - -
0 - - -
99 Glipizid tablet 5 mg (Glucotrol 5 mg) Tab 0 - - -
0 - - -
100 Gliseril Guaiakolat tab 100 mg Tab 0 31 - 31
0 31 - 31
9080 31 281,480 31
0 - - -
101 Gliserin lar 50% Botol 0 - - -
0 - - -
102 Glukosamin tablet 500 mg Tab 0 - - -
0 - - -
103 Glukosa Larutan Infus 5% steril Botol 27 5,720 154,440 5,720
0 - - -
104 Glukosa Larutan Infus 10% steril Botol 15 6,270 94,050 6,270
0 - - -
105 Glukosa Larutan Infus 40% steril Botol 0 - - -
0 - - -
106 Griseofulvin (micronized) tab 125 mg Tab 0 230 - 230
220 230 50,600 230
0 - - -
107 Haloperidol tab 0,5 mg Tab 0 62 - 62
0 - - -
108 Haloperidol tab 1,5 mg Tab 0 76 - 76
190 76 14,440 76
0 - - -
109 Haloperidol tab 5 mg Tab 0 105 - 105
0 105 - 105
0 105 - 105
0 - - -
110 Hidrogen peroksida (H2O2) cairan 3% Botol 0 38,500 - 38,500
0 - - -
111 Hidroklorotiazid (HCT) tab 25 mg Tab 0 40 - 40
9500 40 380,000 40
0 - - -
112 Hidrokortison krim 2,5% Tube 0 - - -
0 - - -
113 Hiosina butilbromida tab 10 mg Tab 0 330 - 330
0 - - -
114 Ibuprofen susp 100 mg/5 ml Botol 0 4,949 - 4,949
0 - - -
115 Ibuprofen tab 200 mg Tab 0 127 - 127
810 121 98,010 121
0 - - -
116 Ibuprofen tab 400 mg Tab 0 157 - 157
370 157 58,090 157
0 - - -
Ipratropium bromida nebulizer 0,025%
117 Botol 0 - - -
(Atroven sol. for inhalation 0.025%)
0 - - -
118 Isoniazid tab 300 mg Tab 0 - - -
0 - - -
119 Isosorbid dinitrat inj 10 mg/10 ml (Fasorbid) Vial 0 - - -
0 - - -
120 Isosorbid dinitrat tab 5 mg Tab 0 98 - 98
90 98 8,820 98
0 - - -
121 KA-EN 3B Cairan Infus Botol 17 10,000 170,000 10,000
0 - - -
122 Kalsium glukonat inj 100 mg/ml Ampul 20 9,519 190,380 9,519
0 - - -
123 Kalsium laktat (kalk) tab 500 mg Tab 0 51 - 51
0 76 - 76
450 76 34,200 300 76
0 - - -
124 Kaptopril tab 12,5 mg Tab 0 69 - 69
70 69 4,830 69
0 - - -
125 Kaptopril tab 25 mg Tab 0 97 - 97
590 97 57,230 600 97
0 - - -
126 Karbamazepin tab 200 mg Tab 0 269 - 269
0 - - -
127 Karbo adsorben (Norit) tab 500 mg Tab 0 - - -
0 - - -
128 Ketamin inj 50 mg/ml (i.v.) Ampul 0 110,000 - 110,000
0 - - -
129 Ketokonazol tab 200 mg Tab 0 320 - 320
10 320 3,200 320
0 - - -
130 Ketokonazol krim 2% Tube 0 5,150 - 5,150
0 5,150 - 5,150
0 - - -
131 Ketorolak inj 10 mg/ml Ampul 0 2,665 - 2,665
90 2,665 239,850 2,665
0 - - -
132 Klaritromisin tab 500 mg Tab 0 - - -
0 - - -
133 Klindamisin kaps 150 mg Kaps 0 405 - 405
0 - - -
134 Kloramfenikol tts mata 0,5% Botol 0 1,680 - 1,680
0 - - -
135 Kloramfenikol kaps 250 mg Kaps 90 275 24,750 275
0 275 - 275
0 - - -
136 Kloramfenikol salep mata 1% Tube 0 1,680 - 1,680
13 1,680 21,840 1,680
0 - - -
137 Kloramfenikol susp 125 mg/5 ml Botol 13 4,016 52,208 4,016
0 - - -
138 Klorfeniramin (CTM) tab 4 mg Tab 0 26 - 26
0 26 - 26
4359 26 115,078 26
0 - - -
139 Klorpromazin inj 25 mg/ml (i.m.) Ampul 0 1,210 - 1,210
0 - - -
140 Klorpromazin tab sal 100 mg Tab sal 0 152 - 152
0 - - -
141 Klorpromazin tab sal 25 mg Tab sal 244 50 12,200 50
0 - - -
0 152 - 152
6583 152 1,000,616 152
0 - - -
Kotrimoksazol (anak) kombinasi :
sulfametoksazol 100 mg+ trimetoprim 20
145 Tab 0 79 - 79
mg
380 79 30,020 79
0 - - -
Kotrimoksazol (dewasa) kombinasi tiap 5 ml
146 suspensi : sulfametoksazol 200 mg + Botol 0 2,298 - 2,298
trimetoprim 40 mg
0 - - -
147 Kuinin inj 25% (i.v.) Vial 0 6,820 - 6,820
0 6,820 - 6,820
0 - - -
148 Kloroquin tab 150 mg Tab 0 112 - 112
0 - - -
149 Lansoprazol kaps 30 mg Kaps 0 - - -
0 - - -
150 Levofloksasin tab 500 mg Tab 0 581 - 581
0 - - -
151 Lidokain gel 2% Tube 0 - - -
0 - - -
152 Lidokain inj 2% (hcl) Vial 0 1,499 - 1,499
82 1,499 122,918 1,499
0 1,499 - 1,499
0 - - -
153 Lisol Botol 0 54,995 - 54,995
0 54,995 - 54,995
0 - - -
154 Loperamid tab 2 mg Tab 0 97 - 97
525 97 50,925 97
0 - - -
155 Loratadin tab 10 mg Tab 0 170 - 170
0 - - -
156 Magnesium sulfat inj 20% Vial 0 7,260 - 7,260
0 7,260 - 7,260
0 - - -
157 Magnesium sulfat inj 40% Vial 0 7,260 - 7,260
20 7,260 145,200 7,260
0 - - -
158 Magnesium sulfat serb, ktg 30 g Sachet 0 1,130 - 1,130
0 - - -
159 Mebendazol sir 50 mg/ml Botol 0 3,887 - 3,887
0 - - -
160 Mebendazol tab 100 mg Tan 90 248 22,320 248
0 - - -
161 Metformin tab 500 mg Tab 0 - - -
0 - - -
162 Metformin tab 850 mg Tab 0 - - -
0 - - -
163 Metilergometrin inj 0,2 mg/ml Ampul 0 1,639 - 1,639
0 - - -
164 Metilergometrin tab salut 0,125 mg Tab sal 190 133 25,289 133
0 - - -
165 Metilprednisolon tab 4 mg Tab 0 - - -
0 - - -
166 Metoklopramid inj 5 mg/ml Vial 0 1,100 - 1,100
0 1,100 - 1,100
0 1,100 - 1,100
0 - - -
167 Metoklopramid sir 5 mg/5 ml (Lexapram sirup) Botol 0 - - -
0 - - -
168 Metoklopramid tab 10 mg Tab 230 100 23,000 100
0 - - -
169 Metronidazol supposutoria 500 mg suppo 0 - - -
0 - - -
170 Metronidazol larutan infus Botol 0 12,980 - 12,980
8 12,980 103,840 12,980
0 - - -
171 Metronidazol tab 250 mg Tab 0 116 - 116
480 116 55,680 116
0 - - -
172 Metronidazol tab 500 mg Tab 0 - - -
820 169 138,580 169
0 - - -
173 Mikonazol krim 2% Tube 0 3,150 - 3,150
21 3,150 66,150 24 3,150
0 - - -
174 Natrium diklofenak tab 25 mg Tab 0 146 - 146
0 146 - 146
480 146 70,080 146
0 - - -
175 Natrium diklofenak tab 50 mg Tab 0 193 - 193
0 193 - 193
0 193 - 193
140 193 27,020 400 193
0 - - -
176 NaCl 0,9% Larutan infus Botol 0 5,170 - 5,170
0 5,170 - 5,170
55 5,170 284,350 5,170
0 - - -
177 Nifedipin kaps 10 mg Kaps 0 127 - 127
710 127 90,170 127
0 - - -
178 Nistatin tab salut 500.000 UI Tab 0 704 - 704
400 704 281,600 704
0 - - -
179 Nistatin tab vaginal 100.000 UI Tab 190 448 85,120 448
0 - - -
180 Obat Batuk Hitam (OBH) Botol 0 2,310 - 2,310
93 2,310 214,830 2,310
0 - - -
181 Ofloksasin tab 200 mg Tab 0 440 - 440
0 - - -
182 Ofloksasin tab 400 mg Tab 0 700 - 700
40 700 28,000 700
0 - - -
183 Oksitetrasiklin hcl inj 500 mg/ml Vial 0 3,410 - 3,410
0 - - -
184 Oksitetrasiklin hcl salep kulit 3% Tube 0 2,010 - 2,010
0 1,646 - 1,646
28 1,646 46,088 1,646
0 - - -
185 Oksitetrasiklin hcl salep mata 1 % Tube 0 2,772 - 2,772
127 2,772 352,044 2,772
0 - - -
186 Oksitosin inj 10 UI/ml Ampul 0 6,875 - 6,875
13 1,900 24,700 1,900
0 - - -
187 Omeprazol kaps 20 mg Kaps 0 221 - 221
0 221 - 221
90 221 19,890 221
0 - - -
188 Papaverin tablet 40 mg Tab 0 109 - 109
2830 109 308,470 109
0 - - -
189 Parasetamol sir 120 mg/5 ml Botol 0 1,535 - 1,535
0 1,535 - 1,535
304 1,535 466,640 1,535
0 - - -
190 Parasetamol tab 100 mg Tab 0 105 - 105
678 105 71,190 105
0 - - -
191 Parasetamol tab 500 mg Tab 0 88 - 88
0 88 - 88
3235 88 284,680 88
0 - - -
192 Parasetamol rectal suppo 0 - - -
0 - - -
193 Pehavral tablet multivitamin Tab 0 849 - 849
0 297 - 297
0 297 - 297
0 297 - 297
0 - - -
230 Sianokobalamin (vitamin B12) inj 500 mcg/ml Vial 52 1,451 75,432 1,451
0 - - -
0 42 - 42
0 - - -
245 Tiamin (vitamin B1) injeksi 100 mg/ml Tab 0 770 - 770
0 - - -
246 Tramadol inj 50 mg/ml Ampul 0 2,680 - 2,680
0 - - -
247 Tramadol tablet 500 mg Tab 0 363 - 363
0 - - -
248 Triheksifenidil tab 2 mg Tab 0 45 - 45
160 45 7,200 45
0 - - -
249 Vitamin B12 tablet 50 mcg Tab 0 63 - 63
0 - - -
250 Vitamin B kompleks injeksi Vial 0 7,392 - 7,392
0 - - -
251 Vitamin B kompleks Tab 0 112 - 112
0 112 - 112
4110 112 460,320 112
0 - - -
252 Zinc tab disp 20 mg Tab 0 521 - 521
345 521 179,745 521
0 521 - 521
0 - - -
253 Zinc sirup 20 mg / 5 ml Botol 0 8,140 - 8,140
13 8,140 105,820 8,140
0 - - -
254 Larutan PK botol 0 573 - 573
2 6,975 13,950 6,975
0 - - -
255 Kanamisin inj Vial 50 10,395 519,750 10,395
0 - - -
256 Antalgin 500mg tab 0 155 - 155
1000 141 141,000 141
0 - - -
257 Klorpromazin inj 25 mg/ml (i.m.) Ampul 0 - - -
0 1,210 - 1,210
0 - - -
0 - - -
Mengetahui
Kepala Puskesmas Rumbia
Rahmat, AMK
Nip. 19721021 199403 1 004
AN OBAT DAN PERBEKES
SELAMA 1 TAHUN
UN 2016
BULAN : JUNI
TAHUN : 2016
- 6,050 - 0 6,050 -
- - - 0 - -
- - - - -
- 78 - 0 78 -
- 2,213 - 0 2,213 -
- - - - -
- - - - -
- - - 0 - -
- - - - -
- 149 - 0 149 -
- 1,265 - 0 1,265 -
- - - - -
- 251 - 0 251 -
- 251 - 275 251 69,025
- - - - -
- 5 1,400 7,000 29 1,400 40,600
- - - - -
- 81 - 0 81 -
- - - - -
- - - 0 - -
- - - - -
- 1,180 - 0 1,180 -
- 3 1,350 4,050 33 1,350 44,550
- - - - -
- 73 - 0 73 -
- 560 55 30,800 0 55 -
- - - - -
- 22,727 - 0 22,727 -
- 22,727 - 4 22,727 90,908
- - - - -
- 1,596 - 0 1,596 -
39,900 18 1,596 28,728 52 1,596 82,992
- - - - -
- - - 0 - -
- - - - -
- - - 0 - -
- - - - -
- - - 0 - -
- - - - -
- - - 0 - -
- - - - -
- - - 0 - -
- - - - -
- 42 - 0 42 -
- - - - -
- 68 - 0 68 -
34,000 530 68 36,040 660 68 44,880
- - - - -
- 1,738 - 168 1,738 291,984
- - - - -
- - - 0 - -
- 9,983 - 3 9,983 29,949
- - - - -
- 2,578 - 0 2,578 -
- 1 2,578 2,578 51 2,578 131,478
- - - - -
- - - 0 - -
- - - - -
- - - 0 - -
- - - - -
- 28 - 0 28 -
- - - - -
- 28 - 77 28 2,156
- - - - -
- - - 0 - -
- - - - -
- 2 1,160 2,320 45 1,160 52,200
- - - - -
- 103 - 100 103 10,300
- - - - -
- - - 0 - -
- - - - -
- 141 - 0 141 -
- 141 - 560 141 78,960
- - - - -
- 30 278 8,349 160 278 44,528
- - - - -
- 3,490 - 0 3,490 -
- 2 3,490 6,980 37 3,490 129,130
- - - - -
- 174 - 0 174 -
- 150 174 26,100 293 174 50,982
- - - - -
- 56 - 0 56 -
5,639 159 56 8,966 110 56 6,203
- - - - -
- 42 - 160 42 6,720
- 42 - 5000 42 210,000
- - - - -
- - - - -
- 20 522 10,440 820 522 428,040
- 522 - 0 522 -
- - - - -
- 7,581 - 24 7,581 181,944
- - - - -
- 35 1,013 35,447 465 1,013 470,938
- 1,023 - 0 1,023 -
- - - - -
- 2,625 - 0 2,625 -
- 2,625 - 0 2,625 -
- 19 2,625 49,875 63 2,625 165,375
- - - - -
- 4,695 - 0 4,695 -
- 1 4,695 4,695 2 4,695 9,390
- - - - -
- 124 - 0 124 -
- - - - -
- - - 0 - -
- 124 - 0 124 -
- - - - -
- - - 0 - -
- - - - -
- - - 0 - -
- 146 - 100 146 14,600
- - - - -
- 37 - 0 37 -
- 1,980 - 90 1,980 178,200
- - - - -
- - - 0 - -
- - - - -
- 37 - 0 37 -
- - - - -
- - - - -
- 698 - 100 698 69,800
- - - - -
- - - 0 - -
- - - - -
- - - 0 - -
- - - - -
- 2,012 - 0 2,012 -
- - - - -
- 5 2,012 10,060 34 2,012 68,408
- - - - -
- 84 - 0 84 -
- 84 - 360 84 30,240
- - - - -
- 317 - 0 317 -
- 317 - 0 317 -
- - - - -
- 2,420 - 0 2,420 -
- - - - -
- 323 - 0 323 -
- - - - -
- - - 0 - -
- - - - -
- 3,739 - 0 3,739 -
- - - - -
- - - 0 - -
- - - - -
- 2,340 - 0 2,340 -
44,070 14 1,469 20,566 40 1,469 58,760
- - - - -
- 3,194 - 0 3,194 -
- - - - -
- 61 - 0 61 -
- 70 61 4,270 130 61 7,930
- - - - -
- - - 0 - -
- - - - -
- - - 0 - -
- - - - -
- 31 - 0 31 -
- 31 - 0 31 -
- 710 31 22,010 8370 31 259,470
- - - - -
- - - 0 - -
- - - - -
- - - 0 - -
- - - - -
- 5,720 - 27 5,720 154,440
- - - - -
- 6,270 - 15 6,270 94,050
- - - - -
- - - 0 - -
- - - - -
- 230 - 0 230 -
- 120 230 27,600 100 230 23,000
- - - - -
- 62 - 0 62 -
- - - - -
- 76 - 0 76 -
- 76 - 190 76 14,440
- - - - -
- 105 - 0 105 -
- 105 - 0 105 -
- 105 - 0 105 -
- - - - -
- 38,500 - 0 38,500 -
- - - - -
- 40 - 0 40 -
- 40 - 9500 40 380,000
- - - - -
- - - 0 - -
- - - - -
- 330 - 0 330 -
- - - - -
- 4,949 - 0 4,949 -
- - - - -
- 127 - 0 127 -
- 340 121 41,140 470 121 56,870
- - - - -
- 157 - 0 157 -
- 210 157 32,970 160 157 25,120
- - - - -
- - - 0 - -
- - - - -
- - - 0 - -
- - - - -
- - - 0 - -
- - - - -
- 98 - 0 98 -
- 98 - 90 98 8,820
- - - - -
- 10,000 - 17 10,000 170,000
- - - - -
- 9,519 - 20 9,519 190,380
- - - - -
- 51 - 0 51 -
- 76 - 0 76 -
22,800 300 76 22,800 450 76 34,200
- - - - -
- 69 - 0 69 -
- 69 - 70 69 4,830
- - - - -
- 97 - 0 97 -
58,200 308 97 29,876 882 97 85,554
- - - - -
- 269 - 0 269 -
- - - - -
- - - 0 - -
- - - - -
- 110,000 - 0 110,000 -
- - - - -
- 320 - 0 320 -
- 10 320 3,200 0 320 -
- - - - -
- 5,150 - 0 5,150 -
- 5,150 - 0 5,150 -
- - - - -
- 2,665 - 0 2,665 -
- 2,665 - 90 2,665 239,850
- - - - -
- - - 0 - -
- - - - -
- 405 - 0 405 -
- - - - -
- 1,680 - 0 1,680 -
- - - - -
- 275 - 90 275 24,750
- 275 - 0 275 -
- - - - -
- 1,680 - 0 1,680 -
- 1,680 - 13 1,680 21,840
- - - - -
- 4,016 - 13 4,016 52,208
- - - - -
- 26 - 0 26 -
- 26 - 0 26 -
- 960 26 25,344 3399 26 89,734
- - - - -
- 1,210 - 0 1,210 -
- - - - -
- 152 - 0 152 -
- - - - -
- 50 - 244 50 12,200
- - - - -
- 531 - 0 531 -
- - - - -
- - - 0 - -
- - - - -
- 152 - 0 152 -
- 152 - 6583 152 1,000,616
- - - - -
- 79 - 0 79 -
- 79 - 380 79 30,020
- - - - -
- 2,298 - 0 2,298 -
- - - - -
- 6,820 - 0 6,820 -
- 6,820 - 0 6,820 -
- - - - -
- 112 - 0 112 -
- - - - -
- - - 0 - -
- - - - -
- 581 - 0 581 -
- - - - -
- - - 0 - -
- - - - -
- 1,499 - 0 1,499 -
- 23 1,499 34,477 59 1,499 88,441
- 1,499 - 0 1,499 -
- - - - -
- 54,995 - 0 54,995 -
- 54,995 - 0 54,995 -
- - - - -
- 97 - 0 97 -
- 86 97 8,342 439 97 42,583
- - - - -
- 170 - 0 170 -
- - - - -
- 7,260 - 0 7,260 -
- 7,260 - 0 7,260 -
- - - - -
- 7,260 - 0 7,260 -
- 7,260 - 20 7,260 145,200
- - - - -
- 1,130 - 0 1,130 -
- - - - -
- 3,887 - 0 3,887 -
- - - - -
- 248 - 90 248 22,320
- - - - -
- - - 0 - -
- - - - -
- - - 0 - -
- - - - -
- 1,639 - 0 1,639 -
- - - - -
- 20 133 2,662 170 133 22,627
- - - - -
- - - 0 - -
- - - - -
- 1,100 - 0 1,100 -
- 1,100 - 0 1,100 -
- 1,100 - 0 1,100 -
- - - - -
- - - 0 - -
- - - - -
- 100 - 230 100 23,000
- - - - -
- - - 0 - -
- - - - -
- 12,980 - 0 12,980 -
- 12,980 - 8 12,980 103,840
- - - - -
- 116 - 0 116 -
- 90 116 10,440 390 116 45,240
- - - - -
- - - 0 - -
- 210 169 35,490 610 169 103,090
- - - - -
- 3,150 - 0 3,150 -
75,600 14 3,150 44,100 31 3,150 97,650
- - - - -
- 146 - 0 146 -
- 146 - 0 146 -
- 420 146 61,320 60 146 8,760
- - - - -
- 193 - 0 193 -
- 193 - 0 193 -
- 193 - 0 193 -
77,200 120 193 23,160 420 193 81,060
- - - - -
- 5,170 - 0 5,170 -
- 5,170 - 0 5,170 -
- 18 5,170 93,060 37 5,170 191,290
- - - - -
- 127 - 0 127 -
- 10 127 1,270 700 127 88,900
- - - - -
- 704 - 0 704 -
- 704 - 400 704 281,600
- - - - -
- 448 - 190 448 85,120
- - - - -
- 2,310 - 0 2,310 -
- 22 2,310 50,820 71 2,310 164,010
- - - - -
- 440 - 0 440 -
- - - - -
- 700 - 0 700 -
- 700 - 40 700 28,000
- - - - -
- 3,410 - 0 3,410 -
- - - - -
- 2,010 - 0 2,010 -
- 1,646 - 0 1,646 -
- 5 1,646 8,230 23 1,646 37,858
- - - - -
- 2,772 - 0 2,772 -
- 9 2,772 24,948 118 2,772 327,096
- - - - -
- 6,875 - 0 6,875 -
- 10 1,900 19,000 3 1,900 5,700
- - - - -
- 221 - 0 221 -
- 221 - 0 221 -
- 90 221 19,890 0 221 -
- - - - -
- 109 - 0 109 -
- 50 109 5,450 2780 109 303,020
- - - - -
- 1,535 - 0 1,535 -
- 1,535 - 0 1,535 -
- 65 1,535 99,775 239 1,535 366,865
- - - - -
- 105 - 0 105 -
- 278 105 29,190 400 105 42,000
- - - - -
- 88 - 0 88 -
- 88 - 0 88 -
- 1345 88 118,360 1890 88 166,320
- - - - -
- - - 0 - -
- - - - -
- 849 - 0 849 -
- 297 - 0 297 -
- 297 - 0 297 -
- 297 - 0 297 -
- - - - -
- 25,350 - 0 25,350 -
- 2,344 - 0 2,344 -
- 40,202 - 0 40,202 -
- 40,202 - 0 40,202 -
- - - - -
- 98 - 0 98 -
- 610 98 59,780 1594 98 156,212
- - - - -
- 125 - 985 125 123,125
- - - - -
- 12,021 - 0 12,021 -
- 4 12,021 48,084 43 12,021 516,903
- - - - -
- 100 297 29,700 100 297 29,700
- - - - -
- 80 - 90 80 7,200
- - - - -
- - - 0 - -
- - - - -
- 128 - 0 128 -
- 420 128 53,760 320 128 40,960
- - - - -
- - - 0 - -
- - - - -
- 440 - 0 440 -
- - - - -
- 624 - 0 624 -
- - - - -
- 863 - 0 863 -
- - - - -
- 5,720 - 0 5,720 -
- 30 5,720 171,600 143 5,720 817,960
- - - - -
- 92 - 0 92 -
- 65 - 0 65 -
- 30 65 1,950 550 65 35,750
- - - - -
- 93 - 0 93 -
- 60 93 5,580 220 93 20,460
- - - - -
- 1,980 - 0 1,980 -
- - - - -
- 150 - 0 150 -
- - - - -
- 138 - 0 138 -
- 50 138 6,900 690 138 95,220
- - - - -
- 177 - 0 177 -
- - - - -
- 480 - 0 480 -
- - - - -
- - - 0 - -
- - - - -
- 312 - 700 312 218,680
- - - - -
- - - 0 - -
- 350 - 200 350 70,000
- - - - -
- - - 0 - -
- - - - -
- - - 0 - -
- - - - -
- - - 0 - -
- 477 - 400 477 190,800
- - - - -
- - - 0 - -
- 1,155 - 100 1,155 115,500
- - - - -
- 183 - 700 183 128,398
- - - - -
- 283 - 0 283 -
- - - - -
- 42 - 0 42 -
- 42 - 0 42 -
- - - - -
- 770 - 0 770 -
- - - - -
- 2,680 - 0 2,680 -
- - - - -
- 363 - 0 363 -
- - - - -
- 45 - 0 45 -
- 45 - 160 45 7,200
- - - - -
- 63 - 0 63 -
- - - - -
- 7,392 - 0 7,392 -
- - - - -
- 112 - 0 112 -
- 112 - 0 112 -
- 1010 112 113,120 3100 112 347,200
- - - - -
- 521 - 0 521 -
- 521 - 345 521 179,745
- 521 - 0 521 -
- - - - -
- 8,140 - 0 8,140 -
- 8,140 - 13 8,140 105,820
- - - - -
- 573 - 0 573 -
- 6,975 - 2 6,975 13,950
- - - - -
- 2 10,395 20,790 48 10,395 498,960
- - - - -
- 155 - 0 155 -
- 141 - 1000 141 141,000
- - - - -
- - - 0 - -
- 1,210 - 0 1,210 -
- - - - -
- 57 - 0 57 -
- - - - -
- 116 - 0 116 -
- 572 - 0 572 -
- - - - -
- 191 - 100 191 19,100
- - - - -
- 275 - 0 275 -
- 275 - 0 275 -
- - - - -
- 162 - 0 162 -
- - - - -
- 1,108 - 0 1,108 -
- 1,109 - 16 1,109 17,744
- - - - -
- 162 - 0 162 -
- - - - -
- 116 - 0 116 -
- - - - -
- 167 - 0 167 -
- - - - -
- 125 - 0 125 -
- - - - -
- 318 - 0 318 -
- - - - -
- 109 - 0 109 -
- - - - -
- 45 - 0 45 -
- - - - -
- 854 - 0 854 -
- - - - -
- 42,727 - 0 42,727 -
- 42,727 - 0 42,727 -
- - - - -
- 1,480 - 0 1,480 -
- 260 1,480 384,800 40 1,480 59,200
- - - - -
- 31 - 0 31 -
- - - - -
- 56 - 0 56 -
- - - - -
- - - 0 - -
- 765,000 - 0 765,000 -
- 765,000 - 1 765,000 765,000
- - - - -
- 242,000 - 0 242,000 -
- - - - -
- 338,800 - 0 338,800 -
- 338,800 - 1 338,800 338,800
- - - - -
- 390,000 - 0 390,000 -
- 390,000 - 0 390,000 -
- - - - -
- 18,333 - 0 18,333 -
- 18,333 - 1 18,333 18,333
- - - - -
- 105,000 - 0 105,000 -
- 1 105,000 105,000 1 105,000 105,000
- - - - -
- 170,000 - 0 170,000 -
- - - - -
- 395,000 - 0 395,000 -
- 197,895 - 1 197,895 197,895
- - - - -
- 55,000 - 1 55,000 55,000
- - - - -
- 93,500 - 0 93,500 -
- 93,500 - 2 93,500 187,000
- - - - -
- 34,000 - 0 34,000 -
- 34,000 - 0 34,000 -
- - - - -
- 176,000 - 0 176,000 -
- - - - -
- - - 0 - -
- 425 - 0 425 -
- 24,384 - 0 24,384 -
- 27,569 - 0 27,569 -
- 27,569 - 8 27,569 220,552
- - - - -
- 104 - 0 104 -
- 104 - 2000 104 208,000
- - - - -
- 825,000 - 0 825,000 -
- 4,545 - 0 4,545 -
- 236,490 - 0 236,490 -
- 396,000 - 0 396,000 -
- 1,319,990 - 0 1,319,990 -
- 175,899 - 0 175,899 -
- 145,000 - 0 145,000 -
- 150,000 - 0 150,000 -
- 168,300 - 0 168,300 -
- 46,200 - 0 46,200 -
- 45,560 - 0 45,560 -
- 42,350 - 0 42,350 -
- 20,454 - 0 20,454 -
- 4,438 - 0 4,438 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 285,000 - 0 285,000 -
- 695,752 - 0 695,752 -
- 412 - 0 412 -
- 286 - 0 286 -
- 497 - 0 497 -
- - - 0 - -
- - - 0 - -
- 1,093 - 0 1,093 -
- 848 - 0 848 -
- 12 848 10,179 126 848 106,880
- - - - -
- 1,038 - 0 1,038 -
- 31 848 26,296 0 848 -
- - - - -
- 1,038 - 0 1,038 -
- 848 - 0 848 -
- 12 848 10,179 168 848 142,506
- - - - -
- 1,038 - 0 1,038 -
- 3 979 2,936 437 979 427,714
- - - - -
- 2,099 - 0 2,099 -
- 10 2,100 21,000 93 2,100 195,300
- - - - -
- 2,099 - 0 2,099 -
- 14 2,100 29,400 2 2,100 4,200
- - - - -
- 5 6,400 32,000 7 6,400 44,800
- 25,920 - 48 25,920 1,244,160
- - - - -
- 5,900 - 0 5,900 -
- 3 27,000 81,000 3 27,000 81,000
- - - - -
- 6,595 - 0 6,595 -
- - - - -
659,500 6,595 - 100 6,595 659,500
- - - - -
- 4,250 - 0 4,250 -
- 7,684 - 0 7,684 -
- - - - -
- 4,250 - 0 4,250 -
- 95 7,684 729,980 3 7,684 23,052
- - - - -
- 3,500 - 0 3,500 -
- 9 4,176 37,584 45 4,176 187,920
- - - - -
- 4,000 - 0 4,000 -
- 4,568 - 5 4,568 22,840
- - - - -
- 7,937 - 0 7,937 -
- - - - -
- 6,600 - 0 6,600 -
- - - - -
- 7,787 - 0 7,787 -
- 7,787 - 46 7,787 358,202
- - - - -
- 7,787 - 0 7,787 -
- 8 7,937 63,496 44 7,937 349,228
- - - - -
- 8 7,787 62,296 56 7,787 436,072
- - - - -
- 10,440 - 0 10,440 -
- - - - -
- 8,495 - 0 8,495 -
- 10,440 - 0 10,440 -
- - - - -
- 8,495 - 0 8,495 -
- 10,440 - 0 10,440 -
- - - - -
- 495 - 0 495 -
- 1 10,440 10,440 8 10,440 83,520
- - - - -
- 7,500 - 0 7,500 -
- 27,821 - 2 27,821 55,642
- - - - -
- 17,250 - 0 17,250 -
- - - - -
- 800 - 0 800 -
- - - - -
- 887 - 0 887 -
- - - - -
- 607 - 0 607 -
- 22 6,121 134,662 10 6,121 61,210
- - - - -
- 887 - 0 887 -
- - - - -
- 1,871 - 0 1,871 -
- 5,621 - 0 5,621 -
- - - - -
- 8,600 - 0 8,600 -
- 11,724 - 0 11,724 -
- - - - -
- 10,467 - 0 10,467 -
- 13,221 - 0 13,221 -
- - - - -
- - - 0 - -
- 137,025 - 0 137,025 -
- - - - -
- 55,200 - 0 55,200 -
133,821 1 133,821 133,821 0 133,821 -
- - - - -
- 32,500 - 2 32,500 65,000
- - - - -
- 23,625 - 0 23,625 -
- 3 23,625 70,875 0 23,625 -
- - - - -
- 5,082 - 0 5,082 -
- 5 18,781 93,905 69 18,781 1,295,889
- - - - -
- - - 0 - -
- - - - -
- - - 0 - -
- - - - -
- - - 0 - -
- - - - -
- 4,000 - 0 4,000 -
- - - - -
- 5,770 - 0 5,770 -
- 5,770 - 200 5,770 1,154,000
- - - - -
- 5,770 - 67 5,770 386,590
- 5,770 - 199 5,770 1,148,230
- - - - -
- 5,770 - 0 5,770 -
- 5,770 - 200 5,770 1,154,000
- - - - -
- 5,770 - 0 5,770 -
- - - - -
- 22,000 - 0 22,000 -
- - - - -
- 22,000 - 0 22,000 -
- - - - -
- 1,125 - 0 1,125 -
- 1,125 - 0 1,125 -
- - - - -
- 200,455 - 0 200,455 -
- 8,018 - 80 8,018 641,440
- - - - -
- 68,181 - 0 68,181 -
- - - - -
- 68,181 - 0 68,181 -
- - - - -
- 6,825 - 0 6,825 -
793,321 1,550,049 10,328,894
1,256,450 5,684,153 35,883,435
Penanggung Jawab
Laporan
1 Air untuk injeksi amp 25 ml (aqua pro injeksi) Ampul 0 6,050 - 6,050
0 - - -
0 - - -
mg + heksaklorofen 2,5 mg + lidokain
lidokain 10 mg+ seng oksida 120 mg + sup
21 ad 2 g Suppo 10 33,000 330,000 33,000
0 - - -
0 - - 2,367
0 - - -
41 Bedak salisil serb 2% Botol 0 1,180 - 1,180
33 1,350 44,550 1,350
0 - - 1,180
Besi (II) sulfat 200 mg + asam folat 0.25 mg
42 Sachet 0 73 - 73
(tablet tambah darah)
0 55 - 55
0 - - 3,000 2,200
0 - - -
56 Diazepam supposutoria suppo 0 - - -
0 - - -
57 Diazepam tab 2 mg Tab 0 28 - 28
0 - - -
58 Diazepam tab 5 mg Tab 77 28 2,156 28
0 - - -
59 Dietilkarbamazin tab 100 mg Tab 0 - - -
0 - - -
60 Difenhidramin inj 10 mg/ml (i.v./i.m.) Ampul 45 1,160 52,200 1,160
0 - - -
61 Digoksin tab 0,25 mg Tab 100 103 10,300 103
0 - - -
62 Diltiazem kaps SR 100 mg Kaps 0 - - -
0 - - -
63 Diltiazem tab 30 mg Tab 0 141 - 141
560 141 78,960 141
0 - - -
64 Doksisiklin tablet 100 mg Tab 160 278 44,528 278
0 - - -
65 Domperidon susp 5 mg/5 ml Botol 0 3,490 - 3,490
37 3,490 129,130 3,490
0 - - -
66 Domperidon tab 10 mg Tab 0 174 - 174
293 174 50,982 500 174
0 - - -
67 Efedrin HCl tablet Tab 0 56 - 56
110 56 6,203 500 56
0 - - -
68 Ekstrak belladon tablet 10 mg tab 160 42 6,720 42
5000 42 210,000 42
0 - - -
0 - - -
70 Eritromisin kaps 250 mg Kaps 820 522 428,040 522
0 522 - 522
0 - - -
71 Eritromisin sir 200 mg/5 ml Botol 24 7,581 181,944 7,581
0 - - -
72 Eritromisin tab 500 mg Tab 465 1,013 470,938 1,013
0 1,023 - 1,023
0 - - -
73 Etanol 70% cairan 70% Botol 0 2,625 - 2,625
0 2,625 - 2,625
63 2,625 165,375 20 2,625
0 - - -
74 Etakridin (rivanol) larutan 0.1% Botol 0 4,695 - 4,695
2 4,695 9,390 3 4,695
0 - - -
75 Etil klorida semprot 100 ml Botol 0 124 - 124
0 - - -
76 Famotidin tablet 20 mg Tab 0 - - -
0 124 - 124
0 - - -
77 Fenitoin Na inj 50 mg/ml Ampul 0 - - -
0 - - -
78 Fenitoin Na kaps 100 mg Kaps 0 - - -
100 146 14,600 146
0 - - -
79 Fenobarbital inj 50 mg/ml Ampul 0 37 - 37
90 1,980 178,200 1,980
0 - - -
80 Fenobarbital tab 100 mg Tab 0 - - -
0 - - -
81 Fenobarbital tab 30 mg Tab 0 37 - 37
0 - - -
0 - - -
83 Fitomenadion (vitamin K 1) tab sal 10 mg Tab sal 100 698 69,800 698
0 - - -
84 Flukonazol kaps 150 mg Kaps 0 - - -
0 - - -
85 Flusinolon asetonid krim 0,025% Tube 0 - - -
0 - - -
86 Flunarizin tablet tablet 0 2,012 - 2,012
0 - - -
87 Furosemid inj 10 mg/ml (i.v./i.m.) Ampul 34 2,012 68,408 2,012
0 - - -
88 Furosemid tab 40 mg Tab 0 84 - 84
360 84 30,240 84
0 - - -
Garam oralit kombinasi : natrium klorida 0,52
g + kalium klorida 0,30 g + trinatrium sitrat
89 Sachet 0 317 - 317
0,58 g + glukosa anhidrat 2,7 g
0 317 - 317
0 - - -
90 Gameksan lotion 1 % Botol 0 2,420 - 2,420
0 - - -
91 Gemfibrozil kaps 300 mg Kaps 0 323 - 323
0 - - -
92 Gemfibrozil kaps 600 mg Kaps 0 - - -
0 - - -
93 Gentamisin inj 10 mg/ml Ampul 0 3,739 - 3,739
0 - - -
94 Gentamisin salep mata 0,3% Tube 0 - - -
0 - - -
95 Gentamisin salep Kulit Tube 0 2,340 - 2,340
40 1,469 58,760 1,469
0 - - 30 3,513
0 - - -
Kotrimoksazol (dewasa) kombinasi :
sulfametoksazol 400 mg+ trimetoprim 80
144 Tab 800 152 121,600 152
mg
380 79 30,020 79
0 - - -
Kotrimoksazol (dewasa) kombinasi tiap 5 ml
146 suspensi : sulfametoksazol 200 mg + Botol 0 2,298 - 2,298
trimetoprim 40 mg
0 - - -
147 Kuinin inj 25% (i.v.) Vial 0 6,820 - 6,820
0 6,820 - 6,820
0 - - -
148 Kloroquin tab 150 mg Tab 0 112 - 112
0 - - -
149 Lansoprazol kaps 30 mg Kaps 0 - - -
0 - - -
150 Levofloksasin tab 500 mg Tab 0 581 - 581
0 - - -
151 Lidokain gel 2% Tube 0 - - -
0 - - -
152 Lidokain inj 2% (hcl) Vial 0 1,499 - 1,499
59 1,499 88,441 1,499
0 - - 180 929
0 - - -
168 Metoklopramid tab 10 mg Tab 230 100 23,000 100
0 - - -
169 Metronidazol supposutoria 500 mg suppo 0 - - -
0 - - -
170 Metronidazol larutan infus Botol 0 12,980 - 12,980
8 12,980 103,840 12,980
0 - - -
171 Metronidazol tab 250 mg Tab 0 116 - 116
390 116 45,240 400 116
0 - - -
172 Metronidazol tab 500 mg Tab 0 - - -
610 169 103,090 1,100 169
0 - - -
173 Mikonazol krim 2% Tube 0 3,150 - 3,150
31 3,150 97,650 3,150
0 - - -
174 Natrium diklofenak tab 25 mg Tab 0 146 - 146
60 146 8,760 650 146
0 - - -
175 Natrium diklofenak tab 50 mg Tab 0 193 - 193
420 193 81,060 750 193
0 - - -
176 NaCl 0,9% Larutan infus Botol 0 5,170 - 5,170
37 5,170 191,290 5,170
0 - - -
177 Nifedipin kaps 10 mg Kaps 0 127 - 127
700 127 88,900 127
0 - - -
178 Nistatin tab salut 500.000 UI Tab 0 704 - 704
400 704 281,600 704
0 - - -
179 Nistatin tab vaginal 100.000 UI Tab 190 448 85,120 448
0 - - -
180 Obat Batuk Hitam (OBH) Botol 0 2,310 - 2,310
71 2,310 164,010 20 2,310
0 - - -
181 Ofloksasin tab 200 mg Tab 0 440 - 440
0 - - -
182 Ofloksasin tab 400 mg Tab 0 700 - 700
40 700 28,000 700
0 - - -
183 Oksitetrasiklin hcl inj 500 mg/ml Vial 0 3,410 - 3,410
0 - - -
184 Oksitetrasiklin hcl salep kulit 3% Tube 0 2,010 - 2,010
23 1,646 37,858 1,646
0 - - -
185 Oksitetrasiklin hcl salep mata 1 % Tube 0 2,772 - 2,772
118 2,772 327,096 25 2,772
0 - - -
186 Oksitosin inj 10 UI/ml Ampul 0 6,875 - 6,875
3 1,900 5,700 1,900
0 - - 20 6,875
230 Sianokobalamin (vitamin B12) inj 500 mcg/ml Vial 49 1,451 71,080 1,451
0 - - -
0 - - -
232 Simetidin tablet 200 mg Tab 0 138 - 138
690 138 95,220 138
0 - - -
233 Simvastatin tab sal 10 mg Tab sal 0 177 - 177
0 - - -
234 Simvastatin tab sal 20 mg Tab sal 0 480 - 480
0 - - -
235 Siprofloksasin inf 2 mg/ml Botol 0 - - -
0 - - -
236 Siprofloksasin tab scored 500 mg Tab 700 312 218,680 312
0 - - -
237 Spironolakton tab 100 mg Tab 0 - - -
200 350 70,000 350
0 - - -
238 Sulfasetamid Natrium Tetes mata 1.5% Botol 0 - - -
0 - - -
239 Sukralfat susp 500 mg/5 ml (Ulsafate) Botol 0 - - -
0 - - -
240 Sukralfat tab 500 mg (Ulsidex) Tab 0 - - -
400 477 190,800 477
0 - - -
241 Teofilin tab SR 300 mg (Rethapyl) Tab 0 - - -
100 1,155 115,500 1,155
0 - - -
242 Tetrasiklin kaps 250 mg Kaps 700 183 128,398 183
0 - - -
243 Tetrasiklin kaps 500 mg Kaps 0 283 - 283
0 - - -
0 42 - 42
0 - - -
245 Tiamin (vitamin B1) injeksi 100 mg/ml Tab 0 770 - 770
0 - - -
246 Tramadol inj 50 mg/ml Ampul 0 2,680 - 2,680
0 - - -
247 Tramadol tablet 500 mg Tab 0 363 - 100 363
0 - - -
248 Triheksifenidil tab 2 mg Tab 0 45 - 45
160 45 7,200 45
0 - - -
249 Vitamin B12 tablet 50 mcg Tab 0 63 - 63
0 - - -
250 Vitamin B kompleks injeksi Vial 0 7,392 - 7,392
0 - - -
251 Vitamin B kompleks Tab 0 112 - 112
3100 112 347,200 3,600 112
0 - - -
252 Zinc tab disp 20 mg Tab 0 521 - 521
345 521 179,745 521
0 - - -
253 Zinc sirup 20 mg / 5 ml Botol 0 8,140 - 8,140
13 8,140 105,820 8,140
0 - - -
254 Larutan PK botol 0 573 - 573
2 6,975 13,950 6,975
0 - - -
255 Kanamisin inj Vial 48 10,395 498,960 10,395
0 - - -
256 Antalgin 500mg tab 0 155 - 155
1000 141 141,000 141
0 - - -
257 Klorpromazin inj 25 mg/ml (i.m.) Ampul 0 - - -
0 1,210 - 1,210
0 - - -
0 - - -
10,328,894
35,883,435
Mengetahui
Kepala Puskesmas Rumbia
Rahmat, AMK
Nip. 19721021 199403 1 004
AN OBAT DAN PERBEKES
SELAMA 1 TAHUN
UN 2016
BULAN : JULI
TAHUN : 2016
- 6,050 - 0 6,050 -
- 1,499 - 0 1,499 -
- - - - -
- 78 - 0 78 -
- 2,213 - 0 2,213 -
- - - - -
- - - - -
- 1,650 - 0 1,650 -
- - - - -
- 149 - 0 149 -
- 1,265 - 0 1,265 -
- - - - -
- 2,367 - 0 2,367 -
- - -
- 251 - 0 251 -
- 251 - 275 251 69,025
- - - - -
- 1,400 - 29 1,400 40,600
- - - - -
- 81 - 0 81 -
- - - - -
- 13,500 - 0 13,500 -
- - - - -
- 1,180 - 0 1,180 -
- 3 1,350 4,050 30 1,350 40,500
- 1,180 - 0 1,180 -
- - -
- 73 - 0 73 -
- 55 - 0 55 -
6,600,000 1170 2,200 2,574,000 1830 2,200 4,026,000
- - -
- 22,727 - 0 22,727 -
- 22,727 - 4 22,727 90,908
- - - - -
- 1,596 - 0 1,596 -
79,800 13 1,596 20,748 89 1,596 142,044
- - - - -
36,000 60 600 36,000 0 600 -
- - 0 - -
- - - 0 - -
- - - - -
- - - 0 - -
- - - - -
- - - 0 - -
- - - - -
- - - 0 - -
- - - - -
- 42 - 0 42 -
- - - - -
- 68 - 0 68 -
34,000 430 68 29,240 730 68 49,640
- - - - -
- 1,738 - 168 1,738 291,984
- - - - -
- - - 0 - -
- 9,983 - 3 9,983 29,949
- - - - -
- 2,578 - 0 2,578 -
- 2,578 - 51 2,578 131,478
- - - - -
- - - 0 - -
- - - - -
- - - 0 - -
- - - - -
- 28 - 0 28 -
- - - - -
- 1 28 28 76 28 2,128
- - - - -
- - - 0 - -
- - - - -
- 1,160 - 45 1,160 52,200
- - - - -
- 103 - 100 103 10,300
- - - - -
- - - 0 - -
- - - - -
- 141 - 0 141 -
- 141 - 560 141 78,960
- - - - -
- 278 - 160 278 44,528
- - - - -
- 3,490 - 0 3,490 -
- 11 3,490 38,390 26 3,490 90,740
- - - - -
- 174 - 0 174 -
87,000 85 174 14,790 708 174 123,192
- - - - -
- 56 - 0 56 -
28,195 120 56 6,767 490 56 27,631
- - - - -
- 42 - 160 42 6,720
- 42 - 5000 42 210,000
- - - - -
- - - - -
- 522 - 820 522 428,040
- 522 - 0 522 -
- - - - -
- 7,581 - 24 7,581 181,944
- - - - -
- 1,013 - 465 1,013 470,938
- 1,023 - 0 1,023 -
- - - - -
- 2,625 - 0 2,625 -
- 2,625 - 0 2,625 -
52,500 5 2,625 13,125 78 2,625 204,750
- - - - -
- 4,695 - 0 4,695 -
14,085 4,695 - 5 4,695 23,475
- - - - -
- 124 - 0 124 -
- - - - -
- - - 0 - -
- 124 - 0 124 -
- - - - -
- - - 0 - -
- - - - -
- - - 0 - -
- 146 - 100 146 14,600
- - - - -
- 37 - 0 37 -
- 1,980 - 90 1,980 178,200
- - - - -
- - - 0 - -
- - - - -
- 37 - 0 37 -
- - - - -
- - - - -
- 698 - 100 698 69,800
- - - - -
- - - 0 - -
- - - - -
- - - 0 - -
- - - - -
- 2,012 - 0 2,012 -
- - - - -
- 2,012 - 34 2,012 68,408
- - - - -
- 84 - 0 84 -
- 84 - 360 84 30,240
- - - - -
- 317 - 0 317 -
- 317 - 0 317 -
- - - - -
- 2,420 - 0 2,420 -
- - - - -
- 323 - 0 323 -
- - - - -
- - - 0 - -
- - - - -
- 3,739 - 0 3,739 -
- - - - -
- - - 0 - -
- - - - -
- 2,340 - 0 2,340 -
- 10 1,469 14,690 30 1,469 44,070
105,390 3,513 - 30 3,513 105,390
- - -
- 3,194 - 0 3,194 -
- - - - -
- 61 - 0 61 -
- 61 - 130 61 7,930
- - - - -
- - - 0 - -
- - - - -
- - - 0 - -
- - - - -
- 31 - 0 31 -
- 557 31 17,267 7813 31 242,203
- - - - -
- - - 0 - -
- - - - -
- - - 0 - -
- - - - -
- 1 5,720 5,720 26 5,720 148,720
- - - - -
- 6,270 - 15 6,270 94,050
- - - - -
- - - 0 - -
- - - - -
- 230 - 0 230 -
46,000 230 - 300 230 69,000
- - - - -
- 62 - 0 62 -
- - - - -
- 76 - 0 76 -
- 76 - 190 76 14,440
- - - - -
- 105 - 0 105 -
- 105 - 0 105 -
- - - - -
- 38,500 - 0 38,500 -
- - - - -
- 40 - 0 40 -
- 40 - 9500 40 380,000
- - - - -
- 24 - 0 24 -
32,000 10 3,200 32,000 0 3,200 -
- - -
- 330 - 0 330 -
- - - - -
- 4,949 - 0 4,949 -
- - - - -
- 127 - 0 127 -
- 448 121 54,208 22 121 2,662
76,200 127 - 600 127 76,200
- - -
- 157 - 0 157 -
- 100 157 15,700 60 157 9,420
- - - - -
- - - 0 - -
- - - - -
- - - 0 - -
- - - - -
- - - 0 - -
- - - - -
- 98 - 0 98 -
- 98 - 90 98 8,820
- - - - -
- 10,000 - 17 10,000 170,000
- - - - -
- 9,519 - 20 9,519 190,380
- - - - -
- 51 - 0 51 -
- 140 76 10,640 310 76 23,560
- - - - -
- 69 - 0 69 -
- 69 - 70 69 4,830
- - - - -
- 97 - 0 97 -
77,600 385 97 37,345 1297 97 125,809
- - - - -
- 269 - 0 269 -
- - - - -
- - - 0 - -
- - - - -
- 110,000 - 0 110,000 -
- - - - -
- 320 - 0 320 -
- 320 - 0 320 -
- - - - -
- 5,150 - 0 5,150 -
- 5,150 - 0 5,150 -
- - - - -
- 2,665 - 0 2,665 -
- 12 2,665 31,980 78 2,665 207,870
- - - - -
- - - 0 - -
- - - - -
- 405 - 0 405 -
- - - - -
- 1,680 - 0 1,680 -
- - - - -
- 275 - 90 275 24,750
- 275 - 0 275 -
- - - - -
- 1,680 - 0 1,680 -
- 1,680 - 13 1,680 21,840
- - - - -
- 4,016 - 13 4,016 52,208
- - - - -
- 26 - 0 26 -
26,400 840 26 22,176 3559 26 93,958
- - - - -
- 1,210 - 0 1,210 -
- - - - -
- 152 - 0 152 -
- - - - -
- 50 - 244 50 12,200
- - - - -
- 531 - 0 531 -
- - - - -
- - - 0 - -
- - - - -
- 79 - 380 79 30,020
- - - - -
- 2,298 - 0 2,298 -
- - - - -
- 6,820 - 0 6,820 -
- 6,820 - 0 6,820 -
- - - - -
- 112 - 0 112 -
- - - - -
- - - 0 - -
- - - - -
- 581 - 0 581 -
- - - - -
- - - 0 - -
- - - - -
- 1,499 - 0 1,499 -
- 26 1,499 38,974 33 1,499 49,467
167,220 929 - 180 929 167,220
- - -
- 54,995 - 0 54,995 -
- 54,995 - 0 54,995 -
- - - - -
- 97 - 0 97 -
- 274 97 26,578 165 97 16,005
- - - - -
8,500 170 - 50 170 8,500
- - - - -
- 7,260 - 0 7,260 -
- 7,260 - 0 7,260 -
- - - - -
- 7,260 - 0 7,260 -
- 2 7,260 14,520 18 7,260 130,680
- - - - -
- 1,130 - 0 1,130 -
- - - - -
- 3,887 - 0 3,887 -
- - - - -
- 248 - 90 248 22,320
- - - - -
- - - 0 - -
- - - - -
- - - 0 - -
- - - - -
- 1,639 - 0 1,639 -
- - - - -
- 133 - 170 133 22,627
- - - - -
- - - 0 - -
- - - - -
- 1,100 - 0 1,100 -
- 1,100 - 0 1,100 -
- - - - -
- - - 0 - -
- - - - -
- 100 - 230 100 23,000
- - - - -
- - - 0 - -
- - - - -
- 12,980 - 0 12,980 -
- 1 12,980 12,980 7 12,980 90,860
- - - - -
- 116 - 0 116 -
46,400 100 116 11,600 690 116 80,040
- - - - -
- - - 0 - -
185,900 190 169 32,110 1520 169 256,880
- - - - -
- 3,150 - 0 3,150 -
- 5 3,150 15,750 26 3,150 81,900
- - - - -
- 146 - 0 146 -
94,900 30 146 4,380 680 146 99,280
- - - - -
- 193 - 0 193 -
144,750 610 193 117,730 560 193 108,080
- - - - -
- 5,170 - 0 5,170 -
- 6 5,170 31,020 31 5,170 160,270
- - - - -
- 127 - 0 127 -
- 127 - 700 127 88,900
- - - - -
- 704 - 0 704 -
- 704 - 400 704 281,600
- - - - -
- 448 - 190 448 85,120
- - - - -
- 2,310 - 0 2,310 -
46,200 13 2,310 30,030 78 2,310 180,180
- - - - -
- 440 - 0 440 -
- - - - -
- 700 - 0 700 -
- 700 - 40 700 28,000
- - - - -
- 3,410 - 0 3,410 -
- - - - -
- 2,010 - 0 2,010 -
- 6 1,646 9,876 17 1,646 27,982
- - - - -
- 2,772 - 0 2,772 -
69,300 9 2,772 24,948 134 2,772 371,448
- - - - -
- 6,875 - 0 6,875 -
- 3 1,900 5,700 0 1,900 -
137,500 2 6,875 13,750 18 6,875 123,750
- - -
- 221 - 0 221 -
- 221 - 0 221 -
- - - - -
- 109 - 0 109 -
- 500 109 54,500 2280 109 248,520
- - - - -
- 1,535 - 0 1,535 -
- 70 1,535 107,450 169 1,535 259,415
- - - - -
- 105 - 0 105 -
10,500 100 105 10,500 400 105 42,000
- - - - -
- 88 - 0 88 -
220,000 995 88 87,560 3395 88 298,760
- - - - -
- - - 0 - -
- - - - -
- 849 - 0 849 -
- 297 - 0 297 -
- - - - -
- 25,350 - 0 25,350 -
- 2,344 - 0 2,344 -
- 15,386 - 0 15,386 -
- 40,202 - 0 40,202 -
- 40,202 - 0 40,202 -
- - - - -
- 98 - 0 98 -
98,000 810 98 79,380 1784 98 174,832
- - - - -
- 125 - 985 125 123,125
- - - - -
- 12,021 - 0 12,021 -
- 3 12,021 36,063 40 12,021 480,840
- - - - -
29,700 297 - 200 297 59,400
- - - - -
- 80 - 90 80 7,200
- - - - -
- - - 0 - -
- - - - -
- 128 - 0 128 -
230,400 560 128 71,680 1560 128 199,680
- - - - -
- - - 0 - -
- - - - -
- 440 - 0 440 -
- - - - -
- 624 - 0 624 -
- - - - -
- 863 - 0 863 -
- - - - -
- 5,720 - 0 5,720 -
- 12 5,720 68,640 131 5,720 749,320
- - - - -
- 92 - 0 92 -
- 150 65 9,750 400 65 26,000
- - - - -
- 93 - 0 93 -
37,200 110 93 10,230 510 93 47,430
- - - - -
- 1,980 - 0 1,980 -
- - - - -
- 150 - 0 150 -
- - - - -
- 138 - 0 138 -
- 50 138 6,900 640 138 88,320
- - - - -
- 177 - 0 177 -
- - - - -
- 480 - 0 480 -
- - - - -
- - - 0 - -
- - - - -
- 312 - 700 312 218,680
- - - - -
- - - 0 - -
- 350 - 200 350 70,000
- - - - -
- - - 0 - -
- - - - -
- - - 0 - -
- - - - -
- - - 0 - -
- 477 - 400 477 190,800
- - - - -
- - - 0 - -
- 1,155 - 100 1,155 115,500
- - - - -
- 183 - 700 183 128,398
- - - - -
- 283 - 0 283 -
- - - - -
- 42 - 0 42 -
- 42 - 0 42 -
- - - - -
- 770 - 0 770 -
- - - - -
- 2,680 - 0 2,680 -
- - - - -
36,300 2 363 726 98 363 35,574
- - - - -
- 45 - 0 45 -
- 45 - 160 45 7,200
- - - - -
- 63 - 0 63 -
- - - - -
- 7,392 - 0 7,392 -
- - - - -
- 112 - 0 112 -
403,200 1010 112 113,120 5690 112 637,280
- - - - -
- 521 - 0 521 -
- 45 521 23,445 300 521 156,300
- - - - -
- 8,140 - 0 8,140 -
- 8,140 - 13 8,140 105,820
- - - - -
- 573 - 0 573 -
- 6,975 - 2 6,975 13,950
- - - - -
- 10,395 - 48 10,395 498,960
- - - - -
- 155 - 0 155 -
- 141 - 1000 141 141,000
- - - - -
- - - 0 - -
- 1,210 - 0 1,210 -
- - - - -
- 57 - 0 57 -
- - - - -
- 116 - 0 116 -
- 572 - 0 572 -
- - - - -
- 191 - 100 191 19,100
- - - - -
- 275 - 0 275 -
- 275 - 0 275 -
- - - - -
- 162 - 0 162 -
- - - - -
- 1,108 - 0 1,108 -
- 1,109 - 16 1,109 17,744
- - - - -
- 162 - 0 162 -
- - - - -
- 116 - 0 116 -
- - - - -
- 167 - 0 167 -
- - - - -
- 125 - 0 125 -
- - - - -
- 318 - 0 318 -
- - - - -
- 109 - 0 109 -
- - - - -
- 45 - 0 45 -
- - - - -
- 854 - 0 854 -
- - - - -
- 42,727 - 0 42,727 -
- 42,727 - 0 42,727 -
- - - - -
- 1,480 - 0 1,480 -
1,480,000 120 1,480 177,600 920 1,480 1,361,600
- - - - -
- 31 - 0 31 -
- - - - -
- 56 - 0 56 -
- - - - -
- - - 0 - -
- 765,000 - 0 765,000 -
765,000 765,000 - 2 765,000 1,530,000
- - - - -
- 242,000 - 0 242,000 -
- - - - -
- 338,800 - 0 338,800 -
338,800 338,800 - 2 338,800 677,600
- - - - -
- 390,000 - 0 390,000 -
- 390,000 - 0 390,000 -
- - - - -
- 18,333 - 0 18,333 -
- 18,333 - 1 18,333 18,333
- - - - -
- 105,000 - 0 105,000 -
315,000 105,000 - 4 105,000 420,000
- - - - -
- 170,000 - 0 170,000 -
- - - - -
- 395,000 - 0 395,000 -
- 197,895 - 1 197,895 197,895
- - - - -
- 55,000 - 1 55,000 55,000
- - - - -
- 93,500 - 0 93,500 -
- 93,500 - 2 93,500 187,000
- - - - -
- 34,000 - 0 34,000 -
- 34,000 - 0 34,000 -
- - - - -
- 176,000 - 0 176,000 -
- - - - -
- - - 0 - -
- 425 - 0 425 -
- 24,384 - 0 24,384 -
- 27,569 - 0 27,569 -
- 27,569 - 8 27,569 220,552
- - - - -
- 104 - 0 104 -
- 104 - 2000 104 208,000
- - - - -
- 825,000 - 0 825,000 -
- 4,545 - 0 4,545 -
- 236,490 - 0 236,490 -
- 396,000 - 0 396,000 -
- 1,319,990 - 0 1,319,990 -
- 175,899 - 0 175,899 -
- 145,000 - 0 145,000 -
- 150,000 - 0 150,000 -
- 168,300 - 0 168,300 -
- 46,200 - 0 46,200 -
- 45,560 - 0 45,560 -
- 42,350 - 0 42,350 -
- 20,454 - 0 20,454 -
- 4,438 - 0 4,438 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 285,000 - 0 285,000 -
- 695,752 - 0 695,752 -
- 412 - 0 412 -
- 286 - 0 286 -
- 497 - 0 497 -
- - - 0 - -
- - - 0 - -
- 1,093 - 0 1,093 -
- 119 848 100,942 7 848 5,938
99,000 990 - 100 990 99,000
- - - - -
- 1,038 - 0 1,038 -
- 848 - 0 848 -
- 650 - 0 650 -
- - -
- 1,038 - 0 1,038 -
- 14 848 11,876 154 848 130,631
79,200 792 - 100 792 79,200
- - -
- 1,038 - 0 1,038 -
- 979 - 437 979 427,714
- - - - -
- 2,099 - 0 2,099 -
- 15 2,100 31,500 78 2,100 163,800
209,900 2,099 - 100 2,099 209,900
- - -
- 2,099 - 0 2,099 -
- 2,100 - 2 2,100 4,200
104,950 2,099 - 50 2,099 104,950
- - -
- 7 6,400 44,800 0 6,400 -
- 3 25,920 77,760 45 25,920 1,166,400
307,200 6,400 - 48 6,400 307,200
- - -
- 5,900 - 0 5,900 -
- 3 27,000 81,000 0 27,000 -
141,600 4 5,900 23,600 20 5,900 118,000
- - -
- 6,595 - 0 6,595 -
- 11,990 - 0 11,990 -
- - -
- 50 6,595 329,750 50 6,595 329,750
- 11,990 - 0 - -
- - -
- 4,250 - 0 4,250 -
- 7,684 - 0 7,684 -
- 11,990 - 0 11,990 -
- - -
- 4,250 - 0 4,250 -
- 3 7,684 23,052 0 7,684 -
1,199,000 21 11,990 251,790 79 11,990 947,210
- - -
- 3,500 - 0 3,500 -
- 6 4,176 25,056 39 4,176 162,864
247,500 9,900 - 25 9,900 247,500
- - -
- 4,000 - 0 4,000 -
- 2 4,568 9,136 3 4,568 13,704
79,200 9,900 - 8 9,900 79,200
- - -
- 7,937 - 0 7,937 -
- 7,018 - 0 7,018 -
- - -
- 6,600 - 0 6,600 -
- 20,900 - 0 20,900 -
- - -
- 7,787 - 0 7,787 -
- 6 7,787 46,722 40 7,787 311,480
140,360 7,018 - 20 7,018 140,360
- - -
- 7,787 - 0 7,787 -
- 6 7,937 47,622 38 7,937 301,606
- 7,018 - 0 7,018 -
- - -
- 5 7,787 38,935 51 7,787 397,137
140,360 7,018 - 20 7,018 140,360
- - -
- 10,440 - 0 10,440 -
- 8,000 - 0 8,000 -
- - -
- 8,495 - 0 8,495 -
- 10,440 - 0 10,440 -
- 8,000 - 0 8,000 -
- - -
- 8,495 - 0 8,495 -
- 10,440 - 0 10,440 -
- 8,000 - 0 8,000 -
- - -
- 495 - 0 495 -
- 10,440 - 8 10,440 83,520
- 8,000 - 0 8,000 -
- - -
- 7,500 - 0 7,500 -
- 1 27,821 27,821 1 27,821 27,821
24,000 24,000 - 1 24,000 24,000
- - -
- 17,250 - 0 17,250 -
- - - - -
- 800 - 0 800 -
- - - - -
- 887 - 0 887 -
- 1,100 - 0 1,100 -
- - -
- 607 - 0 607 -
- 4 6,121 24,484 6 6,121 36,726
92,000 2,300 - 40 2,300 92,000
- - -
- 887 - 0 887 -
- 3,800 - 0 3,800 -
- - -
- 1,871 - 0 1,871 -
- 5,621 - 0 5,621 -
- 1,800 - 0 1,800 -
- - -
- 8,600 - 0 8,600 -
- 11,724 - 0 11,724 -
- 7,900 - 0 7,900 -
- - -
- 10,467 - 0 10,467 -
- 13,221 - 0 13,221 -
- 9,400 - 0 9,400 -
- - -
- - - 0 - -
- 137,025 - 0 137,025 -
- 104,500 - 0 104,500 -
- - -
- 55,200 - 0 55,200 -
- 133,821 - 0 133,821 -
390,000 130,000 - 3 130,000 390,000
- - -
- 32,500 - 2 32,500 65,000
- - - - -
- 23,625 - 0 23,625 -
378,000 4 23,625 94,500 12 23,625 283,500
- - - - -
- 5,082 - 0 5,082 -
- 7 18,781 131,467 62 18,781 1,164,422
- 5,082 - 0 5,082 -
- - -
- - - 0 - -
- - - - -
- - - 0 - -
- - - - -
- - - 0 - -
- - - - -
- 4,000 - 0 4,000 -
- - - - -
- 5,770 - 0 5,770 -
- 5,770 - 200 5,770 1,154,000
- - - - -
- 5,770 - 67 5,770 386,590
- 5,770 - 199 5,770 1,148,230
- - - - -
- 5,770 - 0 5,770 -
- 5,770 - 200 5,770 1,154,000
- - - - -
- 5,770 - 0 5,770 -
- - - - -
- 22,000 - 0 22,000 -
- - - - -
- 22,000 - 0 22,000 -
- - - - -
- 1,125 - 0 1,125 -
56,250 8 1,125 9,000 42 1,125 47,250
- - - - -
- 200,455 - 0 200,455 -
- 8,018 - 80 8,018 641,440
- - - - -
- 68,181 - 0 68,181 -
- - - - -
- 68,181 - 0 68,181 -
- - - - -
- 6,825 - 0 6,825 -
- 3,413 - 0 3,413 -
Penanggung Jawab
Laporan
1 Air untuk injeksi amp 25 ml (aqua pro injeksi) Ampul 0 6,050 - 6,050
0 - - -
2230 78 173,940 78
0 - - -
Antasida, kombinasi : aluminium hidroksida
18 200 mg + magnesium hidroksida 200 mg Botol 0 2,213 - 2,213
Suspensi
3 2,213 6,639 2,213
0 - - -
Antibakteri, kombinasi : basitrasin 500 UI/g+
19 Tube 7 2,767 19,369 2,767
Polimiskin B 10.000 UI/g
Antifungi salep, kombinasi : asam benzoat 6% 0 - - -
+ asam salisilat 3%
20 Tube 8 2,096 16,768 2,096
0 - - -
mg + heksaklorofen 2,5 mg + lidokain
lidokain 10 mg+ seng oksida 120 mg + sup
21 ad 2 g Suppo 3 33,000 99,000 33,000
0 - - -
0 2,367 - 2,367
0 - - -
37 Asiklovir tab 200 mg Tab 0 251 - 251
275 251 69,025 251
0 - - -
38 Atropin inj 0,25 mg/ml (i.m./i.v./s.k) Ampul 29 1,400 40,600 1,400
0 - - -
39 Atropin tab 0,5 mg Tab 0 81 - 81
0 - - -
40 Atropin tts mata 0,5% (Cendotropin 0,5%) Botol 0 13,500 - 13,500
0 - - -
41 Bedak salisil serb 2% Botol 0 1,180 - 1,180
30 1,350 40,500 1,350
0 1,180 - 1,180
0 - - -
Besi (II) sulfat 200 mg + asam folat 0.25 mg
42 Sachet 0 73 - 73
(tablet tambah darah)
0 55 - 55
1830 2,200 4,026,000 2,200
0 - - -
43 Becefort syrup Botol 0 22,727 - 22,727
4 22,727 90,908 22,727
0 - - -
44 Betametason krim 0,1% Tube 0 1,596 - 1,596
89 1,596 142,044 1,596
0 - - -
45 Betahistin mesilate tablet tablet 0 600 - 600
0 - - -
46 Bisakodil sup 10 mg (Stolax) Botol 0 - - -
0 - - -
47 Bisakodil tab sal 5 mg Tab sal 0 - - -
0 - - -
48 Bismecon salep tube 0 - - -
0 - - -
Budesonid-formoterol (fixed combination)* ih
49 Botol 0 - - -
80/4,5 mcg
0 - - -
50 Bromheksin tablet tablet 0 42 - 42
0 - - -
51 Deksametason tab 0,5 mg Tab 0 68 - 68
730 68 49,640 68
0 - - -
52 Deksametason inj 5 mg/ml (i.v./i.m.) Vial 168 1,738 291,984 1,738
0 - - -
53 Desoksimetason salep 0,25% Tube 0 - - -
3 9,983 29,949 9,983
0 - - -
54 Diazepam inj 5 mg/ml (i.v./i.m.) Vial 0 2,578 - 2,578
51 2,578 131,478 2,578
0 - - -
0 - - -
56 Diazepam supposutoria suppo 0 - - -
0 - - -
57 Diazepam tab 2 mg Tab 0 28 - 28
0 - - -
58 Diazepam tab 5 mg Tab 76 28 2,128 28
0 - - -
59 Dietilkarbamazin tab 100 mg Tab 0 - - -
0 - - -
60 Difenhidramin inj 10 mg/ml (i.v./i.m.) Ampul 45 1,160 52,200 1,160
0 - - -
61 Digoksin tab 0,25 mg Tab 100 103 10,300 103
0 - - -
62 Diltiazem kaps SR 100 mg Kaps 0 - - -
0 - - -
63 Diltiazem tab 30 mg Tab 0 141 - 141
560 141 78,960 141
0 - - -
64 Doksisiklin tablet 100 mg Tab 160 278 44,528 278
0 - - -
65 Domperidon susp 5 mg/5 ml Botol 0 3,490 - 3,490
26 3,490 90,740 3,490
0 - - -
66 Domperidon tab 10 mg Tab 0 174 - 174
708 174 123,192 174
0 - - -
67 Efedrin HCl tablet Tab 0 56 - 56
490 56 27,631 56
0 - - -
68 Ekstrak belladon tablet 10 mg tab 160 42 6,720 42
5000 42 210,000 42
0 - - -
0 - - -
70 Eritromisin kaps 250 mg Kaps 820 522 428,040 522
0 522 - 522
0 - - -
71 Eritromisin sir 200 mg/5 ml Botol 24 7,581 181,944 7,581
0 - - -
72 Eritromisin tab 500 mg Tab 465 1,013 470,938 1,013
0 1,023 - 1,023
0 - - -
73 Etanol 70% cairan 70% Botol 0 2,625 - 2,625
0 2,625 - 2,625
78 2,625 204,750 2,625
0 - - -
74 Etakridin (rivanol) larutan 0.1% Botol 0 4,695 - 4,695
5 4,695 23,475 4,695
0 - - -
75 Etil klorida semprot 100 ml Botol 0 124 - 124
0 - - -
76 Famotidin tablet 20 mg Tab 0 - - -
0 124 - 124
0 - - -
77 Fenitoin Na inj 50 mg/ml Ampul 0 - - -
0 - - -
78 Fenitoin Na kaps 100 mg Kaps 0 - - -
100 146 14,600 146
0 - - -
79 Fenobarbital inj 50 mg/ml Ampul 0 37 - 37
90 1,980 178,200 1,980
0 - - -
80 Fenobarbital tab 100 mg Tab 0 - - -
0 - - -
81 Fenobarbital tab 30 mg Tab 0 37 - 37
0 - - -
0 - - -
83 Fitomenadion (vitamin K 1) tab sal 10 mg Tab sal 100 698 69,800 698
0 - - -
84 Flukonazol kaps 150 mg Kaps 0 - - -
0 - - -
85 Flusinolon asetonid krim 0,025% Tube 0 - - -
0 - - -
86 Flunarizin tablet tablet 0 2,012 - 2,012
0 - - -
87 Furosemid inj 10 mg/ml (i.v./i.m.) Ampul 34 2,012 68,408 2,012
0 - - -
88 Furosemid tab 40 mg Tab 0 84 - 84
360 84 30,240 84
0 - - -
Garam oralit kombinasi : natrium klorida 0,52
g + kalium klorida 0,30 g + trinatrium sitrat
89 Sachet 0 317 - 317
0,58 g + glukosa anhidrat 2,7 g
0 317 - 317
0 - - -
90 Gameksan lotion 1 % Botol 0 2,420 - 2,420
0 - - -
91 Gemfibrozil kaps 300 mg Kaps 0 323 - 323
0 - - -
92 Gemfibrozil kaps 600 mg Kaps 0 - - -
0 - - -
93 Gentamisin inj 10 mg/ml Ampul 0 3,739 - 3,739
0 - - -
94 Gentamisin salep mata 0,3% Tube 0 - - -
0 - - -
95 Gentamisin salep Kulit Tube 0 2,340 - 2,340
30 1,469 44,070 1,469
30 3,513 105,390 3,513
0 - - -
96 Gentamisin tts mata 0,3% Botol 0 3,194 - 3,194
0 - - -
97 Glibenklamid tab 5 mg Tab 0 61 - 61
130 61 7,930 61
0 - - -
98 Glimepirid tab 4 mg Tab 0 - - -
0 - - -
99 Glipizid tablet 5 mg (Glucotrol 5 mg) Tab 0 - - -
0 - - -
100 Gliseril Guaiakolat tab 100 mg Tab 0 31 - 31
7813 31 242,203 31
0 - - -
101 Gliserin lar 50% Botol 0 - - -
0 - - -
102 Glukosamin tablet 500 mg Tab 0 - - -
0 - - -
103 Glukosa Larutan Infus 5% steril Botol 26 5,720 148,720 5,720
0 - - -
104 Glukosa Larutan Infus 10% steril Botol 15 6,270 94,050 6,270
0 - - -
105 Glukosa Larutan Infus 40% steril Botol 0 - - -
0 - - -
106 Griseofulvin (micronized) tab 125 mg Tab 0 230 - 230
300 230 69,000 230
0 - - -
107 Haloperidol tab 0,5 mg Tab 0 62 - 62
0 - - -
108 Haloperidol tab 1,5 mg Tab 0 76 - 76
190 76 14,440 76
0 - - -
109 Haloperidol tab 5 mg Tab 0 105 - 105
0 105 - 105
0 - - -
110 Hidrogen peroksida (H2O2) cairan 3% Botol 0 38,500 - 38,500
0 - - -
111 Hidroklorotiazid (HCT) tab 25 mg Tab 0 40 - 40
9500 40 380,000 40
0 - - -
112 Hidrokortison krim 2,5% Tube 0 24 - 24
0 3,200 - 3,200
0 - - -
113 Hiosina butilbromida tab 10 mg Tab 0 330 - 330
0 - - -
114 Ibuprofen susp 100 mg/5 ml Botol 0 4,949 - 4,949
0 - - -
115 Ibuprofen tab 200 mg Tab 0 127 - 127
22 121 2,662 121
600 127 76,200 127
0 - - -
116 Ibuprofen tab 400 mg Tab 0 157 - 157
60 157 9,420 157
0 - - -
Ipratropium bromida nebulizer 0,025%
117 Botol 0 - - -
(Atroven sol. for inhalation 0.025%)
0 - - -
118 Isoniazid tab 300 mg Tab 0 - - -
0 - - -
119 Isosorbid dinitrat inj 10 mg/10 ml (Fasorbid) Vial 0 - - -
0 - - -
120 Isosorbid dinitrat tab 5 mg Tab 0 98 - 98
90 98 8,820 98
0 - - -
121 KA-EN 3B Cairan Infus Botol 17 10,000 170,000 10,000
0 - - -
122 Kalsium glukonat inj 100 mg/ml Ampul 20 9,519 190,380 9,519
0 - - -
123 Kalsium laktat (kalk) tab 500 mg Tab 0 51 - 51
310 76 23,560 1,000 76
0 - - -
124 Kaptopril tab 12,5 mg Tab 0 69 - 69
70 69 4,830 69
0 - - -
125 Kaptopril tab 25 mg Tab 0 97 - 97
1297 97 125,809 97
0 - - -
126 Karbamazepin tab 200 mg Tab 0 269 - 269
0 - - -
127 Karbo adsorben (Norit) tab 500 mg Tab 0 - - -
0 - - -
128 Ketamin inj 50 mg/ml (i.v.) Ampul 0 110,000 - 110,000
0 - - -
129 Ketokonazol tab 200 mg Tab 0 320 - 320
0 320 - 320
0 - - -
130 Ketokonazol krim 2% Tube 0 5,150 - 5,150
0 5,150 - 5,150
0 - - -
131 Ketorolak inj 10 mg/ml Ampul 0 2,665 - 2,665
78 2,665 207,870 2,665
0 - - -
132 Klaritromisin tab 500 mg Tab 0 - - -
0 - - -
133 Klindamisin kaps 150 mg Kaps 0 405 - 405
0 - - -
134 Kloramfenikol tts mata 0,5% Botol 0 1,680 - 1,680
0 - - -
135 Kloramfenikol kaps 250 mg Kaps 90 275 24,750 275
0 275 - 275
0 - - -
136 Kloramfenikol salep mata 1% Tube 0 1,680 - 1,680
13 1,680 21,840 1,680
0 - - -
137 Kloramfenikol susp 125 mg/5 ml Botol 13 4,016 52,208 4,016
0 - - -
138 Klorfeniramin (CTM) tab 4 mg Tab 0 26 - 26
3559 26 93,958 26
0 - - -
139 Klorpromazin inj 25 mg/ml (i.m.) Ampul 0 1,210 - 1,210
0 - - -
140 Klorpromazin tab sal 100 mg Tab sal 0 152 - 152
0 - - -
141 Klorpromazin tab sal 25 mg Tab sal 244 50 12,200 50
0 - - -
142 Kombinasi : Pirimethamin 25 mg + sulfadoksin Tab 0 531 - 531
0 - - -
Kotrimoksazol (dewasa) kombinasi :
sulfametoksazol 400 mg+ trimetoprim 80
144 Tab 750 152 114,000 152
mg
380 79 30,020 79
0 - - -
Kotrimoksazol (dewasa) kombinasi tiap 5 ml
146 suspensi : sulfametoksazol 200 mg + Botol 0 2,298 - 50 2,298
trimetoprim 40 mg
0 - - -
147 Kuinin inj 25% (i.v.) Vial 0 6,820 - 6,820
0 6,820 - 6,820
0 - - -
148 Kloroquin tab 150 mg Tab 0 112 - 112
0 - - -
149 Lansoprazol kaps 30 mg Kaps 0 - - -
0 - - -
150 Levofloksasin tab 500 mg Tab 0 581 - 581
0 - - -
151 Lidokain gel 2% Tube 0 - - -
0 - - -
152 Lidokain inj 2% (hcl) Vial 0 1,499 - 1,499
33 1,499 49,467 1,499
180 929 167,220 100 929
0 - - -
153 Lisol Botol 0 54,995 - 54,995
0 54,995 - 54,995
0 - - -
154 Loperamid tab 2 mg Tab 0 97 - 97
165 97 16,005 97
0 - - -
155 Loratadin tab 10 mg Tab 50 170 8,500 170
0 - - -
156 Magnesium sulfat inj 20% Vial 0 7,260 - 7,260
0 7,260 - 7,260
0 - - -
157 Magnesium sulfat inj 40% Vial 0 7,260 - 7,260
18 7,260 130,680 7,260
0 - - -
158 Magnesium sulfat serb, ktg 30 g Sachet 0 1,130 - 1,130
0 - - -
159 Mebendazol sir 50 mg/ml Botol 0 3,887 - 3,887
0 - - -
160 Mebendazol tab 100 mg Tan 90 248 22,320 248
0 - - -
161 Metformin tab 500 mg Tab 0 - - -
0 - - -
162 Metformin tab 850 mg Tab 0 - - -
0 - - -
163 Metilergometrin inj 0,2 mg/ml Ampul 0 1,639 - 1,639
0 - - -
164 Metilergometrin tab salut 0,125 mg Tab sal 170 133 22,627 133
0 - - -
165 Metilprednisolon tab 4 mg Tab 0 - - -
0 - - -
166 Metoklopramid inj 5 mg/ml Vial 0 1,100 - 1,100
0 1,100 - 1,100
0 - - -
0 - - -
168 Metoklopramid tab 10 mg Tab 230 100 23,000 100
0 - - -
169 Metronidazol supposutoria 500 mg suppo 0 - - -
0 - - -
170 Metronidazol larutan infus Botol 0 12,980 - 12,980
7 12,980 90,860 12,980
0 - - -
171 Metronidazol tab 250 mg Tab 0 116 - 116
690 116 80,040 116
0 - - -
172 Metronidazol tab 500 mg Tab 0 - - -
1520 169 256,880 169
0 - - -
173 Mikonazol krim 2% Tube 0 3,150 - 3,150
26 3,150 81,900 3,150
0 - - -
174 Natrium diklofenak tab 25 mg Tab 0 146 - 146
680 146 99,280 146
0 - - -
175 Natrium diklofenak tab 50 mg Tab 0 193 - 193
560 193 108,080 193
0 - - -
176 NaCl 0,9% Larutan infus Botol 0 5,170 - 5,170
31 5,170 160,270 5,170
0 - - -
177 Nifedipin kaps 10 mg Kaps 0 127 - 127
700 127 88,900 127
0 - - -
178 Nistatin tab salut 500.000 UI Tab 0 704 - 704
400 704 281,600 704
0 - - -
179 Nistatin tab vaginal 100.000 UI Tab 190 448 85,120 448
0 - - -
180 Obat Batuk Hitam (OBH) Botol 0 2,310 - 2,310
78 2,310 180,180 2,310
0 - - -
181 Ofloksasin tab 200 mg Tab 0 440 - 440
0 - - -
182 Ofloksasin tab 400 mg Tab 0 700 - 700
40 700 28,000 700
0 - - -
183 Oksitetrasiklin hcl inj 500 mg/ml Vial 0 3,410 - 3,410
0 - - -
184 Oksitetrasiklin hcl salep kulit 3% Tube 0 2,010 - 2,010
17 1,646 27,982 1,646
0 - - -
185 Oksitetrasiklin hcl salep mata 1 % Tube 0 2,772 - 2,772
134 2,772 371,448 2,772
0 - - -
186 Oksitosin inj 10 UI/ml Ampul 0 6,875 - 6,875
0 1,900 - 1,900
18 6,875 123,750 6,875
0 - - -
187 Omeprazol kaps 20 mg Kaps 0 221 - 221
0 221 - 221
0 - - -
188 Papaverin tablet 40 mg Tab 0 109 - 109
2280 109 248,520 109
0 - - -
189 Parasetamol sir 120 mg/5 ml Botol 0 1,535 - 1,535
169 1,535 259,415 1,535
0 - - -
190 Parasetamol tab 100 mg Tab 0 105 - 105
400 105 42,000 105
0 - - -
191 Parasetamol tab 500 mg Tab 0 88 - 88
3395 88 298,760 88
0 - - -
192 Parasetamol rectal suppo 0 - - -
0 - - -
193 Pehavral tablet multivitamin Tab 0 849 - 849
0 297 - 297
0 - - -
230 Sianokobalamin (vitamin B12) inj 500 mcg/ml Vial 38 1,451 55,124 1,451
0 - - -
0 - - -
232 Simetidin tablet 200 mg Tab 0 138 - 138
640 138 88,320 138
0 - - -
233 Simvastatin tab sal 10 mg Tab sal 0 177 - 177
0 - - -
234 Simvastatin tab sal 20 mg Tab sal 0 480 - 480
0 - - -
235 Siprofloksasin inf 2 mg/ml Botol 0 - - -
0 - - -
236 Siprofloksasin tab scored 500 mg Tab 700 312 218,680 312
0 - - -
237 Spironolakton tab 100 mg Tab 0 - - -
200 350 70,000 350
0 - - -
238 Sulfasetamid Natrium Tetes mata 1.5% Botol 0 - - -
0 - - -
239 Sukralfat susp 500 mg/5 ml (Ulsafate) Botol 0 - - -
0 - - -
240 Sukralfat tab 500 mg (Ulsidex) Tab 0 - - -
400 477 190,800 477
0 - - -
241 Teofilin tab SR 300 mg (Rethapyl) Tab 0 - - -
100 1,155 115,500 1,155
0 - - -
242 Tetrasiklin kaps 250 mg Kaps 700 183 128,398 183
0 - - -
243 Tetrasiklin kaps 500 mg Kaps 0 283 - 283
0 - - -
0 42 - 42
0 - - -
245 Tiamin (vitamin B1) injeksi 100 mg/ml Tab 0 770 - 770
0 - - -
246 Tramadol inj 50 mg/ml Ampul 0 2,680 - 2,680
0 - - -
247 Tramadol tablet 500 mg Tab 98 363 35,574 363
0 - - -
248 Triheksifenidil tab 2 mg Tab 0 45 - 45
160 45 7,200 45
0 - - -
249 Vitamin B12 tablet 50 mcg Tab 0 63 - 63
0 - - -
250 Vitamin B kompleks injeksi Vial 0 7,392 - 7,392
0 - - -
251 Vitamin B kompleks Tab 0 112 - 112
5690 112 637,280 112
0 - - -
252 Zinc tab disp 20 mg Tab 0 521 - 521
300 521 156,300 521
0 - - -
253 Zinc sirup 20 mg / 5 ml Botol 0 8,140 - 8,140
13 8,140 105,820 8,140
0 - - -
254 Larutan PK botol 0 573 - 573
2 6,975 13,950 6,975
0 - - -
255 Kanamisin inj Vial 48 10,395 498,960 10,395
0 - - -
256 Antalgin 500mg tab 0 155 - 155
1000 141 141,000 141
0 - - -
257 Klorpromazin inj 25 mg/ml (i.m.) Ampul 0 - - -
0 1,210 - 1,210
0 - - -
258 Kalsium laktat (kalk) tab 500 mg Tab 0 57 - 57
0 - - -
12,586,602
48,241,658
Mengetahui
Kepala Puskesmas Rumbia
Rahmat, AMK
Nip. 19721021 199403 1 004
AAN OBAT DAN PERBEKES
SELAMA 1 TAHUN
UN 2016
BULAN : AGUSTUS
TAHUN : 2016
- 6,050 - 0 6,050 -
- 1,499 - 0 1,499 -
- - - 0 - -
- 78 - 0 78 -
- 2,213 - 0 2,213 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 149 - 0 149 -
- 1,265 - 0 1,265 -
- - - 0 - -
- 2,367 - 0 2,367 -
- - - 0 - -
- 251 - 0 251 -
- 20 251 5,020 255 251 64,005
- - - 0 - -
- 1,400 - 29 1,400 40,600
- - - 0 - -
- 81 - 0 81 -
- - - 0 - -
- 13,500 - 0 13,500 -
- - - 0 - -
- 1,180 - 0 1,180 -
- 7 1,350 9,450 23 1,350 31,050
- 1,180 - 0 1,180 -
- - - 0 - -
- 73 - 0 73 -
- 55 - 0 55 -
- 1000 2,200 2,200,000 830 2,200 1,826,000
- - - 0 - -
- 22,727 - 0 22,727 -
- 22,727 - 4 22,727 90,908
- - - 0 - -
- 1,596 - 0 1,596 -
- 7 1,596 11,172 82 1,596 130,872
- - - 0 - -
- 600 - 0 600 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 42 - 0 42 -
- - - 0 - -
- 68 - 0 68 -
- 255 68 17,340 475 68 32,300
- - - 0 - -
- 1,738 - 168 1,738 291,984
- - - 0 - -
- - - 0 - -
- 9,983 - 3 9,983 29,949
- - - 0 - -
- 2,578 - 0 2,578 -
- 2,578 - 51 2,578 131,478
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 28 - 0 28 -
- - - 0 - -
- 21 28 588 55 28 1,540
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 1,160 - 45 1,160 52,200
- - - 0 - -
- 103 - 100 103 10,300
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 141 - 0 141 -
- 141 - 560 141 78,960
- - - 0 - -
- 278 - 160 278 44,528
- - - 0 - -
- 3,490 - 0 3,490 -
- 11 3,490 38,390 15 3,490 52,350
- - - 0 - -
- 174 - 0 174 -
- 95 174 16,530 613 174 106,662
- - - 0 - -
- 56 - 0 56 -
- 140 56 7,895 350 56 19,737
- - - 0 - -
- 42 - 160 42 6,720
- 42 - 5000 42 210,000
- - - 0 - -
- - - 0 - -
- 522 - 820 522 428,040
- 522 - 0 522 -
- - - 0 - -
- 7,581 - 24 7,581 181,944
- - - 0 - -
- 1,013 - 465 1,013 470,938
- 1,023 - 0 1,023 -
- - - 0 - -
- 2,625 - 0 2,625 -
- 2,625 - 0 2,625 -
- 10 2,625 26,250 68 2,625 178,500
- - - 0 - -
- 4,695 - 0 4,695 -
- 4,695 - 5 4,695 23,475
- - - 0 - -
- 124 - 0 124 -
- - - 0 - -
- - - 0 - -
- 124 - 0 124 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 146 - 100 146 14,600
- - - 0 - -
- 37 - 0 37 -
- 1,980 - 90 1,980 178,200
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 37 - 0 37 -
- - - 0 - -
- - - 0 - -
- 698 - 100 698 69,800
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 2,012 - 0 2,012 -
- - - 0 - -
- 2,012 - 34 2,012 68,408
- - - 0 - -
- 84 - 0 84 -
- 84 - 360 84 30,240
- - - 0 - -
- 317 - 0 317 -
- 317 - 0 317 -
- - - 0 - -
- 2,420 - 0 2,420 -
- - - 0 - -
- 323 - 0 323 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 3,739 - 0 3,739 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 2,340 - 0 2,340 -
- 3 1,469 4,407 27 1,469 39,663
- 3,513 - 30 3,513 105,390
- - - 0 - -
- 3,194 - 0 3,194 -
- - - 0 - -
- 61 - 0 61 -
- 10 61 610 120 61 7,320
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 31 - 0 31 -
- 1133 31 35,123 6680 31 207,080
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 5,720 - 26 5,720 148,720
- - - 0 - -
- 6,270 - 15 6,270 94,050
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 230 - 0 230 -
- 170 230 39,100 130 230 29,900
- - - 0 - -
- 62 - 0 62 -
- - - 0 - -
- 76 - 0 76 -
- 15 76 1,140 175 76 13,300
- - - 0 - -
- 105 - 0 105 -
- 105 - 0 105 -
- - - 0 - -
- 38,500 - 0 38,500 -
- - - 0 - -
- 40 - 0 40 -
- 40 - 9500 40 380,000
- - - 0 - -
- 24 - 0 24 -
- 3,200 - 0 3,200 -
- - - 0 - -
- 330 - 0 330 -
- - - 0 - -
- 4,949 - 0 4,949 -
- - - 0 - -
- 127 - 0 127 -
- 22 121 2,662 0 121 -
- 365 127 46,355 235 127 29,845
- - - 0 - -
- 157 - 0 157 -
- 157 - 60 157 9,420
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 98 - 0 98 -
- 98 - 90 98 8,820
- - - 0 - -
- 10,000 - 17 10,000 170,000
- - - 0 - -
- 9,519 - 20 9,519 190,380
- - - 0 - -
- 51 - 0 51 -
76,000 530 76 40,280 780 76 59,280
- - - 0 - -
- 69 - 0 69 -
- 69 - 70 69 4,830
- - - 0 - -
- 97 - 0 97 -
- 607 97 58,879 690 97 66,930
- - - 0 - -
- 269 - 0 269 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 110,000 - 0 110,000 -
- - - 0 - -
- 320 - 0 320 -
- 320 - 0 320 -
- - - 0 - -
- 5,150 - 0 5,150 -
- 5,150 - 0 5,150 -
- - - 0 - -
- 2,665 - 0 2,665 -
- 2,665 - 78 2,665 207,870
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 405 - 0 405 -
- - - 0 - -
- 1,680 - 0 1,680 -
- - - 0 - -
- 275 - 90 275 24,750
- 275 - 0 275 -
- - - 0 - -
- 1,680 - 0 1,680 -
- 1,680 - 13 1,680 21,840
- - - 0 - -
- 4,016 - 13 4,016 52,208
- - - 0 - -
- 26 - 0 26 -
- 620 26 16,368 2939 26 77,590
- - - 0 - -
- 1,210 - 0 1,210 -
- - - 0 - -
- 152 - 0 152 -
- - - 0 - -
- 12 50 600 232 50 11,600
- - - 0 - -
- 531 - 0 531 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 79 - 0 79 -
- 79 - 380 79 30,020
- - - 0 - -
- - - 0 - -
- 6,820 - 0 6,820 -
- 6,820 - 0 6,820 -
- - - 0 - -
- 112 - 0 112 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 581 - 0 581 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 1,499 - 0 1,499 -
- 33 1,499 49,467 0 1,499 -
92,900 72 929 66,888 208 929 193,232
- - - 0 - -
- 54,995 - 0 54,995 -
- 54,995 - 0 54,995 -
- - - 0 - -
- 97 - 0 97 -
- 160 97 15,520 5 97 485
- - - 0 - -
- 170 - 50 170 8,500
- - - 0 - -
- 7,260 - 0 7,260 -
- 7,260 - 0 7,260 -
- - - 0 - -
- 7,260 - 0 7,260 -
- 7,260 - 18 7,260 130,680
- - - 0 - -
- 1,130 - 0 1,130 -
- - - 0 - -
- 3,887 - 0 3,887 -
- - - 0 - -
- 248 - 90 248 22,320
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 1,639 - 0 1,639 -
- - - 0 - -
- 10 133 1,331 160 133 21,296
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 1,100 - 0 1,100 -
- 1,100 - 0 1,100 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 8 100 800 222 100 22,200
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 12,980 - 0 12,980 -
- 12,980 - 7 12,980 90,860
- - - 0 - -
- 116 - 0 116 -
- 100 116 11,600 590 116 68,440
- - - 0 - -
- - - 0 - -
- 90 169 15,210 1430 169 241,670
- - - 0 - -
- 3,150 - 0 3,150 -
- 9 3,150 28,350 17 3,150 53,550
- - - 0 - -
- 146 - 0 146 -
- 360 146 52,560 320 146 46,720
- - - 0 - -
- 193 - 0 193 -
- 420 193 81,060 140 193 27,020
- - - 0 - -
- 5,170 - 0 5,170 -
- 12 5,170 62,040 19 5,170 98,230
- - - 0 - -
- 127 - 0 127 -
- 70 127 8,890 630 127 80,010
- - - 0 - -
- 704 - 0 704 -
- 704 - 400 704 281,600
- - - 0 - -
- 448 - 190 448 85,120
- - - 0 - -
- 2,310 - 0 2,310 -
- 6 2,310 13,860 72 2,310 166,320
- - - 0 - -
- 440 - 0 440 -
- - - 0 - -
- 700 - 0 700 -
- 700 - 40 700 28,000
- - - 0 - -
- 3,410 - 0 3,410 -
- - - 0 - -
- 2,010 - 0 2,010 -
- 2 1,646 3,292 15 1,646 24,690
- - - 0 - -
- 2,772 - 0 2,772 -
- 1 2,772 2,772 133 2,772 368,676
- - - 0 - -
- 6,875 - 0 6,875 -
- 1,900 - 0 1,900 -
- 6,875 - 18 6,875 123,750
- - - 0 - -
- 221 - 0 221 -
- 221 - 0 221 -
- - - 0 - -
- 109 - 0 109 -
- 109 - 2280 109 248,520
- - - 0 - -
- 1,535 - 0 1,535 -
- 56 1,535 85,960 113 1,535 173,455
- - - 0 - -
- 105 - 0 105 -
- 200 105 21,000 200 105 21,000
- - - 0 - -
- 88 - 0 88 -
- 800 88 70,400 2595 88 228,360
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 849 - 0 849 -
- 297 - 0 297 -
- - - 0 - -
- 25,350 - 0 25,350 -
- 2,344 - 0 2,344 -
- 15,386 - 0 15,386 -
- 40,202 - 0 40,202 -
- 40,202 - 0 40,202 -
- - - 0 - -
- 98 - 0 98 -
- 270 98 26,460 1514 98 148,372
- - - 0 - -
- 125 - 985 125 123,125
- - - 0 - -
- 12,021 - 0 12,021 -
- 4 12,021 48,084 36 12,021 432,756
- - - 0 - -
- 297 - 200 297 59,400
- - - 0 - -
- 80 - 90 80 7,200
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 128 - 0 128 -
- 410 128 52,480 1150 128 147,200
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 440 - 0 440 -
- - - 0 - -
- 624 - 0 624 -
- - - 0 - -
- 863 - 0 863 -
- - - 0 - -
- 5,720 - 0 5,720 -
- 10 5,720 57,200 121 5,720 692,120
- - - 0 - -
- 92 - 0 92 -
- 30 65 1,950 370 65 24,050
- - - 0 - -
- 93 - 0 93 -
- 110 93 10,230 400 93 37,200
- - - 0 - -
- 1,980 - 0 1,980 -
- - - 0 - -
- 150 - 0 150 -
- - - 0 - -
- 138 - 0 138 -
- 138 - 640 138 88,320
- - - 0 - -
- 177 - 0 177 -
- - - 0 - -
- 480 - 0 480 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 312 - 700 312 218,680
- - - 0 - -
- - - 0 - -
- 350 - 200 350 70,000
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 477 - 400 477 190,800
- - - 0 - -
- - - 0 - -
- 1,155 - 100 1,155 115,500
- - - 0 - -
- 183 - 700 183 128,398
- - - 0 - -
- 283 - 0 283 -
- - - 0 - -
- 42 - 0 42 -
- 42 - 0 42 -
- - - 0 - -
- 770 - 0 770 -
- - - 0 - -
- 2,680 - 0 2,680 -
- - - 0 - -
- 5 363 1,815 93 363 33,759
- - - 0 - -
- 45 - 0 45 -
- 45 - 160 45 7,200
- - - 0 - -
- 63 - 0 63 -
- - - 0 - -
- 7,392 - 0 7,392 -
- - - 0 - -
- 112 - 0 112 -
- 1170 112 131,040 4520 112 506,240
- - - 0 - -
- 521 - 0 521 -
- 130 521 67,730 170 521 88,570
- - - 0 - -
- 8,140 - 0 8,140 -
- 8,140 - 13 8,140 105,820
- - - 0 - -
- 573 - 0 573 -
- 1 6,975 6,975 1 6,975 6,975
- - - 0 - -
- 1 10,395 10,395 47 10,395 488,565
- - - 0 - -
- 155 - 0 155 -
- 141 - 1000 141 141,000
- - - 0 - -
- - - 0 - -
- 1,210 - 0 1,210 -
- - - 0 - -
- 57 - 0 57 -
- - - 0 - -
- 116 - 0 116 -
- 572 - 0 572 -
- - - 0 - -
- 191 - 100 191 19,100
- - - 0 - -
- 275 - 0 275 -
- 275 - 0 275 -
- - - 0 - -
- 162 - 0 162 -
- - - 0 - -
- 1,108 - 0 1,108 -
- 1,109 - 16 1,109 17,744
- - - 0 - -
- 162 - 0 162 -
- - - 0 - -
- 116 - 0 116 -
- - - 0 - -
- 167 - 0 167 -
- - - 0 - -
- 125 - 0 125 -
- - - 0 - -
- 318 - 0 318 -
- - - 0 - -
- 109 - 0 109 -
- - - 0 - -
- 45 - 0 45 -
- - - 0 - -
- 854 - 0 854 -
- - - 0 - -
- 42,727 - 0 42,727 -
- 42,727 - 0 42,727 -
- - - 0 - -
- 1,480 - 0 1,480 -
- 265 1,480 392,200 655 1,480 969,400
- - - 0 - -
- 31 - 0 31 -
- - - 0 - -
- 56 - 0 56 -
- - - 0 - -
- - - 0 - -
- 765,000 - 0 765,000 -
- 765,000 - 2 765,000 1,530,000
- - - 0 - -
- 242,000 - 0 242,000 -
- - - 0 - -
- 338,800 - 0 338,800 -
- 1 338,800 338,800 1 338,800 338,800
- - - 0 - -
- 390,000 - 0 390,000 -
- 390,000 - 0 390,000 -
- - - 0 - -
- 18,333 - 0 18,333 -
- 18,333 - 1 18,333 18,333
- - - 0 - -
- 105,000 - 0 105,000 -
- 1 105,000 105,000 3 105,000 315,000
- - - 0 - -
- 170,000 - 0 170,000 -
- - - 0 - -
- 395,000 - 0 395,000 -
- 197,895 - 1 197,895 197,895
- - - 0 - -
- 55,000 - 1 55,000 55,000
- - - 0 - -
- 93,500 - 0 93,500 -
- 93,500 - 2 93,500 187,000
- - - 0 - -
- 34,000 - 0 34,000 -
- 34,000 - 0 34,000 -
- - - 0 - -
- 176,000 - 0 176,000 -
- - - 0 - -
- - - 0 - -
- 425 - 0 425 -
- 24,384 - 0 24,384 -
- 27,569 - 0 27,569 -
- 27,569 - 8 27,569 220,552
- - - 0 - -
- 104 - 0 104 -
- 104 - 2000 104 208,000
- - - 0 - -
- 825,000 - 0 825,000 -
- 4,545 - 0 4,545 -
- 236,490 - 0 236,490 -
- 396,000 - 0 396,000 -
- 1,319,990 - 0 1,319,990 -
- 175,899 - 0 175,899 -
- 145,000 - 0 145,000 -
- 150,000 - 0 150,000 -
- 168,300 - 0 168,300 -
- 46,200 - 0 46,200 -
- 45,560 - 0 45,560 -
- 42,350 - 0 42,350 -
- 20,454 - 0 20,454 -
- 4,438 - 0 4,438 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 285,000 - 0 285,000 -
- 695,752 - 0 695,752 -
- 412 - 0 412 -
- 286 - 0 286 -
- 497 - 0 497 -
- - - 0 - -
- - - 0 - -
- 1,093 - 0 1,093 -
- 1 848 848 6 848 5,090
- 990 - 100 990 99,000
- - - 0 - -
- 1,038 - 0 1,038 -
- 848 - 0 848 -
- 650 - 0 650 -
- - - 0 - -
- 1,038 - 0 1,038 -
- 5 848 4,241 149 848 126,389
- 792 - 100 792 79,200
- - - 0 - -
- 1,038 - 0 1,038 -
- 16 979 15,660 421 979 412,054
- - - 0 - -
- 2,099 - 0 2,099 -
- 11 2,100 23,100 67 2,100 140,700
- 2,099 - 100 2,099 209,900
- - - 0 - -
- 2,099 - 0 2,099 -
- 2 2,100 4,200 0 2,100 -
- 5 2,099 10,495 45 2,099 94,455
- - - 0 - -
- 6,400 - 0 6,400 -
- 25,920 - 45 25,920 1,166,400
- 6,400 - 48 6,400 307,200
- - - 0 - -
- 5,900 - 0 5,900 -
- 27,000 - 0 27,000 -
- 2 5,900 11,800 18 5,900 106,200
- - - 0 - -
- 6,595 - 0 6,595 -
- 11,990 - 0 11,990 -
- - - 0 - -
- 41 6,595 270,395 9 6,595 59,355
- - - 0 - -
- - - 0 - -
- 4,250 - 0 4,250 -
- 7,684 - 0 7,684 -
- 11,990 - 0 11,990 -
- - - 0 - -
- 4,250 - 0 4,250 -
- 7,684 - 0 7,684 -
- 41 11,990 491,590 38 11,990 455,620
- - - 0 - -
- 3,500 - 0 3,500 -
- 8 4,176 33,408 31 4,176 129,456
- 9,900 - 25 9,900 247,500
- - - 0 - -
- 4,000 - 0 4,000 -
- 4,568 - 3 4,568 13,704
- 9,900 - 8 9,900 79,200
- - - 0 - -
- 7,937 - 0 7,937 -
- 7,018 - 0 7,018 -
- - - 0 - -
- 6,600 - 0 6,600 -
- 20,900 - 0 20,900 -
- - - 0 - -
- 7,787 - 0 7,787 -
- 1 7,787 7,787 39 7,787 303,693
- 7,018 - 20 7,018 140,360
- - - 0 - -
- 7,787 - 0 7,787 -
- 7,937 - 38 7,937 301,606
- 7,018 - 0 7,018 -
- - - 0 - -
- 5 7,787 38,935 46 7,787 358,202
- 7,018 - 20 7,018 140,360
- - - 0 - -
- 10,440 - 0 10,440 -
- 8,000 - 0 8,000 -
- - - 0 - -
- 8,495 - 0 8,495 -
- 10,440 - 0 10,440 -
- 8,000 - 0 8,000 -
- - - 0 - -
- 8,495 - 0 8,495 -
- 10,440 - 0 10,440 -
- 8,000 - 0 8,000 -
- - - 0 - -
- 495 - 0 495 -
- 10,440 - 8 10,440 83,520
- 8,000 - 0 8,000 -
- - - 0 - -
- 7,500 - 0 7,500 -
- 1 27,821 27,821 0 27,821 -
- 24,000 - 1 24,000 24,000
- - - 0 - -
- 17,250 - 0 17,250 -
- - - 0 - -
- 800 - 0 800 -
- - - 0 - -
- 887 - 0 887 -
- 1,100 - 0 1,100 -
- - - 0 - -
- 607 - 0 607 -
- 6 6,121 36,726 0 6,121 -
- 30 2,300 69,000 10 2,300 23,000
- - - 0 - -
- 887 - 0 887 -
- 3,800 - 0 3,800 -
- - - 0 - -
- 1,871 - 0 1,871 -
- 5,621 - 0 5,621 -
- 1,800 - 0 1,800 -
- - - 0 - -
- 8,600 - 0 8,600 -
- 11,724 - 0 11,724 -
- 7,900 - 0 7,900 -
- - - 0 - -
- 10,467 - 0 10,467 -
- 13,221 - 0 13,221 -
- 9,400 - 0 9,400 -
- - - 0 - -
- - - 0 - -
- 137,025 - 0 137,025 -
- 104,500 - 0 104,500 -
- - - 0 - -
- 55,200 - 0 55,200 -
- 133,821 - 0 133,821 -
- 1 130,000 130,000 2 130,000 260,000
- - - 0 - -
- 32,500 - 2 32,500 65,000
- - - 0 - -
- 23,625 - 0 23,625 -
- 1 23,625 23,625 11 23,625 259,875
- - - 0 - -
- 5,082 - 0 5,082 -
- 15 18,781 281,715 47 18,781 882,707
- 5,082 - 0 5,082 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 4,000 - 0 4,000 -
- - - 0 - -
- 5,770 - 0 5,770 -
- 5,770 - 200 5,770 1,154,000
- - - 0 - -
- 1 5,770 5,770 66 5,770 380,820
- 5,770 - 199 5,770 1,148,230
- - - 0 - -
- 5,770 - 0 5,770 -
- 5,770 - 200 5,770 1,154,000
- - - 0 - -
- 5,770 - 0 5,770 -
- - - 0 - -
- 22,000 - 0 22,000 -
- - - 0 - -
- 22,000 - 0 22,000 -
- - - 0 - -
- 1,125 - 0 1,125 -
- 7 1,125 7,875 35 1,125 39,375
- - - 0 - -
- 200,455 - 0 200,455 -
- 8,018 - 80 8,018 641,440
- - - 0 - -
- 68,181 - 0 68,181 -
- - - 0 - -
- 68,181 - 0 68,181 -
- - - 0 - -
- 6,825 - 0 6,825 -
- 3,413 - 0 3,413 -
- 1,494,992 11,091,611
437,400 7,393,189 41,285,869
Penanggung Jawab
Laporan
1 Air untuk injeksi amp 25 ml (aqua pro injeksi) Ampul 0 6,050 - 6,050
0 - - -
1710 78 133,380 78
0 - - -
Antasida, kombinasi : aluminium hidroksida
18 200 mg + magnesium hidroksida 200 mg Botol 0 2,213 - 2,213
Suspensi
0 2,213 - 5 2,213
0 - - -
Antibakteri, kombinasi : basitrasin 500 UI/g+
19 Tube 7 2,767 19,369 2,767
Polimiskin B 10.000 UI/g
Antifungi salep, kombinasi : asam benzoat 6% 0 - - -
+ asam salisilat 3%
20 Tube 3 2,096 6,288 2,096
0 - - -
mg + heksaklorofen 2,5 mg + lidokain
lidokain 10 mg+ seng oksida 120 mg + sup
21 ad 2 g Suppo 0 33,000 - 33,000
0 - - -
0 2,367 - 2,367
0 - - -
37 Asiklovir tab 200 mg Tab 0 251 - 251
255 251 64,005 251
0 - - -
38 Atropin inj 0,25 mg/ml (i.m./i.v./s.k) Ampul 29 1,400 40,600 1,400
0 - - -
39 Atropin tab 0,5 mg Tab 0 81 - 81
0 - - -
0 - - -
41 Bedak salisil serb 2% Botol 0 1,180 - 1,180
23 1,350 31,050 1,350
0 1,180 - 1,180
0 - - -
Besi (II) sulfat 200 mg + asam folat 0.25 mg
42 Sachet 0 73 - 73
(tablet tambah darah)
0 55 - 55
830 2,200 1,826,000 2,200
0 - - -
43 Becefort syrup Botol 0 22,727 - 22,727
4 22,727 90,908 22,727
0 - - -
44 Betametason krim 0,1% Tube 0 1,596 - 1,596
82 1,596 130,872 1,596
0 - - -
45 Betahistin mesilate tablet tablet 0 600 - 600
0 - - -
46 Bisakodil sup 10 mg (Stolax) Botol 0 - - -
0 - - -
47 Bisakodil tab sal 5 mg Tab sal 0 - - -
0 - - -
48 Bismecon salep tube 0 - - -
0 - - -
Budesonid-formoterol (fixed combination)* ih
49 Botol 0 - - -
80/4,5 mcg
0 - - -
50 Bromheksin tablet tablet 0 42 - 42
0 - - -
51 Deksametason tab 0,5 mg Tab 0 68 - 68
475 68 32,300 68
0 - - -
52 Deksametason inj 5 mg/ml (i.v./i.m.) Vial 168 1,738 291,984 1,738
0 - - -
53 Desoksimetason salep 0,25% Tube 0 - - -
3 9,983 29,949 9,983
0 - - -
54 Diazepam inj 5 mg/ml (i.v./i.m.) Vial 0 2,578 - 2,578
51 2,578 131,478 2,578
0 - - -
0 - - -
70 Eritromisin kaps 250 mg Kaps 820 522 428,040 522
0 522 - 522
0 - - -
71 Eritromisin sir 200 mg/5 ml Botol 24 7,581 181,944 7,581
0 - - -
72 Eritromisin tab 500 mg Tab 465 1,013 470,938 1,013
0 1,023 - 1,023
0 - - -
73 Etanol 70% cairan 70% Botol 0 2,625 - 2,625
0 2,625 - 2,625
68 2,625 178,500 2,625
0 - - -
74 Etakridin (rivanol) larutan 0.1% Botol 0 4,695 - 4,695
5 4,695 23,475 4,695
0 - - -
75 Etil klorida semprot 100 ml Botol 0 124 - 124
0 - - -
76 Famotidin tablet 20 mg Tab 0 - - -
0 124 - 124
0 - - -
77 Fenitoin Na inj 50 mg/ml Ampul 0 - - -
0 - - -
78 Fenitoin Na kaps 100 mg Kaps 0 - - -
100 146 14,600 146
0 - - -
79 Fenobarbital inj 50 mg/ml Ampul 0 37 - 37
90 1,980 178,200 1,980
0 - - -
80 Fenobarbital tab 100 mg Tab 0 - - -
0 - - -
81 Fenobarbital tab 30 mg Tab 0 37 - 37
0 - - -
0 - - -
83 Fitomenadion (vitamin K 1) tab sal 10 mg Tab sal 100 698 69,800 698
0 - - -
84 Flukonazol kaps 150 mg Kaps 0 - - -
0 - - -
85 Flusinolon asetonid krim 0,025% Tube 0 - - -
0 - - -
86 Flunarizin tablet tablet 0 2,012 - 2,012
0 - - -
87 Furosemid inj 10 mg/ml (i.v./i.m.) Ampul 34 2,012 68,408 2,012
0 - - -
88 Furosemid tab 40 mg Tab 0 84 - 84
360 84 30,240 84
0 - - -
Garam oralit kombinasi : natrium klorida 0,52
g + kalium klorida 0,30 g + trinatrium sitrat
89 Sachet 0 317 - 317
0,58 g + glukosa anhidrat 2,7 g
0 317 - 317
0 - - -
90 Gameksan lotion 1 % Botol 0 2,420 - 2,420
0 - - -
91 Gemfibrozil kaps 300 mg Kaps 0 323 - 323
0 - - -
92 Gemfibrozil kaps 600 mg Kaps 0 - - -
0 - - -
93 Gentamisin inj 10 mg/ml Ampul 0 3,739 - 3,739
0 - - -
94 Gentamisin salep mata 0,3% Tube 0 - - -
0 - - -
95 Gentamisin salep Kulit Tube 0 2,340 - 2,340
27 1,469 39,663 1,469
30 3,513 105,390 3,513
0 - - -
96 Gentamisin tts mata 0,3% Botol 0 3,194 - 3,194
0 - - -
97 Glibenklamid tab 5 mg Tab 0 61 - 61
120 61 7,320 61
0 - - -
98 Glimepirid tab 4 mg Tab 0 - - -
0 - - -
99 Glipizid tablet 5 mg (Glucotrol 5 mg) Tab 0 - - -
0 - - -
100 Gliseril Guaiakolat tab 100 mg Tab 0 31 - 31
6680 31 207,080 31
0 - - -
101 Gliserin lar 50% Botol 0 - - -
0 - - -
102 Glukosamin tablet 500 mg Tab 0 - - -
0 - - -
103 Glukosa Larutan Infus 5% steril Botol 26 5,720 148,720 5,720
0 - - -
104 Glukosa Larutan Infus 10% steril Botol 15 6,270 94,050 6,270
0 - - -
105 Glukosa Larutan Infus 40% steril Botol 0 - - -
0 - - -
106 Griseofulvin (micronized) tab 125 mg Tab 0 230 - 230
130 230 29,900 230
0 - - -
107 Haloperidol tab 0,5 mg Tab 0 62 - 62
0 - - -
108 Haloperidol tab 1,5 mg Tab 0 76 - 76
175 76 13,300 76
0 - - -
109 Haloperidol tab 5 mg Tab 0 105 - 105
0 105 - 105
0 - - -
110 Hidrogen peroksida (H2O2) cairan 3% Botol 0 38,500 - 38,500
0 - - -
111 Hidroklorotiazid (HCT) tab 25 mg Tab 0 40 - 40
9500 40 380,000 40
0 - - -
112 Hidrokortison krim 2,5% Tube 0 24 - 24
0 3,200 - 3,200
0 - - -
113 Hiosina butilbromida tab 10 mg Tab 0 330 - 330
0 - - -
114 Ibuprofen susp 100 mg/5 ml Botol 0 4,949 - 4,949
0 - - -
115 Ibuprofen tab 200 mg Tab 0 127 - 127
0 121 - 121
235 127 29,845 127
0 - - -
116 Ibuprofen tab 400 mg Tab 0 157 - 157
60 157 9,420 157
0 - - -
Ipratropium bromida nebulizer 0,025%
117 Botol 0 - - -
(Atroven sol. for inhalation 0.025%)
0 - - -
118 Isoniazid tab 300 mg Tab 0 - - -
0 - - -
119 Isosorbid dinitrat inj 10 mg/10 ml (Fasorbid) Vial 0 - - -
0 - - -
120 Isosorbid dinitrat tab 5 mg Tab 0 98 - 98
90 98 8,820 98
0 - - -
121 KA-EN 3B Cairan Infus Botol 17 10,000 170,000 10,000
0 - - -
122 Kalsium glukonat inj 100 mg/ml Ampul 20 9,519 190,380 9,519
0 - - -
123 Kalsium laktat (kalk) tab 500 mg Tab 0 51 - 51
780 76 59,280 76
0 - - -
124 Kaptopril tab 12,5 mg Tab 0 69 - 69
70 69 4,830 69
0 - - -
125 Kaptopril tab 25 mg Tab 0 97 - 97
690 97 66,930 300 97
0 - - -
126 Karbamazepin tab 200 mg Tab 0 269 - 269
0 - - -
127 Karbo adsorben (Norit) tab 500 mg Tab 0 - - -
0 - - -
128 Ketamin inj 50 mg/ml (i.v.) Ampul 0 110,000 - 110,000
0 - - -
129 Ketokonazol tab 200 mg Tab 0 320 - 320
0 320 - 320
0 - - -
130 Ketokonazol krim 2% Tube 0 5,150 - 5,150
0 5,150 - 5,150
0 - - -
131 Ketorolak inj 10 mg/ml Ampul 0 2,665 - 2,665
78 2,665 207,870 2,665
0 - - -
132 Klaritromisin tab 500 mg Tab 0 - - -
0 - - -
133 Klindamisin kaps 150 mg Kaps 0 405 - 405
0 - - -
134 Kloramfenikol tts mata 0,5% Botol 0 1,680 - 1,680
0 - - -
135 Kloramfenikol kaps 250 mg Kaps 90 275 24,750 275
0 275 - 275
0 - - -
136 Kloramfenikol salep mata 1% Tube 0 1,680 - 1,680
13 1,680 21,840 1,680
0 - - -
137 Kloramfenikol susp 125 mg/5 ml Botol 13 4,016 52,208 4,016
0 - - -
138 Klorfeniramin (CTM) tab 4 mg Tab 0 26 - 26
2939 26 77,590 26
0 - - -
139 Klorpromazin inj 25 mg/ml (i.m.) Ampul 0 1,210 - 1,210
0 - - -
140 Klorpromazin tab sal 100 mg Tab sal 0 152 - 152
0 - - -
141 Klorpromazin tab sal 25 mg Tab sal 232 50 11,600 50
0 - - -
0 - - -
Kotrimoksazol (dewasa) kombinasi :
sulfametoksazol 400 mg+ trimetoprim 80
144 Tab 700 152 106,400 152
mg
380 79 30,020 79
0 - - -
Kotrimoksazol (dewasa) kombinasi tiap 5 ml
146 suspensi : sulfametoksazol 200 mg + Botol 31 2,298 71,238 2,298
trimetoprim 40 mg
0 - - -
147 Kuinin inj 25% (i.v.) Vial 0 6,820 - 6,820
0 6,820 - 6,820
0 - - -
148 Kloroquin tab 150 mg Tab 0 112 - 112
0 - - -
149 Lansoprazol kaps 30 mg Kaps 0 - - -
0 - - -
150 Levofloksasin tab 500 mg Tab 0 581 - 581
0 - - -
151 Lidokain gel 2% Tube 0 - - -
0 - - -
152 Lidokain inj 2% (hcl) Vial 0 1,499 - 1,499
0 1,499 - 1,499
208 929 193,232 929
0 - - -
153 Lisol Botol 0 54,995 - 54,995
0 54,995 - 54,995
0 - - -
154 Loperamid tab 2 mg Tab 0 97 - 97
5 97 485 200 97
0 - - -
155 Loratadin tab 10 mg Tab 50 170 8,500 170
0 - - -
156 Magnesium sulfat inj 20% Vial 0 7,260 - 7,260
0 7,260 - 7,260
0 - - -
157 Magnesium sulfat inj 40% Vial 0 7,260 - 7,260
18 7,260 130,680 7,260
0 - - -
158 Magnesium sulfat serb, ktg 30 g Sachet 0 1,130 - 1,130
0 - - -
159 Mebendazol sir 50 mg/ml Botol 0 3,887 - 3,887
0 - - -
160 Mebendazol tab 100 mg Tan 90 248 22,320 248
0 - - -
161 Metformin tab 500 mg Tab 0 - - -
0 - - -
162 Metformin tab 850 mg Tab 0 - - -
0 - - -
163 Metilergometrin inj 0,2 mg/ml Ampul 0 1,639 - 1,639
0 - - -
164 Metilergometrin tab salut 0,125 mg Tab sal 160 133 21,296 133
0 - - -
165 Metilprednisolon tab 4 mg Tab 0 - - -
0 - - -
166 Metoklopramid inj 5 mg/ml Vial 0 1,100 - 1,100
0 1,100 - 1,100
0 - - -
0 - - -
168 Metoklopramid tab 10 mg Tab 222 100 22,200 100
0 - - -
169 Metronidazol supposutoria 500 mg suppo 0 - - -
0 - - -
170 Metronidazol larutan infus Botol 0 12,980 - 12,980
7 12,980 90,860 12,980
0 - - -
171 Metronidazol tab 250 mg Tab 0 116 - 116
590 116 68,440 116
0 - - -
172 Metronidazol tab 500 mg Tab 0 - - -
1430 169 241,670 169
0 - - -
173 Mikonazol krim 2% Tube 0 3,150 - 3,150
17 3,150 53,550 3,150
0 - - -
174 Natrium diklofenak tab 25 mg Tab 0 146 - 146
320 146 46,720 146
0 - - -
175 Natrium diklofenak tab 50 mg Tab 0 193 - 193
140 193 27,020 600 193
0 - - -
176 NaCl 0,9% Larutan infus Botol 0 5,170 - 5,170
19 5,170 98,230 5,170
0 - - -
177 Nifedipin kaps 10 mg Kaps 0 127 - 127
630 127 80,010 200 127
0 - - -
178 Nistatin tab salut 500.000 UI Tab 0 704 - 704
400 704 281,600 704
0 - - -
179 Nistatin tab vaginal 100.000 UI Tab 190 448 85,120 448
0 - - -
180 Obat Batuk Hitam (OBH) Botol 0 2,310 - 2,310
72 2,310 166,320 2,310
0 - - -
181 Ofloksasin tab 200 mg Tab 0 440 - 440
0 - - -
182 Ofloksasin tab 400 mg Tab 0 700 - 700
40 700 28,000 700
0 - - -
183 Oksitetrasiklin hcl inj 500 mg/ml Vial 0 3,410 - 3,410
0 - - -
184 Oksitetrasiklin hcl salep kulit 3% Tube 0 2,010 - 2,010
15 1,646 24,690 1,646
0 - - -
185 Oksitetrasiklin hcl salep mata 1 % Tube 0 2,772 - 2,772
133 2,772 368,676 2,772
0 - - -
186 Oksitosin inj 10 UI/ml Ampul 0 6,875 - 6,875
0 1,900 - 1,900
18 6,875 123,750 6,875
0 - - -
187 Omeprazol kaps 20 mg Kaps 0 221 - 221
0 221 - 221
0 - - -
188 Papaverin tablet 40 mg Tab 0 109 - 109
2280 109 248,520 109
0 - - -
189 Parasetamol sir 120 mg/5 ml Botol 0 1,535 - 1,535
113 1,535 173,455 1,535
0 - - -
190 Parasetamol tab 100 mg Tab 0 105 - 105
200 105 21,000 105
0 - - -
191 Parasetamol tab 500 mg Tab 0 88 - 88
2595 88 228,360 88
0 - - -
192 Parasetamol rectal suppo 0 - - -
0 - - -
193 Pehavral tablet multivitamin Tab 0 849 - 849
0 297 - 297
0 - - -
230 Sianokobalamin (vitamin B12) inj 500 mcg/ml Vial 38 1,451 55,124 1,451
0 - - -
0 - - -
232 Simetidin tablet 200 mg Tab 0 138 - 138
640 138 88,320 138
0 - - -
233 Simvastatin tab sal 10 mg Tab sal 0 177 - 177
0 - - -
234 Simvastatin tab sal 20 mg Tab sal 0 480 - 480
0 - - -
235 Siprofloksasin inf 2 mg/ml Botol 0 - - -
0 - - -
236 Siprofloksasin tab scored 500 mg Tab 700 312 218,680 312
0 - - -
237 Spironolakton tab 100 mg Tab 0 - - -
200 350 70,000 350
0 - - -
238 Sulfasetamid Natrium Tetes mata 1.5% Botol 0 - - -
0 - - -
239 Sukralfat susp 500 mg/5 ml (Ulsafate) Botol 0 - - -
0 - - -
240 Sukralfat tab 500 mg (Ulsidex) Tab 0 - - -
400 477 190,800 477
0 - - -
241 Teofilin tab SR 300 mg (Rethapyl) Tab 0 - - -
100 1,155 115,500 1,155
0 - - -
242 Tetrasiklin kaps 250 mg Kaps 700 183 128,398 183
0 - - -
243 Tetrasiklin kaps 500 mg Kaps 0 283 - 283
0 - - -
0 42 - 42
0 - - -
245 Tiamin (vitamin B1) injeksi 100 mg/ml Tab 0 770 - 770
0 - - -
246 Tramadol inj 50 mg/ml Ampul 0 2,680 - 2,680
0 - - -
247 Tramadol tablet 500 mg Tab 93 363 33,759 50 363
0 - - -
248 Triheksifenidil tab 2 mg Tab 0 45 - 45
160 45 7,200 45
0 - - -
249 Vitamin B12 tablet 50 mcg Tab 0 63 - 63
0 - - -
250 Vitamin B kompleks injeksi Vial 0 7,392 - 7,392
0 - - -
251 Vitamin B kompleks Tab 0 112 - 112
4520 112 506,240 112
0 - - -
252 Zinc tab disp 20 mg Tab 0 521 - 521
170 521 88,570 521
0 - - -
253 Zinc sirup 20 mg / 5 ml Botol 0 8,140 - 8,140
13 8,140 105,820 8,140
0 - - -
254 Larutan PK botol 0 573 - 573
1 6,975 6,975 6,975
0 - - -
255 Kanamisin inj Vial 47 10,395 488,565 10,395
0 - - -
256 Antalgin 500mg tab 0 155 - 155
1000 141 141,000 141
0 - - -
257 Klorpromazin inj 25 mg/ml (i.m.) Ampul 0 - - -
0 1,210 - 1,210
0 - - -
11,091,611
41,285,869
Mengetahui
Kepala Puskesmas Rumbia
Rahmat, AMK
Nip. 19721021 199403 1 004
N OBAT DAN PERBEKES
LAMA 1 TAHUN
N 2016
BULAN : SEPTEMBER
TAHUN : 2016
- 6,050 - 0 6,050 -
- 1,499 - 0 1,499 -
- - - 0 - -
- 78 - 0 78 -
- 2,213 - 0 2,213 -
- - - 0 - -
- - - 0 - -
- 33,000 - 0 33,000 -
- 1,650 - 0 1,650 -
- - - 0 - -
- 149 - 0 149 -
- 1,265 - 0 1,265 -
- - - 0 - -
- 2,367 - 0 2,367 -
- - - 0 - -
- 251 - 0 251 -
- 251 - 255 251 64,005
- - - 0 - -
- 1,400 - 29 1,400 40,600
- - - 0 - -
- 81 - 0 81 -
- - - 0 - -
- 13,500 - 0 13,500 -
- - - 0 - -
- 1,180 - 0 1,180 -
- 13 1,350 17,550 10 1,350 13,500
- 1,180 - 0 1,180 -
- - - 0 - -
- 73 - 0 73 -
- 55 - 0 55 -
- 830 2,200 1,826,000 0 2,200 -
- - - 0 - -
- 22,727 - 0 22,727 -
- 22,727 - 4 22,727 90,908
- - - 0 - -
- 1,596 - 0 1,596 -
- 19 1,596 30,324 63 1,596 100,548
- - - 0 - -
- 600 - 0 600 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 42 - 0 42 -
- - - 0 - -
- 68 - 0 68 -
- 275 68 18,700 200 68 13,600
- - - 0 - -
- 1,738 - 168 1,738 291,984
- - - 0 - -
- - - 0 - -
- 9,983 - 3 9,983 29,949
- - - 0 - -
- 2,578 - 0 2,578 -
- 2,578 - 51 2,578 131,478
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 28 - 0 28 -
- - - 0 - -
- 28 - 55 28 1,540
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 1,160 - 45 1,160 52,200
- - - 0 - -
- 103 - 100 103 10,300
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 141 - 0 141 -
- 141 - 560 141 78,960
- - - 0 - -
- 278 - 160 278 44,528
- - - 0 - -
- 3,490 - 0 3,490 -
174,500 5 3,490 17,450 60 3,490 209,400
- - - 0 - -
- 174 - 0 174 -
- 65 174 11,310 548 174 95,352
- - - 0 - -
- 56 - 0 56 -
- 50 56 2,820 300 56 16,917
- - - 0 - -
- 42 - 160 42 6,720
- 42 - 5000 42 210,000
- - - 0 - -
- - - 0 - -
- 522 - 820 522 428,040
- 522 - 0 522 -
- - - 0 - -
- 7,581 - 24 7,581 181,944
- - - 0 - -
- 1,013 - 465 1,013 470,938
- 1,023 - 0 1,023 -
- - - 0 - -
- 2,625 - 0 2,625 -
- 2,625 - 0 2,625 -
- 13 2,625 34,125 55 2,625 144,375
- - - 0 - -
- 4,695 - 0 4,695 -
- 4,695 - 5 4,695 23,475
- - - 0 - -
- 124 - 0 124 -
- - - 0 - -
- - - 0 - -
- 124 - 0 124 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 146 - 100 146 14,600
- - - 0 - -
- 37 - 0 37 -
- 1,980 - 90 1,980 178,200
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 37 - 0 37 -
- - - 0 - -
- - - 0 - -
- 698 - 100 698 69,800
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 2,012 - 0 2,012 -
- - - 0 - -
- 2,012 - 34 2,012 68,408
- - - 0 - -
- 84 - 0 84 -
- 84 - 360 84 30,240
- - - 0 - -
- 317 - 0 317 -
- 317 - 0 317 -
- - - 0 - -
- 2,420 - 0 2,420 -
- - - 0 - -
- 323 - 0 323 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 3,739 - 0 3,739 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 2,340 - 0 2,340 -
- 9 1,469 13,221 18 1,469 26,442
- 3,513 - 30 3,513 105,390
- - - 0 - -
- 3,194 - 0 3,194 -
- - - 0 - -
- 61 - 0 61 -
- 61 - 120 61 7,320
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 31 - 0 31 -
- 480 31 14,880 6200 31 192,200
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 5,720 - 26 5,720 148,720
- - - 0 - -
- 6,270 - 15 6,270 94,050
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 230 - 0 230 -
- 60 230 13,800 70 230 16,100
- - - 0 - -
- 62 - 0 62 -
- - - 0 - -
- 76 - 0 76 -
- 76 - 175 76 13,300
- - - 0 - -
- 105 - 0 105 -
- 105 - 0 105 -
- - - 0 - -
- 38,500 - 0 38,500 -
- - - 0 - -
- 40 - 0 40 -
- 40 - 9500 40 380,000
- - - 0 - -
- 24 - 0 24 -
- 3,200 - 0 3,200 -
- - - 0 - -
- 330 - 0 330 -
- - - 0 - -
- 4,949 - 0 4,949 -
- - - 0 - -
- 127 - 0 127 -
- 121 - 0 121 -
- 235 127 29,845 0 127 -
- - - 0 - -
- 157 - 0 157 -
- 60 157 9,420 0 157 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 98 - 0 98 -
- 98 - 90 98 8,820
- - - 0 - -
- 10,000 - 17 10,000 170,000
- - - 0 - -
- 9,519 - 20 9,519 190,380
- - - 0 - -
- 51 - 0 51 -
- 310 76 23,560 470 76 35,720
- - - 0 - -
- 69 - 0 69 -
- 69 - 70 69 4,830
- - - 0 - -
- 97 - 0 97 -
29,100 278 97 26,966 712 97 69,064
- - - 0 - -
- 269 - 0 269 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 110,000 - 0 110,000 -
- - - 0 - -
- 320 - 0 320 -
- 320 - 0 320 -
- - - 0 - -
- 5,150 - 0 5,150 -
- 5,150 - 0 5,150 -
- - - 0 - -
- 2,665 - 0 2,665 -
- 2,665 - 78 2,665 207,870
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 405 - 0 405 -
- - - 0 - -
- 1,680 - 0 1,680 -
- - - 0 - -
- 90 275 24,750 0 275 -
- 275 - 0 275 -
- - - 0 - -
- 1,680 - 0 1,680 -
- 1 1,680 1,680 12 1,680 20,160
- - - 0 - -
- 4,016 - 13 4,016 52,208
- - - 0 - -
- 26 - 0 26 -
- 570 26 15,048 2369 26 62,542
- - - 0 - -
- 1,210 - 0 1,210 -
- - - 0 - -
- 152 - 0 152 -
- - - 0 - -
- 50 - 232 50 11,600
- - - 0 - -
- 531 - 0 531 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 79 - 0 79 -
- - - 0 - -
- 6,820 - 0 6,820 -
- 6,820 - 0 6,820 -
- - - 0 - -
- 112 - 0 112 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 581 - 0 581 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 1,499 - 0 1,499 -
- 1,499 - 0 1,499 -
- 177 929 164,433 31 929 28,799
- - - 0 - -
- 54,995 - 0 54,995 -
- 54,995 - 0 54,995 -
- - - 0 - -
- 97 - 0 97 -
19,400 100 97 9,700 105 97 10,185
- - - 0 - -
- 170 - 50 170 8,500
- - - 0 - -
- 7,260 - 0 7,260 -
- 7,260 - 0 7,260 -
- - - 0 - -
- 7,260 - 0 7,260 -
- 7,260 - 18 7,260 130,680
- - - 0 - -
- 1,130 - 0 1,130 -
- - - 0 - -
- 3,887 - 0 3,887 -
- - - 0 - -
- 248 - 90 248 22,320
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 1,639 - 0 1,639 -
- - - 0 - -
- 133 - 160 133 21,296
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 1,100 - 0 1,100 -
- 1,100 - 0 1,100 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 20 100 2,000 202 100 20,200
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 12,980 - 0 12,980 -
- 12,980 - 7 12,980 90,860
- - - 0 - -
- 116 - 0 116 -
- 10 116 1,160 580 116 67,280
- - - 0 - -
- - - 0 - -
- 190 169 32,110 1240 169 209,560
- - - 0 - -
- 3,150 - 0 3,150 -
- 8 3,150 25,200 9 3,150 28,350
- - - 0 - -
- 146 - 0 146 -
- 260 146 37,960 60 146 8,760
- - - 0 - -
- 193 - 0 193 -
115,800 150 193 28,950 590 193 113,870
- - - 0 - -
- 5,170 - 0 5,170 -
- 6 5,170 31,020 13 5,170 67,210
- - - 0 - -
- 127 - 0 127 -
25,400 127 - 830 127 105,410
- - - 0 - -
- 704 - 0 704 -
- 704 - 400 704 281,600
- - - 0 - -
- 448 - 190 448 85,120
- - - 0 - -
- 2,310 - 0 2,310 -
- 1 2,310 2,310 71 2,310 164,010
- - - 0 - -
- 440 - 0 440 -
- - - 0 - -
- 700 - 0 700 -
- 700 - 40 700 28,000
- - - 0 - -
- 3,410 - 0 3,410 -
- - - 0 - -
- 2,010 - 0 2,010 -
- 8 1,646 13,168 7 1,646 11,522
- - - 0 - -
- 2,772 - 0 2,772 -
- 1 2,772 2,772 132 2,772 365,904
- - - 0 - -
- 6,875 - 0 6,875 -
- 1,900 - 0 1,900 -
- 10 6,875 68,750 8 6,875 55,000
- - - 0 - -
- 221 - 0 221 -
- 221 - 0 221 -
- - - 0 - -
- 109 - 0 109 -
- 109 - 2280 109 248,520
- - - 0 - -
- 1,535 - 0 1,535 -
- 39 1,535 59,865 74 1,535 113,590
- - - 0 - -
- 105 - 0 105 -
- 100 105 10,500 100 105 10,500
- - - 0 - -
- 88 - 0 88 -
- 791 88 69,608 1804 88 158,752
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 849 - 0 849 -
- 297 - 0 297 -
- - - 0 - -
- 25,350 - 0 25,350 -
- 2,344 - 0 2,344 -
- 15,386 - 0 15,386 -
- 40,202 - 0 40,202 -
- 40,202 - 0 40,202 -
- - - 0 - -
- 98 - 0 98 -
- 350 98 34,300 1164 98 114,072
- - - 0 - -
- 125 - 985 125 123,125
- - - 0 - -
- 12,021 - 0 12,021 -
- 8 12,021 96,168 28 12,021 336,588
- - - 0 - -
- 297 - 200 297 59,400
- - - 0 - -
- 80 - 90 80 7,200
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 128 - 0 128 -
- 510 128 65,280 640 128 81,920
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 440 - 0 440 -
- - - 0 - -
- 624 - 0 624 -
- - - 0 - -
- 863 - 0 863 -
- - - 0 - -
- 5,720 - 0 5,720 -
- 15 5,720 85,800 106 5,720 606,320
- - - 0 - -
- 92 - 0 92 -
- 160 65 10,400 210 65 13,650
- - - 0 - -
- 93 - 0 93 -
- 120 93 11,160 280 93 26,040
- - - 0 - -
- 1,980 - 0 1,980 -
- - - 0 - -
- 150 - 0 150 -
- - - 0 - -
- 138 - 0 138 -
- 138 - 640 138 88,320
- - - 0 - -
- 177 - 0 177 -
- - - 0 - -
- 480 - 0 480 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 312 - 700 312 218,680
- - - 0 - -
- - - 0 - -
- 350 - 200 350 70,000
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 477 - 400 477 190,800
- - - 0 - -
- - - 0 - -
- 1,155 - 100 1,155 115,500
- - - 0 - -
- 183 - 700 183 128,398
- - - 0 - -
- 283 - 0 283 -
- - - 0 - -
- 42 - 0 42 -
- 42 - 0 42 -
- - - 0 - -
- 770 - 0 770 -
- - - 0 - -
- 2,680 - 0 2,680 -
- - - 0 - -
18,150 31 363 11,253 112 363 40,656
- - - 0 - -
- 45 - 0 45 -
- 45 - 160 45 7,200
- - - 0 - -
- 63 - 0 63 -
- - - 0 - -
- 7,392 - 0 7,392 -
- - - 0 - -
- 112 - 0 112 -
- 520 112 58,240 4000 112 448,000
- - - 0 - -
- 521 - 0 521 -
- 170 521 88,570 0 521 -
- - - 0 - -
- 8,140 - 0 8,140 -
- 1 8,140 8,140 12 8,140 97,680
- - - 0 - -
- 573 - 0 573 -
- 1 6,975 6,975 0 6,975 -
- - - 0 - -
- 10,395 - 47 10,395 488,565
- - - 0 - -
- 155 - 0 155 -
- 141 - 1000 141 141,000
- - - 0 - -
- - - 0 - -
- 1,210 - 0 1,210 -
- - - 0 - -
- 57 - 0 57 -
- - - 0 - -
- 116 - 0 116 -
- 572 - 0 572 -
- - - 0 - -
- 191 - 100 191 19,100
- - - 0 - -
- 275 - 0 275 -
- 275 - 0 275 -
- - - 0 - -
- 162 - 0 162 -
- - - 0 - -
- 1,108 - 0 1,108 -
- 1,109 - 16 1,109 17,744
- - - 0 - -
- 162 - 0 162 -
- - - 0 - -
- 116 - 0 116 -
- - - 0 - -
- 167 - 0 167 -
- - - 0 - -
- 125 - 0 125 -
- - - 0 - -
- 318 - 0 318 -
- - - 0 - -
- 109 - 0 109 -
- - - 0 - -
- 45 - 0 45 -
- - - 0 - -
- 854 - 0 854 -
- - - 0 - -
- 42,727 - 0 42,727 -
- 42,727 - 0 42,727 -
- - - 0 - -
- 1,480 - 0 1,480 -
- 430 1,480 636,400 225 1,480 333,000
- - - 0 - -
- 31 - 0 31 -
- - - 0 - -
- 56 - 0 56 -
- - - 0 - -
- - - 0 - -
- 765,000 - 0 765,000 -
- 765,000 - 2 765,000 1,530,000
- - - 0 - -
- 242,000 - 0 242,000 -
- - - 0 - -
- 338,800 - 0 338,800 -
- 338,800 - 1 338,800 338,800
- - - 0 - -
- 390,000 - 0 390,000 -
- 390,000 - 0 390,000 -
- - - 0 - -
- 18,333 - 0 18,333 -
- 1 18,333 18,333 0 18,333 -
- - - 0 - -
- 105,000 - 0 105,000 -
- 2 105,000 210,000 1 105,000 105,000
- - - 0 - -
- 170,000 - 0 170,000 -
- - - 0 - -
- 395,000 - 0 395,000 -
- 197,895 - 1 197,895 197,895
- - - 0 - -
- 55,000 - 1 55,000 55,000
- - - 0 - -
- 93,500 - 0 93,500 -
- 93,500 - 2 93,500 187,000
- - - 0 - -
- 34,000 - 0 34,000 -
- 34,000 - 0 34,000 -
- - - 0 - -
- 176,000 - 0 176,000 -
- - - 0 - -
- - - 0 - -
- 425 - 0 425 -
- 24,384 - 0 24,384 -
- 27,569 - 0 27,569 -
- 27,569 - 8 27,569 220,552
- - - 0 - -
- 104 - 0 104 -
- 104 - 2000 104 208,000
- - - 0 - -
- 825,000 - 0 825,000 -
- 4,545 - 0 4,545 -
- 236,490 - 0 236,490 -
- 396,000 - 0 396,000 -
- 1,319,990 - 0 1,319,990 -
- 175,899 - 0 175,899 -
- 145,000 - 0 145,000 -
- 150,000 - 0 150,000 -
- 168,300 - 0 168,300 -
- 46,200 - 0 46,200 -
- 45,560 - 0 45,560 -
- 42,350 - 0 42,350 -
- 20,454 - 0 20,454 -
- 4,438 - 0 4,438 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 285,000 - 0 285,000 -
- 695,752 - 0 695,752 -
- 412 - 0 412 -
- 286 - 0 286 -
- 497 - 0 497 -
- - - 0 - -
- - - 0 - -
- 1,093 - 0 1,093 -
- 848 - 6 848 5,090
- 990 - 100 990 99,000
- - - 0 - -
- 1,038 - 0 1,038 -
- 848 - 0 848 -
- 650 - 0 650 -
- - - 0 - -
- 1,038 - 0 1,038 -
- 71 848 60,226 78 848 66,164
- 792 - 100 792 79,200
- - - 0 - -
- 1,038 - 0 1,038 -
- 15 979 14,681 406 979 397,373
- - - 0 - -
- 2,099 - 0 2,099 -
- 2,100 - 67 2,100 140,700
- 2,099 - 100 2,099 209,900
- - - 0 - -
- 2,099 - 0 2,099 -
- 2,100 - 0 2,100 -
- 36 2,099 75,564 9 2,099 18,891
- - - 0 - -
- 6,400 - 0 6,400 -
- 4 25,920 103,680 41 25,920 1,062,720
- 6,400 - 48 6,400 307,200
- - - 0 - -
- 5,900 - 0 5,900 -
- 27,000 - 0 27,000 -
- 8 5,900 47,200 10 5,900 59,000
- - - 0 - -
- 6,595 - 0 6,595 -
- 11,990 - 0 11,990 -
- - - 0 - -
- 9 6,595 59,355 0 6,595 -
- - - 0 - -
- - - 0 - -
- 4,250 - 0 4,250 -
- 7,684 - 0 7,684 -
- 11,990 - 0 11,990 -
- - - 0 - -
- 4,250 - 0 4,250 -
- 7,684 - 0 7,684 -
599,500 40 11,990 479,600 48 11,990 575,520
- - - 0 - -
- 3,500 - 0 3,500 -
- 6 4,176 25,056 25 4,176 104,400
- 9,900 - 25 9,900 247,500
- - - 0 - -
- 4,000 - 0 4,000 -
- 4,568 - 3 4,568 13,704
- 9,900 - 8 9,900 79,200
- - - 0 - -
- 7,937 - 0 7,937 -
- 7,018 - 0 7,018 -
- - - 0 - -
- 6,600 - 0 6,600 -
- 20,900 - 0 20,900 -
- - - 0 - -
- 7,787 - 0 7,787 -
- 3 7,787 23,361 36 7,787 280,332
- 7,018 - 20 7,018 140,360
- - - 0 - -
- 7,787 - 0 7,787 -
- 7,937 - 38 7,937 301,606
- 7,018 - 0 7,018 -
- - - 0 - -
- 7,787 - 46 7,787 358,202
- 7,018 - 20 7,018 140,360
- - - 0 - -
- 10,440 - 0 10,440 -
- 8,000 - 0 8,000 -
- - - 0 - -
- 8,495 - 0 8,495 -
- 10,440 - 0 10,440 -
- 8,000 - 0 8,000 -
- - - 0 - -
- 8,495 - 0 8,495 -
- 10,440 - 0 10,440 -
- 8,000 - 0 8,000 -
- - - 0 - -
- 495 - 0 495 -
- 10,440 - 8 10,440 83,520
- 8,000 - 0 8,000 -
- - - 0 - -
- 7,500 - 0 7,500 -
- 27,821 - 0 27,821 -
- 24,000 - 1 24,000 24,000
- - - 0 - -
- 17,250 - 0 17,250 -
- - - 0 - -
- 800 - 0 800 -
- - - 0 - -
- 887 - 0 887 -
- 1,100 - 0 1,100 -
- - - 0 - -
- 607 - 0 607 -
- 6,121 - 0 6,121 -
- 5 2,300 11,500 5 2,300 11,500
- - - 0 - -
- 887 - 0 887 -
- 3,800 - 0 3,800 -
- - - 0 - -
- 1,871 - 0 1,871 -
- 5,621 - 0 5,621 -
- 1,800 - 0 1,800 -
- - - 0 - -
- 8,600 - 0 8,600 -
- 11,724 - 0 11,724 -
- 7,900 - 0 7,900 -
- - - 0 - -
- 10,467 - 0 10,467 -
- 13,221 - 0 13,221 -
- 9,400 - 0 9,400 -
- - - 0 - -
- - - 0 - -
- 137,025 - 0 137,025 -
- 104,500 - 0 104,500 -
- - - 0 - -
- 55,200 - 0 55,200 -
- 133,821 - 0 133,821 -
- 1 130,000 130,000 1 130,000 130,000
- - - 0 - -
- 32,500 - 2 32,500 65,000
- - - 0 - -
- 23,625 - 0 23,625 -
- 2 23,625 47,250 9 23,625 212,625
- - - 0 - -
- 5,082 - 0 5,082 -
- 9 18,781 169,029 38 18,781 713,678
- 5,082 - 0 5,082 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 4,000 - 0 4,000 -
- - - 0 - -
- 5,770 - 0 5,770 -
- 5,770 - 200 5,770 1,154,000
- - - 0 - -
- 6 5,770 34,620 60 5,770 346,200
- 5,770 - 199 5,770 1,148,230
- - - 0 - -
- 5,770 - 0 5,770 -
- 5,770 - 200 5,770 1,154,000
- - - 0 - -
- 5,770 - 0 5,770 -
- - - 0 - -
- 22,000 - 0 22,000 -
- - - 0 - -
- 22,000 - 0 22,000 -
- - - 0 - -
- 1,125 - 0 1,125 -
- 1,125 - 35 1,125 39,375
- - - 0 - -
- 200,455 - 0 200,455 -
- 8,018 - 80 8,018 641,440
- - - 0 - -
- 68,181 - 0 68,181 -
- - - 0 - -
- 68,181 - 0 68,181 -
- - - 0 - -
- 6,825 - 0 6,825 -
- 3,413 - 0 3,413 -
Penanggung Jawab
Laporan
1 Air untuk injeksi amp 25 ml (aqua pro injeksi) Ampul 0 6,050 - 6,050
0 - - -
0 - - -
mg + heksaklorofen 2,5 mg + lidokain
lidokain 10 mg+ seng oksida 120 mg + sup
21 ad 2 g Suppo 0 33,000 - 33,000
0 2,200 - 2,200
34 33,000 1,122,000 20 33,000
0 - - -
Anti Parkinson kombinasi : benzerasid 25 mg +
22 Kaps 0 1,650 - 1,650
levodopa 100 mg
0 - - -
Anti Migren, kombinasi : ergotamin 1 mg+
23 Tab 0 149 - 149
kafein 50 mg
487 149 72,563 500 149
0 - - -
24 Antalgin (metampirom) tablet 100 mg Tab 0 155 - 155
0 - - -
25 Antalgin (metampirom) injeksi 250 mg/ml-2 ml Ampul 0 1,346 - 1,346
0 - - -
26 Asam asetilsalisilat (asetosal) tab 100 mg Tab 30 110 3,300 110
1100 127 139,700 127
0 110 - 110
0 - - -
27 Asam asetilsalisilat (asetosal) tab 500 mg Tab 0 178 - 178
0 - - -
Asam asetilsalisilat (asetosal) tab 80 mg
28 Tab 0 163 - 163
(Miniaspi 80)
0 - - -
29 Asam askorbat (vitamin C) tab 50 mg Tab 0 105 - 105
1010 105 106,050 2,500 105
0 - - -
30 Asam folat tab 1 mg Tab 0 52 - 52
520 52 27,040 52
0 - - -
31 Asam mefenamat kaps 250 mg Kaps 0 - - -
0 - - -
32 Asam mefenamat kaps 500 mg Kaps 0 127 - 127
1720 127 218,440 2,000 127
0 - - -
33 Asam traneksamat inj 50 mg/ml Ampul 25 3,650 91,250 3,650
0 - - -
0 - - -
0 2,367 - 2,367
0 - - -
37 Asiklovir tab 200 mg Tab 0 251 - 251
255 251 64,005 251
0 - - -
38 Atropin inj 0,25 mg/ml (i.m./i.v./s.k) Ampul 29 1,400 40,600 1,400
0 - - -
39 Atropin tab 0,5 mg Tab 0 81 - 81
0 - - -
0 - - -
41 Bedak salisil serb 2% Botol 0 1,180 - 1,180
10 1,350 13,500 1,350
0 1,180 - 1,180
0 - - -
Besi (II) sulfat 200 mg + asam folat 0.25 mg
42 Sachet 0 73 - 73
(tablet tambah darah)
0 55 - 55
0 2,200 - 3,000 2,200
0 - - -
43 Becefort syrup Botol 0 22,727 - 22,727
4 22,727 90,908 22,727
0 - - -
44 Betametason krim 0,1% Tube 0 1,596 - 1,596
63 1,596 100,548 1,596
0 - - -
45 Betahistin mesilate tablet tablet 0 600 - 210 600
0 - - -
46 Bisakodil sup 10 mg (Stolax) Botol 0 - - -
0 - - -
47 Bisakodil tab sal 5 mg Tab sal 0 - - -
0 - - -
48 Bismecon salep tube 0 - - -
0 - - -
Budesonid-formoterol (fixed combination)* ih
49 Botol 0 - - -
80/4,5 mcg
0 - - -
50 Bromheksin tablet tablet 0 42 - 42
0 - - -
51 Deksametason tab 0,5 mg Tab 0 68 - 68
200 68 13,600 68
0 - - -
52 Deksametason inj 5 mg/ml (i.v./i.m.) Vial 168 1,738 291,984 1,738
0 - - -
53 Desoksimetason salep 0,25% Tube 0 - - -
3 9,983 29,949 5 9,983
0 - - -
54 Diazepam inj 5 mg/ml (i.v./i.m.) Vial 0 2,578 - 2,578
51 2,578 131,478 2,578
0 - - -
0 - - -
56 Diazepam supposutoria suppo 0 - - -
0 - - -
57 Diazepam tab 2 mg Tab 0 28 - 28
0 - - -
58 Diazepam tab 5 mg Tab 55 28 1,540 28
0 - - -
59 Dietilkarbamazin tab 100 mg Tab 0 - - -
0 - - -
60 Difenhidramin inj 10 mg/ml (i.v./i.m.) Ampul 45 1,160 52,200 30 1,160
0 - - -
61 Digoksin tab 0,25 mg Tab 100 103 10,300 400 103
0 - - -
62 Diltiazem kaps SR 100 mg Kaps 0 - - -
0 - - -
63 Diltiazem tab 30 mg Tab 0 141 - 141
560 141 78,960 141
0 - - -
64 Doksisiklin tablet 100 mg Tab 160 278 44,528 278
0 - - -
65 Domperidon susp 5 mg/5 ml Botol 0 3,490 - 3,490
60 3,490 209,400 3,490
0 - - -
66 Domperidon tab 10 mg Tab 0 174 - 174
548 174 95,352 200 174
0 - - -
67 Efedrin HCl tablet Tab 0 56 - 56
300 56 16,917 300 56
0 - - -
68 Ekstrak belladon tablet 10 mg tab 160 42 6,720 42
5000 42 210,000 42
0 - - -
0 - - -
83 Fitomenadion (vitamin K 1) tab sal 10 mg Tab sal 100 698 69,800 698
0 - - -
84 Flukonazol kaps 150 mg Kaps 0 - - -
0 - - -
85 Flusinolon asetonid krim 0,025% Tube 0 - - -
0 - - -
86 Flunarizin tablet tablet 0 2,012 - 2,012
0 - - -
87 Furosemid inj 10 mg/ml (i.v./i.m.) Ampul 34 2,012 68,408 2,012
0 - - -
88 Furosemid tab 40 mg Tab 0 84 - 84
360 84 30,240 84
0 - - -
Garam oralit kombinasi : natrium klorida 0,52
g + kalium klorida 0,30 g + trinatrium sitrat
89 Sachet 0 317 - 317
0,58 g + glukosa anhidrat 2,7 g
0 - - -
Kotrimoksazol (dewasa) kombinasi :
sulfametoksazol 400 mg+ trimetoprim 80
144 Tab 610 152 92,720 152
mg
0 - - -
168 Metoklopramid tab 10 mg Tab 202 100 20,200 100
0 - - -
169 Metronidazol supposutoria 500 mg suppo 0 - - -
0 - - -
170 Metronidazol larutan infus Botol 0 12,980 - 12,980
7 12,980 90,860 12,980
0 - - -
171 Metronidazol tab 250 mg Tab 0 116 - 116
580 116 67,280 100 116
0 - - -
172 Metronidazol tab 500 mg Tab 0 - - -
1240 169 209,560 169
0 - - -
173 Mikonazol krim 2% Tube 0 3,150 - 3,150
9 3,150 28,350 24 3,150
0 - - -
174 Natrium diklofenak tab 25 mg Tab 0 146 - 146
60 146 8,760 500 146
0 - - -
175 Natrium diklofenak tab 50 mg Tab 0 193 - 193
590 193 113,870 750 193
0 - - -
176 NaCl 0,9% Larutan infus Botol 0 5,170 - 5,170
13 5,170 67,210 5,170
0 - - -
177 Nifedipin kaps 10 mg Kaps 0 127 - 127
830 127 105,410 127
0 - - -
178 Nistatin tab salut 500.000 UI Tab 0 704 - 704
400 704 281,600 400 704
0 - - -
179 Nistatin tab vaginal 100.000 UI Tab 190 448 85,120 448
0 - - -
180 Obat Batuk Hitam (OBH) Botol 0 2,310 - 2,310
71 2,310 164,010 2,310
0 - - -
181 Ofloksasin tab 200 mg Tab 0 440 - 150 440
0 - - -
182 Ofloksasin tab 400 mg Tab 0 700 - 700
40 700 28,000 100 700
0 - - -
183 Oksitetrasiklin hcl inj 500 mg/ml Vial 0 3,410 - 3,410
0 - - -
184 Oksitetrasiklin hcl salep kulit 3% Tube 0 2,010 - 2,010
7 1,646 11,522 1,646
0 - - -
185 Oksitetrasiklin hcl salep mata 1 % Tube 0 2,772 - 2,772
132 2,772 365,904 2,772
0 - - -
186 Oksitosin inj 10 UI/ml Ampul 0 6,875 - 6,875
0 1,900 - 1,900
8 6,875 55,000 20 6,875
0 - - -
187 Omeprazol kaps 20 mg Kaps 0 221 - 221
0 221 - 300 221
0 - - -
188 Papaverin tablet 40 mg Tab 0 109 - 109
2280 109 248,520 109
0 - - -
189 Parasetamol sir 120 mg/5 ml Botol 0 1,535 - 1,535
74 1,535 113,590 1,535
0 - - -
190 Parasetamol tab 100 mg Tab 0 105 - 105
100 105 10,500 105
0 - - -
191 Parasetamol tab 500 mg Tab 0 88 - 88
1804 88 158,752 1,900 88
0 - - -
192 Parasetamol rectal suppo 0 - - -
0 - - -
193 Pehavral tablet multivitamin Tab 0 849 - 849
0 297 - 297
0 - - -
194 Perak sulfadiazin krim 1% (Burnazin 35 gr) Tube 0 25,350 - 25,350
0 - - -
0 - - -
232 Simetidin tablet 200 mg Tab 0 138 - 138
640 138 88,320 138
0 - - -
233 Simvastatin tab sal 10 mg Tab sal 0 177 - 177
0 - - -
234 Simvastatin tab sal 20 mg Tab sal 0 480 - 480
0 - - -
235 Siprofloksasin inf 2 mg/ml Botol 0 - - -
0 - - -
236 Siprofloksasin tab scored 500 mg Tab 700 312 218,680 312
0 - - -
237 Spironolakton tab 100 mg Tab 0 - - -
200 350 70,000 350
0 - - -
238 Sulfasetamid Natrium Tetes mata 1.5% Botol 0 - - -
0 - - -
239 Sukralfat susp 500 mg/5 ml (Ulsafate) Botol 0 - - -
0 - - -
240 Sukralfat tab 500 mg (Ulsidex) Tab 0 - - -
400 477 190,800 477
0 - - -
241 Teofilin tab SR 300 mg (Rethapyl) Tab 0 - - -
100 1,155 115,500 1,155
0 - - -
242 Tetrasiklin kaps 250 mg Kaps 700 183 128,398 183
0 - - -
243 Tetrasiklin kaps 500 mg Kaps 0 283 - 283
0 - - -
0 42 - 42
0 - - -
245 Tiamin (vitamin B1) injeksi 100 mg/ml Tab 0 770 - 770
0 - - -
246 Tramadol inj 50 mg/ml Ampul 0 2,680 - 2,680
0 - - -
247 Tramadol tablet 500 mg Tab 112 363 40,656 500 363
0 - - -
248 Triheksifenidil tab 2 mg Tab 0 45 - 45
160 45 7,200 45
0 - - -
249 Vitamin B12 tablet 50 mcg Tab 0 63 - 63
0 - - -
250 Vitamin B kompleks injeksi Vial 0 7,392 - 90 7,392
0 - - -
251 Vitamin B kompleks Tab 0 112 - 112
4000 112 448,000 100 112
0 - - -
252 Zinc tab disp 20 mg Tab 0 521 - 521
0 521 - 521
0 - - -
253 Zinc sirup 20 mg / 5 ml Botol 0 8,140 - 8,140
12 8,140 97,680 8,140
0 - - -
254 Larutan PK botol 0 573 - 573
0 6,975 - 6,975
0 - - -
255 Kanamisin inj Vial 47 10,395 488,565 10,395
0 - - -
256 Antalgin 500mg tab 0 155 - 155
1000 141 141,000 141
0 - - -
257 Klorpromazin inj 25 mg/ml (i.m.) Ampul 0 - - -
0 1,210 - 1,210
0 - - -
0 - - -
10,409,989
35,945,532
Mengetahui
Kepala Puskesmas Rumbia
Rahmat, AMK
Nip. 19721021 199403 1 004
N OBAT DAN PERBEKES
LAMA 1 TAHUN
N 2016
BULAN : OKTOBER
TAHUN : 2016
- 6,050 - 0 6,050 -
- 1,499 - 0 1,499 -
- - - 0 - -
- 78 - 0 78 -
- 2,213 - 0 2,213 -
- 2,213 - 0 2,213 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 33,000 - 0 33,000 -
- 2,200 - 0 2,200 -
660,000 19 33,000 627,000 35 33,000 1,155,000
- - - 0 - -
- 1,650 - 0 1,650 -
- - - 0 - -
- 149 - 0 149 -
- 1,265 - 0 1,265 -
- - - 0 - -
- 2,367 - 0 2,367 -
- - - 0 - -
- 251 - 0 251 -
- 31 251 7,781 224 251 56,224
- - - 0 - -
- 1,400 - 29 1,400 40,600
- - - 0 - -
- 81 - 0 81 -
- - - 0 - -
- 13,500 - 0 13,500 -
- - - 0 - -
- 1,180 - 0 1,180 -
- 2 1,350 2,700 8 1,350 10,800
- 1,180 - 0 1,180 -
- - - 0 - -
- 73 - 0 73 -
- 55 - 0 55 -
6,600,000 980 2,200 2,156,000 2020 2,200 4,444,000
- - - 0 - -
- 22,727 - 0 22,727 -
- 22,727 - 4 22,727 90,908
- - - 0 - -
- 1,596 - 0 1,596 -
- 8 1,596 12,768 55 1,596 87,780
- - - 0 - -
126,000 30 600 18,000 180 600 108,000
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 42 - 0 42 -
- - - 0 - -
- 68 - 0 68 -
- 160 68 10,880 40 68 2,720
- - - 0 - -
- 1,738 - 168 1,738 291,984
- - - 0 - -
- - - 0 - -
49,915 9,983 - 8 9,983 79,864
- - - 0 - -
- 2,578 - 0 2,578 -
- 2,578 - 51 2,578 131,478
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 28 - 0 28 -
- - - 0 - -
- 55 28 1,540 0 28 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
34,800 1,160 - 75 1,160 87,000
- - - 0 - -
41,200 103 - 500 103 51,500
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 141 - 0 141 -
- 141 - 560 141 78,960
- - - 0 - -
- 278 - 160 278 44,528
- - - 0 - -
- 3,490 - 0 3,490 -
- 5 3,490 17,450 55 3,490 191,950
- - - 0 - -
- 174 - 0 174 -
34,800 170 174 29,580 578 174 100,572
- - - 0 - -
- 56 - 0 56 -
16,917 210 56 11,842 390 56 21,992
- - - 0 - -
- 42 - 160 42 6,720
- 42 - 5000 42 210,000
- - - 0 - -
- - - 0 - -
- 100 698 69,800 0 698 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 2,012 - 0 2,012 -
- - - 0 - -
- 2,012 - 34 2,012 68,408
- - - 0 - -
- 84 - 0 84 -
- 84 - 360 84 30,240
- - - 0 - -
- 317 - 0 317 -
- - - 0 - -
- - - 0 - -
- 79 - 0 79 -
118,500 300 79 23,700 1380 79 109,020
- - - 0 - -
- - - 0 - -
- 6,820 - 0 6,820 -
- 6,820 - 0 6,820 -
- - - 0 - -
- 112 - 0 112 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 581 - 0 581 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 1,499 - 0 1,499 -
- 1,499 - 0 1,499 -
92,900 63 929 58,527 68 929 63,172
- - - 0 - -
- 54,995 - 0 54,995 -
109,990 1 54,995 54,995 1 54,995 54,995
- - - 0 - -
- 97 - 0 97 -
203,700 130 97 12,610 2075 97 201,275
- - - 0 - -
- 170 - 50 170 8,500
- - - 0 - -
- 7,260 - 0 7,260 -
- 7,260 - 0 7,260 -
- - - 0 - -
- 7,260 - 0 7,260 -
- 7,260 - 18 7,260 130,680
- - - 0 - -
- 1,130 - 0 1,130 -
- - - 0 - -
- 3,887 - 0 3,887 -
- - - 0 - -
- 248 - 90 248 22,320
- - - 0 - -
50,000 20 125 2,500 380 125 47,500
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 1,639 - 0 1,639 -
- - - 0 - -
- 133 - 160 133 21,296
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 1,100 - 0 1,100 -
- 1,100 - 0 1,100 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 20 100 2,000 182 100 18,200
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 12,980 - 0 12,980 -
- 12,980 - 7 12,980 90,860
- - - 0 - -
- 116 - 0 116 -
11,600 80 116 9,280 600 116 69,600
- - - 0 - -
- - - 0 - -
- 270 169 45,630 970 169 163,930
- - - 0 - -
- 3,150 - 0 3,150 -
75,600 11 3,150 34,650 22 3,150 69,300
- - - 0 - -
- 146 - 0 146 -
73,000 146 - 560 146 81,760
- - - 0 - -
- 193 - 0 193 -
144,750 530 193 102,290 810 193 156,330
- - - 0 - -
- 5,170 - 0 5,170 -
- 6 5,170 31,020 7 5,170 36,190
- - - 0 - -
- 127 - 0 127 -
- 127 - 830 127 105,410
- - - 0 - -
- 704 - 0 704 -
281,600 704 - 800 704 563,200
- - - 0 - -
- 190 448 85,120 0 448 -
- - - 0 - -
- 2,310 - 0 2,310 -
- 3 2,310 6,930 68 2,310 157,080
- - - 0 - -
66,000 440 - 150 440 66,000
- - - 0 - -
- 700 - 0 700 -
70,000 700 - 140 700 98,000
- - - 0 - -
- 3,410 - 0 3,410 -
- - - 0 - -
- 2,010 - 0 2,010 -
- 3 1,646 4,938 4 1,646 6,584
- - - 0 - -
- 2,772 - 0 2,772 -
- 2 2,772 5,544 130 2,772 360,360
- - - 0 - -
- 6,875 - 0 6,875 -
- 1,900 - 0 1,900 -
137,500 1 6,875 6,875 27 6,875 185,625
- - - 0 - -
- 221 - 0 221 -
66,300 221 - 300 221 66,300
- - - 0 - -
- 109 - 0 109 -
- 1590 109 173,310 690 109 75,210
- - - 0 - -
- 1,535 - 0 1,535 -
- 67 1,535 102,845 7 1,535 10,745
- - - 0 - -
- 105 - 0 105 -
- 100 105 10,500 0 105 -
- - - 0 - -
- 88 - 0 88 -
167,200 929 88 81,752 2775 88 244,200
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 849 - 0 849 -
- 297 - 0 297 -
- - - 0 - -
- 25,350 - 0 25,350 -
- 2,344 - 0 2,344 -
- 40,202 - 0 40,202 -
- 1,980 - 0 1,980 -
- - - 0 - -
- 150 - 0 150 -
- - - 0 - -
- 138 - 0 138 -
- 138 - 640 138 88,320
- - - 0 - -
- 177 - 0 177 -
- - - 0 - -
- 480 - 0 480 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 312 - 700 312 218,680
- - - 0 - -
- - - 0 - -
- 350 - 200 350 70,000
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 477 - 400 477 190,800
- - - 0 - -
- - - 0 - -
- 1,155 - 100 1,155 115,500
- - - 0 - -
- 183 - 700 183 128,398
- - - 0 - -
- 283 - 0 283 -
- - - 0 - -
- 42 - 0 42 -
- - - 0 - -
- 770 - 0 770 -
- - - 0 - -
- 2,680 - 0 2,680 -
- - - 0 - -
181,500 363 - 612 363 222,156
- - - 0 - -
- 45 - 0 45 -
- 45 - 160 45 7,200
- - - 0 - -
- 63 - 0 63 -
- - - 0 - -
665,280 7,392 - 90 7,392 665,280
- - - 0 - -
- 112 - 0 112 -
11,200 860 112 96,320 3240 112 362,880
- - - 0 - -
- 521 - 0 521 -
- 521 - 0 521 -
- - - 0 - -
- 8,140 - 0 8,140 -
- 8,140 - 12 8,140 97,680
- - - 0 - -
- 573 - 0 573 -
- 6,975 - 0 6,975 -
- - - 0 - -
- 10,395 - 47 10,395 488,565
- - - 0 - -
- 155 - 0 155 -
- 141 - 1000 141 141,000
- - - 0 - -
- - - 0 - -
- 1,210 - 0 1,210 -
- - - 0 - -
- 57 - 0 57 -
- - - 0 - -
- 116 - 0 116 -
- 572 - 0 572 -
- - - 0 - -
- 191 - 100 191 19,100
- - - 0 - -
- 275 - 0 275 -
- 275 - 0 275 -
- - - 0 - -
- 162 - 0 162 -
- - - 0 - -
- 1,108 - 0 1,108 -
- 1,109 - 16 1,109 17,744
- - - 0 - -
- 162 - 0 162 -
- - - 0 - -
115,500 116 - 1000 116 115,500
- - - 0 - -
- 167 - 0 167 -
- - - 0 - -
- 125 - 0 125 -
- - - 0 - -
- 318 - 0 318 -
- - - 0 - -
- 109 - 0 109 -
- - - 0 - -
- 45 - 0 45 -
- - - 0 - -
- 854 - 0 854 -
- - - 0 - -
- 42,727 - 0 42,727 -
- 42,727 - 0 42,727 -
- - - 0 - -
- 1,480 - 0 1,480 -
1,480,000 195 1,480 288,600 1030 1,480 1,524,400
- - - 0 - -
- 31 - 0 31 -
- - - 0 - -
- 56 - 0 56 -
- - - 0 - -
- - - 0 - -
- 765,000 - 0 765,000 -
- 765,000 - 2 765,000 1,530,000
- - - 0 - -
- 242,000 - 0 242,000 -
- - - 0 - -
- 338,800 - 0 338,800 -
338,800 338,800 - 2 338,800 677,600
- - - 0 - -
- 390,000 - 0 390,000 -
- 390,000 - 0 390,000 -
- - - 0 - -
- 18,333 - 0 18,333 -
18,333 18,333 - 1 18,333 18,333
- - - 0 - -
- 105,000 - 0 105,000 -
- 105,000 - 1 105,000 105,000
- - - 0 - -
- 170,000 - 0 170,000 -
- - - 0 - -
- 395,000 - 0 395,000 -
- 197,895 - 1 197,895 197,895
- - - 0 - -
- 55,000 - 1 55,000 55,000
- - - 0 - -
- 93,500 - 0 93,500 -
- 93,500 - 2 93,500 187,000
- - - 0 - -
- 34,000 - 0 34,000 -
- 34,000 - 0 34,000 -
- - - 0 - -
- 176,000 - 0 176,000 -
- - - 0 - -
- - - 0 - -
- 425 - 0 425 -
- 24,384 - 0 24,384 -
- 27,569 - 0 27,569 -
- 27,569 - 8 27,569 220,552
- - - 0 - -
- 104 - 0 104 -
- 104 - 2000 104 208,000
- - - 0 - -
- 825,000 - 0 825,000 -
- 4,545 - 0 4,545 -
- 236,490 - 0 236,490 -
- 396,000 - 0 396,000 -
- 1,319,990 - 0 1,319,990 -
- 175,899 - 0 175,899 -
- 145,000 - 0 145,000 -
- 150,000 - 0 150,000 -
- 168,300 - 0 168,300 -
- 46,200 - 0 46,200 -
- 45,560 - 0 45,560 -
- 42,350 - 0 42,350 -
- 20,454 - 0 20,454 -
- 4,438 - 0 4,438 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 285,000 - 0 285,000 -
- 695,752 - 0 695,752 -
- 412 - 0 412 -
- 286 - 0 286 -
- 497 - 0 497 -
- - - 0 - -
- - - 0 - -
- 1,093 - 0 1,093
- 848 - 6 848 5,090
99,000 990 - 200 990 198,000
- - - 0 - -
- 1,038 - 0 1,038 -
- 848 - 0 848 -
- 650 - 0 650 -
- - - 0 - -
- 1,038 - 0 1,038 -
- 42 848 35,627 36 848 30,537
- 792 - 100 792 79,200
- - - 0 - -
- 1,038 - 0 1,038 -
- 20 979 19,575 386 979 377,798
- - - 0 - -
- 2,099 - 0 2,099 -
- 2,100 - 67 2,100 140,700
209,900 2,099 - 200 2,099 419,800
- - - 0 - -
- 2,099 - 0 2,099 -
- 2,100 - 0 2,100 -
209,900 9 2,099 18,891 100 2,099 209,900
- - - 0 - -
- 6,400 - 0 6,400 -
- 25,920 - 41 25,920 1,062,720
- 6,400 - 48 6,400 307,200
- - - 0 - -
- 5,900 - 0 5,900 -
- 27,000 - 0 27,000 -
141,600 2 5,900 11,800 32 5,900 188,800
- - - 0 - -
- 6,595 - 0 6,595 -
- 11,990 - 0 11,990 -
- - - 0 - -
- 6,595 - 0 6,595 -
- - - 0 - -
- - - 0 - -
- 4,250 - 0 4,250 -
- 7,684 - 0 7,684 -
599,500 22 11,990 263,780 28 11,990 335,720
- - - 0 - -
- 4,250 - 0 4,250 -
- 7,684 - 0 7,684 -
599,500 40 11,990 479,600 58 11,990 695,420
- - - 0 - -
- 3,500 - 0 3,500 -
- 10 4,176 41,760 15 4,176 62,640
- 9,900 - 25 9,900 247,500
- - - 0 - -
- 4,000 - 0 4,000 -
- 1 4,568 4,568 2 4,568 9,136
- 9,900 - 8 9,900 79,200
- - - 0 - -
- 7,937 - 0 7,937 -
- 7,018 - 0 7,018 -
- - - 0 - -
- 6,600 - 0 6,600 -
418,000 20,900 - 20 20,900 418,000
- - - 0 - -
- 7,787 - 0 7,787 -
- 7,787 - 36 7,787 280,332
- 7,018 - 20 7,018 140,360
- - - 0 - -
- 7,787 - 0 7,787 -
- 7,937 - 38 7,937 301,606
- 7,018 - 0 7,018 -
- - - 0 - -
- 15 7,787 116,805 31 7,787 241,397
- 7,018 - 20 7,018 140,360
- - - 0 - -
- 10,440 - 0 10,440 -
- 8,000 - 0 8,000 -
- - - 0 - -
- 8,495 - 0 8,495 -
- 10,440 - 0 10,440 -
- 8,000 - 0 8,000 -
- - - 0 - -
- 8,495 - 0 8,495 -
- 10,440 - 0 10,440 -
- 8,000 - 0 8,000 -
- - - 0 - -
- 495 - 0 495 -
- 10,440 - 8 10,440 83,520
- 8,000 - 0 8,000 -
- - - 0 - -
- 7,500 - 0 7,500 -
- 27,821 - 0 27,821 -
72,000 24,000 - 4 24,000 96,000
- - - 0 - -
172,500 1 17,250 17,250 9 17,250 155,250
- - - 0 - -
- 800 - 0 800 -
- - - 0 - -
- 887 - 0 887 -
- 1,100 - 0 1,100 -
- - - 0 - -
- 607 - 0 607 -
- 6,121 - 0 6,121 -
69,000 1 2,300 2,300 34 2,300 78,200
- - - 0 - -
- 887 - 0 887 -
- 3,800 - 0 3,800 -
- - - 0 - -
- 1,871 - 0 1,871 -
- 5,621 - 0 5,621 -
- 1,800 - 0 1,800 -
- - - 0 - -
- 8,600 - 0 8,600 -
- 11,724 - 0 11,724 -
- 7,900 - 0 7,900 -
- - - 0 - -
- 10,467 - 0 10,467 -
- 13,221 - 0 13,221 -
- 9,400 - 0 9,400 -
- - - 0 - -
- - - 0 - -
- 137,025 - 0 137,025 -
- 104,500 - 0 104,500 -
- - - 0 - -
- 55,200 - 0 55,200 -
- 133,821 - 0 133,821 -
260,000 1 130,000 130,000 2 130,000 260,000
- - - 0 - -
- 2 32,500 65,000 0 32,500 -
- - - 0 - -
- 23,625 - 0 23,625 -
70,875 2 23,625 47,250 10 23,625 236,250
- - - 0 - -
- 5,082 - 0 5,082 -
- 10 18,781 187,810 28 18,781 525,868
- 5,082 - 0 5,082 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 4,000 - 0 4,000 -
- - - 0 - -
- 5,770 - 0 5,770 -
577,000 5,770 - 300 5,770 1,731,000
- - - 0 - -
- 1 5,770 5,770 59 5,770 340,430
- 5,770 - 199 5,770 1,148,230
- - - 0 - -
- 5,770 - 0 5,770 -
173,100 5,770 - 230 5,770 1,327,100
- - - 0 - -
- 5,770 - 0 5,770 -
- - - 0 - -
- 22,000 - 0 22,000 -
- - - 0 - -
- 22,000 - 0 22,000 -
- - - 0 - -
- 1,125 - 0 1,125 -
- 16 1,125 18,000 19 1,125 21,375
- - - 0 - -
- 200,455 - 0 200,455 -
601,350 80 8,018 641,440 75 8,018 601,350
- - - 0 - -
- 68,181 - 0 68,181 -
- - - 0 - -
- 68,181 - 0 68,181 -
- - - 0 - -
- 6,825 - 0 6,825 -
- 3,413 - 0 3,413 -
Penanggung Jawab
Laporan
Wa Ode Wahyuni Hambe, S. Si, Apt
Nip. 19870305 201101 2 019
REKAPAN PENGGUNAAN OBAT DAN PERBEK
PUSKESMAS SELAMA 1 TAHUN
TAHUN 2016
1 Air untuk injeksi amp 25 ml (aqua pro injeksi) Ampul 0 6,050 - 6,050
0 - - -
1470 78 114,660 78
0 - - -
Antasida, kombinasi : aluminium hidroksida
18 200 mg + magnesium hidroksida 200 mg Botol 0 2,213 - 2,213
Suspensi
0 2,213 - 2,213
0 - - -
Antibakteri, kombinasi : basitrasin 500 UI/g+
19 Tube 7 2,767 19,369 2,767
Polimiskin B 10.000 UI/g
Antifungi salep, kombinasi : asam benzoat 6% 0 - - -
+ asam salisilat 3%
20 Tube 50 2,096 104,800 2,096
0 - - -
mg + heksaklorofen 2,5 mg + lidokain
lidokain 10 mg+ seng oksida 120 mg + sup
21 ad 2 g Suppo 0 33,000 - 33,000
0 2,200 - 2,200
35 33,000 1,155,000 10 33,000
0 - - -
Anti Parkinson kombinasi : benzerasid 25 mg +
22 Kaps 0 1,650 - 1,650
levodopa 100 mg
0 - - -
Anti Migren, kombinasi : ergotamin 1 mg+
23 Tab 0 149 - 149
kafein 50 mg
481 149 71,669 149
0 - - -
24 Antalgin (metampirom) tablet 100 mg Tab 0 155 - 155
0 - - -
25 Antalgin (metampirom) injeksi 250 mg/ml-2 ml Ampul 0 1,346 - 1,346
0 - - -
26 Asam asetilsalisilat (asetosal) tab 100 mg Tab 30 110 3,300 110
1100 127 139,700 127
0 110 - 110
0 - - -
27 Asam asetilsalisilat (asetosal) tab 500 mg Tab 0 178 - 178
0 - - -
Asam asetilsalisilat (asetosal) tab 80 mg
28 Tab 0 163 - 163
(Miniaspi 80)
0 - - -
29 Asam askorbat (vitamin C) tab 50 mg Tab 0 105 - 105
2850 105 299,250 105
0 - - -
30 Asam folat tab 1 mg Tab 0 52 - 52
400 52 20,800 52
0 - - -
31 Asam mefenamat kaps 250 mg Kaps 0 - - -
0 - - -
32 Asam mefenamat kaps 500 mg Kaps 0 127 - 127
2800 127 355,600 127
0 - - -
33 Asam traneksamat inj 50 mg/ml Ampul 25 3,650 91,250 3,650
0 - - -
0 - - -
0 2,367 - 2,367
0 - - -
37 Asiklovir tab 200 mg Tab 0 251 - 251
224 251 56,224 251
0 - - -
38 Atropin inj 0,25 mg/ml (i.m./i.v./s.k) Ampul 29 1,400 40,600 1,400
0 - - -
39 Atropin tab 0,5 mg Tab 0 81 - 81
0 - - -
0 - - -
41 Bedak salisil serb 2% Botol 0 1,180 - 1,180
8 1,350 10,800 1,350
0 1,180 - 1,180
0 - - -
Besi (II) sulfat 200 mg + asam folat 0.25 mg
42 Sachet 0 73 - 73
(tablet tambah darah)
0 55 - 55
2020 2,200 4,444,000 2,200
0 - - -
43 Becefort syrup Botol 0 22,727 - 22,727
4 22,727 90,908 22,727
0 - - -
44 Betametason krim 0,1% Tube 0 1,596 - 1,596
55 1,596 87,780 1,596
0 - - -
45 Betahistin mesilate tablet tablet 180 600 108,000 150 600
0 - - -
46 Bisakodil sup 10 mg (Stolax) Botol 0 - - -
0 - - -
47 Bisakodil tab sal 5 mg Tab sal 0 - - -
0 - - -
48 Bismecon salep tube 0 - - -
0 - - -
Budesonid-formoterol (fixed combination)* ih
49 Botol 0 - - -
80/4,5 mcg
0 - - -
50 Bromheksin tablet tablet 0 42 - 42
0 - - -
51 Deksametason tab 0,5 mg Tab 0 68 - 68
40 68 2,720 68
0 - - -
52 Deksametason inj 5 mg/ml (i.v./i.m.) Vial 168 1,738 291,984 1,738
0 - - -
53 Desoksimetason salep 0,25% Tube 0 - - -
8 9,983 79,864 9,983
0 - - -
54 Diazepam inj 5 mg/ml (i.v./i.m.) Vial 0 2,578 - 2,578
51 2,578 131,478 2,578
0 - - -
0 - - -
56 Diazepam supposutoria suppo 0 - - -
0 - - -
57 Diazepam tab 2 mg Tab 0 28 - 28
0 - - -
58 Diazepam tab 5 mg Tab 0 28 - 28
0 - - -
59 Dietilkarbamazin tab 100 mg Tab 0 - - -
0 - - -
60 Difenhidramin inj 10 mg/ml (i.v./i.m.) Ampul 75 1,160 87,000 1,160
0 - - -
61 Digoksin tab 0,25 mg Tab 500 103 51,500 103
0 - - -
62 Diltiazem kaps SR 100 mg Kaps 0 - - -
0 - - -
63 Diltiazem tab 30 mg Tab 0 141 - 141
560 141 78,960 141
0 - - -
64 Doksisiklin tablet 100 mg Tab 160 278 44,528 278
0 - - -
65 Domperidon susp 5 mg/5 ml Botol 0 3,490 - 3,490
55 3,490 191,950 3,490
0 - - -
66 Domperidon tab 10 mg Tab 0 174 - 174
578 174 100,572 174
0 - - -
67 Efedrin HCl tablet Tab 0 56 - 56
390 56 21,992 200 56
0 - - -
68 Ekstrak belladon tablet 10 mg tab 160 42 6,720 42
5000 42 210,000 42
0 - - -
69 Epinefrin (adrenalin) inj 0,1% (i.v./s.k./i.m.) Ampul 120 8,910 1,069,200 8,910
0 - - -
70 Eritromisin kaps 250 mg Kaps 820 522 428,040 522
0 522 - 522
0 - - -
71 Eritromisin sir 200 mg/5 ml Botol 24 7,581 181,944 7,581
0 - - -
72 Eritromisin tab 500 mg Tab 465 1,013 470,938 1,013
0 1,023 - 1,023
0 - - -
73 Etanol 70% cairan 70% Botol 0 2,625 - 2,625
0 2,625 - 2,625
35 2,625 91,875 2,625
0 - - -
74 Etakridin (rivanol) larutan 0.1% Botol 0 4,695 - 4,695
5 4,695 23,475 4,695
0 - - -
75 Etil klorida semprot 100 ml Botol 0 124 - 124
0 - - -
76 Famotidin tablet 20 mg Tab 0 - - -
0 124 - 124
0 - - -
77 Fenitoin Na inj 50 mg/ml Ampul 0 - - -
0 - - -
78 Fenitoin Na kaps 100 mg Kaps 0 - - -
100 146 14,600 146
0 - - -
79 Fenobarbital inj 50 mg/ml Ampul 0 37 - 37
90 1,980 178,200 1,980
0 - - -
80 Fenobarbital tab 100 mg Tab 0 - - -
0 - - -
81 Fenobarbital tab 30 mg Tab 0 37 - 37
0 - - -
0 - - -
83 Fitomenadion (vitamin K 1) tab sal 10 mg Tab sal 0 698 - 698
0 - - -
84 Flukonazol kaps 150 mg Kaps 0 - - -
0 - - -
85 Flusinolon asetonid krim 0,025% Tube 0 - - -
0 - - -
86 Flunarizin tablet tablet 0 2,012 - 2,012
0 - - -
87 Furosemid inj 10 mg/ml (i.v./i.m.) Ampul 34 2,012 68,408 25 2,012
0 - - -
88 Furosemid tab 40 mg Tab 0 84 - 84
360 84 30,240 84
0 - - -
Garam oralit kombinasi : natrium klorida 0,52
g + kalium klorida 0,30 g + trinatrium sitrat
89 Sachet 0 317 - 317
0,58 g + glukosa anhidrat 2,7 g
0 - - -
Kotrimoksazol (dewasa) kombinasi :
sulfametoksazol 400 mg+ trimetoprim 80
144 Tab 525 152 79,800 152
mg
1380 79 109,020 79
0 - - -
Kotrimoksazol (dewasa) kombinasi tiap 5 ml
146 suspensi : sulfametoksazol 200 mg + Botol 24 2,298 55,152 2,298
trimetoprim 40 mg
0 - - -
147 Kuinin inj 25% (i.v.) Vial 0 6,820 - 6,820
0 6,820 - 6,820
0 - - -
148 Kloroquin tab 150 mg Tab 0 112 - 112
0 - - -
149 Lansoprazol kaps 30 mg Kaps 0 - - -
0 - - -
150 Levofloksasin tab 500 mg Tab 0 581 - 581
0 - - -
151 Lidokain gel 2% Tube 0 - - -
0 - - -
152 Lidokain inj 2% (hcl) Vial 0 1,499 - 1,499
0 1,499 - 1,499
68 929 63,172 60 929
0 - - -
153 Lisol Botol 0 54,995 - 54,995
1 54,995 54,995 54,995
0 - - -
154 Loperamid tab 2 mg Tab 0 97 - 97
2075 97 201,275 97
0 - - -
155 Loratadin tab 10 mg Tab 50 170 8,500 170
0 - - -
156 Magnesium sulfat inj 20% Vial 0 7,260 - 7,260
0 7,260 - 7,260
0 - - -
157 Magnesium sulfat inj 40% Vial 0 7,260 - 7,260
18 7,260 130,680 7,260
0 - - -
158 Magnesium sulfat serb, ktg 30 g Sachet 0 1,130 - 1,130
0 - - -
159 Mebendazol sir 50 mg/ml Botol 0 3,887 - 3,887
0 - - -
160 Mebendazol tab 100 mg Tan 90 248 22,320 248
0 - - -
161 Metformin tab 500 mg Tab 380 125 47,500 125
0 - - -
162 Metformin tab 850 mg Tab 0 - - -
0 - - -
163 Metilergometrin inj 0,2 mg/ml Ampul 0 1,639 - 1,639
0 - - -
164 Metilergometrin tab salut 0,125 mg Tab sal 160 133 21,296 133
0 - - -
165 Metilprednisolon tab 4 mg Tab 0 - - -
0 - - -
166 Metoklopramid inj 5 mg/ml Vial 0 1,100 - 1,100
0 1,100 - 1,100
0 - - -
0 - - -
168 Metoklopramid tab 10 mg Tab 182 100 18,200 100
0 - - -
169 Metronidazol supposutoria 500 mg suppo 0 - - -
0 - - -
170 Metronidazol larutan infus Botol 0 12,980 - 12,980
7 12,980 90,860 12,980
0 - - -
171 Metronidazol tab 250 mg Tab 0 116 - 116
600 116 69,600 116
0 - - -
172 Metronidazol tab 500 mg Tab 0 - - -
970 169 163,930 169
0 - - -
173 Mikonazol krim 2% Tube 0 3,150 - 3,150
22 3,150 69,300 12 3,150
0 - - -
174 Natrium diklofenak tab 25 mg Tab 0 146 - 146
560 146 81,760 146
0 - - -
175 Natrium diklofenak tab 50 mg Tab 0 193 - 193
810 193 156,330 450 193
0 - - -
176 NaCl 0,9% Larutan infus Botol 0 5,170 - 5,170
7 5,170 36,190 20 5,170
0 - - -
177 Nifedipin kaps 10 mg Kaps 0 127 - 127
830 127 105,410 127
0 - - -
178 Nistatin tab salut 500.000 UI Tab 0 704 - 704
800 704 563,200 704
0 - - -
179 Nistatin tab vaginal 100.000 UI Tab 0 448 - 448
0 - - -
180 Obat Batuk Hitam (OBH) Botol 0 2,310 - 2,310
68 2,310 157,080 2,310
0 - - -
181 Ofloksasin tab 200 mg Tab 150 440 66,000 440
0 - - -
182 Ofloksasin tab 400 mg Tab 0 700 - 700
140 700 98,000 700
0 - - -
183 Oksitetrasiklin hcl inj 500 mg/ml Vial 0 3,410 - 3,410
0 - - -
184 Oksitetrasiklin hcl salep kulit 3% Tube 0 2,010 - 2,010
4 1,646 6,584 1,646
0 - - -
185 Oksitetrasiklin hcl salep mata 1 % Tube 0 2,772 - 2,772
130 2,772 360,360 2,772
0 - - -
186 Oksitosin inj 10 UI/ml Ampul 0 6,875 - 6,875
0 1,900 - 1,900
27 6,875 185,625 6,875
0 - - -
187 Omeprazol kaps 20 mg Kaps 0 221 - 221
300 221 66,300 221
0 - - -
188 Papaverin tablet 40 mg Tab 0 109 - 109
690 109 75,210 109
0 - - -
189 Parasetamol sir 120 mg/5 ml Botol 0 1,535 - 1,535
7 1,535 10,745 140 1,535
0 - - -
190 Parasetamol tab 100 mg Tab 0 105 - 105
0 105 - 105
0 - - -
191 Parasetamol tab 500 mg Tab 0 88 - 88
2775 88 244,200 88
0 - - -
192 Parasetamol rectal suppo 0 - - -
0 - - -
193 Pehavral tablet multivitamin Tab 0 849 - 849
0 297 - 297
0 - - -
0 - - -
0 - - -
232 Simetidin tablet 200 mg Tab 0 138 - 138
640 138 88,320 138
0 - - -
233 Simvastatin tab sal 10 mg Tab sal 0 177 - 177
0 - - -
234 Simvastatin tab sal 20 mg Tab sal 0 480 - 480
0 - - -
235 Siprofloksasin inf 2 mg/ml Botol 0 - - -
0 - - -
236 Siprofloksasin tab scored 500 mg Tab 700 312 218,680 312
0 - - -
237 Spironolakton tab 100 mg Tab 0 - - -
200 350 70,000 350
0 - - -
238 Sulfasetamid Natrium Tetes mata 1.5% Botol 0 - - -
0 - - -
239 Sukralfat susp 500 mg/5 ml (Ulsafate) Botol 0 - - -
0 - - -
240 Sukralfat tab 500 mg (Ulsidex) Tab 0 - - -
400 477 190,800 477
0 - - -
241 Teofilin tab SR 300 mg (Rethapyl) Tab 0 - - -
100 1,155 115,500 1,155
0 - - -
242 Tetrasiklin kaps 250 mg Kaps 700 183 128,398 183
0 - - -
243 Tetrasiklin kaps 500 mg Kaps 0 283 - 283
0 - - -
0 42 - 42
0 - - -
245 Tiamin (vitamin B1) injeksi 100 mg/ml Tab 0 770 - 770
0 - - -
246 Tramadol inj 50 mg/ml Ampul 0 2,680 - 2,680
0 - - -
247 Tramadol tablet 500 mg Tab 612 363 222,156 363
0 - - -
248 Triheksifenidil tab 2 mg Tab 0 45 - 45
160 45 7,200 45
0 - - -
249 Vitamin B12 tablet 50 mcg Tab 0 63 - 63
0 - - -
250 Vitamin B kompleks injeksi Vial 90 7,392 665,280 7,392
0 - - -
251 Vitamin B kompleks Tab 0 112 - 112
3240 112 362,880 112
0 - - -
252 Zinc tab disp 20 mg Tab 0 521 - 521
0 521 - 521
0 - - -
253 Zinc sirup 20 mg / 5 ml Botol 0 8,140 - 8,140
12 8,140 97,680 8,140
0 - - -
254 Larutan PK botol 0 573 - 573
0 6,975 - 6,975
0 - - -
255 Kanamisin inj Vial 47 10,395 488,565 10,395
0 - - -
256 Antalgin 500mg tab 0 155 - 155
1000 141 141,000 141
0 - - -
257 Klorpromazin inj 25 mg/ml (i.m.) Ampul 0 - - -
0 1,210 - 1,210
0 - - -
0 - - -
12,575,988
74,782,943
Mengetahui
Kepala Puskesmas Rumbia
Rahmat, AMK
Nip. 19721021 199403 1 004
N OBAT DAN PERBEKES
LAMA 1 TAHUN
N 2016
BULAN : NOVEMBER
TAHUN : 2016
- 6,050 - 0 6,050 -
- 1,499 - 0 1,499 -
- - - 0 - -
- 78 - 0 78 -
- 2,213 - 0 2,213 -
- 2,213 - 0 2,213 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 33,000 - 0 33,000 -
- 2,200 - 0 2,200 -
330,000 3 33,000 99,000 42 33,000 1,386,000
- - - 0 - -
- 1,650 - 0 1,650 -
- - - 0 - -
- 149 - 0 149 -
- 1,265 - 0 1,265 -
- - - 0 - -
- 15,900 - 0 15,900 -
- 9,000 - 0 9,000 -
- - - 0 - -
- 2,367 - 0 2,367 -
- - - 0 - -
- 251 - 0 251 -
- 4 251 1,004 220 251 55,220
- - - 0 - -
- 1,400 - 29 1,400 40,600
- - - 0 - -
- 81 - 0 81 -
- - - 0 - -
- 13,500 - 0 13,500 -
- - - 0 - -
- 1,180 - 0 1,180 -
- 5 1,350 6,750 3 1,350 4,050
- 1,180 - 0 1,180 -
- - - 0 - -
- 73 - 0 73 -
- 55 - 0 55 -
- 1380 2,200 3,036,000 640 2,200 1,408,000
- - - 0 - -
- 22,727 - 0 22,727 -
- 22,727 - 4 22,727 90,908
- - - 0 - -
- 1,596 - 0 1,596 -
- 8 1,596 12,768 47 1,596 75,012
- - - 0 - -
90,000 240 600 144,000 90 600 54,000
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 42 - 0 42 -
- - - 0 - -
- 68 - 0 68 -
- 68 - 40 68 2,720
- - - 0 - -
- 1,738 - 168 1,738 291,984
- - - 0 - -
- - - 0 - -
- 9,983 - 8 9,983 79,864
- - - 0 - -
- 2,578 - 0 2,578 -
- 2,578 - 51 2,578 131,478
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 28 - 0 28 -
- - - 0 - -
- 28 - 0 28 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 1 1,160 1,160 74 1,160 85,840
- - - 0 - -
- 103 - 500 103 51,500
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 141 - 0 141 -
- 141 - 560 141 78,960
- - - 0 - -
- 278 - 160 278 44,528
- - - 0 - -
- 3,490 - 0 3,490 -
- 9 3,490 31,410 46 3,490 160,540
- - - 0 - -
- 174 - 0 174 -
- 86 174 14,964 492 174 85,608
- - - 0 - -
- 56 - 0 56 -
11,278 50 56 2,820 540 56 30,451
- - - 0 - -
- 160 42 6,720 0 42 -
- 1840 42 77,280 3160 42 132,720
- - - 0 - -
- - - 0 - -
- 522 - 820 522 428,040
- 522 - 0 522 -
- - - 0 - -
- 7,581 - 24 7,581 181,944
- - - 0 - -
- 1,013 - 465 1,013 470,938
- 1,023 - 0 1,023 -
- - - 0 - -
- 2,625 - 0 2,625 -
- 2,625 - 0 2,625 -
- 2 2,625 5,250 33 2,625 86,625
- - - 0 - -
- 4,695 - 0 4,695 -
- 2 4,695 9,390 3 4,695 14,085
- - - 0 - -
- 124 - 0 124 -
- - - 0 - -
- - - 0 - -
- 124 - 0 124 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 146 - 100 146 14,600
- - - 0 - -
- 37 - 0 37 -
- 1,980 - 90 1,980 178,200
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 37 - 0 37 -
- - - 0 - -
- - - 0 - -
- 698 - 0 698 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 2,012 - 0 2,012 -
- - - 0 - -
50,300 2,012 - 59 2,012 118,708
- - - 0 - -
- 84 - 0 84 -
- 50 84 4,200 310 84 26,040
- - - 0 - -
- 317 - 0 317 -
- - - 0 - -
- 5,990 - 0 5,990 -
- - - 0 - -
- 79 - 0 79 -
- 79 - 1380 79 109,020
- - - 0 - -
- 9 2,298 20,682 15 2,298 34,470
- - - 0 - -
- 6,820 - 0 6,820 -
- 6,820 - 0 6,820 -
- - - 0 - -
- 112 - 0 112 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 581 - 0 581 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 1,499 - 0 1,499 -
- 1,499 - 0 1,499 -
55,740 48 929 44,592 80 929 74,320
- - - 0 - -
- 54,995 - 0 54,995 -
- 1 54,995 54,995 0 54,995 -
- - - 0 - -
- 97 - 0 97 -
- 110 97 10,670 1965 97 190,605
- - - 0 - -
- 170 - 50 170 8,500
- - - 0 - -
- 7,260 - 0 7,260 -
- 7,260 - 0 7,260 -
- - - 0 - -
- 7,260 - 0 7,260 -
- 7,260 - 18 7,260 130,680
- - - 0 - -
- 1,130 - 0 1,130 -
- - - 0 - -
- 3,887 - 0 3,887 -
- - - 0 - -
- 90 248 22,320 0 248 -
- - - 0 - -
- 180 125 22,500 200 125 25,000
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 1,639 - 0 1,639 -
- - - 0 - -
- 10 133 1,331 150 133 19,965
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 1,100 - 0 1,100 -
- 1,100 - 0 1,100 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 10 100 1,000 172 100 17,200
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 12,980 - 0 12,980 -
- 12,980 - 7 12,980 90,860
- - - 0 - -
- 116 - 0 116 -
- 10 116 1,160 590 116 68,440
- - - 0 - -
- - - 0 - -
- 220 169 37,180 750 169 126,750
- - - 0 - -
- 3,150 - 0 3,150 -
37,800 17 3,150 53,550 17 3,150 53,550
- - - 0 - -
- 146 - 0 146 -
- 90 146 13,140 470 146 68,620
- - - 0 - -
- 193 - 0 193 -
86,850 610 193 117,730 650 193 125,450
- - - 0 - -
- 5,170 - 0 5,170 -
103,400 11 5,170 56,870 16 5,170 82,720
- - - 0 - -
- 127 - 0 127 -
- 100 127 12,700 730 127 92,710
- - - 0 - -
- 704 - 0 704 -
- 704 - 800 704 563,200
- - - 0 - -
- 448 - 0 448 -
- - - 0 - -
- 2,310 - 0 2,310 -
- 18 2,310 41,580 50 2,310 115,500
- - - 0 - -
- 440 - 150 440 66,000
- - - 0 - -
- 700 - 0 700 -
- 700 - 140 700 98,000
- - - 0 - -
- 3,410 - 0 3,410 -
- - - 0 - -
- 2,010 - 0 2,010 -
- 1,646 - 4 1,646 6,584
- - - 0 - -
- 2,772 - 0 2,772 -
- 3 2,772 8,316 127 2,772 352,044
- - - 0 - -
- 6,875 - 0 6,875 -
- 1,900 - 0 1,900 -
- 4 6,875 27,500 23 6,875 158,125
- - - 0 - -
- 221 - 0 221 -
- 70 221 15,470 230 221 50,830
- - - 0 - -
- 109 - 0 109 -
- 280 109 30,520 410 109 44,690
- - - 0 - -
- 1,535 - 0 1,535 -
214,900 81 1,535 124,335 66 1,535 101,310
- - - 0 - -
- 105 - 0 105 -
- 105 - 0 105 -
- - - 0 - -
- 88 - 0 88 -
- 1145 88 100,760 1630 88 143,440
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 849 - 0 849 -
- 297 - 0 297 -
- - - 0 - -
- 25,350 - 0 25,350 -
- 25,350 - 1 25,350 25,350
- - - 0 - -
- 107 - 800 107 85,600
- 107 - 0 107 -
- - - 0 - -
- 964 - 0 964 -
- 964 - 490 964 472,360
- - - 0 - -
- 854 - 0 854 -
- 100 854 85,400 420 854 358,680
- - - 0 - -
- 20 60,500 1,210,000 430 60,500 26,015,000
- - - 0 - -
- 9,100 - 38 9,100 345,800
- - - 0 - -
- 318 - 0 318 -
- 114 318 36,252 1014 318 322,452
- - - 0 - -
- 19 - 0 19 -
- 1300 19 24,700 790 19 15,010
- - - 0 - -
- 116 - 0 116 -
- 50 116 5,800 885 116 102,660
- - - 0 - -
- 18,635 - 0 18,635 -
- 18,635 - 7 18,635 130,445
- - - 0 - -
- 2,344 - 0 2,344 -
- 15,386 - 0 15,386 -
- 40,202 - 0 40,202 -
- 1,980 - 0 1,980 -
- - - 0 - -
- 150 - 0 150 -
- - - 0 - -
- 138 - 0 138 -
- 10 138 1,380 630 138 86,940
- - - 0 - -
- 177 - 0 177 -
- - - 0 - -
- 480 - 0 480 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 312 - 700 312 218,680
- - - 0 - -
- - - 0 - -
- 350 - 200 350 70,000
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 477 - 400 477 190,800
- - - 0 - -
- - - 0 - -
- 1,155 - 100 1,155 115,500
- - - 0 - -
- 700 183 128,398 0 183 -
- - - 0 - -
- 283 - 0 283 -
- - - 0 - -
- 42 - 0 42 -
- - - 0 - -
- 770 - 0 770 -
- - - 0 - -
- 2,680 - 0 2,680 -
- - - 0 - -
- 20 363 7,260 592 363 214,896
- - - 0 - -
- 45 - 0 45 -
- 45 - 160 45 7,200
- - - 0 - -
- 63 - 0 63 -
- - - 0 - -
- 1 7,392 7,392 89 7,392 657,888
- - - 0 - -
- 112 - 0 112 -
- 820 112 91,840 2420 112 271,040
- - - 0 - -
- 521 - 0 521 -
- 521 - 0 521 -
- - - 0 - -
- 8,140 - 0 8,140 -
- 7 8,140 56,980 5 8,140 40,700
- - - 0 - -
- 573 - 0 573 -
- 6,975 - 0 6,975 -
- - - 0 - -
- 10,395 - 47 10,395 488,565
- - - 0 - -
- 155 - 0 155 -
- 141 - 1000 141 141,000
- - - 0 - -
- - - 0 - -
- 1,210 - 0 1,210 -
- - - 0 - -
- 57 - 0 57 -
- - - 0 - -
- 116 - 0 116 -
- 572 - 0 572 -
- - - 0 - -
- 191 - 100 191 19,100
- - - 0 - -
- 275 - 0 275 -
- 275 - 0 275 -
- - - 0 - -
- 162 - 0 162 -
- - - 0 - -
- 1,108 - 0 1,108 -
- 1,109 - 16 1,109 17,744
- - - 0 - -
- 162 - 0 162 -
- - - 0 - -
- 116 - 1000 116 115,500
- - - 0 - -
- 167 - 0 167 -
- - - 0 - -
- 125 - 0 125 -
- - - 0 - -
- 318 - 0 318 -
- - - 0 - -
- 109 - 0 109 -
- - - 0 - -
- 45 - 0 45 -
- - - 0 - -
- 854 - 0 854 -
- - - 0 - -
- 42,727 - 0 42,727 -
- 42,727 - 0 42,727 -
- - - 0 - -
- 1,480 - 0 1,480 -
- 485 1,480 717,800 545 1,480 806,600
- - - 0 - -
- 31 - 0 31 -
- - - 0 - -
- 56 - 0 56 -
- - - 0 - -
- - - 0 - -
- 765,000 - 0 765,000 -
- 765,000 - 2 765,000 1,530,000
- - - 0 - -
- 242,000 - 0 242,000 -
- - - 0 - -
- 338,800 - 0 338,800 -
- 338,800 - 2 338,800 677,600
- - - 0 - -
- 390,000 - 0 390,000 -
- 390,000 - 0 390,000 -
- - - 0 - -
- 18,333 - 0 18,333 -
- 18,333 - 1 18,333 18,333
- - - 0 - -
- 105,000 - 0 105,000 -
- 1 105,000 105,000 0 105,000 -
- - - 0 - -
- 170,000 - 0 170,000 -
- - - 0 - -
- 395,000 - 0 395,000 -
- 197,895 - 1 197,895 197,895
- - - 0 - -
- 55,000 - 1 55,000 55,000
- - - 0 - -
- 93,500 - 0 93,500 -
- 93,500 - 2 93,500 187,000
- - - 0 - -
- 34,000 - 0 34,000 -
- 34,000 - 0 34,000 -
- - - 0 - -
- 176,000 - 0 176,000 -
- - - 0 - -
- - - 0 - -
- 425 - 0 425 -
- 24,384 - 0 24,384 -
- 27,569 - 0 27,569 -
- 27,569 - 8 27,569 220,552
- - - 0 - -
- 104 - 0 104 -
- 104 - 2000 104 208,000
- - - 0 - -
- 825,000 - 0 825,000 -
- 4,545 - 0 4,545 -
- 236,490 - 0 236,490 -
- 396,000 - 0 396,000 -
- 1,319,990 - 0 1,319,990 -
- 175,899 - 0 175,899 -
- 145,000 - 0 145,000 -
- 150,000 - 0 150,000 -
- 168,300 - 0 168,300 -
- 46,200 - 0 46,200 -
- 45,560 - 0 45,560 -
- 42,350 - 0 42,350 -
- 20,454 - 0 20,454 -
- 4,438 - 0 4,438 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 285,000 - 0 285,000 -
- 695,752 - 0 695,752 -
- 412 - 0 412 -
- 286 - 0 286 -
- 497 - 0 497 -
- - - 0 - -
- - - 0 - -
- 1,093 - 0 1,093 -
- 848 - 6 848 5,090
- 990 - 200 990 198,000
- - - 0 - -
- 1,038 - 0 1,038 -
- 848 - 0 848 -
65,000 650 - 100 650 65,000
- - - 0 - -
- 1,038 - 0 1,038 -
- 36 848 30,537 0 848 -
- 9 792 7,128 91 792 72,072
- - - 0 - -
- 1,038 - 0 1,038 -
- 9 979 8,809 377 979 368,989
- - - 0 - -
- 2,099 - 0 2,099 -
- 11 2,100 23,100 56 2,100 117,600
- 2,099 - 200 2,099 419,800
- - - 0 - -
- 2,099 - 0 2,099 -
- 2,100 - 0 2,100 -
- 21 2,099 44,079 79 2,099 165,821
- - - 0 - -
- 6,400 - 0 6,400 -
- 1 25,920 25,920 40 25,920 1,036,800
- 6,400 - 48 6,400 307,200
- - - 0 - -
- 5,900 - 0 5,900 -
- 27,000 - 0 27,000 -
- 5 5,900 29,500 27 5,900 159,300
- - - 0 - -
- 6,595 - 0 6,595 -
- 11,990 - 0 11,990 -
- - - 0 - -
- 6,595 - 0 6,595 -
- - - 0 - -
- - - 0 - -
- 4,250 - 0 4,250 -
- 7,684 - 0 7,684 -
599,500 28 11,990 335,720 50 11,990 599,500
- - - 0 - -
- 4,250 - 0 4,250 -
- 7,684 - 0 7,684 -
- 23 11,990 275,770 35 11,990 419,650
- - - 0 - -
- 3,500 - 0 3,500 -
- 13 4,176 54,288 2 4,176 8,352
- 9,900 - 25 9,900 247,500
- - - 0 - -
- 4,000 - 0 4,000 -
- 4,568 - 2 4,568 9,136
- 9,900 - 8 9,900 79,200
- - - 0 - -
- 7,937 - 0 7,937 -
- 7,018 - 0 7,018 -
- - - 0 - -
- 6,600 - 0 6,600 -
- 1 20,900 20,900 19 20,900 397,100
- - - 0 - -
- 7,787 - 0 7,787 -
- 1 7,787 7,787 35 7,787 272,545
- 7,018 - 20 7,018 140,360
- - - 0 - -
- 7,787 - 0 7,787 -
- 10 7,937 79,370 28 7,937 222,236
- 7,018 - 0 7,018 -
- - - 0 - -
- 5 7,787 38,935 26 7,787 202,462
- 7,018 - 20 7,018 140,360
- - - 0 - -
- 10,440 - 0 10,440 -
- 8,000 - 0 8,000 -
- - - 0 - -
- 8,495 - 0 8,495 -
- 10,440 - 0 10,440 -
- 8,000 - 0 8,000 -
- - - 0 - -
- 8,495 - 0 8,495 -
- 10,440 - 0 10,440 -
- 8,000 - 0 8,000 -
- - - 0 - -
- 495 - 0 495 -
- 10,440 - 8 10,440 83,520
- 8,000 - 0 8,000 -
- - - 0 - -
- 7,500 - 0 7,500 -
- 27,821 - 0 27,821 -
- 24,000 - 4 24,000 96,000
- - - 0 - -
- 17,250 - 9 17,250 155,250
- - - 0 - -
- 800 - 0 800 -
- - - 0 - -
- 887 - 0 887 -
- 1,100 - 0 1,100 -
- - - 0 - -
- 607 - 0 607 -
- 6,121 - 0 6,121 -
- 4 2,300 9,200 30 2,300 69,000
- - - 0 - -
- 887 - 0 887 -
- 3,800 - 0 3,800 -
- - - 0 - -
- 1,871 - 0 1,871 -
- 5,621 - 0 5,621 -
- 1,800 - 0 1,800 -
- - - 0 - -
- 8,600 - 0 8,600 -
- 11,724 - 0 11,724 -
- 7,900 - 0 7,900 -
- - - 0 - -
- 10,467 - 0 10,467 -
- 13,221 - 0 13,221 -
- 9,400 - 0 9,400 -
- - - 0 - -
- - - 0 - -
- 137,025 - 0 137,025 -
- 104,500 - 0 104,500 -
- - - 0 - -
- 55,200 - 0 55,200 -
- 133,821 - 0 133,821 -
- 1 130,000 130,000 1 130,000 130,000
- - - 0 - -
- 32,500 - 0 32,500 -
- - - 0 - -
- 23,625 - 0 23,625 -
- 3 23,625 70,875 7 23,625 165,375
- - - 0 - -
- 5,082 - 0 5,082 -
- 18 18,781 338,058 10 18,781 187,810
- 5,082 - 0 5,082 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 4,000 - 0 4,000 -
- - - 0 - -
- 5,770 - 0 5,770 -
- 5,770 - 300 5,770 1,731,000
- - - 0 - -
- 2 5,770 11,540 57 5,770 328,890
- 5,770 - 199 5,770 1,148,230
- - - 0 - -
- 5,770 - 0 5,770 -
- 5,770 - 230 5,770 1,327,100
- - - 0 - -
- 5,770 - 0 5,770 -
- - - 0 - -
- 22,000 - 0 22,000 -
- - - 0 - -
- 22,000 - 0 22,000 -
- - - 0 - -
- 1,125 - 0 1,125 -
56,250 65 1,125 73,125 4 1,125 4,500
- - - 0 - -
- 200,455 - 0 200,455 -
- 8,018 - 75 8,018 601,350
- - - 0 - -
- 68,181 - 0 68,181 -
- - - 0 - -
- 68,181 - 0 68,181 -
- - - 0 - -
- 6,825 - 0 6,825 -
- 3,413 - 0 3,413 -
Penanggung Jawab
Laporan
Wa Ode Wahyuni Hambe, S. Si, Apt
Nip. 19870305 201101 2 019
REKAPAN PENGGUNAAN OBAT DAN PERBEK
PUSKESMAS SELAMA 1 TAHUN
TAHUN 2016
1 Air untuk injeksi amp 25 ml (aqua pro injeksi) Ampul 0 6,050 - 6,050
0 - - -
790 78 61,620 78
0 - - -
Antasida, kombinasi : aluminium hidroksida
18 200 mg + magnesium hidroksida 200 mg Botol 0 2,213 - 2,213
Suspensi
0 2,213 - 50 2,213
0 - - -
Antibakteri, kombinasi : basitrasin 500 UI/g+
19 Tube 0 2,767 - 2,767
Polimiskin B 10.000 UI/g
Antifungi salep, kombinasi : asam benzoat 6% 0 - - -
+ asam salisilat 3%
20 Tube 50 2,096 104,800 2,096
0 - - -
mg + heksaklorofen 2,5 mg + lidokain
lidokain 10 mg+ seng oksida 120 mg + sup
21 ad 2 g Suppo 0 33,000 - 33,000
0 2,200 - 2,200
42 33,000 1,386,000 33,000
0 - - -
Anti Parkinson kombinasi : benzerasid 25 mg +
22 Kaps 0 1,650 - 1,650
levodopa 100 mg
0 - - -
Anti Migren, kombinasi : ergotamin 1 mg+
23 Tab 0 149 - 149
kafein 50 mg
481 149 71,669 149
0 - - -
24 Antalgin (metampirom) tablet 100 mg Tab 0 155 - 155
0 - - -
25 Antalgin (metampirom) injeksi 250 mg/ml-2 ml Ampul 0 1,346 - 1,346
0 - - -
26 Asam asetilsalisilat (asetosal) tab 100 mg Tab 30 110 3,300 110
1100 127 139,700 127
0 110 - 110
0 - - -
27 Asam asetilsalisilat (asetosal) tab 500 mg Tab 0 178 - 178
0 - - -
Asam asetilsalisilat (asetosal) tab 80 mg
28 Tab 0 163 - 163
(Miniaspi 80)
0 - - -
29 Asam askorbat (vitamin C) tab 50 mg Tab 0 105 - 105
1960 105 205,800 105
0 - - -
30 Asam folat tab 1 mg Tab 0 52 - 52
200 52 10,400 52
0 - - -
31 Asam mefenamat kaps 250 mg Kaps 0 - - -
0 - - -
32 Asam mefenamat kaps 500 mg Kaps 0 127 - 127
2030 127 257,810 127
0 - - -
33 Asam traneksamat inj 50 mg/ml Ampul 25 3,650 91,250 3,650
0 - - -
0 - - -
0 2,367 - 2,367
0 - - -
37 Asiklovir tab 200 mg Tab 0 251 - 251
220 251 55,220 251
0 - - -
38 Atropin inj 0,25 mg/ml (i.m./i.v./s.k) Ampul 29 1,400 40,600 1,400
0 - - -
39 Atropin tab 0,5 mg Tab 0 81 - 81
0 - - -
0 - - -
41 Bedak salisil serb 2% Botol 0 1,180 - 1,180
3 1,350 4,050 1,350
0 1,180 - 25 1,180
0 - - -
Besi (II) sulfat 200 mg + asam folat 0.25 mg
42 Sachet 0 73 - 73
(tablet tambah darah)
0 55 - 55
640 2,200 1,408,000 2,200
0 - - -
43 Becefort syrup Botol 0 22,727 - 22,727
4 22,727 90,908 22,727
0 - - -
44 Betametason krim 0,1% Tube 0 1,596 - 1,596
47 1,596 75,012 1,596
0 - - -
45 Betahistin mesilate tablet tablet 90 600 54,000 600
0 - - -
46 Bisakodil sup 10 mg (Stolax) Botol 0 - - -
0 - - -
47 Bisakodil tab sal 5 mg Tab sal 0 - - -
0 - - -
48 Bismecon salep tube 0 - - -
0 - - -
Budesonid-formoterol (fixed combination)* ih
49 Botol 0 - - -
80/4,5 mcg
0 - - -
50 Bromheksin tablet tablet 0 42 - 42
0 - - -
51 Deksametason tab 0,5 mg Tab 0 68 - 68
40 68 2,720 700 68
0 - - -
52 Deksametason inj 5 mg/ml (i.v./i.m.) Vial 168 1,738 291,984 1,738
0 - - -
53 Desoksimetason salep 0,25% Tube 0 - - -
8 9,983 79,864 9,983
0 - - -
54 Diazepam inj 5 mg/ml (i.v./i.m.) Vial 0 2,578 - 2,578
51 2,578 131,478 2,578
0 - - -
0 - - -
56 Diazepam supposutoria suppo 0 - - -
0 - - -
57 Diazepam tab 2 mg Tab 0 28 - 28
0 - - -
58 Diazepam tab 5 mg Tab 0 28 - 28
0 - - -
59 Dietilkarbamazin tab 100 mg Tab 0 - - -
0 - - -
60 Difenhidramin inj 10 mg/ml (i.v./i.m.) Ampul 74 1,160 85,840 1,160
0 - - -
61 Digoksin tab 0,25 mg Tab 500 103 51,500 103
0 - - -
62 Diltiazem kaps SR 100 mg Kaps 0 - - -
0 - - -
63 Diltiazem tab 30 mg Tab 0 141 - 141
560 141 78,960 141
0 - - -
64 Doksisiklin tablet 100 mg Tab 160 278 44,528 278
0 - - -
65 Domperidon susp 5 mg/5 ml Botol 0 3,490 - 3,490
46 3,490 160,540 3,490
0 - - -
66 Domperidon tab 10 mg Tab 0 174 - 174
492 174 85,608 174
0 - - -
67 Efedrin HCl tablet Tab 0 56 - 56
540 56 30,451 56
0 - - -
68 Ekstrak belladon tablet 10 mg tab 0 42 - 42
3160 42 132,720 42
0 - - -
69 Epinefrin (adrenalin) inj 0,1% (i.v./s.k./i.m.) Ampul 120 8,910 1,069,200 8,910
0 - - -
70 Eritromisin kaps 250 mg Kaps 820 522 428,040 522
0 522 - 522
0 - - -
71 Eritromisin sir 200 mg/5 ml Botol 24 7,581 181,944 7,581
0 - - -
72 Eritromisin tab 500 mg Tab 465 1,013 470,938 1,013
0 1,023 - 1,023
0 - - -
73 Etanol 70% cairan 70% Botol 0 2,625 - 2,625
0 2,625 - 2,625
33 2,625 86,625 1 2,625
0 - - -
74 Etakridin (rivanol) larutan 0.1% Botol 0 4,695 - 4,695
3 4,695 14,085 4,695
0 - - -
75 Etil klorida semprot 100 ml Botol 0 124 - 124
0 - - -
76 Famotidin tablet 20 mg Tab 0 - - -
0 124 - 124
0 - - -
77 Fenitoin Na inj 50 mg/ml Ampul 0 - - -
0 - - -
78 Fenitoin Na kaps 100 mg Kaps 0 - - -
100 146 14,600 146
0 - - -
79 Fenobarbital inj 50 mg/ml Ampul 0 37 - 37
90 1,980 178,200 1,980
0 - - -
80 Fenobarbital tab 100 mg Tab 0 - - -
0 - - -
81 Fenobarbital tab 30 mg Tab 0 37 - 37
0 - - -
0 - - -
83 Fitomenadion (vitamin K 1) tab sal 10 mg Tab sal 0 698 - 698
0 - - -
84 Flukonazol kaps 150 mg Kaps 0 - - -
0 - - -
85 Flusinolon asetonid krim 0,025% Tube 0 - - -
0 - - -
86 Flunarizin tablet tablet 0 2,012 - 2,012
0 - - -
87 Furosemid inj 10 mg/ml (i.v./i.m.) Ampul 59 2,012 118,708 2,012
0 - - -
88 Furosemid tab 40 mg Tab 0 84 - 84
310 84 26,040 84
0 - - -
Garam oralit kombinasi : natrium klorida 0,52
g + kalium klorida 0,30 g + trinatrium sitrat
89 Sachet 0 317 - 317
0,58 g + glukosa anhidrat 2,7 g
0 - - -
Kotrimoksazol (dewasa) kombinasi :
sulfametoksazol 400 mg+ trimetoprim 80
144 Tab 433 152 65,816 152
mg
1380 79 109,020 79
0 - - -
Kotrimoksazol (dewasa) kombinasi tiap 5 ml
146 suspensi : sulfametoksazol 200 mg + Botol 15 2,298 34,470 2,298
trimetoprim 40 mg
0 - - -
147 Kuinin inj 25% (i.v.) Vial 0 6,820 - 6,820
0 6,820 - 6,820
0 - - -
148 Kloroquin tab 150 mg Tab 0 112 - 112
0 - - -
149 Lansoprazol kaps 30 mg Kaps 0 - - -
0 - - -
150 Levofloksasin tab 500 mg Tab 0 581 - 581
0 - - -
151 Lidokain gel 2% Tube 0 - - -
0 - - -
152 Lidokain inj 2% (hcl) Vial 0 1,499 - 1,499
0 1,499 - 1,499
80 929 74,320 929
0 - - -
153 Lisol Botol 0 54,995 - 54,995
0 54,995 - 54,995
0 - - -
154 Loperamid tab 2 mg Tab 0 97 - 97
1965 97 190,605 97
0 - - -
155 Loratadin tab 10 mg Tab 50 170 8,500 170
0 - - -
156 Magnesium sulfat inj 20% Vial 0 7,260 - 7,260
0 7,260 - 7,260
0 - - -
157 Magnesium sulfat inj 40% Vial 0 7,260 - 7,260
18 7,260 130,680 7,260
0 - - -
158 Magnesium sulfat serb, ktg 30 g Sachet 0 1,130 - 1,130
0 - - -
159 Mebendazol sir 50 mg/ml Botol 0 3,887 - 3,887
0 - - -
160 Mebendazol tab 100 mg Tan 0 248 - 248
0 - - -
161 Metformin tab 500 mg Tab 200 125 25,000 125
0 - - -
162 Metformin tab 850 mg Tab 0 - - -
0 - - -
163 Metilergometrin inj 0,2 mg/ml Ampul 0 1,639 - 1,639
0 - - -
164 Metilergometrin tab salut 0,125 mg Tab sal 150 133 19,965 133
0 - - -
165 Metilprednisolon tab 4 mg Tab 0 - - -
0 - - -
166 Metoklopramid inj 5 mg/ml Vial 0 1,100 - 1,100
0 1,100 - 1,100
0 - - -
0 - - -
168 Metoklopramid tab 10 mg Tab 172 100 17,200 100
0 - - -
169 Metronidazol supposutoria 500 mg suppo 0 - - -
0 - - -
170 Metronidazol larutan infus Botol 0 12,980 - 12,980
7 12,980 90,860 12,980
0 - - -
171 Metronidazol tab 250 mg Tab 0 116 - 116
590 116 68,440 116
0 - - -
172 Metronidazol tab 500 mg Tab 0 - - -
750 169 126,750 169
0 - - -
173 Mikonazol krim 2% Tube 0 3,150 - 3,150
17 3,150 53,550 3,150
0 - - -
174 Natrium diklofenak tab 25 mg Tab 0 146 - 146
470 146 68,620 146
0 - - -
175 Natrium diklofenak tab 50 mg Tab 0 193 - 193
650 193 125,450 193
0 - - -
176 NaCl 0,9% Larutan infus Botol 0 5,170 - 5,170
16 5,170 82,720 20 5,170
0 - - -
177 Nifedipin kaps 10 mg Kaps 0 127 - 127
730 127 92,710 127
0 - - -
178 Nistatin tab salut 500.000 UI Tab 0 704 - 704
800 704 563,200 704
0 - - -
179 Nistatin tab vaginal 100.000 UI Tab 0 448 - 448
0 - - -
180 Obat Batuk Hitam (OBH) Botol 0 2,310 - 2,310
50 2,310 115,500 2,310
0 - - -
181 Ofloksasin tab 200 mg Tab 150 440 66,000 440
0 - - -
182 Ofloksasin tab 400 mg Tab 0 700 - 700
140 700 98,000 700
0 - - -
183 Oksitetrasiklin hcl inj 500 mg/ml Vial 0 3,410 - 3,410
0 - - -
184 Oksitetrasiklin hcl salep kulit 3% Tube 0 2,010 - 2,010
4 1,646 6,584 1,646
0 - - -
185 Oksitetrasiklin hcl salep mata 1 % Tube 0 2,772 - 2,772
127 2,772 352,044 2,772
0 - - -
186 Oksitosin inj 10 UI/ml Ampul 0 6,875 - 6,875
0 1,900 - 1,900
23 6,875 158,125 6,875
0 - - -
187 Omeprazol kaps 20 mg Kaps 0 221 - 221
230 221 50,830 221
0 - - -
188 Papaverin tablet 40 mg Tab 0 109 - 109
410 109 44,690 109
0 - - -
189 Parasetamol sir 120 mg/5 ml Botol 0 1,535 - 1,535
66 1,535 101,310 1,535
0 - - -
190 Parasetamol tab 100 mg Tab 0 105 - 105
0 105 - 105
0 - - -
191 Parasetamol tab 500 mg Tab 0 88 - 88
1630 88 143,440 88
0 - - -
192 Parasetamol rectal suppo 0 - - -
0 - - -
193 Pehavral tablet multivitamin Tab 0 849 - 849
0 297 - 297
0 - - -
230 Sianokobalamin (vitamin B12) inj 500 mcg/ml Vial 37 1,451 53,673 1,451
0 - - -
0 - - -
232 Simetidin tablet 200 mg Tab 0 138 - 138
630 138 86,940 138
0 - - -
233 Simvastatin tab sal 10 mg Tab sal 0 177 - 177
0 - - -
234 Simvastatin tab sal 20 mg Tab sal 0 480 - 480
0 - - -
235 Siprofloksasin inf 2 mg/ml Botol 0 - - -
0 - - -
236 Siprofloksasin tab scored 500 mg Tab 700 312 218,680 312
0 - - -
237 Spironolakton tab 100 mg Tab 0 - - -
200 350 70,000 350
0 - - -
238 Sulfasetamid Natrium Tetes mata 1.5% Botol 0 - - -
0 - - -
239 Sukralfat susp 500 mg/5 ml (Ulsafate) Botol 0 - - -
0 - - -
240 Sukralfat tab 500 mg (Ulsidex) Tab 0 - - -
400 477 190,800 477
0 - - -
241 Teofilin tab SR 300 mg (Rethapyl) Tab 0 - - -
100 1,155 115,500 1,155
0 - - -
242 Tetrasiklin kaps 250 mg Kaps 0 183 - 183
0 - - -
243 Tetrasiklin kaps 500 mg Kaps 0 283 - 283
0 - - -
0 42 - 42
0 - - -
245 Tiamin (vitamin B1) injeksi 100 mg/ml Tab 0 770 - 770
0 - - -
246 Tramadol inj 50 mg/ml Ampul 0 2,680 - 2,680
0 - - -
247 Tramadol tablet 500 mg Tab 592 363 214,896 363
0 - - -
248 Triheksifenidil tab 2 mg Tab 0 45 - 45
160 45 7,200 45
0 - - -
249 Vitamin B12 tablet 50 mcg Tab 0 63 - 63
0 - - -
250 Vitamin B kompleks injeksi Vial 89 7,392 657,888 7,392
0 - - -
251 Vitamin B kompleks Tab 0 112 - 112
2420 112 271,040 112
0 - - -
252 Zinc tab disp 20 mg Tab 0 521 - 521
0 521 - 521
0 - - -
253 Zinc sirup 20 mg / 5 ml Botol 0 8,140 - 8,140
5 8,140 40,700 8,140
0 - - -
254 Larutan PK botol 0 573 - 573
0 6,975 - 6,975
0 - - -
255 Kanamisin inj Vial 47 10,395 488,565 10,395
0 - - -
256 Antalgin 500mg tab 0 155 - 155
1000 141 141,000 141
0 - - -
257 Klorpromazin inj 25 mg/ml (i.m.) Ampul 0 - - -
0 1,210 - 1,210
0 - - -
0 - - -
11,682,097
66,493,502
Mengetahui
Kepala Puskesmas Rumbia
Rahmat, AMK
Nip. 19721021 199403 1 004
N OBAT DAN PERBEKES
LAMA 1 TAHUN
N 2016
BULAN : DESEMBER
TAHUN : 2016
- 6,050 - 0 6,050 -
- 1,499 - 0 1,499 -
- - - 0 - -
- 78 - 0 78 -
- 2,213 - 0 2,213 -
- 2,767 - 0 2,767 -
- - - 0 - -
- - - 0 - -
- 33,000 - 0 33,000 -
- 2,200 - 0 2,200 -
- 6 33,000 198,000 36 33,000 1,188,000
- - - 0 - -
- 1,650 - 0 1,650 -
- - - 0 - -
- 149 - 0 149 -
- 1,265 - 0 1,265 -
- - - 0 - -
- 15,900 - 0 15,900 -
- 9,000 - 0 9,000 -
- - - 0 - -
- 2,367 - 0 2,367 -
- - - 0 - -
- 251 - 0 251 -
- 251 - 220 251 55,220
- - - 0 - -
- 1,400 - 29 1,400 40,600
- - - 0 - -
- 81 - 0 81 -
- - - 0 - -
- 13,500 - 0 13,500 -
- - - 0 - -
- 1,180 - 0 1,180 -
- 3 1,350 4,050 0 1,350 -
29,500 3 1,180 3,540 22 1,180 25,960
- - - 0 - -
- 73 - 0 73 -
- 55 - 0 55 -
- 640 2,200 1,408,000 0 2,200 -
- - - 0 - -
- 22,727 - 0 22,727 -
- 22,727 - 4 22,727 90,908
- - - 0 - -
- 1,596 - 0 1,596 -
- 24 1,596 38,304 23 1,596 36,708
- - - 0 - -
- 10 600 6,000 80 600 48,000
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 42 - 0 42 -
- - - 0 - -
- 68 - 0 68 -
47,600 170 68 11,560 570 68 38,760
- - - 0 - -
- 1,738 - 168 1,738 291,984
- - - 0 - -
- - - 0 - -
- 9,983 - 8 9,983 79,864
- - - 0 - -
- 2,578 - 0 2,578 -
- 50 2,578 128,900 1 2,578 2,578
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 28 - 0 28 -
- - - 0 - -
- 28 - 0 28 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 1 1,160 1,160 73 1,160 84,680
- - - 0 - -
- 103 - 500 103 51,500
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 141 - 0 141 -
- 190 141 26,790 370 141 52,170
- - - 0 - -
- 278 - 160 278 44,528
- - - 0 - -
- 3,490 - 0 3,490 -
- 15 3,490 52,350 31 3,490 108,190
- - - 0 - -
- 174 - 0 174 -
- 59 174 10,266 433 174 75,342
- - - 0 - -
- 56 - 0 56 -
- 56 - 540 56 30,451
- - - 0 - -
- 42 - 0 42 -
- 3160 42 132,720 0 42 -
- - - 0 - -
- - - 0 - -
- 522 - 820 522 428,040
- 522 - 0 522 -
- - - 0 - -
- 7,581 - 24 7,581 181,944
- - - 0 - -
- 1,013 - 465 1,013 470,938
- 1,023 - 0 1,023 -
- - - 0 - -
- 2,625 - 0 2,625 -
- 2,625 - 0 2,625 -
2,625 4 2,625 10,500 30 2,625 78,750
- - - 0 - -
- 4,695 - 0 4,695 -
- 4,695 - 3 4,695 14,085
- - - 0 - -
- 124 - 0 124 -
- - - 0 - -
- - - 0 - -
- 124 - 0 124 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 146 - 100 146 14,600
- - - 0 - -
- 37 - 0 37 -
- 1,980 - 90 1,980 178,200
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 37 - 0 37 -
- - - 0 - -
- - - 0 - -
- 698 - 0 698 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 2,012 - 0 2,012 -
- - - 0 - -
- 2,012 - 59 2,012 118,708
- - - 0 - -
- 84 - 0 84 -
- 9 84 756 301 84 25,284
- - - 0 - -
- 317 - 0 317 -
- - - 0 - -
- 5,990 - 0 5,990 -
- - - 0 - -
- 79 - 0 79 -
- 79 - 1380 79 109,020
- - - 0 - -
- - - 0 - -
- 6,820 - 0 6,820 -
- 6,820 - 0 6,820 -
- - - 0 - -
- 112 - 0 112 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 581 - 0 581 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 1,499 - 0 1,499 -
- 1,499 - 0 1,499 -
- 53 929 49,237 27 929 25,083
- - - 0 - -
- 54,995 - 0 54,995 -
- 54,995 - 0 54,995 -
- - - 0 - -
- 97 - 0 97 -
- 153 97 14,841 1812 97 175,764
- - - 0 - -
- 170 - 50 170 8,500
- - - 0 - -
- 7,260 - 0 7,260 -
- 7,260 - 0 7,260 -
- - - 0 - -
- 7,260 - 0 7,260 -
- 7,260 - 18 7,260 130,680
- - - 0 - -
- 1,130 - 0 1,130 -
- - - 0 - -
- 3,887 - 0 3,887 -
- - - 0 - -
- 248 - 0 248 -
- - - 0 - -
- 30 125 3,750 170 125 21,250
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 1,639 - 0 1,639 -
- - - 0 - -
- 133 - 150 133 19,965
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 1,100 - 0 1,100 -
- 1,100 - 0 1,100 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 100 - 172 100 17,200
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 12,980 - 0 12,980 -
- 12,980 - 7 12,980 90,860
- - - 0 - -
- 116 - 0 116 -
- 330 116 38,280 260 116 30,160
- - - 0 - -
- - - 0 - -
- 169 - 750 169 126,750
- - - 0 - -
- 3,150 - 0 3,150 -
- 1 3,150 3,150 16 3,150 50,400
- - - 0 - -
- 146 - 0 146 -
- 106 146 15,476 364 146 53,144
- - - 0 - -
- 193 - 0 193 -
- 500 193 96,500 150 193 28,950
- - - 0 - -
- 5,170 - 0 5,170 -
103,400 8 5,170 41,360 28 5,170 144,760
- - - 0 - -
- 127 - 0 127 -
- 127 - 730 127 92,710
- - - 0 - -
- 704 - 0 704 -
- 704 - 800 704 563,200
- - - 0 - -
- 448 - 0 448 -
- - - 0 - -
- 2,310 - 0 2,310 -
- 8 2,310 18,480 42 2,310 97,020
- - - 0 - -
- 440 - 150 440 66,000
- - - 0 - -
- 700 - 0 700 -
- 700 - 140 700 98,000
- - - 0 - -
- 3,410 - 0 3,410 -
- - - 0 - -
- 2,010 - 0 2,010 -
- 3 1,646 4,938 1 1,646 1,646
- - - 0 - -
- 2,772 - 0 2,772 -
- 13 2,772 36,036 114 2,772 316,008
- - - 0 - -
- 6,875 - 0 6,875 -
- 1,900 - 0 1,900 -
- 5 6,875 34,375 18 6,875 123,750
- - - 0 - -
- 221 - 0 221 -
- 230 221 50,830 0 221 -
- - - 0 - -
- 109 - 0 109 -
- 190 109 20,710 220 109 23,980
- - - 0 - -
- 1,535 - 0 1,535 -
- 50 1,535 76,750 16 1,535 24,560
- - - 0 - -
- 105 - 0 105 -
- 105 - 0 105 -
- - - 0 - -
- 88 - 0 88 -
- 530 88 46,640 1100 88 96,800
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 849 - 0 849 -
- 297 - 0 297 -
- - - 0 - -
- 25,350 - 0 25,350 -
- 2,344 - 0 2,344 -
- 15,386 - 0 15,386 -
- 40,202 - 0 40,202 -
- 1,980 - 0 1,980 -
- - - 0 - -
- 150 - 0 150 -
- - - 0 - -
- 138 - 0 138 -
- 220 138 30,360 410 138 56,580
- - - 0 - -
- 177 - 0 177 -
- - - 0 - -
- 480 - 0 480 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 312 - 700 312 218,680
- - - 0 - -
- - - 0 - -
- 350 - 200 350 70,000
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 477 - 400 477 190,800
- - - 0 - -
- - - 0 - -
- 1,155 - 100 1,155 115,500
- - - 0 - -
- 183 - 0 183 -
- - - 0 - -
- 283 - 0 283 -
- - - 0 - -
- 42 - 0 42 -
- - - 0 - -
- 770 - 0 770 -
- - - 0 - -
- 2,680 - 0 2,680 -
- - - 0 - -
- 363 - 592 363 214,896
- - - 0 - -
- 45 - 0 45 -
- 45 - 160 45 7,200
- - - 0 - -
- 63 - 0 63 -
- - - 0 - -
- 2 7,392 14,784 87 7,392 643,104
- - - 0 - -
- 112 - 0 112 -
- 840 112 94,080 1580 112 176,960
- - - 0 - -
- 521 - 0 521 -
- 521 - 0 521 -
- - - 0 - -
- 8,140 - 0 8,140 -
- 3 8,140 24,420 2 8,140 16,280
- - - 0 - -
- 573 - 0 573 -
- 6,975 - 0 6,975 -
- - - 0 - -
- 1 10,395 10,395 46 10,395 478,170
- - - 0 - -
- 155 - 0 155 -
- 141 - 1000 141 141,000
- - - 0 - -
- - - 0 - -
- 1,210 - 0 1,210 -
- - - 0 - -
- 57 - 0 57 -
- - - 0 - -
- 116 - 0 116 -
- 572 - 0 572 -
- - - 0 - -
- 191 - 100 191 19,100
- - - 0 - -
- 275 - 0 275 -
- 275 - 0 275 -
- - - 0 - -
- 162 - 0 162 -
- - - 0 - -
- 1,108 - 0 1,108 -
- 1,109 - 16 1,109 17,744
- - - 0 - -
- 162 - 0 162 -
- - - 0 - -
- 116 - 1000 116 115,500
- - - 0 - -
- 167 - 0 167 -
- - - 0 - -
- 125 - 0 125 -
- - - 0 - -
- 318 - 0 318 -
- - - 0 - -
- 109 - 0 109 -
- - - 0 - -
- 45 - 0 45 -
- - - 0 - -
- 854 - 0 854 -
- - - 0 - -
- 42,727 - 0 42,727 -
- 42,727 - 0 42,727 -
- - - 0 - -
- 1,480 - 0 1,480 -
- 110 1,480 162,800 435 1,480 643,800
- - - 0 - -
- 31 - 0 31 -
- - - 0 - -
- 56 - 0 56 -
- - - 0 - -
- - - 0 - -
- 765,000 - 0 765,000 -
- 765,000 - 2 765,000 1,530,000
- - - 0 - -
- 242,000 - 0 242,000 -
- - - 0 - -
- 338,800 - 0 338,800 -
- 338,800 - 2 338,800 677,600
- - - 0 - -
- 390,000 - 0 390,000 -
- 390,000 - 0 390,000 -
- - - 0 - -
- 18,333 - 0 18,333 -
- 18,333 - 1 18,333 18,333
- - - 0 - -
- 105,000 - 0 105,000 -
- 105,000 - 0 105,000 -
- - - 0 - -
- 170,000 - 0 170,000 -
- - - 0 - -
- 395,000 - 0 395,000 -
- 197,895 - 1 197,895 197,895
- - - 0 - -
- 55,000 - 1 55,000 55,000
- - - 0 - -
- 93,500 - 0 93,500 -
- 93,500 - 2 93,500 187,000
- - - 0 - -
- 34,000 - 0 34,000 -
- 34,000 - 0 34,000 -
- - - 0 - -
- 176,000 - 0 176,000 -
- - - 0 - -
- - - 0 - -
- 425 - 0 425 -
- 24,384 - 0 24,384 -
- 27,569 - 0 27,569 -
- 27,569 - 8 27,569 220,552
- - - 0 - -
- 104 - 0 104 -
- 104 - 2000 104 208,000
- - - 0 - -
- 825,000 - 0 825,000 -
- 4,545 - 0 4,545 -
- 236,490 - 0 236,490 -
- 396,000 - 0 396,000 -
- 1,319,990 - 0 1,319,990 -
- 175,899 - 0 175,899 -
- 145,000 - 0 145,000 -
- 150,000 - 0 150,000 -
- 168,300 - 0 168,300 -
- 46,200 - 0 46,200 -
- 45,560 - 0 45,560 -
- 42,350 - 0 42,350 -
- 20,454 - 0 20,454 -
- 4,438 - 0 4,438 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 285,000 - 0 285,000 -
- 695,752 - 0 695,752 -
- 412 - 0 412 -
- 286 - 0 286 -
- 497 - 0 497 -
- - - 0 - -
- - - 0 - -
- 1,093 - 0 1,093 -
- 6 848 5,090 0 848 -
- 62 990 61,380 138 990 136,620
- - - 0 - -
- 1,038 - 0 1,038 -
- 848 - 0 848 -
- 6 650 3,900 94 650 61,100
- - - 0 - -
- 1,038 - 0 1,038 -
- 848 - 0 848 -
- 39 792 30,888 52 792 41,184
- - - 0 - -
- 1,038 - 0 1,038 -
- 7 979 6,851 370 979 362,138
- - - 0 - -
- 2,099 - 0 2,099 -
- 12 2,100 25,200 44 2,100 92,400
- 2,099 - 200 2,099 419,800
- - - 0 - -
- 2,099 - 0 2,099 -
- 2,100 - 0 2,100 -
- 5 2,099 10,495 74 2,099 155,326
- - - 0 - -
- 6,400 - 0 6,400 -
- 1 25,920 25,920 39 25,920 1,010,880
- 6,400 - 48 6,400 307,200
- - - 0 - -
- 5,900 - 0 5,900 -
- 27,000 - 0 27,000 -
- 5 5,900 29,500 22 5,900 129,800
- - - 0 - -
- 6,595 - 0 6,595 -
- 11,990 - 0 11,990 -
- - - 0 - -
- 6,595 - 0 6,595 -
- - - 0 - -
- - - 0 - -
- 4,250 - 0 4,250 -
- 7,684 - 0 7,684 -
- 6 11,990 71,940 44 11,990 527,560
- - - 0 - -
- 4,250 - 0 4,250 -
- 7,684 - 0 7,684 -
- 35 11,990 419,650 0 11,990 -
- - - 0 - -
- 3,500 - 0 3,500 -
- 2 4,176 8,352 0 4,176 -
- 2 9,900 19,800 23 9,900 227,700
- - - 0 - -
- 4,000 - 0 4,000 -
- 1 4,568 4,568 1 4,568 4,568
- 9,900 - 8 9,900 79,200
- - - 0 - -
- 7,937 - 0 7,937 -
- 7,018 - 0 7,018 -
- - - 0 - -
- 6,600 - 0 6,600 -
- 1 20,900 20,900 18 20,900 376,200
- - - 0 - -
- 7,787 - 0 7,787 -
- 7,787 - 35 7,787 272,545
- 7,018 - 20 7,018 140,360
- - - 0 - -
- 7,787 - 0 7,787 -
- 7,937 - 28 7,937 222,236
- 7,018 - 0 7,018 -
- - - 0 - -
- 7,787 - 26 7,787 202,462
- 7,018 - 20 7,018 140,360
- - - 0 - -
- 10,440 - 0 10,440 -
- 8,000 - 0 8,000 -
- - - 0 - -
- 8,495 - 0 8,495 -
- 10,440 - 0 10,440 -
- 8,000 - 0 8,000 -
- - - 0 - -
- 8,495 - 0 8,495 -
- 10,440 - 0 10,440 -
- 8,000 - 0 8,000 -
- - - 0 - -
- 495 - 0 495 -
- 10,440 - 8 10,440 83,520
- 8,000 - 0 8,000 -
- - - 0 - -
- 7,500 - 0 7,500 -
- 27,821 - 0 27,821 -
- 24,000 - 4 24,000 96,000
- - - 0 - -
- 1 17,250 17,250 8 17,250 138,000
- - - 0 - -
- 800 - 0 800 -
- - - 0 - -
- 887 - 0 887 -
- 1,100 - 0 1,100 -
- - - 0 - -
- 607 - 0 607 -
- 6,121 - 0 6,121 -
- 10 2,300 23,000 20 2,300 46,000
- - - 0 - -
- 887 - 0 887 -
- 3,800 - 0 3,800 -
- - - 0 - -
- 1,871 - 0 1,871 -
- 5,621 - 0 5,621 -
- 1,800 - 0 1,800 -
- - - 0 - -
- 8,600 - 0 8,600 -
- 11,724 - 0 11,724 -
- 7,900 - 0 7,900 -
- - - 0 - -
- 10,467 - 0 10,467 -
- 13,221 - 0 13,221 -
- 9,400 - 0 9,400 -
- - - 0 - -
- - - 0 - -
- 137,025 - 0 137,025 -
- 104,500 - 0 104,500 -
- - - 0 - -
- 55,200 - 0 55,200 -
- 133,821 - 0 133,821 -
390,000 130,000 - 4 130,000 520,000
- - - 0 - -
- 32,500 - 0 32,500 -
- - - 0 - -
- 23,625 - 0 23,625 -
- 2 23,625 47,250 5 23,625 118,125
- - - 0 - -
- 5,082 - 0 5,082 -
- 2 18,781 37,562 8 18,781 150,248
- 5,082 - 0 5,082 -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- - - 0 - -
- 4,000 - 0 4,000 -
- - - 0 - -
- 5,770 - 0 5,770 -
- 5,770 - 300 5,770 1,731,000
- - - 0 - -
- 12 5,770 69,240 45 5,770 259,650
- 5,770 - 199 5,770 1,148,230
- - - 0 - -
- 5,770 - 0 5,770 -
- 5,770 - 230 5,770 1,327,100
- - - 0 - -
- 5,770 - 0 5,770 -
- - - 0 - -
- 22,000 - 0 22,000 -
- - - 0 - -
- 22,000 - 0 22,000 -
- - - 0 - -
- 1,125 - 0 1,125 -
- 4 1,125 4,500 0 1,125 -
- - - 0 - -
- 200,455 - 0 200,455 -
- 8,018 - 75 8,018 601,350
- - - 0 - -
- 68,181 - 0 68,181 -
- - - 0 - -
- 68,181 - 0 68,181 -
- - - 0 - -
- 6,825 - 0 6,825 -
- 3,413 - 0 3,413 -